
<html lang="en"     class="pb-page"  data-request-id="189d6b10-de62-4030-9419-24a273a17b0b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm070034i;issue:issue:10.1021/jmcmar.2007.50.issue-18;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Design, Synthesis, and Evaluation of Orally Active Benzimidazoles and Benzoxazoles as Vascular Endothelial Growth Factor-2 Receptor Tyrosine Kinase Inhibitors" /></meta><meta name="dc.Creator" content="Michele H.  Potashman,*,†" /></meta><meta name="dc.Creator" content="James  Bready,‡" /></meta><meta name="dc.Creator" content="Angela  Coxon,‡" /></meta><meta name="dc.Creator" content="Thomas M.  DeMelfi, Jr.,‡" /></meta><meta name="dc.Creator" content="Lucian  DiPietro,†" /></meta><meta name="dc.Creator" content="Nicholas  Doerr,‡" /></meta><meta name="dc.Creator" content="Daniel  Elbaum,†" /></meta><meta name="dc.Creator" content="Juan  Estrada,‡" /></meta><meta name="dc.Creator" content="Paul  Gallant,§" /></meta><meta name="dc.Creator" content="Julie  Germain,†" /></meta><meta name="dc.Creator" content="Yan  Gu,‖" /></meta><meta name="dc.Creator" content="Jean-Christophe  Harmange,†" /></meta><meta name="dc.Creator" content="Stephen A.  Kaufman,⊥" /></meta><meta name="dc.Creator" content="Rick  Kendall,‡" /></meta><meta name="dc.Creator" content="Joseph L.  Kim,‖" /></meta><meta name="dc.Creator" content="Gondi N.  Kumar,#" /></meta><meta name="dc.Creator" content="Alexander M.  Long,‖" /></meta><meta name="dc.Creator" content="Seshadri  Neervannan,○" /></meta><meta name="dc.Creator" content="Vinod F.  Patel,†" /></meta><meta name="dc.Creator" content="Anthony  Polverino,‡" /></meta><meta name="dc.Creator" content="Paul  Rose,‖" /></meta><meta name="dc.Creator" content="Simon  van der Plas,†" /></meta><meta name="dc.Creator" content="Douglas  Whittington,‖" /></meta><meta name="dc.Creator" content="Roger  Zanon,* and" /></meta><meta name="dc.Creator" content="Huilin  Zhao‖" /></meta><meta name="dc.Description" content="Inhibition of the VEGF signaling pathway has become a valuable approach in the treatment of cancers. Guided by X-ray crystallography and molecular modeling, a series of 2-aminobenzimidazoles and 2-..." /></meta><meta name="Description" content="Inhibition of the VEGF signaling pathway has become a valuable approach in the treatment of cancers. Guided by X-ray crystallography and molecular modeling, a series of 2-aminobenzimidazoles and 2-..." /></meta><meta name="dc.Publisher" content=" American Chemical Society " /></meta><meta name="dc.Date" scheme="WTN8601" content="August 15, 2007" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm070034i" /></meta><meta name="dc.Identifier" scheme="crossover-key" content="JMCMAr-50-18-4351" /></meta><meta name="dc.Identifier" scheme="pii" content="S0022-2623(07)00034-9" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2007 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm070034i" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm070034i" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm070034i" /></link>
        
    
    

<title>Design, Synthesis, and Evaluation of Orally Active Benzimidazoles and Benzoxazoles as Vascular Endothelial Growth Factor-2 Receptor Tyrosine Kinase Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm070034i" /></meta><meta property="og:title" content="Design, Synthesis, and Evaluation of Orally Active Benzimidazoles and Benzoxazoles as Vascular Endothelial Growth Factor-2 Receptor Tyrosine Kinase Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034in00001.jpeg" /></meta><meta property="og:description" content=" Inhibition of the VEGF signaling pathway has become a valuable approach in the treatment of cancers. Guided by X-ray crystallography and molecular modeling, a series of 2-aminobenzimidazoles and 2-aminobenzoxazoles were identified as potent inhibitors of VEGFR-2 (KDR) in both enzymatic and HUVEC cellular proliferation assays. In this report we describe the synthesis and structure−activity relationship of a series of 2-aminobenzimidazoles and benzoxazoles, culminating in the identification of benzoxazole 22 as a potent and selective VEGFR-2 inhibitor displaying a good pharmacokinetic profile. Compound 22 demonstrated efficacy in both the murine matrigel model for vascular permeability (79% inhibition observed at 100 mg/kg) and the rat corneal angiogenesis model (ED50 = 16.3 mg/kg).  " /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm070034i"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm070034i">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm070034i&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm070034i&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm070034i&amp;href=/doi/10.1021/jm070034i" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2007</span><span class="cit-fg-volume">, 50</span><span class="cit-fg-issue">, 18</span><span class="cit-fg-pageRange">, 4351-4373</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/50/18" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm061288r" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm070319v" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Design, Synthesis, and Evaluation of Orally Active Benzimidazoles and Benzoxazoles as Vascular Endothelial Growth Factor-2 Receptor Tyrosine Kinase Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michele+H.++Potashman">Michele H. Potashman</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=James++Bready">James Bready</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Angela++Coxon">Angela Coxon</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas+M.++DeMelfi%2C">Thomas M. DeMelfi,</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lucian++DiPietro">Lucian DiPietro</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicholas++Doerr">Nicholas Doerr</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Elbaum">Daniel Elbaum</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Juan++Estrada">Juan Estrada</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Gallant">Paul Gallant</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Julie++Germain">Julie Germain</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yan++Gu">Yan Gu</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jean-Christophe++Harmange">Jean-Christophe Harmange</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+A.++Kaufman">Stephen A. Kaufman</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rick++Kendall">Rick Kendall</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+L.++Kim">Joseph L. Kim</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gondi+N.++Kumar">Gondi N. Kumar</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alexander+M.++Long">Alexander M. Long</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Seshadri++Neervannan">Seshadri Neervannan</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vinod+F.++Patel">Vinod F. Patel</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anthony++Polverino">Anthony Polverino</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Rose">Paul Rose</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Simon++van+der+Plas">Simon van der Plas</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Douglas++Whittington">Douglas Whittington</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Roger++Zanon">Roger Zanon</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Huilin++Zhao">Huilin Zhao</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Department of Medicinal Chemistry, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Oncology Research, Pharmaceutics, and Pharmacokinetic Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="JMCMAr" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm070034i&amp;href=/doi/10.1021%2Fjm070034i" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2007</span></span><span class="cit-volume">, 50</span><span class="cit-issue">, 18</span><span class="cit-pageRange">, 4351–4373</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 15, 2007</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>10 January 2007</li><li><span class="item_label"><b>Published</b> online</span>15 August 2007</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 1 September 2007</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm070034i" title="DOI URL">https://doi.org/10.1021/jm070034i</a></div><div class="article_header-article-copyright"><strong>Copyright © 2007 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4351%26pageCount%3D23%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMichele%2BH.%2BPotashman%252C%2BJames%2BBready%252C%2BAngela%2BCoxon%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D50%26issueNum%3D18%26contentID%3Djm070034i%26title%3DDesign%252C%2BSynthesis%252C%2Band%2BEvaluation%2Bof%2BOrally%2BActive%2BBenzimidazoles%2Band%2BBenzoxazoles%2Bas%2BVascular%2BEndothelial%2BGrowth%2BFactor-2%2BReceptor%2BTyrosine%2BKinase%2BInhibitors%26numPages%3D23%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4373%26publicationDate%3DSeptember%2B2007">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm070034i"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">4706</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">110</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm070034i" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Design, Synthesis, and Evaluation of Orally Active Benzimidazoles and Benzoxazoles as Vascular Endothelial Growth Factor-2 Receptor Tyrosine Kinase Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Michele&quot;,&quot;last_name&quot;:&quot;H. Potashman&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;Bready&quot;},{&quot;first_name&quot;:&quot;Angela&quot;,&quot;last_name&quot;:&quot;Coxon&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;M. DeMelfi,&quot;},{&quot;first_name&quot;:&quot;Lucian&quot;,&quot;last_name&quot;:&quot;DiPietro&quot;},{&quot;first_name&quot;:&quot;Nicholas&quot;,&quot;last_name&quot;:&quot;Doerr&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Elbaum&quot;},{&quot;first_name&quot;:&quot;Juan&quot;,&quot;last_name&quot;:&quot;Estrada&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Gallant&quot;},{&quot;first_name&quot;:&quot;Julie&quot;,&quot;last_name&quot;:&quot;Germain&quot;},{&quot;first_name&quot;:&quot;Yan&quot;,&quot;last_name&quot;:&quot;Gu&quot;},{&quot;first_name&quot;:&quot;Jean-Christophe&quot;,&quot;last_name&quot;:&quot;Harmange&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;A. Kaufman&quot;},{&quot;first_name&quot;:&quot;Rick&quot;,&quot;last_name&quot;:&quot;Kendall&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;L. Kim&quot;},{&quot;first_name&quot;:&quot;Gondi&quot;,&quot;last_name&quot;:&quot;N. Kumar&quot;},{&quot;first_name&quot;:&quot;Alexander&quot;,&quot;last_name&quot;:&quot;M. Long&quot;},{&quot;first_name&quot;:&quot;Seshadri&quot;,&quot;last_name&quot;:&quot;Neervannan&quot;},{&quot;first_name&quot;:&quot;Vinod&quot;,&quot;last_name&quot;:&quot;F. Patel&quot;},{&quot;first_name&quot;:&quot;Anthony&quot;,&quot;last_name&quot;:&quot;Polverino&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Rose&quot;},{&quot;first_name&quot;:&quot;Simon&quot;,&quot;last_name&quot;:&quot;van der Plas&quot;},{&quot;first_name&quot;:&quot;Douglas&quot;,&quot;last_name&quot;:&quot;Whittington&quot;},{&quot;first_name&quot;:&quot;Roger&quot;,&quot;last_name&quot;:&quot;Zanon&quot;},{&quot;first_name&quot;:&quot;Huilin&quot;,&quot;last_name&quot;:&quot;Zhao&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2007&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;18&quot;,&quot;volume&quot;:&quot;50&quot;,&quot;pages&quot;:&quot;4351-4373&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm070034i&quot;},&quot;abstract&quot;:&quot;Inhibition of the VEGF signaling pathway has become a valuable approach in the treatment of cancers. Guided by X-ray crystallography and molecular modeling, a series of 2-aminobenzimidazoles and 2-aminobenzoxazoles were identified as potent inhibitors of VEGFR-2 (KDR) in both enzymatic and HUVEC cellular proliferation assays. In this report we describe the synthesis and structure−activity relationship of a series of 2-aminobenzimidazoles and benzoxazoles, culminating in the identification of benzoxazole 22 as a potent and selective VEGFR-2 inhibitor displaying a good pharmacokinetic profile. Compound 22 demonstrated efficacy in both the murine matrigel model for vascular permeability (79% inhibition observed at 100 mg/kg) and the rat corneal angiogenesis model (ED50 = 16.3 mg/kg).&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm070034i&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm070034i" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm070034i&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm070034i" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm070034i&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm070034i" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm070034i&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm070034i&amp;href=/doi/10.1021/jm070034i" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm070034i" /></input><a href="/doi/pdf/10.1021/jm070034i" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (673 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm070034i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm070034i%26sid%3Dliteratum%253Aachs%26pmid%3D17696416%26genre%3Darticle%26aulast%3DPotashman%26date%3D2007%26atitle%3DDesign%252C%2BSynthesis%252C%2Band%2BEvaluation%2Bof%2BOrally%2BActive%2BBenzimidazoles%2Band%2BBenzoxazoles%2Bas%2BVascular%2BEndothelial%2BGrowth%2BFactor-2%2BReceptor%2BTyrosine%2BKinase%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D50%26issue%3D18%26spage%3D4351%26epage%3D4373%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292529" title="Aromatic compounds">Aromatic compounds</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/50/18" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034in00001.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034in00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070034i&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Inhibition of the VEGF signaling pathway has become a valuable approach in the treatment of cancers. Guided by X-ray crystallography and molecular modeling, a series of 2-aminobenzimidazoles and 2-aminobenzoxazoles were identified as potent inhibitors of VEGFR-2 (KDR) in both enzymatic and HUVEC cellular proliferation assays. In this report we describe the synthesis and structure−activity relationship of a series of 2-aminobenzimidazoles and benzoxazoles, culminating in the identification of benzoxazole <b>22</b> as a potent and selective VEGFR-2 inhibitor displaying a good pharmacokinetic profile. Compound <b>22</b> demonstrated efficacy in both the murine matrigel model for vascular permeability (79% inhibition observed at 100 mg/kg) and the rat corneal angiogenesis model (ED<sub>50</sub> = 16.3 mg/kg). </p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec fnGroup"><div class="fnGroupItem" id="jm070034iAF1"><span><h4><span class="NLM_fn-symbol">*</span></h4></span><span><p class="last">  To whom correspondence should be addressed. Phone:  (617) 444-5010. Fax:  (617) 577-9822. E-mail:  <a href="/cdn-cgi/l/email-protection" class="__cf_email__" data-cfemail="1e73777d767b727b6e5e7f73797b70307d717330">[email protected]</a></p></span></div><div class="fnGroupItem" id="jm070034iAF2"><span><h4><span class="NLM_fn-symbol">†</span></h4></span><span><p class="last">  Department of Medicinal Chemistry.</p></span></div><div class="fnGroupItem" id="jm070034iAF3"><span><h4><span class="NLM_fn-symbol">‡</span></h4></span><span><p class="last">  Department of Cancer Biology.</p></span></div><div class="fnGroupItem" id="jm070034iAF4"><span><h4><span class="NLM_fn-symbol">§</span></h4></span><span><p class="last">  Department of HTS and Molecular Pharmacology.</p></span></div><div class="fnGroupItem" id="jm070034iAF5"><span><h4><span class="NLM_fn-symbol">‖</span></h4></span><span><p class="last">  Department of Molecular Structure.</p></span></div><div class="fnGroupItem" id="jm070034iAF6"><span><h4><span class="NLM_fn-symbol">⊥</span></h4></span><span><p class="last">  Department of Pathology.</p></span></div><div class="fnGroupItem" id="jm070034iAF10"><span><h4><span class="NLM_fn-symbol">#</span></h4></span><span><p class="last">  Department of Pharmacokinetics and Drug Metabolism.</p></span></div><div class="fnGroupItem" id="jm070034iAF9"><span><h4><span class="NLM_fn-symbol">○</span></h4></span><span><p class="last">  Department of Pharmaceutics.</p></span></div><div class="fnGroupItem" id="jm070034in00001"><span><h4></h4></span><span><p class="first last">Abbreviations:  VEGF, vascular endothelial growth factor; KDR, kinase insert domain receptor; HUVEC, human umbilical vein endothelial cells.</p></span></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68303" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68303" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Angiogenesis, the formation of new blood vessels from existing vasculature, is a normal physiological event that occurs during embryonic growth, wound healing and the menstrual cycle. Abnormal regulation of angiogenesis has been implicated in the pathogenesis of several disorders including diabetic retinopathy,<sup><a onclick="showRef(event, 'jm070034ib00001'); return false;" href="javascript:void(0);" class="ref jm070034ib00001">1</a></sup> rheumatoid arthritis,<sup><a onclick="showRef(event, 'jm070034ib00002'); return false;" href="javascript:void(0);" class="ref jm070034ib00002">2</a></sup> age-related macular degeneration,<sup><a onclick="showRef(event, 'jm070034ib00003'); return false;" href="javascript:void(0);" class="ref jm070034ib00003">3</a></sup> and cancer.<sup><a onclick="showRef(event, 'jm070034ib00004 jm070034ib00005'); return false;" href="javascript:void(0);" class="ref jm070034ib00004 jm070034ib00005">4,5</a></sup> As angiogenesis is required for tumor growth and metastasis, the concept of limiting the growth of a solid tumor by restricting the blood supply has been evaluated in human cancer and has proven successful.<sup><a onclick="showRef(event, 'jm070034ib00006'); return false;" href="javascript:void(0);" class="ref jm070034ib00006">6</a></sup></div><div class="NLM_p">Vascular endothelial growth factor (VEGF<i><sup>a</sup></i><sup></sup><a class="ref internalNav" href="#jm070034in00001" aria-label=""></a>) is a known promoter of angiogenesis, and the increased expression of VEGF has been implicated in tumor growth and metastasis.<sup>4,5</sup> VEGF signaling through its receptor tyrosine kinase VEGFR-2 (or KDR, kinase insert domain receptor) promotes several events required for the formation of new blood vessels, such as endothelial cell survival, proliferation, migration, and vascular permeability. </div><div class="NLM_p">Inhibition of the VEGF signaling pathway has become a valuable approach in the treatment of cancers. For example, the use of the neutralizing monoclonal antibody to VEGF, bevacizumab (Genentech), has demonstrated a prolonged survival in colorectal cancer patients.<sup><a onclick="showRef(event, 'jm070034ib00007'); return false;" href="javascript:void(0);" class="ref jm070034ib00007">7</a></sup> The compounds in Figure 1<a data-tab="pane-pcw-Figures" href="#jm070034if00001" id="" class=" internalNav"></a> represent the structural diversity of small molecule, ATP-competitive, KDR inhibitors under clinical investigation. In particular, sunitinib (SU-11248)<sup><a onclick="showRef(event, 'jm070034ib00008'); return false;" href="javascript:void(0);" class="ref jm070034ib00008">8</a></sup> and sorafenib (Bay 43-9006, <b>2</b>;<sup><a onclick="showRef(event, 'jm070034ib00009'); return false;" href="javascript:void(0);" class="ref jm070034ib00009">9</a></sup> a dual raf-KDR inhibitor) have recently been approved for the treatment of cancers.<sup><a onclick="showRef(event, 'jm070034ib00010'); return false;" href="javascript:void(0);" class="ref jm070034ib00010">10</a></sup><div id="_i4"><figure id="jm070034if00001" data-index="1" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034if00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034if00001.jpeg" id="_i5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 1 KDR inhibitors under clinical investigation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034if00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070034i&amp;id=jm070034if00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">Our independent medicinal chemistry efforts in finding a selective VEGFR inhibitor led to motesanib diphosphate (AMG 706, <b>1</b>), currently in phase II clinical trials for the treatment of various cancers.<sup>10e</sup> We were also interested in identifying a second generation of KDR inhibitor belonging to a completely different structural class from the nicotinamide. Urea <b>2</b> was originally described solely as a raf inhibitor, however, we serendipitously discovered that it inhibited KDR as well, with a <i>K</i><sub>i</sub> of 2 nM.<sup><a onclick="showRef(event, 'jm070034ib00011'); return false;" href="javascript:void(0);" class="ref jm070034ib00011">11</a></sup> As a means to understand the binding mode and generate a new chemotype for KDR inhibition, we docked <b>2</b> into the cocrystal structure of <b>1</b> and KDR<sup><a onclick="showRef(event, 'jm070034ib00012'); return false;" href="javascript:void(0);" class="ref jm070034ib00012">12</a></sup> to identify the key interactions between this molecule and the protein. One of the key features of the cocrystal structure of <b>1</b> bound KDR is the reorganization of Phe 1047 (of the Asp 1046, Phe 1047, Gly 1048 triad, the “DFG” motif) to induce the inactive “DFG-out” conformation, similar to that observed upon binding of imatinib to its target kinase Abl.<sup><a onclick="showRef(event, 'jm070034ib00013'); return false;" href="javascript:void(0);" class="ref jm070034ib00013">13</a></sup> This conformational change inhibits the ability of the kinase to bind ATP productively and accommodates the binding of an appropriately substituted inhibitor into an extended lipophilic pocket. On the basis of the presumed <i>cis</i>-conformation of the urea moiety and the size of the terminal aryl group, we reasoned that <b>2</b> would also bind KDR in a DFG-out fashion. </div><div class="NLM_p">The docking of <b>2</b> in the crystal structure of <b>1</b> bound to KDR is depicted in Figure 2<a data-tab="pane-pcw-Figures" href="#jm070034if00002" id="" class=" internalNav"></a>. The pyridine ring of <b>2</b> is positioned to overlay with the 4-aminomethylpyridine moiety of the nicotinamide to satisfy the critical interaction between the ring nitrogens and the Cys 919-NH in the kinase hinge region. This positioning also allows the amide-NH of <b>2</b> to engage in a second hydrogen bond with the backbone amide-CO of Cys 919. The biaryl-ether linkage projects the substituted phenyl ring into the lipophilic pocket neighboring the ATP binding site, adjacent to the gatekeeper residue, Val 916. This portion of <b>2</b> overlays well with the nicotinamide moiety. Further, this model places the urea carbonyl and its internal NH within hydrogen bond distances to the backbone of Asp 1046 and side chain of Glu 885, respectively, similar to the amide of <b>1</b>. The preferred <i>cis</i>-conformation of the urea places terminal aryl of <b>2</b> in a second <a name="jm005001804352" id="jm005001804352"></a> lipophilic pocket created by the movement of Phe 1047, similarly placed as the 3,3-dimethylindoline portion of the nicotinamide. <div id="_i6"><figure id="jm070034if00002" data-index="2" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034if00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034if00002.jpeg" id="_i7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 2 Model of urea <b>2</b> (yellow) overlaid with cocrystal structure of nicotinamide <b>1</b> (green) and KDR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034if00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070034i&amp;id=jm070034if00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">Based on the above model, we proposed the cyclization of <b>2</b> to the corresponding 2-aminobenzimidazole to enhance conformational rigidity while maintaining the key hydrogen-bonding interactions. Reduced flexibility is expected to improve potency and oral bioavailablity.<sup><a onclick="showRef(event, 'jm070034ib00014'); return false;" href="javascript:void(0);" class="ref jm070034ib00014">14</a></sup></div><div class="NLM_p last">To test this hypothesis, compound <b>3</b><sup><a onclick="showRef(event, 'jm070034ib00015'); return false;" href="javascript:void(0);" class="ref jm070034ib00015">15</a></sup> was prepared and found to be a potent KDR enzyme inhibitor, with a <i>K</i><sub>i</sub> of 9 nM (Figure 3<a data-tab="pane-pcw-Figures" href="#jm070034if00003" id="" class=" internalNav"></a>). The cellular activity was assessed by measuring the inhibition of VEGF-stimulated cellular proliferation of human umbilical vein endothelial cells (HUVEC). Surprisingly, lead compound <b>3</b> exhibited weak cellular activity (IC<sub>50</sub> ≥ 1140 nM). Guided by structural information, we varied the three main components of compound <b>3</b> (aniline ring, heterocyclic core, and hinge binding element) to improve the cellular potency. Herein, we describe the synthesis, structure−activity relationship, and pharmacological characterization of this new class of KDR inhibitors, which culminated in the identification of a potent, selective, and orally active 2-aminobenzoxazole <b>22</b> that demonstrated suppression of capillary formation in a rat-corneal model of angiogenesis. <div id="_i8"><figure id="jm070034if00003" data-index="3" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034if00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034if00003.jpeg" id="_i9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 3 Lead compound <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034if00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070034i&amp;id=jm070034if00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73817" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73817" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The benzo-1,3-azoles described in this paper were prepared according to the general method represented in Scheme 1. Benzimidazoles <b>3</b>−<b>19</b> were prepared in a two-step, one-pot protocol by treatment of bis-anilines <b>39a</b>−<b>i</b> with isothiocyanates <a name="jm005001804353" id="jm005001804353"></a><b>40</b> to afford thiourea intermediates that were directly cyclized to the desired products employing 1-(3-dimethyl-aminopropyl)-3-ethylcarbodiimide (EDC). In a sequence similar to that used to prepare the benzimidazoles, treatment of amino-phenols <b>39j</b>−<b>t</b> with thioisocyanates <b>40</b> and direct cyclization of the urea intermediates with EDC afforded the benzoxazoles <b>20</b>−<b>38</b> in good yields. The thiourea intermediates were not isolated, but rather cyclized directly to the desired core structure in situ. This convergent route allowed for rapid analoging of the 2-aniline moiety, as each variation could be introduced by simply employing the corresponding thioisocyanate. </div><div class="NLM_p">The anilines required for the synthesis of the arylthioisocyanates <b>40</b> were prepared via one of the methods described in Schemes<a data-tab="pane-pcw-Figures" href="#jm070034ih00001" id="" class=" internalNav"></a> 2 and 3<a data-tab="pane-pcw-Figures" href="#jm070034ih00002" id="" class=" internalNav"></a><a data-tab="pane-pcw-Figures" href="#jm070034ih00003" id="" class=" internalNav"></a>. Compounds containing an ether-linked tether to the amino group were synthesized from the corresponding nitro anisole <b>41</b>. Demethylation of <b>41</b> using strongly acidic conditions afforded phenols <b>42</b> with excellent yields. Compounds <b>43</b> were prepared by either a Mitsunobu etherification or alkylation of the phenol with generally high yields. Reduction of the nitro groups using either SnCl<sub>2</sub> or catalytic hydrogenation afforded anilines <b>44a</b>−<b>d</b>. <div id="_i11"><figure id="jm070034ih00001" data-index="4" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034ih00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034ih00001.jpeg" id="_i12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 1.  General Synthesis of 2-Aminobenzimidazoles and 2-Aminobenzoxazoles <b>3</b>−<b>38</b><i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) EDC, CH<sub>3</sub>CN.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034ih00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070034i&amp;id=jm070034ih00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm070034ih00002" data-index="5" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034ih00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034ih00002.jpeg" id="_i13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 2.  Preparation of Substituted Anilines<i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) pyridine·HCl, 210 °C; (b) HOAc, HBr, 140−180 °C; (c) R-Cl, K<sub>2</sub>CO<sub>3</sub>, Bu<sub>4</sub>N<sup>+</sup>I<sup>-</sup>, acetone; (d) R-Cl, K<sub>2</sub>CO<sub>3</sub>, DMF; (e) triphenylphosphine, DIAD, R-OH, THF; (f) Pd/C, H<sub>2</sub>, ethyl acetate or MeOH; (g) SnCl<sub>2</sub>, EtOH; (h) amine, NaBH(OAc)<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034ih00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070034i&amp;id=jm070034ih00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm070034ih00003" data-index="6" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034ih00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034ih00003.jpeg" id="_i14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 3.  Preparation of <i>N</i>-Methylpyrrolidine-Substituted Anilines<i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) (<i>S</i> or <i>R</i>)-(−)-1-(<i>tert</i>-butoxycarbonyl)-2-pyrrolidinemethanol, triphenylphosphine, DIAD, THF; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>; (c) NaBH<sub>3</sub>CN, CH<sub>2</sub>O, CH<sub>3</sub>CN; (d) Pd/C, H<sub>2</sub>, MeOH and dioxane/ethyl acetate or SnCl<sub>2</sub>, EtOH. </p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034ih00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070034i&amp;id=jm070034ih00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">Alternatively, anilines <b>46</b> containing an all-carbon tether to the amino group were prepared from 2-chloro-5-nitrobenzaldehyde in two steps. Reductive amination of the benzaldehyde with the appropriate amine afforded intermediate <b>45</b>. Reduction of the nitro arenes with SnCl<sub>2</sub>-generated anilines <b>46</b> in good yields. </div><div class="NLM_p">Anilines containing the <i>N</i>-methylpyrrolidine amino group were prepared using a variation to the chemistry described above (Scheme 3). Etherification of the phenols <b>42</b> with the <i>N</i>-Boc-pyrrolidinol using Mitsunobu conditions afforded the nitro intermediates <b>47</b> with good yields. Compounds <b>47</b> were deprotected using TFA and the free amine subjected to reductive amination conditions to yield compounds <b>49</b> in good yields. Subsequent reduction of the nitro groups to the corresponding anilines (using either catalytic hydrogenation for the perfluorinated compounds or SnCl<sub>2</sub> for the halogenated compound) afforded compounds <b>50</b> in excellent yields. </div><div class="NLM_p">Some arylthioisocyanates were commercially available, however, the remaining were prepared from condensation of the corresponding aniline with 1,1‘-thiocarbonyldiimidazole (Scheme 4<a data-tab="pane-pcw-Figures" href="#jm070034ih00004" id="" class=" internalNav"></a>). Intermediates <b>40</b> were either purified before use or used crude in the cyclization sequence (as a 1:2 mixture with imidazole). <div id="_i15"><figure id="jm070034ih00004" data-index="7" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034ih00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034ih00004.jpeg" id="_i16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 4.  Synthesis of Thioisocyanates<i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) 1,1’-thiocarbonyldiimidazole, CH<sub>3</sub>CN.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034ih00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070034i&amp;id=jm070034ih00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">The phenylene diamines <b>39a</b>−<b>h</b>, required for the synthesis of benzimidazoles <b>3</b>−<b>18</b> described in Tables 1−3, were prepared according to the generic route shown in Scheme 5<a data-tab="pane-pcw-Figures" href="#jm070034ih00005" id="" class=" internalNav"></a>. The substitution reactions of 3,4-dinitro phenol with the chlorinated heterocycles <b>51</b> afforded the biarylether <b>52</b>.<sup><a onclick="showRef(event, 'jm070034ib00016'); return false;" href="javascript:void(0);" class="ref jm070034ib00016">16</a></sup> Subsequent reduction of the nitro groups using either catalytic hydrogenation or zinc dust afforded the desired phenylene diamines <b>39a</b>−<b>h</b> in good to excellent yields. <div id="_i17"><figure id="jm070034ih00005" data-index="8" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034ih00005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034ih00005.jpeg" id="_i18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 5.  Preparation of Phenylene Diamines<i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) neat, 145−170 °C; (b) NEt<sub>3</sub>/TFA; (c) HCl, 145−150 °C; (d) Pd/C, H<sub>2</sub>, MeOH and/or ethyl acetate; (e) Zn, AcOH, THF.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034ih00005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070034i&amp;id=jm070034ih00005"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">Scheme 6<a data-tab="pane-pcw-Figures" href="#jm070034ih00006" id="" class=" internalNav"></a><a data-tab="pane-pcw-Figures" href="#jm070034ih00007" id="" class=" internalNav"></a> depicts the synthesis of the <i>N</i>-methylphenylene diamine <b>39i</b>, a precursor to <i>N</i>-methylbenzimidazole <b>19</b> (Table 4). The substitution reaction of the 4-chloropyridine carboxamide <b>53</b> with 4-amino-3-nitro phenol afforded aniline <b>54</b>. Regioselective monomethylation was achieved in a one-pot procedure by employing in situ protection of the amine with the trifluoroacetate group, followed by methylation with dimethyl sulfate to afford compound <b>55</b> in excellent yield. Reduction of the nitro <a name="jm005001804354" id="jm005001804354"></a> group of <b>55</b>, achieved using SnCl<sub>2</sub>, then yielded the desired monomethylated bisaniline <b>39i</b>. <div id="_i19"><figure id="jm070034ih00006" data-index="9" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034ih00006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034ih00006.jpeg" id="_i20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 6.  Synthesis of Intermediate <b>39i</b><i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) KO<i>t</i>-Bu, K<sub>2</sub>CO<sub>3</sub>, DMSO, rt−110 °C; (b) (i) TFAA, (ii) TBACl, Me<sub>2</sub>SO<sub>4</sub>, (iii) NaOH, H<sub>2</sub>O; (c) Pd/C, H<sub>2</sub>, MeOH/ethyl acetate.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034ih00006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070034i&amp;id=jm070034ih00006"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="jm070034ih00007" data-index="10" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034ih00007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034ih00007.jpeg" id="_i21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 7.  Preparation of Aminophenols<i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) NaH, DMF, rt−85 °C; (b) NEt<sub>3</sub>/TFA, 150 °C; (c) Pd/C, H<sub>2</sub>, MeOH, ethyl acetate; (d) TFA, heat; (e) HNO<sub>3</sub>, AcOH; (f) Fe, HCl, EtOH; (g) Zn, AcOH, THF; (h) SnCl<sub>2</sub>, EtOH.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034ih00007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070034i&amp;id=jm070034ih00007"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p">The amino phenol moieties required for the synthesis of 2-aminobenzoxazoles <b>20</b>−<b>38</b> described in Tables 4−6 were prepared according to the method described in Scheme 7. Chlorinated nitrogen-containing heterocycles <b>51</b> were treated with the preformed sodium phenolate of a 4-benzyloxyphenol to yield biarylethers <b>57</b> in generally good yields. Debenzylation of <b>57</b> was accomplished using either catalytic hydrogenation or trifluoroacetic acid (TFA; depending on the substrate) to give corresponding phenols <b>58</b>. The benzyl groups of compounds <b>57c</b> and <b>57d</b> (R<sub>1</sub> = Cl; heterocycle = quinoline and pyridine carboxamide, respectively) were removed under the TFA conditions. Regioselective nitration of phenols <b>58</b> using nitric acid afforded compounds <b>59</b> in good yields. Reduction of the nitro groups yielding amino phenols <b>39j</b>−<b>t</b> proceeded in generally excellent yields. </div><div class="NLM_p last"><b>Structural Information on Lead Compound 3.</b> A crystal structure of <b>3</b> bound to KDR (Figure 4<a data-tab="pane-pcw-Figures" href="#jm070034if00004" id="" class=" internalNav"></a>) confirmed the proposed binding mode and allowed us to use structural information to guide our medicinal chemistry efforts. As shown in Figure 4, compound <b>3</b> binds largely as predicted based on our model of compound <b>2</b> within the AMG 706/KDR structure. Hydrogen bonds between the hinge-region Cys 919 are observed with both the nitrogen of the pyridine and the carboxamide-NH. The benzimidazole core is oriented in the hydrophobic pocket flanked by Val 917. The endocyclic nitrogen of the benzimidazole hydrogen bonds with the NH of Asp 1046 and either the exocyclic or the endocyclic NH may interact with the side chain of Glu 885. Also consistent with the modeling studies, the aniline aryl ring occupies the second hydrophobic pocket created by the rearrangement of the protein into the “DFG-out” conformation. The <i>meta</i>-trifluoromethyl substituent orients toward a small lipophilic pocket away from the solvent exposed portion of the protein. <div id="_i22"><figure id="jm070034if00004" data-index="11" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034if00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034if00004.jpeg" id="_i23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 4 Crystal structure of <b>3</b> bound to KDR. Asp 1046, Phe 1047, and Gly 1048 (not shown for clarity) constitute the residues of the “DFG” motif. Potential hydrogen-bond interactions are indicated by dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034if00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070034i&amp;id=jm070034if00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_74375" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_74375" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All compounds depicted in Tables 1−6 were screened for inhibition of KDR tyrosine kinase activity with select compounds further assayed in the HUVEC cellular assay. Our initial work focused on exploring variants to the pyridine carboxamide moiety of the 2-aminobenzimidazole <b>3</b> (Table 1). As shown in Table 1, removal of the carboxamide group (<b>4</b> vs <b>3</b>) led to an 18-fold reduction in enzyme potency, presumably due to the loss of the hydrogen-bond interaction between the NH of the carboxamide and the carbonyl of Cys 919. By incorporating nitrogen-containing heterocycles with a hydrogen-bond donor and acceptor appropriately spaced to interact with the hinge greater potency was realized. For example, quinazoline <b>5</b> (with the proton of C8 engaged in a hydrogen bond with the carbonyl of Cys 919)<sup><a onclick="showRef(event, 'jm070034ib00017'); return false;" href="javascript:void(0);" class="ref jm070034ib00017">17</a></sup> and azaindole-substituted <b>6</b> showed improved enzyme potency by 20-fold and 3-fold, respectively, compared to pyridine <b>4</b>. Compound <b>5</b> displayed improved potency in the cellular assay (IC<sub>50</sub> = 49 nM), however, this was insufficient for advancement of this compound. Although <b>3</b> and <b>6</b> exhibited modest to good enzyme potencies, they lacked the desired activity in the HUVEC cellular proliferation assay. </div><div class="NLM_p">In an effort to improve the solubility and potentially improve cellular potency of the 2-aminobenzimidazoles, analogs containing a basic amine were investigated (Table 2). Guided by the structural information, we attached the amine from the 3-position of the phenyl ring with a 2- to 4-atom tether to direct the group toward bulk solvent. As exemplified by compound <b>7</b>, no significant change was observed at the enzyme level compared to parent compound <b>3</b>, however, the enzyme to cellular shift was 36-fold, resulting in a cellular potency of 146 nM. As shown by compounds <b>7</b>−<b>10</b>, varying the amino moiety (e.g., acyclic vs cyclic), the tether linkage (e.g., O-linked vs C-linked), and the group at the 4-position (e.g., Cl vs CF<sub>3</sub>, vs C<sub>2</sub>H<sub>5</sub>) resulted in relatively small differences in the cellular potencies, with enzyme-to-cell shifts ranging from 10- to 40-fold. Other aniline substitution patterns (i.e., 3,5-substituted, <b>11</b>) proved suboptimal for potency.<a class="ref showTableEvent internalNav" data-ID="jm070034it00001" href="#jm070034it00001"></a><a class="ref showTableEvent internalNav" data-ID="jm070034it00002" href="#jm070034it00002"></a><a class="ref showTableEvent internalNav" data-ID="jm070034it00003" href="#jm070034it00003"></a><a class="ref showTableEvent internalNav" data-ID="jm070034it00004" href="#jm070034it00004"></a><a class="ref showTableEvent internalNav" data-ID="jm070034it00005" href="#jm070034it00005"></a><a class="ref showTableEvent internalNav" data-ID="jm070034it00006" href="#jm070034it00006"></a><div class="NLM_table-wrap" id="jm070034it00001"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 1.  Investigation of the Hinge-Binding Moiety<i><sup>a</sup></i><sup></sup></p></div></div><div class="scrollable-table-wrap"><table class="table single-image " width="100%"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034iu00001a.gif" alt="" id="_i25" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Enzyme binding and cellular IC<sub>50</sub> data are determined by one single experiment. See Experimental Section for a description of the assay conditions.<i><sup>b</sup></i><sup></sup> Human umbilical vein endothelial cells.</p></div></div><div class="NLM_table-wrap" id="jm070034it00002"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 2.  Investigation of Amino Group to Improve Cellular Potency<i><sup>a</sup></i><sup></sup></p></div></div><div class="scrollable-table-wrap"><table class="table single-image " width="100%"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034iu00002a.gif" alt="" id="_i26" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Enzyme binding and cellular IC<sub>50</sub> data are determined by one single experiment, except where noted. See Experimental Section for a description of the assay conditions.<i><sup>b</sup></i><sup></sup> Human umbilical vein endothelial cells.<i><sup>c</sup></i><sup></sup> <i>N</i> = 2 for enzyme binding (3.9 nM ± 3.0 nM).<i><sup>d</sup></i><sup></sup> n.d.= not determined.</p></div></div><div class="NLM_table-wrap" id="jm070034it00003"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 3.  Further Investigation of Hinge-Binding Moiety<i><sup>a</sup></i><sup></sup></p></div></div><div class="scrollable-table-wrap"><table class="table single-image " width="100%"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034iu00003a.gif" alt="" id="_i27" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Enzyme binding and cellular IC<sub>50</sub> data are determined by one single experiment, except where noted. See Experimental Section for a description of the assay conditions.<i><sup>b</sup></i><sup></sup> Human umbilical vein endothelial cells.<i><sup>c</sup></i><sup></sup> <i>N</i> = 2 for IC<sub>50</sub> determination (32.4 nM ± 5.4 nM).<i><sup>d</sup></i><sup></sup> <i>N</i> = 2 for IC<sub>50</sub> determination (16.6 nM ± 4.6 nM).<i><sup>e</sup></i><sup></sup> n.d.= not determined.</p></div></div><div class="NLM_table-wrap" id="jm070034it00004"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 4.  Investigation of the 1,3-Azole Core<i><sup>a</sup></i><sup></sup><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034iu00004a.gif" alt="" id="_i28" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">cmpd</td><td class="colsep2 rowsep2">X</td><td class="colsep2 rowsep2"><i>K</i><sub>i</sub> <sub>phos</sub> (nM)</td><td class="colsep2 rowsep2">V-HUVEC<i><sup>b</sup></i><sup></sup> IC<sub>50</sub> (nM) </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">7 </td><td class="colsep2 rowsep2">NH </td><td class="colsep2 rowsep2">4 </td><td class="colsep2 rowsep2">146 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">19 </td><td class="colsep2 rowsep2">N−Me </td><td class="colsep2 rowsep2">10 </td><td class="colsep2 rowsep2">31 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">20 </td><td class="colsep2 rowsep2">O </td><td class="colsep2 rowsep2">4 </td><td class="colsep2 rowsep2">36</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Enzyme binding and cellular IC<sub>50</sub> data are determined by one single experiment. See Experimental Section for a description of the assay conditions.<i><sup>b</sup></i><sup></sup> Human umbilical vein endothelial cells. </p></div></div><div class="NLM_table-wrap" id="jm070034it00005"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 5.  Investigation of Pendant Tertiary Amines on the Aniline Moiety<i><sup>a</sup></i><sup></sup></p></div></div><div class="scrollable-table-wrap"><table class="table single-image " width="100%"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034iu00005a.gif" alt="" id="_i29" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Enzyme binding and cellular IC<sub>50</sub> data are determined by one single experiment, except where noted. See Experimental Section for a description of the assay conditions.<i><sup>b</sup></i><sup></sup> Human umbilical vein endothelial cells.<i><sup>c</sup></i><sup></sup> <i>N</i> = 2 for <i>K</i><sub>i</sub> determination (2.8 nM ± 1.6 nM).<i><sup>d</sup></i><sup></sup> <i>N</i> = 3 for IC<sub>50</sub> determination (15.3 nM ± 5.2 nM).</p></div></div><div class="NLM_table-wrap" id="jm070034it00006"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 6.  Benzoxazoles:  Investigation of the Hinge-Binding Element<i><sup>a</sup></i><sup></sup></p></div></div><div class="scrollable-table-wrap"><table class="table single-image " width="100%"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034iu00006a.gif" alt="" id="_i30" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Enzyme binding and cellular IC<sub>50</sub> data are determined by one single experiment, except where noted. See Experimental Section for a description of the assay conditions.<i><sup>b</sup></i><sup></sup> Human umbilical vein endothelial cells.<i><sup>c</sup></i><sup></sup> <i>N</i> = 2 for <i>K</i><sub>i</sub> determination (0.5 nM ± 0.1 nM).<i><sup>d</sup></i><sup></sup> <i>N</i> = 2 for <i>K</i><sub>i</sub> determination (3.6 nM ± 2.3 nM).<i><sup>e</sup></i><sup></sup> <i>N</i> = 2 for <i>K</i><sub>i</sub> determination (1.6 nM ± 0.5 nM).</p></div></div></div><div class="NLM_p"><a name="jm005001804355" id="jm005001804355"></a>Encouraged by the improved cellular potency of compounds <b>7</b>−<b>10</b> compared to the parent compound <b>3</b>, we investigated the effect of substituting the pyridine carboxamide with other nitrogen-containing heterocycles (Table 3). Consistent with previous observations (i.e., quinazoline <b>5</b>, Table 1), compounds <b>12</b>−<b>14</b> containing the quinoline moiety were more potent at the cellular levels than the analogs bearing a pyrrolopyrimidine (<b>15</b>), an azaindole (<b>16</b>), or a 2-aminopyrimidine (<b>17</b>). The improved potency observed with quinoline derivatives <b>12</b>−<b>14</b> reflected a slight decrease in enzyme-to-cell shift. Modifying either the bicyclic pyrollopyrimidine <b>15</b> or the azaindole <b>16</b> to the monocylic 2-aminopyridine <b>17</b> resulted in a loss of potency at the enzyme and cellular level. Although this is consistent with data in other series (ex:  benzoxazole series (vide infra) and unpublished results), it could not be rationalized by structural information. As anticipated based on earlier studies, removal of the hydrogen-bond donor to the hinge region resulted in a 3-fold decline in enzyme potency (<b>17</b> vs <b>18</b>). The 2-aminobenzimidazole <b>14</b>, containing a 6,7-dimethoxyquinoline moiety, displayed the best overall potency with a 10-fold increase in enzyme affinity (<i>K</i><sub>i</sub> = 0.2 nM) compared to the <a name="jm005001804356" id="jm005001804356"></a> unsubstituted quinoline <b>13</b> (<i>K</i><sub>i</sub> = 2 nM). This improved enzyme potency could result from an increased donor character of the C8-hydrogen of the 6,7-dimethoxyquinoline moiety binding the hinge region. In addition, compound <b>14</b> displayed an IC<sub>50</sub> of 17 nM in the HUVEC assay. Although cellular efficacy was greatly improved by adding a tertiary amino group and varying the nitrogen-containing heterocycle, the shift between enzyme potency and cellular potency was difficult to predict and often greater than 10-fold. </div><div class="NLM_p">The crystal structure of <b>3</b> bound to KDR illustrates the hydrogen bond between either the exocyclic or the endocyclic NH of the benzimidazole and the side chain of Glu 885. To evaluate the possibility of removing the endocyclic hydrogen-bond donor, we methylated the benzimidazole core. Indeed, the <i>N</i>-methylbenzimidazole <b>19</b> provided a <i>K</i><sub>i</sub> of 10 nM on phosphorylated KDR and an IC<sub>50</sub> of 31 nM in the cellular assay, exhibiting only a 3-fold enzyme-to-cell shift (compared to the 36-fold shift observed with the parent compound <b>7</b>; Table 4). This result indicates that a possible hydrogen bond between the endocyclic NH and the Glu 885 can be removed due to an interaction between Glu 885 and the exocyclic NH. Encouraged by this data, we altered the aminobenzimidazole core to a 2-aminobenzoxazole, as exemplified by compound <b>20</b>. Compound <b>20</b> displayed good potency at the enzyme (<i>K</i><sub>i</sub> = 4 nM) and cellular (IC<sub>50</sub> = 36 nM) levels. Based on this finding, we elected to investigate other structural variants in the 2-aminobenzoxazole series. </div><div class="NLM_p">The overall structure−activity relationship of the 2-aminobenzoxazoles followed a similar pattern as that of the corresponding 2-aminobenzimidazoles (Tables 5 and 6). As observed in the 2-aminobenzimidazole series, addition of a pendant basic amine was preferred to achieve good cellular potency (Table 5). For example, simply substituted <b>21</b> exhibited a <i>K</i><sub>i</sub> of 12 nM in the enzyme assay, but displayed an IC<sub>50</sub> of 766 nM in the cellular assay. Appendage of a basic amine (<b>20</b>) improved the enzyme potency 3-fold (<i>K</i><sub>i</sub> = 4 nM), with a 20-fold improvement in cellular potency (IC<sub>50</sub> = 36 nM). A brief examination of tertiary amine substituents indicated a variety of groups are tolerated (<b>22</b>−<b>26</b>). In particular, compounds containing an <i>N</i>-methylpyrrolidine (<b>22</b>), an <i>N</i>,<i>N</i>-diethylaminoethyl (<b>24</b>), or an <i>N</i>-methylpiperazine (<b>20</b>) substituent are optimum for achieving good cellular potency. </div><div class="NLM_p">To further improve the cellular potency, we also explored the hinge binding moiety (Table 6). As shown previously, when combined with the appropriate tertiary amine pendant, compounds containing a pyridine carboxamide were potent KDR inhibitors (compounds <b>20</b>, <b>22</b>, and <b>24</b> in Table 5 and compound <b>27</b> in Table 6). Similar to the benzimidazole series, compounds <b>28</b>−<b>30</b> illustrate that a dimethoxyquinoline and quinazoline heterocycles were optimal. Although removal of the 6- and <a name="jm005001804357" id="jm005001804357"></a> 7-methoxy groups resulted in an 8-fold drop in enzyme potency, the cellular activities were comparable (<b>30</b> vs <b>31</b>). As observed in the benzimidazole series, compounds with an amino pyrimidine hinge binding moiety exemplified exhibited a loss in cellular activity (<b>32</b> and <b>33</b>). Finally, good cellular potency can also be achieved with an azaindole binding the hinge and an appropriately substituted aniline (compound <b>34</b>). </div><div class="NLM_p last">In an attempt to improve the enzyme potency further, we returned to the crystal structure. Based on the structure of <b>3</b> with KDR, we noted a small to medium sized lipophilic pocket that could be accessed by placing a substituent at the 7-position of the bicyclic core (Figure 5). We proposed that placement of a substituent at this position could increase potency. We therefore prepared the 7-fluoro and 7-chloro derivates. Surprisingly, as shown by compounds <b>36</b>−<b>38</b> (Table 7<a class="ref showTableEvent internalNav" data-ID="jm070034it00007" href="#jm070034it00007"></a>), substitution at the 7-position of the benzoxazole did not yield any significant improvement in enzyme or cellular potencies compared to the corresponding unsubstituted analogs. <div class="NLM_table-wrap" id="jm070034it00007"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 7.  Investigation of Substitution on Benzoxazole Core<i><sup>a</sup></i><sup></sup></p></div></div><div class="scrollable-table-wrap"><table class="table single-image " width="100%"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034iu00007a.gif" alt="" id="_i31" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Enzyme binding and cellular IC<sub>50</sub> data are determined by one single experiment. See Experimental Section for a description of the assay conditions.<i><sup>b</sup></i><sup></sup> Human umbilical vein endothelial cells.</p></div></div></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32">Pharmacokinetic Studies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66387" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66387" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Several 2-aminoazoles with suitable inhibitory activity in the kinase enzyme and cellular proliferation assays were evaluated for their in vivo pharmacokinetics in male Sprague−Dawley rats (Table 8<a class="ref showTableEvent internalNav" data-ID="jm070034it00008" href="#jm070034it00008"></a>). Compounds<a data-tab="pane-pcw-Figures" href="#jm070034if00005" id="" class=" internalNav"></a> were administered by both intravenous (i.v.) and oral (p.o.) dosing routes. Compounds <b>12</b> and <b>34</b> displayed reasonable clearance values (Cl = 1.0 and 1.24 L/h/kg, respectively), but had a low oral bioavailablity (24 and 17 %<i>F</i>, respectively). Dimethoxyquinazoline (<b>28</b>), dimethoxyquinoline (<b>30</b>), and pyridine carboxamide (<b>22</b>) had improved bioavailability (40−67 %<i>F</i>). In general, the 2-aminoazoles tested exhibited moderate to high Cl and a high volume of distribution <a name="jm005001804358" id="jm005001804358"></a> after i.v. dosing. Compounds <b>22</b>, <b>28</b>, and <b>30</b> all exhibited acceptable half-lives and oral bioavailability for further in vivo evaluation. <div id="_i33"><figure id="jm070034if00005" data-index="12" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034if00005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034if00005.jpeg" id="_i34" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 5 Surface diagram of compound <b>3</b> bound to KDR. The 7-position is indicated by the arrow.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034if00005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070034i&amp;id=jm070034if00005"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div class="NLM_table-wrap" id="jm070034it00008"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 8.  PK Studies of Leading Compounds<i><sup>a</sup></i><sup></sup></p></div></div><div class="scrollable-table-wrap"><table class="table single-image " width="100%"><colgroup><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034iu00008a.gif" alt="" id="_i35" /></img></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><sup>a</sup> IV dosing at 1 mpk (DMSO), with <i>n</i> = 3 male Sprague−Dawley rats. Oral dosing at 10 mpk (Ora-Plus, pH 2), with <i>n</i> = 2 rats.<i><sup>b</sup></i><sup></sup> Human umbilical vein endothelial cells.<i><sup>c</sup></i><sup></sup> <i>n</i> = 2 rats.<i><sup>d</sup></i><sup></sup> Oral dosing at 3 mpk.</p></div></div></div><div class="NLM_p"><b>Selectivity.</b> To evaluate compounds in an in vivo setting, it was critical to understand the kinase selectivity profile. To measure the selectivity of this series in a cellular assay, compounds <b>22</b>, <b>28</b>, and <b>30</b> were evaluated in a fibroblast growth factor (b-FGF)-driven HUVEC proliferation assay (Table 9<a class="ref showTableEvent internalNav" data-ID="jm070034it00009" href="#jm070034it00009"></a>). While compounds <b>28</b> and <b>30</b> displayed moderate selectivity (10-fold) for VEGF-driven cellular proliferation, compound <b>22</b> exhibited the best selectivity (28-fold) over FGF-induced HUVEC proliferation (IC<sub>50(V-HUVEC</sub>) = 15 nM, IC<sub>50(F-HUVEC)</sub> = 420 nM). <div class="NLM_table-wrap" id="jm070034it00009"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 9.  Cellular Selectivity Profile of Selected Compounds in VEGF- and FGF-Induced Cellular Proliferation<i><sup>a</sup></i><sup></sup></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">cmpd</td><td class="colsep2 rowsep2">V-HUVEC<i><sup>b</sup></i><sup></sup> IC<sub>50</sub> (nM)</td><td class="colsep2 rowsep2">F-HUVEC<i><sup>b</sup></i><sup></sup> IC<sub>50</sub> (nM) </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>22</b></td><td class="colsep2 rowsep2">15<i><sup>c</sup></i><sup></sup></td><td class="colsep2 rowsep2">420<i><sup>d</sup></i><sup></sup></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>28</b></td><td class="colsep2 rowsep2">6 </td><td class="colsep2 rowsep2">55 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><b>30</b></td><td class="colsep2 rowsep2">10 </td><td class="colsep2 rowsep2">101</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> Cellular IC<sub>50</sub> data are determined by one single experiment, except where noted. See Experimental Section for a description of the assay conditions.<i><sup>b</sup></i><sup></sup> Human umbilical vein endothelial cells.<i><sup>c</sup></i><sup></sup> <i>N</i> = 3 for IC<sub>50</sub> determination (15.3 nM ± 5.2 nM).<i><sup>d</sup></i><sup></sup> <i>N</i> = 3 for IC<sub>50</sub> determination (420 nM ± 100 nM).</p></div></div></div><div class="NLM_p">Compound <b>22</b> was further profiled against an extended panel of kinase enzymes, including receptor tyrosine kinases and serine/threonine kinases. As summarized in Table 10<a class="ref showTableEvent internalNav" data-ID="jm070034it00010" href="#jm070034it00010"></a>, compound <b>22</b> exhibited excellent enzymatic selectivity. Within the protein tyrosine kinase family, <b>22</b> showed excellent levels of selectivity (>100-fold) over Tie-2, FGF, Src, IGFR-1, and EGFR. Similar selectivity was seen over kinases in the serine/threonine group (MAP, GSK3-b, CDK). As expected, due to the close homology of KDR to cFMS and cKit, only modest selectivity was observed (16-fold and 6-fold, respectively). Based on its favorable selectivity profile in both the enzyme and the cellular assays and pharmacokinetics, compound <b>22</b> was further examined in our animal efficacy models. <div class="NLM_table-wrap" id="jm070034it00010"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><p class="first last"> Table 10.  Selectivity Profile of <b>22</b><i><sup>a</sup></i><sup></sup></p></div></div><div class="scrollable-table-wrap"><table class="table " width="100%"><colgroup><col /></col><col /></col><col /></col><col /></col></colgroup><tbody><tr valign="top" class="colsep2"><td class="colsep2 rowsep2" colspan="4">enzyme inhibition IC<sub>50</sub> (μM) </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><i>PTK group I</i></td><td class="colsep2 rowsep2"><i>PTK group VI</i></td><td class="colsep2 rowsep2"><i>PTK group X</i></td><td class="colsep2 rowsep2"><i>CMGC group I</i></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">Src = 0.72 </td><td class="colsep2 rowsep2">Zap-70 > 25 </td><td class="colsep2 rowsep2">EGFR > 25 </td><td class="colsep2 rowsep2">CDK5p25 > 40 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">LCK = 1.14 </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">CDK1 > 40 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><i>PTK group XIII</i></td><td class="colsep2 rowsep2"><i>PTK group XIV</i></td><td class="colsep2 rowsep2"><i>PTK group XV</i></td><td class="colsep2 rowsep2"><i>CMGC group II</i></td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">Tie-2 = 3.18 </td><td class="colsep2 rowsep2">KDR = 0.005<i><sup>b</sup></i><sup></sup></td><td class="colsep2 rowsep2">FGF = 4.37 </td><td class="colsep2 rowsep2">p38α > 40 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">cFMS = 0.08 </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">p38β > 40 </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">cKIT = 0.03</td><td class="colsep2 rowsep2"><i>OPK group VII</i></td><td class="colsep2 rowsep2">JNK1 > 40</td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"><i>PTK group XVI</i></td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">E2K2 > 40 </td><td class="colsep2 rowsep2">JNK2 > 40</td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2">IGFR-1 = 4.01 </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">JNK3 > 40</td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2"><i>PTK group XXI</i></td><td class="colsep2 rowsep2"><i>CMGC group III</i></td><td class="colsep2 rowsep2"> </td></tr><tr valign="top" class="colsep2"><td class="colsep2 rowsep2"> </td><td class="colsep2 rowsep2">cMet = 13.7 </td><td class="colsep2 rowsep2">GSK3-b > 40 </td><td class="colsep2 rowsep2"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-"><p class="first last"><i><sup>a</sup></i><sup></sup> IC<sub>50</sub> data are determined by one single experiment. See Experimental Section for a description of the assay conditions.<i><sup>b</sup></i><sup></sup> <i>N</i> = 2 for IC<sub>50</sub> determination (4.6 nM ± 2.8 nM).</p></div></div></div><div class="NLM_p"><b>Animal Efficacy Models. Vascular Permeability</b>. The in vivo activity of compound <b>22</b> on VEGF-induced vascular permeability was assessed in a modified Miles assay<sup><a onclick="showRef(event, 'jm070034ib00018'); return false;" href="javascript:void(0);" class="ref jm070034ib00018">18</a></sup> (Figure 6<a data-tab="pane-pcw-Figures" href="#jm070034if00006" id="" class=" internalNav"></a>). For this assay, HEK 293 cells, transfected with murine VEGF or vector control were mixed with Matrigel and injected subcutaneously into CD-1 Nu/Nu mice. Compound <b>22</b> was administered orally 22 h after injection of the cells at 10, 30, and 100 mg/kg doses. Six hours after administration of compound, vascular permeability in the skin overlying the Matrigel plug was measured by the quantization of extravasated Evan's blue dye. In mice dosed with <b>22</b>, linear pharmacokinetics was observed. Although the responses at 10 and 30 mg/kg were not statistically significant, a strong inhibition of vascular permeability at 100 mg/kg (79%) was observed. <div id="_i36"><figure id="jm070034if00006" data-index="13" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034if00006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034if00006.jpeg" id="_i37" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 6 Effect of <b>22</b> on VEGF-induced vascular permeability in mice. (◆) Indicates drug concentration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034if00006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070034i&amp;id=jm070034if00006"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p"><b>Angiogenesis.</b> To evaluate the in vivo VEGF-mediated anti-angiogenic activity of compound <b>22</b>, a rat corneal model of angiogenesis was performed (Figure 7<a data-tab="pane-pcw-Figures" href="#jm070034if00007" id="" class=" internalNav"></a>). A disk infused with rHu-VEGF was placed in the rat cornea to stimulate blood vessel formation from the limbal vessels of the eye toward the disk. The rats were then treated with <b>22</b> at doses of 1, 3, 10, and 30 mg/kg once a day orally. Treatment began on the day of implantation and continued for 7 days. Two vascular endpoints were evaluated:  the number of blood vessels at the midpoint between the limbus and the disk and the mean blood vessel area. Benzoxazole <b>22</b> significantly reduced both vascular endpoints in a dose-concentration-dependent manner, with an estimated ED<sub>50</sub> of 16.3 mg/kg. Terminal PK analysis estimated the AUC<sub>(0</sub><sub>-</sub><sub>24</sub><sub> </sub><sub>h</sub><sub>)</sub> at the ED<sub>50</sub> as 17.03 μM·h. <div id="_i38"><figure id="jm070034if00007" data-index="14" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034if00007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034if00007.jpeg" id="_i39" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 7 Inhibition of VEGF-induced angiogenesis in rats by <b>22</b>. (◆) Indicates drug concentration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034if00007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070034i&amp;id=jm070034if00007"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div class="NLM_p last"><b>Crystal Structure of 22 Bound to KDR.</b> To confirm the binding mode of <b>22</b>, the crystal structure of the benzoxazole <a name="jm005001804359" id="jm005001804359"></a> complexed with KDR was obtained. As shown in Figure 8<a data-tab="pane-pcw-Figures" href="#jm070034if00008" id="" class=" internalNav"></a>, compound <b>22</b> binds largely as predicted based on our structure of compound <b>3</b> bound to KDR. Hydrogen bonds between the hinge-region Cys 919 are observed with both the nitrogen of the pyridine and the carboxamide-NH. The benzoxazole core is oriented in the hydrophobic pocket flanked by Val 917. The endocyclic nitrogen of the aminobenzoxazole hydrogen bonds with the NH of Asp 1046 and the exocyclic NH picks up a key interaction with side chain of Glu 885. The aniline aryl ring occupies the second hydrophobic pocket with the <i>N</i>-methyl pyrrolidine side chain directed to a solvent-exposed portion of the protein. <div id="_i40"><figure id="jm070034if00008" data-index="15" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034if00008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034if00008.jpeg" id="_i41" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 8 Crystal structure of <b>22</b> bound to KDR. </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034if00008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070034i&amp;id=jm070034if00008"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75433" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75433" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Guided by X-ray crystallography and molecular modeling, we identified a new class of KDR inhibitors:  2-aminobenzimidazoles. While the 2-aminobenzimidazoles were potent enzyme inhibitors, achieving good cellular potency remained a challenge. A detailed understanding of the key interactions between the ligand and the receptor prompted the replacement of the 2-aminobenzimidazole core by a 2-aminobenzoxazole. Optimization of the hinge binding heterocycle as well as the aryl ring occupying the second hydrophobic pocket resulted in several benzoxazoles with good enzyme and cellular potencies. Among them, compound <b>22</b> emerged as the best candidate for in vivo evaluation. Compound <b>22</b> showed on mechanism in vivo activity upon oral dosing in both the mouse Matrigel and the rat corneal models. Although compound <b>22</b> is less efficacious in the rat corneal model compared to motesanib,<sup><a onclick="showRef(event, 'jm070034ib00019'); return false;" href="javascript:void(0);" class="ref jm070034ib00019">19</a></sup> it represents one step toward identification of a novel series of potent KDR inhibitors with strong antitumor activity in vivo. Reports detailing the discovery of these compounds will be published hereafter. </div></div><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76126" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76126" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p"><b>General Considerations.</b> Unless otherwise noted, all materials were obtained from commercial suppliers and used without further purification. Anhydrous solvents were obtained from Aldrich and used directly. All reactions involving air- or moisture-sensitive reagents were performed under a nitrogen or argon atmosphere. All final compounds were purified to >95% purity, as determined by high-performance liquid chromatography (HPLC:  <b>A</b>, Zorbax SB-C8, 4.6 × 150 mm, 15 min; flow rate = 1.5 mL/min; gradient = 0 to 100% 0.1% TFA in CH<sub>3</sub>CN/100 to 0% 0.1% TFA in water; <b>B</b>, Zorbax SB-C8, 4.6 × 150 mm, 12 min; flow rate = 1.5 mL/min; gradient = 10 to 90% 0.1% formic acid in CH<sub>3</sub>CN/90 to 10% 0.1% formic acid in water; <b>C</b>, Phenomenex Synergi, 2 × 50 mm, 3 min, flow rate = 1.0 mL/min; gradient = 5 to 95% 0.1% formic acid in CH<sub>3</sub>CN/95 to 5% 0.1% formic acid in water). Silica gel chromatography was performed using either glass columns packed with silica gel (230−400 mesh), prepacked silica gel cartridges (Isco or Biotage), or preparative thin-layer chromatography plates (Analtech, 1000 microns). NMR spectra were determined using a Varian 300 or 400 MHz spectrometer. Preparative reverse-phase HPLC was performed using Gilson 306 gradient elution pump, YMC ODS-AQ reverse-phase silica gel column and a Gilson variable wavelength UV/vis-155 detector. High-resolution mass spectrometry (HRMS) was performed using an Agilent MSD-TOF mass spectrometer equipped with an ESI dual channel source. The instrument was calibrated using Agilent ESI-MS tuning mixture (ES Tuning Mix PN G2421A). The tuning mixture was continuously infused on the second ESI channel, and the 622.02895 Da ion was used to provide a lock-mass correction to the calibration function. All samples were diluted to an appropriate concentration so that the number of counts per scan was less that 10e5 to prevent dead-time distortion of the measurement. </div><div class="NLM_p"><b>4-((2-((4-Chloro-3-(trifluoromethyl)phenyl)amino)-1</b><b><i>H</i></b><b>-benzimidazol-5-yl)oxy)-</b><b><i>N</i></b><b>-methyl-2-</b><b>pyridinecarboxamide (3).</b> To a solution of 4-(3,4-diamino-phenoxy)-pyridine-2-carboxylic acid methylamide (0.07 g, 0.27 mmol) in CH<sub>3</sub>CN (20 mL) was added dropwise, over 5 min, a solution of 1-chloro-4-isothiocyanato-2-trifluoromethyl-benzene (0.055 g, 0.27 mmol) in CH<sub>3</sub>CN (10 mL). The reaction was stirred 18 h at rt. The reaction was diluted with additional CH<sub>3</sub>CN (10 mL), followed by addition of EDC (0.078 g, 0.41 mmol). The reaction was heated at 80 °C for 3 h, allowed to cool to rt, and concentrated in vacuo. The crude mixture was dissolved in EtOAc and water. The layers were separated, and the <a name="jm005001804360" id="jm005001804360"></a> organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by silica gel column chromatography using a hexane−EtOAc gradient to yield the title compound as a white solid (74 mg, 59%). <sup>1</sup>H NMR indicates a mixture of tautomers (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.42 (s, 0.5H), 11.37 (s, 0.5H), 10.13 (s, 0.5H), 10.09 (s, 0.5H), 8.70−8.80 (m, 1H), 8.45−8.48 (m, 1H), 8.31−8.32 (m, 1H), 8.10−8.14 (m, 1H), 7.62−7.65 (m, 1H), 7.46 (d, <i>J</i> = 8.4, Hz, 0.5H), 7.30−7.40 (m, 2.5H), 7.10−7.14 (m, 1H), 6.84−6.88 (m, 1H), 2.75 (d, <i>J</i> = 1.6 Hz, 1.5H), 2.74 (d, <i>J</i> = 2.0 Hz, 1.5H); HRMS calcd for C<sub>21</sub>H<sub>15</sub>ClF<sub>3</sub>N<sub>5</sub>O<sub>2</sub> (M + H)<sup>+</sup>, 462.0939; found, 462.0943; HPLC purity = 98% (system A), 98% (system B). </div><div class="NLM_p"><b>(4-Chloro-3-trifluoromethyl-phenyl)-[5-(pyridin-4-yloxy)-1</b><b><i>H</i></b><b>-benzimidazol-2-yl]-amine (4).</b> Starting with 4-(3,4-diamino-phenoxy)-pyridine (273 mg, 1.36 mmol), 228 mg (42%) of the title compound was obtained as a white solid according to the method described for the synthesis of <b>3</b>. <sup>1</sup>H NMR indicates a mixture of tautomers (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.37 (s, 0.5H), 11.32 (s, 0.5H), 10.10 (s, 0.5H), 10.06 (s, 0.5H), 8.38−8.45 (m, 2H), 8.30−8.35 (m, 1H), 8.11 (d, <i>J</i> = 8.8 Hz, 1H), 7.64 (dd, <i>J</i> = 8.8, 3.2 Hz, 1H), 7.44 (d, <i>J</i> = 8.4 Hz, 0.5H), 7.35 (d, <i>J</i> = 8.4 Hz, 0.5 H), 7.18 (d, <i>J</i> = 2.0 Hz, 0.5H), 7.08 (d, <i>J</i> = 2.0 Hz, 0.5H), 6.80−6.90 (m, 3H); HRMS calcd for C<sub>19</sub>H<sub>12</sub>ClF<sub>3</sub>N<sub>4</sub>O (M + H)<sup>+</sup>, 405.0725; found, 405.0725; HPLC purity = 100% (system B), 100% (system C). </div><div class="NLM_p"><b>(4-Chloro-phenyl)-[5-(6,7-dimethoxy-quinazolin-4-yloxy)-1</b><b><i>H</i></b><b>-benzoimidazol-2-yl]-amine </b><b>(5).</b> A solution of 4-amino-3-nitrophenol (0.80 g, 5.34 mmol, 1.2 equiv) in DMSO (3.80 mL) was treated with KO<i>t</i>-Bu (0.60 g, 5.34 mmol) and the mixture was stirred at rt for 2 h. To this solution, 4-chloro-6,7-dimethoxyquinazoline (1.00 g, 4.45 mmol) and K<sub>2</sub>CO<sub>3</sub> (0.33 g, 2.4 mmol) were added, and the mixture was heated at 110 °C for 16 h. The mixture was allowed to cool to rt, diluted with EtOAc, and washed with NaHCO<sub>3</sub> (satd). To remove the emulsion, the mixture was filtered through Celite, and then the organic layer was washed with brine, 1 N NaOH, and then brine again. The organic portion was dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated to give 4-(6,7-dimethoxyquinazolin-4-yloxy)-2-nitro-phenylamine as an orange solid (1.0 g, 65%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.54 (s, 1H), 7.86 (d, <i>J</i> = 3.0 Hz, 1H), 7.50−7.55 (m, 3H), 7.44 (dd, <i>J</i> = 9.1, 2.5 Hz, 1H), 7.36 (s, 1H), 7.10 (d, <i>J</i> = 9.1 Hz, 1H), 3.96 (s, 3H), 3.94 (s, 3H). </div><div class="NLM_p">A flask was charged with 4-(6,7-dimethoxyquinazolin-4-yloxy)-2-nitro-phenylamine (1.00 g, 2.90 mmol) and the solid was dissolved in a mixture of EtOH (200 mL) and glacial acetic acid (10 mL) and placed under nitrogen. Pd/C was added, the reaction mixture was blanketed with H<sub>2</sub>, and the mixture was shaken under H<sub>2</sub> for 18 h at 55 psi. The catalyst was removed by filtration through Celite and the solution was concentrated in vacuo. The residue was dissolved in MeOH/water, NH<sub>4</sub>OH was added to adjust to pH 10, and the solvent was evaporated. Partial purification of the residue by column chromatography using a gradient of 0−100% of a 90:10:1 CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH eluent afforded 4-(6,7-dimethoxy-quinazolin-4-yloxy)-benzene-1,2-diamine (impure). A portion of this (60 mg, est 1.44 mmol) was subjected to the conditions used to prepare <b>3</b> to yield the title compound as a yellow solid (22 mg, 34%). <sup>1</sup>H NMR indicates a mixture of tautomers (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.05−11.15 (m, 1H), 9.71 (s, 0.5H), 9.66 (s, 0.5H), 8.48−8.55 (m, 1H), 7.75−7.85 (m, 2H), 7.57 (s, 1H), 7.15−7.40 (m, 5H), 6.80−6.95 (m, 1H), 3.97 (s, 6H); HRMS calcd for C<sub>23</sub>H<sub>18</sub>ClN<sub>5</sub>O<sub>3</sub> (M + H)<sup>+</sup>, 448.1170; found, 448.1169; HPLC purity = 100% (system A), 99% (system B). </div><div class="NLM_p"><b>(4-Chloro-3-trifluoromethyl-phenyl)-[6-(1</b><b><i>H</i></b><b>-pyrrolo[2,3-</b><b><i>b</i></b><b>]pyridin-4-yloxy)-1</b><b><i>H</i></b><b>-benzimidaz</b><b>ol-2-yl]-amine (6).</b> Starting with 4-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yloxy)-benzene-1,2-diamine (82 mg, 0.34 mmol), 58 mg (39%) of the title compound was obtained according to the method described for the synthesis of <b>3</b>. <sup>1</sup>H NMR indicates a mixture of tautomers (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.60−11.65 (m, 1H), 11.30 (s, 0.5H), 11.20 (s, 0.5H), 10.10 (s, 0.5H), 10.00 (s, 0.5H), 8.28−8.35 (m, 1H), 8.10 (d, <i>J</i> = 7.7 Hz, 1H), 7.95−8.05 (m, 1H), 7.60−7.65 (m, 1H), 7.42 (d, <i>J</i> = 7.7 Hz, 0.5H), 7.35 (d, <i>J</i> = 7.7 Hz, 0.5H), 7.28−7.30 (m, 1H), 7.15−7.20 (m, 0.5H), 7.05−7.10 (m, 0.5H), 6.85−6.90 (m, 1H), 6.35 (d, <i>J</i> = 5.8 Hz, 0.5H), 6.30 (d, <i>J</i> = 5.8 Hz, 0.5H), 6.15−6.20 (m, 1H); Anal. (C<sub>21</sub>H<sub>13</sub>ClF<sub>3</sub>N<sub>5</sub>O·0.33 CH<sub>3</sub>OH) C, H, N. </div><div class="NLM_p"><b>4-{2-[4-Chloro-3-(4-methyl-piperazin-1-ylmethyl)-phenylamino]-1</b><b><i>H</i></b><b>-benzimidazol-5-yloxy}</b><b>-pyridine-2-carboxylic Acid Methylamide (7).</b> To a cooled (0 °C) solution of 1-(2-chloro-5-amino-benzyl)-4-methyl-piperazine (252 mg, 1.05 mmol) in CH<sub>3</sub>CN (10 mL) was added 1,1‘-thiocarbonyldiimidazole (225 mg, 1.26 mmol). The reaction mixture was allowed to warm to rt and stirred for 18 h. The mixture was added dropwise to a solution of 4-(3,4-diamino-phenoxy)-pyridine-2-carboxylic acid methylamide (271 mg, 1.05 mmol) in CH<sub>3</sub>CN (20 mL) at rt and stirred 18 h. The reaction mixture was further diluted with CH<sub>3</sub>CN (15 mL), then EDC (0.20 g, 1.05 mmol) was added, and the vessel was heated at 80 °C for 3 h. The mixture was allowed to cool to rt, concentrated in vacuo, and the residue was dissolved in EtOAc and water. The layers were separated, and the organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The mixture was purified by a combination of silica gel column chromatography and silica gel prep plates to obtain the title compound (231 mg, 43%). <sup>1</sup>H NMR indicates a mixture of tautomers (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.11 (s, 0.5H), 11.05 (s, 0.5H), 9.74 (s, 0.5H), 9.69 (s, 0.5H), 8.70−8.80 (m, 1H), 8.45−8.50 (m, 1H), 7.85−7.90 (m, 1H), 7.70−7.75 (m, 1H), 7.30−7.45 (m, 3H), 7.10−7.15 (m, 2H), 6.80−6.90 (m, 1H), 3.50−3.54 (m, 2H), 2.75 (s, 1.5H), 2.74 (s, 1.5H), 2.30−2.50 (m, 8H), 2.17 (s, 1.5H), 2.13 (s, 1.5H); Anal. (C<sub>26</sub>H<sub>28</sub>ClN<sub>7</sub>O<sub>2</sub>·H<sub>2</sub>O·0.5CH<sub>3</sub>OH) C, H, N. </div><div class="NLM_p"><b>4-((2-((3-((2-(Dimethylamino)ethyl)oxy)-4-(trifluoromethyl)phenyl)amino)-1</b><b><i>H</i></b><b>-benzimidazo</b><b>l-5-yl)oxy)-</b><b><i>N</i></b><b>-methyl-2-pyridinecarboxamide (8).</b> Starting from 4-(3,4-diamino-phenoxy)-pyridine-2-carboxylic acid methylamide (217 mg, 0.84 mmol) and [2-(5-isothiocyanato-2-trifluoromethyl-phenoxy)-ethyl]-dimethyl-amine (prepared following the procedure outlined for <b>40d</b> from 3-(2-dimethylamino-ethoxy)-4-trifluoromethylaniline (209 mg, 0.84 mmol) and used crude), 210 mg (48%) of the title compound was obtained as a tan solid according to the method described for the synthesis of <b>3</b>. <sup>1</sup>H NMR indicates a mixture of tautomers (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.33 (s, 0.5H), 11.27 (s, 0.5H), 10.04 (s, 0.5H), 9.98 (s, 0.5H), 8.75−8.76 (m, 1H), 8.46−8.47 (m, 1H), 7.68−7.70 (m, 1H), 7.32−7.52 (m, 4H), 7.13−7.20 (m, 2H), 6.84−6.87 (m, 1H), 4.18−4.21 (m, 2H), 2.75 (d, <i>J</i> = 4.8 Hz, 3H), 2.50−2.54 (m, 2H), 2.20−2.30 (m, 6H); Anal. (C<sub>25</sub>H<sub>25</sub>F<sub>3</sub>N<sub>6</sub>O<sub>3</sub>·0.66 H<sub>2</sub>O·CH<sub>3</sub>OH) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-Methyl-4-((2-((3-((((2</b><b><i>R</i></b><b>)-1-methyl-2-pyrrolidinyl)methyl)oxy)-4-(trifluoromethyl)phenyl)</b><b>amino)-1</b><b><i>H</i></b><b>-benzimidazol-5-yl)oxy)-2-pyridinecarboxamide (9).</b> Starting from 4-(3,4-diamino-phenoxy)-pyridine-2-carboxylic acid methylamide (83 mg, 0.32 mmol), 109 mg (63%) of the title compound was obtained according to the method described for the synthesis of <b>3</b>. <sup>1</sup>H NMR indicates a mixture of tautomers (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.35 (s, 0.5 H), 11.28 (s, 0.5H), 10.05 (s, 0.5H), 9.99 (s, 0.5H), 8.75 (s, 1H), 8.45−8.47 (m, 1H), 7.69 (s, 1H), 7.30−7.50 (m, 4H), 7.10−7.25 (m, 2H), 6.80−6.90 (m, 1H), 4.05−4.15 (m, 1H), 3.85−3.95 (m, 1H), 2.90−3.00 (m, 1H), 2.70−2.75 (m, 3H), 2.60−2.70 (m, 1H), 2.35−2.45 (m, 3H), 2.15−2.25 (m, 1H), 1.90−2.00 (m, 1H), 1.55−1.75 (m, 3H); Anal. (C<sub>27</sub>H<sub>27</sub>F<sub>3</sub>N<sub>6</sub>O<sub>3</sub>·1.5 H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-4-{2-[3-(1-Methyl-pyrrolidin-2-ylmethoxy)-4-pentafluoroethyl-phenylamino]-1</b><b><i>H</i></b><b>-benzi</b><b>midazol-5-yloxy}-pyridine-2-carboxylic Acid Methylamide (10).</b> To a cooled (0 °C) solution of (<i>R</i>)-1-methyl-2-(5-amino-2-pentafluoroethyl-phenoxymethyl)-pyrrolidine (312 mg, 0.96 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (3 mL) was added 1,1‘-thiocarbonyldiimidazole (180 mg, 1.00 mmol). The reaction was allowed to warm to rt and stirred for 18 h. The mixture was concentrated in vacuo, the residue was dissolved in CH<sub>3</sub>CN (7 mL), and 4-(3,4-diamino-phenoxy)-pyridine-2-carboxylic acid methylamide (312 mg, 0.96 mmol) was added. The reaction mixture stirred at rt an additional 16 h, followed by the addition of EDC (276 mg, 1.44 mmol) and CH<sub>3</sub>CH (20 mL). The mixture was heated at 80 °C for 3 h, allowed to cool to rt, and concentrated in vacuo. The residue was taken up into CH<sub>2</sub>Cl<sub>2</sub>, washed with water and brine, dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated. The crude material <a name="jm005001804361" id="jm005001804361"></a> was purified by column chromatography using 0−50% of a 90:10:1 CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH solution as the eluent to yield the title compound as an off-white solid (170 mg, 29%). <sup>1</sup>H NMR indicates a mixture of tautomers (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.25−11.40 (m, 1H), 9.95−10.05 (m, 1H), 8.70−8.80 (m, 1H), 8.46 (d, <i>J</i> = 5.8 Hz, 1H), 7.71 (s, 1H), 7.30−7.50 (m, 4H), 7.10−7.20 (m, 2H), 6.80−6.90 (m, 1H), 3.80−3.90 (m, 1H), 2.90−3.00 (m, 1H), 2.76 (d, <i>J</i> = 4.8 Hz, 3H), 2.55−2.60 (m, 1H), 2.38 (s, 1.5H), 2.35 (s, 1.5H), 2.15−2.25 (m, 1H), 1.90−2.05 (m, 1H), 1.55−1.70 (m, 3H). Anal. (C<sub>28</sub>H<sub>27</sub>F<sub>5</sub>N<sub>6</sub>O<sub>3</sub>·CH<sub>3</sub>OH·0.50H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-Methyl-4-((2-((3-((2-(1-pyrrolidinyl)ethyl)oxy)-5-(trifluoromethyl)phenyl)amino)-1</b><b><i>H</i></b><b>-ben</b><b>zimidazol-5-yl)oxy)-2-pyridinecarboxamide (11).</b> A flask was charged with 3-(2-pyrrolin-1-yl-ethoxy)-5-trifluoromethyl-phenylamine (0.56 m, 2.0 mmol) and CH<sub>2</sub>Cl<sub>2</sub> (10 mL) and cooled in an ice bath. To this solution, 1,1-thiocarbonyldiimidazole (463 mg, 2.6 mmol) was added and the reaction was allowed to warm to rt. After 4 h, the solvent was concentrated in vacuo and the residual yellow solid was titrated with acetone to afford 1-[2-(3-thioisocyanato-5-trifluoromethyl-phenoxy)-ethyl]-pyrrolidine as a 1/1 mixture with imidazole (242 mg). This mixture was used directly in the cyclization step following the procedure described for the synthesis of <b>3</b> using 4-(3,4-diamino-phenoxy)-pyridine-2-carboxylic acid methylamide (0.20 g, 0.63 mmol). The title compound was obtained as a yellow solid (0.20 g, 58%). <sup>1</sup>H NMR indicates a mixture of tautomers (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.32 (s, 0.5 H), 11.28 (s, 0.5H), 9.93 (s, 0.5H), 9.88 (s, 0.5H), 8.70−8.80 (m, 1H), 8.46 (d, <i>J</i> = 5.5 Hz, 1H), 7.77 (s, 1H), 7.65 (s, 1H), 7.45−7.50 (m, 0.5H), 7.30−7.40 (m, 2H), 7.20−7.25 (m, 0.5H), 7.12 (dd, <i>J</i> = 5.5, 2.6 Hz, 1H), 6.82−6.90 (m, 1H), 6.78 (s, 1H), 4.10−4.18 (m, 1H), 2.77−2.85 (m, 2H), 2.76 (d, <i>J</i> = 5.1 Hz, 3H), 2.52−2.58 (m, 4H), 1.60−1.72 (m, 4H); Anal. (C<sub>27</sub>H<sub>27</sub>F<sub>3</sub>N<sub>6</sub>O<sub>3</sub>·H<sub>2</sub>O·0.50CH<sub>3</sub>OH) C, H, N. </div><div class="NLM_p"><b><i>N</i></b><b>-(3-((((2</b><b><i>R</i></b><b>)-1-Methyl-2-pyrrolidinyl)methyl)oxy)-4-(trifluoromethyl)phenyl)-5-(4-quinoliny</b><b>loxy)-1</b><b><i>H</i></b><b>-benzimidazol-2-amine (12).</b> Starting with 4-(quinolin-4-yloxy)-benzene-1,2-diamine (200 mg, 0.80 mmol), 121 mg (28%) of the title compound was obtained according to the method described for the synthesis of <b>3</b>. <sup>1</sup>H NMR indicates a mixture of tautomers (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.35 (s, 0.5H), 11.25 (s, 0.5H), 10.05 (s, 0.5H), 9.95 (s, 0.5H), 8.60−8.65 (m, 1H), 8.35 (d, <i>J</i> = 8.4 Hz, 1H), 8.00 (d, <i>J</i> = 8.4 Hz, 1H), 7.78−7.85 (m, 1H), 7.70 (s, 1H), 7.60−7.68 (m, 1H), 7.40−7.55 (m, 3H), 7.30 (s, 0.5H), 7.20 (s, 0.5H), 6.90−6.95 (m, 1H), 6.50−6.60 (m, 1H), 4.10−4.20 (m, 1H), 3.90−4.00 (m, 1H), 2.90−3.00 (m, 1H), 2.60−2.70 (m, 1H), 2.39−2.42 (m, 3H), 2.20−2.30 (m, 3H), 1.95−2.05 (m, 1H), 1.50−1.80 (m, 3H); Anal. (C<sub>29</sub>H<sub>26</sub>F<sub>3</sub>N<sub>5</sub>O<sub>2</sub>·1.5H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>[4-Chloro-3-(4-methyl-piperazin-1-ylmethyl)-phenyl]-[5-(quinolin-4-yloxy)-1H-benzimidaz</b><b>ol-2-yl]-amine (13).</b> Starting with 4-(quinolin-4-yloxy)-benzene-1,2-diamine (200 mg, 0.80 mmol), 20 mg (5%) of the title compound was obtained according to the method described for the synthesis of <b>7</b>. <sup>1</sup>H NMR indicates a mixture of tautomers (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.10 (s, 0.5 H), 11.05 (s, 0.5 H), 9.75 (s, 0.5H), 9.65 (s, 0.5H), 8.60−8.70 (m, 1H), 8.34 (d, <i>J</i> = 7.4 Hz, 1H), 8.00 (d, <i>J</i> = 7.4 Hz, 1H), 7.85−7.90 (m, 1H), 7.75−7.80 (m, 1H), 7.70−7.80 (m, 1H), 7.60−7.70 (m, 1H), 7.30−7.50 (m ,2H), 7.25 (s, 0.5H), 7.15 (s, 0.5H), 6.80−6.95 (m, 1H), 6.50−6.60 (m, 1H), 3.55 (s, 2H), 2.20−2.60 (m, 8H), 2.18 (s, 1.5H), 2.15 (s, 1.5H); HRMS calcd for C<sub>28</sub>H<sub>27</sub>ClN<sub>6</sub>O (M + H)<sup>+</sup>, 499.2008; found, 499.2005; HPLC purity 99% (system A), 99% (system B). </div><div class="NLM_p"><b>[4-Chloro-3-(4-methylpiperazin-1-ylmethyl)-phenyl]-[5-(6,7-dimethoxyquinolin-4-yloxy)-1</b><b><i>H</i></b><b>-benzimidazol-2-yl]-amine (14).</b> Starting with 4-(6,7-dimethoxyquinolin-4-yloxy)-benzene-1,2-diamine (120 mg, 0.38 mmol), 38 mg (18%) of the title compound was obtained according to the method described for the synthesis of <b>7</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.40 (d, <i>J</i> = 5.0 Hz, 1H), 7.50−7.65 (m, 2H), 7.35−7.50 (m, 2H), 7.30 (d, <i>J</i> = 8.0 Hz, 1H), 7.20−7.28 (m, 4H), 6.93 (dd, <i>J</i> = 8.0, 2.0 Hz, 1H), 6.40 (d, <i>J</i> = 5.0 Hz, 1H), 4.05 (s, 3H), 4.03 (s, 3H), 3.70 (s, 2H), 2.60−2.80 (m, 8H), 2.35 (s, 3H); HRMS calcd for C<sub>30</sub>H<sub>31</sub>ClN<sub>6</sub>O<sub>3</sub> (M + H)<sup>+</sup>, 559.2219; found, 559.2223; HPLC purity 99% (system A), 96% (system B). </div><div class="NLM_p"><b>[4-Chloro-3-(4-methyl-piperazin-1-ylmethyl)-phenyl]-[6-(7</b><b><i>H</i></b><b>-pyrrolo[2,3-</b><b><i>d</i></b><b>]pyrimidin-4-ylo</b><b>xy)-1</b><b><i>H</i></b><b>-benzimidazol-2-yl]-amine (15).</b> Starting with 4-(7<i>H</i>-pyrrolo[2,3-d]pyrimidin-4-yloxy)benzene-1,2-diamine (100 mg, 0.40 mmol), 15 mg (8%) of the title compound was obtained according to the method described for the synthesis of <b>3</b>. <sup>1</sup>H NMR indicates a mixture of tautomers (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.08−12.14 (m, 1H), 11.00 (s, 0.5H), 10.94 (s, 0.5H), 9.65 (s, 0.5H), 9.60 (s, 0.5H), 8.23−8.26 (m, 1H), 7.84−7.92 (m, 1H), 7.68−7.74 (m, 1H), 7.24−7.40 (m, 3H), 7.12−7.17 (m, 1H), 6.80−6.88 (m, 1H), 6.24−6.30 (m, 1H), 3.50 (s, 2H), 2.20−2.50 (m, 8H), 2.15 (s, 1.5H), 2.10 (s, 1.5H); HRMS calcd for C<sub>25</sub>H<sub>25</sub>ClN<sub>8</sub>O (M + H)<sup>+</sup>, 489.1912; found, 489.1911; HPLC purity 95% (system B), 100% (system C). </div><div class="NLM_p"><b>[4-Chloro-3-(4-methyl-piperazin-1-ylmethyl)-phenyl]-[6-(1</b><b><i>H</i></b><b>-pyrrolo[2,3-</b><b><i>b</i></b><b>]pyridin-4-yloxy)</b><b>-1</b><b><i>H</i></b><b>-benzimidazol-2-yl]-amine (16).</b> Starting with 4-(1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yloxy)-benzene-1,2-diamine (106 mg, 0.44 mmol), 84 mg (39%) of the title compound was obtained according to the method described for the synthesis of <b>3</b>. <sup>1</sup>H NMR indicates a mixture of tautomers (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.60−11.70 (m, 1H), 11.05 (s, 0.5H), 10.95 (s, 0.5H), 9.70 (s, 0.5H), 9.65 (s, 0.5H), 7.95−8.05 (m, 1H), 7.85−7.90 (m, 1H), 7.75 (d, <i>J</i> = 3.2 Hz, 1H), 7.30−7.40 (m, 2H), 7.12 (d, <i>J</i> = 2.1 Hz, 0.5H), 7.07 (d, <i>J</i> = 2.1 Hz, 0.5H), 6.80−6.90 (m, 1H), 6.35 (d, <i>J</i> = 5.5 Hz, 0.5H), 6.30 (d, <i>J</i> = 5.5 Hz, 0.5H), 6.15−6.20 (m, 1H), 3.52 (s, 1H), 3.50 (s, 1H), 2.20−2.50 (m, 8H), 2.18 (s, 1.5 H), 2.15 (s, 1.5H); Anal. (C<sub>26</sub>H<sub>26</sub>ClN<sub>7</sub>O·2H<sub>2</sub>0) C, H, N. </div><div class="NLM_p"><b>[4-Chloro-3-(4-methylpiperazin-1-ylmethyl)phenyl]-[5-(2-methylamino-pyrimidin-4-yloxy)-</b><b>1</b><b><i>H</i></b><b>-benzimidazol-2-yl]-amine (17).</b> To a solution of 4-(2-methanesulfonyl-pyrimidin-4-yloxy)-benzene-1,2-diamine (<b>39h</b>; 400 mg, 1.4 mmol) in anhydrous THF (4 mL) was added CH<sub>3</sub>NH<sub>2</sub> (2 M in THF, 1 mL, 2.0 mmol). The solution was heated to 80 °C for 1 h, and the mixture was allowed to cool to rt and concentrated in vacuo. The material was purified by column chromatography (0−10% MeOH/CH<sub>2</sub>Cl<sub>2</sub> with 1% NH<sub>4</sub>OH) to yield 4-(2-methylamino-pyrimidin-4-yloxy)-benzene-1,2-diamine (300 mg, 92%), which was used directly in the next step. </div><div class="NLM_p">To a solution of 4-(2-methylamino-pyrimidin-4-yloxy)-benzene-1,2-diamine (300 mg, 1.3 mmol) in anhydrous CH<sub>3</sub>CN (20 mL) was added dropwise a solution of 1-(2-chloro-5-isothiocyanato-benzyl)-4-methyl-piperazine (405 mg [residual imidazole present], 1.3 mmol) in anhydrous CH<sub>3</sub>CN (10 mL). The solution was stirred for 16 h at rt, then EDC (250 mg, 1.3 mmol) was added, and the reaction mixture was heated at 80 °C for 2 h. The mixture was allowed to cool to rt and concentrated in vacuo. The residue was dissolved in a mixture of CH<sub>2</sub>Cl<sub>2</sub>/MeOH (50 mL) and washed with H<sub>2</sub>O, NaHCO<sub>3</sub> (satd), and brine. The aqueous layers were back-extracted with CH<sub>2</sub>Cl<sub>2</sub>, and the combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated. The material was purified by column chromatography (0−10% MeOH/CH<sub>2</sub>Cl<sub>2</sub> with 1% NH<sub>4</sub>OH) followed by preparative TLC and reverse-phase HPLC (5−100% H<sub>2</sub>O/CH<sub>3</sub>CN with 0.1% TFA) to yield the title compound (57 mg, 9%). <sup>1</sup>H NMR (400 MHz, 325K, DMSO-<i>d</i><sub>6</sub>) δ 10.85−11.00 (bs, 1H), 9.45−9.55 (bs, 1H), 8.10 (d, <i>J</i> = 5.3 Hz, 1H), 7.81 (dd, <i>J</i> = 8.5, 2.3 Hz, 1H), 7.76 (d, <i>J</i> = 2.6 Hz, 1H), 7.25−7.35 (m, 2H), 7.07 (s, 1H), 6.70−6.90 (m, 2H), 5.95−6.00 (m, 1H), 3.55 (s, 2H), 2.71 (d, <i>J</i> = 4.6 Hz, 3H), 2.45−2.55 (m, 8H), 2.24 (s, 3H); Anal. (C<sub>24</sub>H<sub>27</sub>ClN<sub>8</sub>O·H<sub>2</sub>O·1.66CH<sub>3</sub>OH) C, H, N. </div><div class="NLM_p"><b>[4-Chloro-3-(4-methyl-piperazin-1-ylmethyl)-phenyl]-[5-(2-methylsulfanyl-pyrimidin-4-ylo</b><b>xy)-1</b><b><i>H</i></b><b>-benzimidazol-2-yl]-amine (18).</b> Starting with 4-(2-methylsulfanyl-pyrimidin-4-yloxy)-benzene-1,2-diamine (400 mg, 1.6 mmol), 13 mg (2%) of the title compound was obtained according to the method described for the synthesis of <b>7</b>. <sup>1</sup>H NMR indicates a mixture of tautomers (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.95−11.10 (m, 1H), 9.70 (s, 0.5 H), 9.60 (s, 0.5H), 8.40−8.45 (m, 1H), 7.80−7.90 (m, 1H), 7.70−7.78 (m, 1H), 7.25−7.40 (m, 2H), 7.05−7.18 (m, 1H), 6.75−6.90 (m, 1H), 6.55−6.70 (m, 1H), 3.55 (s, 2H), 2.30−2.50 (m, 1H), 2.20 (s, 3H); HRMS <a name="jm005001804362" id="jm005001804362"></a> calcd for C<sub>24</sub>H<sub>26</sub>ClN<sub>7</sub>OS (M + H)<sup>+</sup>, 496.1681; found, 496.1682; HPLC purity = 99% (system B), 99% (system C). </div><div class="NLM_p"><b>4-{2-[4-Chloro-3-(4-methyl-piperazin-1-ylmethyl)-phenylamino]-1-methyl-1</b><b><i>H</i></b><b>-benzimidazol</b><b>-5-yloxy}-pyridine-2-carboxylic Acid Methylamide (19).</b> Starting with 4-(3-amino-4-methylamino-phenoxy)-pyridine-2-carboxylic acid methylamide (25 mg, 0.92 mmol), 5 mg (10%) of the title compound was obtained as an off-white solid according to the method described for the synthesis of <b>7</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.17 (s, 1H), 8.70−8.76 (m, 1H), 8.46 (d, <i>J</i> = 5.9 Hz, 1H), 7.95 (dd, <i>J</i> = 9.2, 2.5 Hz, 1H), 7.85 (d, <i>J</i> = 2.6 Hz, 1 H), 7.40 (d, <i>J</i> = 8.4 Hz, 1H), 7.30−7.35 (m, 2H), 7.17 (d, <i>J</i> = 2.2 Hz, 1H), 7.10−7.14 (m, 1H), 6.88 (d, <i>J</i> = 8.5, 2.2 Hz, 1H), 3.74 (s, 3H), 3.51 (s, 2H), 2.75 (d, <i>J</i> = 4.7 Hz, 3H), 2.30−2.50 (m, 8H), 2.11 (s, 3H); HRMS calcd for C<sub>27</sub>H<sub>30</sub>ClN<sub>7</sub>O<sub>2</sub> (M + H)<sup>+</sup>, 519.2149; found, 520.2222; HPLC purity = 100% (system A), 99% (system B). </div><div class="NLM_p"><b>4-{2-[4-Chloro-3-(4-methyl-piperazin-1-ylmethyl)-phenylamino]-benzoxazol-5-yloxy}-pyrid</b><b>ine-2-carboxylic Acid Methylamide (20).</b> To a cooled (0 °C) solution of 1-(2-chloro-5-amino-benzyl)-4-methyl-piperazine (1.87 g, 7.79 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (30 mL) was added 1,1‘-thiocarbonyldiimidazole (2.08 g, 11.69 mmol). The reaction mixture was allowed to warm to rt and stirred for 2 h. The reaction was concentrated to a small volume and partially purified by short column silica gel chromatography using 1:3 EtOAc/hexanes as the eluent to obtain 1-(2-chloro-5-isothiocyanato-benzyl)-4-methyl-piperazine. A portion of this (350 mg, 0.68 mmol) and 4-(3-amino-4-hydroxy-phenoxy)-pyridine-2-carboxylic acid methylamide (147 mg, 0.57 mmol) were used to prepare the title compound according to the method described for the synthesis of <b>7</b> (63 mg, 22%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.88 (s, 1H), 8.70−8.80 (m, 1H), 8.45−8.50 (m, 1H), 7.75−7.80 (m, 2H), 7.65−7.70 (m, 1H), 7.30−7.45 (m, 3H), 7.15−7.20 (m, 1H), 6.95−7.00 (m, 1H), 3.52 (s, 2H), 2.75−2.77 (m, 3H), 2.30−2.50 (m, 8H), 2.14 (s, 3H); HRMS calcd for C<sub>26</sub>H<sub>27</sub>ClN<sub>6</sub>O<sub>3</sub> (M + H)<sup>+</sup>, 507.1906; found, 507.1906; HPLC purity 100% (system A), 100% (system B). </div><div class="NLM_p"><b>4-((2-((4-Chlorophenyl)-amino)-1,3-benzoxazol-5-yl)oxy)-</b><b><i>N</i></b><b>-methyl-2-pyridinecarboxamide </b><b>(21).</b> Starting from 4-(3-amino-5-fluoro-4-hydroxyphenoxy)-pyridine-2-carboxylic acid methylamide (100 mg, 0.39 mmol), 39 mg (25%) of the title compound was obtained according to the method described for the synthesis of <b>7</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.95 (s, 1H), 8.70−8.80 (m, 1H), 8.50 (d, <i>J</i> = 5.6 Hz, 1H), 7.75−7.80 (m, 2H), 7.62 (d, <i>J</i> = 8.5 Hz, 1H), 7.44 (d, <i>J</i> = 5.6 Hz, 2H), 7.35−7.38 (m, 2H), 7.15−7.18 (m, 1H), 7.00 (dd, <i>J</i> = 8.5, 1.7 Hz, 1H), 2.78 (d, <i>J</i> = 4.8 Hz, 3H); Anal. (C<sub>20</sub>H<sub>15</sub>ClN<sub>4</sub>O<sub>3</sub>) C, H, N. </div><div class="NLM_p"><b>4-((2-((4-Chloro-3-((((2</b><b><i>S</i></b><b>)-1-methyl-2-pyrrolidinyl)methyl)oxy)phenyl)amino)-1,3-benzoxaz</b><b>ol-5-yl)oxy)-</b><b><i>N</i></b><b>-methyl-2-pyridinecarboxamide (22).</b> To a 0 °C solution of (<i>S</i>)-4-chloro-3-(1-methyl-pyrrolidin-2-ylmethoxy)-phenylamine (3.11 g, 12.92 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (30 mL) was added 1,1‘-thiocarbonyldiimidazole (2.87 g, 16.15 mmol). The reaction was allowed to warm to rt and stirred for 2 h. The reaction was concentrated and purified by short column silica gel chromatography using 1:3 EtOAc/hexanes as the eluent to yield (<i>S</i>)-2-((2-chloro-5-isothiocyanatophenoxy)methyl)-1-methylpyrrolidine. A portion of this (1.80 g, 6.37 mmol) and 4-(3-amino-4-hydroxy-phenoxy)-pyridine-2-carboxylic acid methylamide (1.90 g, 7.32 mmol) were used to prepare the title compound according to the method described for the synthesis of <b>7</b> (1.96 g, 60%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.89 (s, 1H), 8.77 (q, <i>J</i> = 5.2 Hz, 1H), 8.49 (d, <i>J</i> = 6.4 Hz, 1H), 7.62 (d, <i>J</i> = 8.8 Hz, 1H), 7.57−7.58 (m, 1H), 7.32−7.41 (m, 4H), 7.14−7.16 (m, 1H), 6.96−6.99 (m, 1H), 3.91−4.02 (m, 2H), 2.92−2.98 (m, 1H), 2.76 (d, <i>J</i> = 5.2 Hz, 3H), 2.62−2.68 (m, 1H), 2.40 (s, 3H), 2.16 −2.28 (m, 1H), 1.90−2.02 (m, 1H), 1.58−1.74 (m, 3H); Anal. (C<sub>26</sub>H<sub>26</sub>ClN<sub>5</sub>O<sub>4</sub>·0.50 H<sub>2</sub>O·0.50CH<sub>3</sub>OH) C, H, N. </div><div class="NLM_p"><b>4-{2-[4-Chloro-3-(2-dimethylamino-ethoxy)-phenylamino]-benzoxazol-5-yloxy}-pyridine-2-</b><b>carboxylic Acid Methylamide (23).</b> Starting from 4-{2-[4-chloro-3-(2-chloro-ethoxy)-phenylamino]-benzoxazolo-5-yloxy}-pyridine-2-carboxylic acid methylamide (as a mixture with the bromo) (0.17 g, 0.36 mmol), 89 mg (50%) of the title compound was obtained as a light yellow solid according to the method described for the synthesis of <b>24</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.91 (s, 1H), 8.76−8.79 (m, 1H), 8.49 (d, <i>J</i> = 5.2 Hz, 1H), 7.62 (d, <i>J</i> = 8.4 Hz, 1H), 7.57 (d, <i>J</i> = 2.0 Hz, 1H), 7.33−7.38 (m, 4H), 7.14−7.16 (m, 1H), 6.98 (dd, <i>J</i> = 8.4, 2.4 Hz, 1H), 4.12 (t, <i>J</i> = 6.0 Hz, 2H), 2.75 (d, <i>J</i> = 4.8 Hz, 3H), 2.67−2.70 (m, 2H), 2.24 (s, 6H); Anal. (C<sub>24</sub>H<sub>24</sub>ClN<sub>5</sub>O<sub>4</sub>·CH<sub>3</sub>OH) C, H, N. </div><div class="NLM_p"><b>4-{2-[4-Chloro-3-(2-diethylamino-ethoxy)-phenylamino]-benzoxazol-5-yloxy}-pyridine-2-ca</b><b>rboxylic Acid Methylamide (24).</b> To a stirring rt solution of 4-(3-amino-4-hydroxy-phenoxy)-pyridine-2-carboxylic acid methylamide (1.51 g, 5.824 mmol) in DMF (8 mL) and CH<sub>3</sub>CN (80 mL) was added 1-chloro-2-(2-chloro-ethoxy)-4-isothiocyanato-benzene (1.39 g, about 5.3 mmol-mixed with the bromo adduct). The reaction mixture was stirred over 4 days at rt, and EDC (1.02 g, 5.30 mmol) was added. The mixture was heated at 50 °C for 16 h and allowed to cool to rt. The solvent was evaporated, and the mixture was diluted with 1 N NaOH and EtOAc. The organic phase was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Silica gel chromatography of the crude residue yielded 4-{2-[4-chloro-3-(2-chloro-ethoxy)-phenylamino]-benzoxazolo-5-yloxy}-pyridine-2-carboxylic acid methylamide (as a mixture with the bromo). A portion of this mixture (156 mg, 0.33 mmol) was combined with excess diethylamine (0.5 mL) and DMSO (1 mL) in a sealed tube, and the mixture was heated with stirring for 2 days at 85 °C. The mixture was allowed to cool to rt and treated with 1 N NaOH and extracted with EtOAc (×3). The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification of the crude residue by thin layer silica gel chromatography yielded the title compound as a light yellow solid (105 mg, 63%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.90 (s, 1H), 8.76−8.79 (m, 1H), 8.49 (d, <i>J</i> = 5.2 Hz, 1H), 7.61 (d, <i>J</i> = 8.4 Hz, 1H), 7.57 (d, <i>J</i> = 2.4 Hz, 1H), 7.32−7.40 (m, 4H), 7.14−7.16 (m, 1H), 6.98 (dd, <i>J</i> = 8.4, 2.8 Hz, 1H), 4.08 (t, <i>J</i> = 5.6 Hz, 2H), 2.80−2.90 (m, 2H), 2.76 (d, <i>J</i> = 4.8 Hz, 3H), 2.56 (q, <i>J</i> = 7.2 Hz, 4H), 0.96 (t, <i>J</i> = 7.2 Hz, 6H). Anal. (C<sub>26</sub>H<sub>28</sub>ClN<sub>5</sub>O<sub>4</sub>·H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>4-((2-((4-Chloro-3-(4-morpholinylmethyl)phenyl)amino)-1,3-benzoxazol-5-yl)oxy)-</b><b><i>N</i></b><b>-methyl</b><b>-2-pyridinecarboxamide (25).</b> Starting from 4-(3-amino-4-hydroxy-phenoxy)-pyridine-2-carboxylic acid methylamide (324 mg, 1.25 mmol), 263 mg (45%) of the title compound was obtained as an off-white solid according to the method described for the synthesis of <b>7</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.89 (s, 1H), 8.77 (q, <i>J</i> = 4.8 Hz, 1H), 8.49 (d, <i>J</i> = 5.6 Hz, 1H), 7.84 (d, <i>J</i> = 2.8 Hz, 1H), 7.77 (dd, <i>J</i> = 8.8, 3.2 Hz, 1H), 7.60 (d, <i>J</i> = 8.4 Hz, 1H), 7.42 (d, <i>J</i> = 8.8 Hz, 1H), 7.35 (dd, <i>J</i> = 10.4, 2.8 Hz, 1H), 7.14−7.16 (m, 1H), 6.97 (dd, <i>J</i> = 8.8, 2.0 Hz, 1H), 3.60−3.62 (m, 4H), 3.54 (s, 2H), 2.76 (d, <i>J</i> = 5.2 Hz, 3H), 2.42−2.47 9 m, 4H); Anal. (C<sub>25</sub>H<sub>24</sub>ClN<sub>5</sub>O<sub>4</sub>·0.33CH<sub>3</sub>OH) C, H, N. </div><div class="NLM_p"><b>4-{2-[4-Chloro-3-(piperidin-4-ylmethoxy)-phenylamino]-benzoxazol-5-yloxy}-pyridine-2-ca</b><b>rboxylic Acid Methylamide (26).</b> To a cooled (0 °C) solution of 4-(5-amino-2-chloro-phenoxymethyl)-piperidine-1-carboxylic acid <i>tert</i>-butyl ester (54 mg, 0.16 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (3 mL) was added 1,1‘-thiocarbonyldiimidazole (28 mg, 0.16 mmol). The reaction was allowed to warm to rt and stirred for 18 h. 4-(3-Amino-4-hydroxy-phenoxy)-pyridine-2-carboxylic acid methylamide (41 mg, 0.16 mmol) was added, and the reaction mixture was stirred an additional 16 h. EDC (45 mg, 0.24 mmol) was added, and the mixture was stirred at rt for 3 h. The reaction mixture was partially purified by prep HPLC to obtain 4-{2-chloro-5-[5-(2-methylcarbamoyl-pyridin-4-yloxy)-benzoxazol-2-ylamino]-phenoxymethyl}-piperidine-1-carboxylic acid <i>tert</i>-butyl ester. This intermediate was stirred with TFA (2 mL) at rt for 3 h and concentrated in vacuo. The residue was taken up into ethyl acetate, washed with 1 N NaOH and NaHCO<sub>3</sub> (satd), dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated. Purification by prep HPLC yielded the title compound as a white solid (13 mg, 39%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.90 (bs, 1H), 8.76−8.82 (m ,1H), 8.50 (d, <i>J</i> = 5.9 Hz, 1H), 8.00−8.30 (bs, 1H), 7.58−7.64 (m, 2H), 7.32−7.42 (m, 4H), 7.15−7.18 (m, 1H), 6.99 (dd, <i>J</i> = 8.7, 2.4 Hz, 1H), <a name="jm005001804363" id="jm005001804363"></a> 3.95 (d, <i>J</i> = 5.8 Hz, 2H), 3.24−3.30 (m, 2H), 2.54−2.84 (m, 2H), 2.75 (d, <i>J</i> = 4.9 Hz, 3H), 2.02−2.14 (m, 1H), 1.90−1.98 (m, 2H), 1.42−1.58 (m, 2H); HRMS calcd for C<sub>26</sub>H<sub>26</sub>ClN<sub>5</sub>O<sub>4</sub> (M + H)<sup>+</sup>, 508.1746; found, 508.1747; HPLC purity 99% (system A), 96% (system B). </div><div class="NLM_p"><b>4-{2-[4-Chloro-3-((2</b><b><i>S</i></b><b>)-1-methyl-pyrrolidin-2-ylmethoxy)-phenylamino]-benzooxazol-5-ylox</b><b>y}-pyridine-2-carboxylic Acid Amide (27).</b> Starting with 4-(3-amino-4-hydroxy-phenoxy)-pyridine-2-carboxylic acid amide (0.22 g, 0.88 mmol), 160 g (37%) of the title compound was obtained as a white solid according to the method described for the synthesis of <b>22</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.88 (s, 1H), 8.50 (d, <i>J</i> = 5.2 Hz, 1H), 8.08−8.12 (m, 1H), 7.65−7.70 (m, 1H), 7.61 (d, <i>J</i> = 8.4 Hz, 1H), 7.57 (d, <i>J</i> = 2.4 Hz, 1H), 7.30−7.40 (m, 4H), 7.17 (dd, <i>J</i> = 8.4, 5.2 Hz, 1H), 6.98 (dd, <i>J</i> = 8.4, 2.4 Hz, 1H), 3.90−4.02 (m, 2H), 2.90−2.98 (m, 1H), 2.60−2.70 (m, 1H), 2.40 (s, 3H), 2.15−2.25 (m, 1H), 1.90−2.02 (m, 1H), 1.58−1.72 (m, 3H); Anal. (C<sub>25</sub>H<sub>24</sub>ClN<sub>5</sub>O<sub>4</sub>·CH<sub>3</sub>OH) C, H, N. </div><div class="NLM_p"><b><i>S-</i></b><b>[4-Chloro-3-(1-methyl-pyrrolidin-2-ylmethoxy)-phenyl]-[5-(6,7-dimethoxy-quinazolin-4-y</b><b>loxy)-benzoxazol-2-yl]-amine (28).</b> Starting with 2-amino-4-(6,7-dimethoxyquinazolin-4-yloxy)-phenol (0.22 g, 0.70 mmol), 125 mg (32%) of the title compound was obtained as a tan solid according to the method described for the synthesis of <b>22</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.82 (s, 1H), 8.51 (s, 1H), 7.50−7.60 (m, 3H), 7.30−7.40 (m, 4H), 7.00−7.10 (m, 1H), 3.85−4.05 (m, 8H), 2.95−3.00 (m, 1H), 2.60−2.80 (m, 1H), 2.42 (s, 3H), 2.20−2.30 (m, 1H), 1.90−2.05 (m, 1H), 1.60−1.80 (m, 3H); HRMS calcd for C<sub>29</sub>H<sub>28</sub>ClN<sub>5</sub>O<sub>5</sub> (M + H)<sup>+</sup>, 562.1852; found, 562.1848; HPLC purity = 95% (system A), 99% (system B). </div><div class="NLM_p"><b><i>S-</i></b><b>[4-Chloro-3-(1-methylpyrrolidin-2-ylmethoxy)-phenyl]-[5-(6,7-dimethoxyquinolin-4-ylox</b><b>y)-benzoxazol-2-yl]-amine (29).</b> Starting with 2-amino-4-(2,3-dimethoxyquinolin-4-yloxy)phenol (200 mg, 0.64 mmol), 50 mg (14%) of the title compound was obtained as a tan solid according to the method described for the synthesis of <b>22</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.85 (s, 1H), 8.42 (d, <i>J</i> = 5.0 Hz, 1H), 7.60 (d, <i>J</i> = 7.3 Hz, 1H), 7.55 (m, 1H), 7.50 (s, 1H), 7.35−7.40 (m, 4H), 7.00 (dd, <i>J</i> = 7.3, 2.3 Hz, 1H), 6.40 (d, <i>J</i> = 5.0 Hz, 1H), 3.90−4.05 (m, 8H), 2.95−3.00 (m, 1H), 2.60−2.70 (m, 1H), 2.40 (s, 3H), 2.15−2.25 (m, 1H), 1.95−2.05 (m, 1H), 1.60−1.80 (m, 3H); HRMS calcd for C<sub>30</sub>H<sub>29</sub>ClN<sub>4</sub>O<sub>5</sub> (M + H)<sup>+</sup>, 560.1826; found, 561.18992; HPLC purity = 99% (system A), 99% (system B). </div><div class="NLM_p"><b>5-((6,7-Bis(methoxy)-4-quinolinyl)oxy)-</b><b><i>N</i></b><b>-(4-chloro-3-((4-methyl-1-piperazinyl)methyl)phen</b><b>yl)-1,3-benzoxazol-2-amine (30).</b> Starting from 2-amino-4-(6,7-dimethoxyquinolin-4-yloxy)phenol (220 mg, 0.70 mmol), 34 mg (9%) of the title compound was obtained as a tan solid according to the method described for the synthesis of <b>20</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.90 (s, 1H), 8.42 (d, <i>J</i> = 3.6 Hz, 1H), 7.80−7.85 (m, 2H), 7.60 (d, <i>J</i> = 8.9 Hz, 1H), 7.50 (s, 1H), 7.30−7.40 (m, 3H), 7.00−7.05 (m, 1H), 6.45 (d, <i>J</i> = 3.6 Hz, 1H), 3.90 (s, 6H), 3.50 (s, 2H), 2.20−2.50 (m, 8H), 2.15 (s, 3H); HRMS calcd for C<sub>30</sub>H<sub>30</sub>ClN<sub>5</sub>O<sub>4</sub> (M + H)<sup>+</sup>, 560.2059; found, 560.2058; HPLC purity 99% (system A), 99% (system B). </div><div class="NLM_p"><b>([4-Chloro-3-(4-methyl-piperazin-1-ylmethyl)-phenyl]-[5-(quinolin-4-yloxy)-benzoxazol-2-y</b><b>l]-amine) (31).</b> Starting from 2-amino-4-(quinolin-4-yloxy)-phenol (150 mg, 0.59 mmol), 50 mg (17%) of the title compound was obtained according to the method described for the synthesis of <b>20</b>. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 8.65 (d, <i>J</i> = 4.2 Hz, 1H), 8.38−8.42 (m, 1H), 8.10 (d, <i>J</i> = 8.3 Hz, 1H), 7.74−7.79 (m, 1H), 7.57−7.67 (m, 4H), 7.32−7.39 (m, 2H), 7.31 (d, <i>J</i> = 2.1 Hz, 1H), 6.95 (dd, <i>J</i> = 8.3, 2.8 Hz, 1H), 6.54 (d, <i>J</i> = 4.2 Hz, 1H), 3.65 (s, 2H), 2.50−2.70 (m, 8H), 2.30 (s, 3H); HRMS calcd for C<sub>28</sub>H<sub>26</sub>ClN<sub>5</sub>O<sub>2</sub> (M + H)<sup>+</sup>, 500.1848; found, 500.1847; HPLC purity 98% (system A), 94% (system B). </div><div class="NLM_p"><b>[4-Chloro-3-(4-methyl-piperazin-1-ylmethyl)-phenyl]-[5-(2-methylamino-pyrimidin-4-yloxy</b><b>)-benzoxazol-2-yl]-amine (32).</b> To a solution of 2-amino-4-(2-methylamino-pyrimidin-4-yloxy)-phenol (0.14 g, 0.62 mmol) in CH<sub>3</sub>CN (30 mL) was added dropwise over 5 min a solution 1-(2-chloro-5-isothiocyanato-benzyl)-4-methyl-piperazine (0.17 g, 0.62 mmol) in CH<sub>3</sub>CN (10 mL). The reaction mixture was stirred 18 h at rt. The reaction mixture was diluted with CH<sub>3</sub>CN (10 mL), then EDC (0.12 g, 0.62 mmol) was added, and the mixture was heated at 80 °C for 3 h. The mixture was allowed to cool to rt and concentrated in vacuo, and the residue was dissolved in EtOAc and water. The layers were separated, and the organic layer washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by a combination of silica gel column chromatography and silica gel prep plates to obtain the title compound (125 mg, 42%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.80 (s, 1H), 8.12 (bs, 1H), 7.75−7.80 (m, 2H), 7.51 (d, <i>J</i> = 8.8 Hz, 1H), 7.41 (d, <i>J</i> = 8.4 Hz, 1H), 7.23 (s, 1H), 6.85−7.00 (m, 2H), 5.90−6.20 (m, 1H), 3.53 (s, 2H), 2.60−2.70 (m, 4H), 2.30−2.50 (m, 7H), 2.17 (s, 3H); Anal. (C<sub>24</sub>H<sub>26</sub>ClN<sub>7</sub>O<sub>2</sub>·H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>[4-Chloro-3-(4-methyl-piperazin-1-ylmethyl)-phenyl]-[5-(6-methylamino-pyrimidin-4-yloxy</b><b>)-benzoxazol-2-yl]-amine (33).</b> Starting with 2-amino-4-(6-methylamino-pyrimidin-4-yloxy)-phenol (132 mg, 0.57 mmol), 80 mg (30%) of the title compound was obtained as a yellow solid according to the method described for the synthesis of <b>32</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.80 (s, 1H), 8.11 (bs, 1H), 7.76−7.80 (m, 2H), 7.50 (d, <i>J</i> = 8.8 Hz, 1H), 7.41 (d, <i>J</i> = 8.4 Hz, 1H), 7.25−7.30 (m, 1H), 7.19 (d, <i>J</i> = 2.4 Hz, 1H), 6.87 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 5.74 (s, 1H), 3.52 (s, 2H), 2.74 (bs, 3H), 2.30−2.50 (m, 8H), 2.15 (s, 3H); Anal. (C<sub>24</sub>H<sub>26</sub>ClN<sub>7</sub>O<sub>2</sub>·H<sub>2</sub>O·0.50CH<sub>3</sub>OH) C,H,N. </div><div class="NLM_p"><b><i>N</i></b><b>-(4-Chloro-3-(((2</b><b><i>S</i></b><b>)-1-methyl-2-pyrrolidinyl)methoxy)phenyl)-5-(1</b><b><i>H</i></b><b>-pyrrolo[2,3-</b><b><i>b</i></b><b>]pyridin</b><b>-4-yloxy)-1,3-benzoxazol-2-amine (34).</b> Starting with 4-(1<i>H</i>-indol-4-yloxy)-2-aminophenol (130 mg, 0.50 mmol), 79 mg (32%) of the title compound was obtained according to the method described for the synthesis of <b>22</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.70 (s, 1H), 10.90 (s, 1H), 8.05 (d, <i>J</i> = 5.8 Hz, 1H), 7.55−7.60 (m, 2H), 7.35−7.45 (m, 3H), 7.30 (d, <i>J</i> = 2.0 Hz, 1H), 6.95 (dd, <i>J</i> = 7.7, 2.0 Hz, 1H), 6.38 (d, <i>J</i> = 5.8 Hz, 1H), 6.20−6.25 (m, 1H), 4.00−4.05 (m, 1H), 3.92−3.97 (m, 1H), 2.92−2.98 (m, 1H), 2.62−2.70 (m, 1H), 2.40 (s, 3H), 2.16−2.25 (m, 1H), 1.90−2.04 (m, 1H), 1.58−1.78 (m, 3H); HRMS calcd for C<sub>26</sub>H<sub>24</sub>ClN<sub>5</sub>O<sub>3</sub> (M + H)<sup>+</sup>, 490.1640; found, 490.1642; HPLC purity = 99% (system B), 100% (system C). </div><div class="NLM_p"><b><i>N</i></b><b>-(4-Chloro-3-((4-methyl-1-piperazinyl)methyl)phenyl)-5-(1</b><b><i>H</i></b><b>-pyrrolo[2,3-</b><b><i>b</i></b><b>]pyridin-4-ylox</b><b>y)-1,3-benzoxazol-2-amine (35).</b> Starting with 4-(1<i>H</i>-indol-4-yloxy)-2-aminophenol (0.13 g, 0.50 mmol), 116 mg (48%) of the title compound was obtained according to the method described for the synthesis of <b>32</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.70 (s, 1H), 10.85 (s, 1H), 8.05 (d, <i>J</i> = 5.6 Hz, 1H), 7.80 (s, 1H), 7.78 (d, <i>J</i> = 7.4 Hz, 1H), 7.55 (d, <i>J</i> = 7.4 Hz, 1H), 7.40 (d, <i>J</i> = 7.4 Hz, 1H), 7.30−7.35 (m, 1H), 7.25 (s, 1H), 6.90−7.0 (m, 1H), 6.38 (d, <i>J</i> = 5.6 Hz, 1H), 6.20−6.25 (m, 1H), 3.55 (s, 2H), 2.30−2.50 (m, 8), 2.15 (s, 3H); Anal. (C<sub>26</sub>H<sub>25</sub>ClN<sub>6</sub>O<sub>2</sub>·0.50CH<sub>3</sub>OH) C, H, N. </div><div class="NLM_p"><b>4-((2-((4-Chloro-3-(((2</b><b><i>S</i></b><b>)-1-methyl-2-pyrrolidinyl)methoxy)phenyl)amino)-7-fluoro-1,3-benz</b><b>oxazol-5-yl)oxy)-</b><b><i>N</i></b><b>-methyl-2-pyridinecarboxamide (36).</b> Starting from 4-(3-amino-5-fluoro-4-hydroxyphenoxy)-pyridine-2-carboxylic acid methylamide (256 mg, 0.93 mmol) and 2-(2-chloro-5-isothiocyanato-phenoxymethyl)-1-methyl-pyrrolidine (249 mg, 0.88 mmol), 244 mg (53%) of the title compound was obtained according to the method described for the synthesis of <b>22</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.15 (s, 1H), 8.79 (q, <i>J</i> = 5.2 Hz, 1H), 8.50 (d, <i>J</i> = 6.0 Hz, 1H), 7.56 (d, <i>J</i> = 2.0 Hz, 1H), 7.39−7.42 (m, 2H), 7.29−7.32 (m, 1H), 7.24 (d, <i>J</i> = 2.0 Hz, 1H), 7.17−7.19 (m, 1H), 7.11−7.14 (m, 1H), 3.90−4.06 (m, 2H), 2.90−3.00 (m, 1H), 2.76 (d, <i>J</i> = 4.8 Hz, 3H), 2.62−2.70 (m, 1H), 2.40 (s, 3H), 2.18−2.28 (m, 1H), 1.92−2.08 (m, 1H), 1.58−1.76 (m, 3H); Anal. (C<sub>26</sub>H<sub>25</sub>ClFN<sub>5</sub>O<sub>4</sub>·H<sub>2</sub>O) C, H, N. </div><div class="NLM_p"><b>4-{7-Chloro-2-[4-chloro-3-(4-methyl-piperazin-1-ylmethyl)-phenylamino]-benzoxazol-5-ylo</b><b>xy}-pyridine-2-carboxylic Acid Methylamide (37).</b> Starting with 4-(3-amino-5-chloro-4-hydroxyphenoxy)-pyridine-2-carboxylic acid methylamide (63 mg, 0.21 mmol), 24 mg (21%) of the title compound was obtained according to the method described for the synthesis of <b>20</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.21 (s, 1H), 8.75−8.80 (m, 1H), 8.40−8.50 (m, 1H), 7.80−7.90 (m, 1H), 7.70−7.80 (m, 1H), 7.30−7.50 (m, <a name="jm005001804364" id="jm005001804364"></a> 3H), 7.05−7.10 (m, 2H), 3.51 (s, 2H), 2.76 (d, <i>J</i> = 4.8 Hz, 3H), 2.20−2.50 (m, 8H), 2.15 (s, 3H); Anal. (C<sub>26</sub>H<sub>26</sub>Cl<sub>2</sub>N<sub>6</sub>O<sub>3</sub>·1.50CH<sub>3</sub>OH) C, H, N. </div><div class="NLM_p"><b>[4-Chloro-3-(4-methylpiperazin-1-ylmethyl)-phenyl]-[7-chloro-5-(quinolin-4-yloxy)-benzox</b><b>azol-2-yl]-amine (38).</b> Starting with 2-chloro-4-(quinolin-4-yloxy)phenol (843 mg, 3.10 mmol), 844 mg of a yellow solid was obtained (as a 1:1 mixture of starting material and 2-chloro-6-nitro-4-(quinolin-4-yloxy)phenol) according to the method described for the synthesis of <b>59a</b>. This crude mixture was combined with Fe (3.2 g, excess), 6 N HCl (2 drops), water (5 mL), and EtOH (24 mL) and refluxed for 2.5 h. The hot mixture was filtered through Celite and concentrated in vacuo. The residue was partially purified by prep HPLC to give 2-amino-6-chloro-4-(quinolin-4-yloxy)phenol (31 mg, 0.10 mmol, 9%), which was dissolved into CH<sub>3</sub>CN and subjected to the procedure described for the synthesis of <b>20</b>. The title compound was obtained as a white solid (11 mg, 21%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.22 (s, 1H), 8.65−8.70 (m, 1H), 8.32 (d, <i>J</i> = 8.8 Hz, 1H), 8.00−8.05 (m, 1H), 7.80−7.85 (m, 2H), 7.70−7.78 (m, 1H), 7.60−7.70 (m, 1H), 7.40−7.45 (m, 2H), 7.25−7.30 (m, 1H), 6.65−6.70 (m, 1H), 3.52 (s, 2H), 2.20−2.60 (m, 8H), 2.15 (s, 3H); HRMS calcd for C<sub>28</sub>H<sub>25</sub>C<sub>l2</sub>N<sub>5</sub>O<sub>2</sub> (M + H)<sup>+</sup>, 534.1458; found, 534.1458; HPLC purity = 95% (system A), 95% (system B). </div><div class="NLM_p"><b>4-(3,4-Diamino-phenoxy)-pyridine-2-carboxylic Acid Methylamide (39a).</b> A flask was charged with 4-(3,4-dinitro-phenoxy)-pyridine-2-carboxylic acid methylamide (0.71 g, 2.23 mmol), MeOH (40 mL), and EtOAc (80 mL). To the argon-degassed solution was added 10% Pd/C (0.20 g). The reaction was vigorously stirred for 42 h at rt under 1 atm of H<sub>2</sub> gas. The reaction was filtered through Celite and the solvent was removed in vacuo to obtain the title compound (71 mg, 95%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.70−8.75 (m, 1H), 8.42 (d, <i>J</i> = 5.6 Hz, 1H), 7.32 (d, <i>J</i> = 2.8 Hz, 1H), 7.04−7.06 (m, 1H), 6.53 (d, <i>J</i> = 8.4 Hz, 1H), 6.27 (d, <i>J</i> = 2.8 Hz, 1H), 6.16 (dd, <i>J</i> = 8.4, 2.8 Hz, 1H), 4.76 (bs, 1H), 4.51 (bs, 2H), 2.75 (d, <i>J</i> = 4.4 Hz, 3H). </div><div class="NLM_p"><b>4-(6,7-Dimethoxyquinolin-4-yloxy)-benzene-1,2-diamine (39b).</b> Starting with 4-(3,4-dinitrophenoxy)-6,7-dimethoxyquinoline (0.256 g, 0.74 mmol), 122 mg (57%) of the title compounds was obtained according to the method described for the synthesis of <b>39m</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.40 (d, <i>J</i> = 5.5 Hz, 1H), 7.45 (s, 1H), 7.30 (s, 1H), 6.55 (d, <i>J</i> = 8.2 Hz, 1H), 6.40 (d, <i>J</i> = 5.5 Hz, 1H), 6.35 (d, <i>J</i> = 2.7 Hz, 1H), 6.25 (dd, <i>J</i> = 8.2, 2.7 Hz, 1H), 4.40−4.80 (bm, 4H), 3.90 (m 6H). </div><div class="NLM_p"><b>4-(Quinolin-4-yloxy)-benzene-1,2-diamine (39c).</b> A flask was charged with 4-(3,4-dinitro-phenoxy)-quinoline (400 mg, 1.2 mmol), and the compound was dissolved in THF. The mixture was cooled to 0 °C and AcOH (1.5 mL) and zinc dust (2.5 g, 38 mmol) were added sequentially. The mixture was allowed to warm to rt, stirred for 1 h, filtered through a pad of silica gel, and concentrated in vacuo. The residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub> and washed with 1 M NaOH. The organic phases were dried, filtered, and evaporated to give the title compound as a brown-orange oil (210 mg, 65%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.61 (d, <i>J</i> = 5.7 Hz, 1H), 8.24−8.27 (m, 1H), 7.74−7.79 (m, 1H), 7.56−7.62 (m, 1H), 6.53−6.58 (m, 2H), 6.37 (d, <i>J</i> = 3.8 Hz, 1H), 6.25 (dd, <i>J</i> = 7.6, 2.8 Hz, 1H), 5.75 (bs, 2H), 5.50 (bs, 2H). </div><div class="NLM_p"><b>4-(7</b><b><i>H</i></b><b>-Pyrrolo[2,3-</b><b><i>d</i></b><b>]pyrimidin-4-yloxy)benzene-1,2-diamine (39d).</b> Starting with 4-(3,4-dinitro-phenoxy)-7,7a-dihydro-4a<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (0.16 g, 0.53 mmol), 284 mg (118%) of the title compound was obtained according to the method described for the synthesis of <b>39o</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.05 (bs, 1H), 8.25 (s, 1H), 7.30−7.35 (m, 1H), 6.50 (d, <i>J</i> = 7.0 Hz, 1H), 6.35 (s, 1H), 6.20−6.25 (m, 1H), 6.10−6.12 (m, 1H), 4.36−4.70 (bm, 4H). </div><div class="NLM_p"><b>4-(1</b><b><i>H</i></b><b>-Pyrrolo[2,3-</b><b><i>b</i></b><b>]pyridin-4-yloxy)-benzene-1,2-diamine (39e).</b> Starting with 4-(3,4-dinitro-phenoxy)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (0.284 g, 0.95 mmol), 190 mg (83%) of the title compound was obtained according to the method described for the synthesis of <b>39o</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.55 (bs, 1H), 7.97 (d, <i>J</i> = 5.8 Hz, 1H), 7.24−7.28 (m, 1H), 6.51 (d, <i>J</i> = 8.3 Hz, 1H), 6.32 (d, <i>J</i> = 3.3 Hz, 1H), 6.29 (d, <i>J</i> = 5.8 Hz, 1H), 6.16−6.21 (m, 2H), 4.70 (bs, 2H), 4.40 (bs, 2H). </div><div class="NLM_p"><b>4-(3,4-Diamino-phenoxy)-pyridine (39f).</b> Starting with 4-(3,4-dinitro-phenoxy)-pyridine (1.36 g, 5.21 mmol), 0.97 g (92%) of the title compound was obtained as a dark brown solid according to the method described for the synthesis of <b>39o</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.32−8.38 (m, 2H), 6.75−6.83 (m, 2H), 6.51 (d, <i>J</i> = 8.0 Hz, 1H), 6.26 (d, <i>J</i> = 2.4 Hz, 1H), 6.14 (dd, <i>J</i> = 8.0, 2.4 Hz, 1H), 4.40−4.80 (bm, 4H). </div><div class="NLM_p"><b>4-(2-Methylsulfanyl-pyrimidin-4-yloxy)-benzene-1,2-diamine (39g).</b> A flask was charged with 4-(3,4-dinitro-phenoxy)-2-methylsulfanyl-pyrimidine (1.00 g, 3.20 mmol) and the solid was dissolved in MeOH (10 mL). To the argon-degassed solution, a catalytic amount of Pd/C (10% by wt) was added, and the mixture was shaken under H<sub>2</sub> at 60 psi until the reaction was complete. The mixture was filtered through a pad of Celite and the material was purified using column chromatography (0−100% EtOAc in hexanes) to give the title compound (500 mg, 63%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.41 (d, <i>J</i> = 6.0 Hz, 1H), 6.62 (d, <i>J</i> = 7.5 Hz, 1H), 6.33 (d, <i>J</i> = 6.0 Hz, 1H), 6.37 (d, <i>J</i> = 3.0 Hz, 1H), 6.24 (dd, <i>J</i> = 7.5, 3.0 Hz, 1H), 2.40 (s, 3H). </div><div class="NLM_p"><b>4-(2-Methylsulfonyl-pyrimidin-4-yloxy)-benzene-1,2-diamine (39h).</b> Starting with 4-(3,4-dinitro-phenoxy)-2-methylsulfonyl-pyrimidine (1.0 g, 2.9 mmol), 0.80 g (97%) of the title compound was obtained according to the method described for the synthesis of <b>39a</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.78 (d, <i>J</i> = 5.4 Hz, 1H), 7.15 (d, <i>J</i> = 5.4 Hz, 1H), 6.55 (d, <i>J</i> = 8.2 Hz, 1H), 6.35−6.40 (m, 1H), 6.25 (dd, <i>J</i> = 8.2, 3.0 Hz, 1H), 4.80 (s, 2H), 4.50 (s, 2H), 3.30 (s, 3H). </div><div class="NLM_p"><b>4-(3-Amino-4-methylamino-phenoxy)-pyridine-2-carboxylic Acid Methylamide (39i).</b> Starting from 4-(4-methylamino-3-nitrophenoxy)-pyridine-2-carboxylic acid methylamide (100 mg, 0.33 mmol), the title compound was obtained using the method described in <b>39a</b> (28 mg, 31%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.70−8.80 (m, 1H), 8.41 (d, <i>J</i> = 5.5 Hz, 1H), 7.31 (d, <i>J</i> = 2.5 Hz, 1H), 7.06 (dd, <i>J</i> = 5.5, 2.5 Hz, 1H), 6.38 (d, <i>J</i> = 8.0 Hz, 1H), 6.25−6.35 (m, 2H), 4.80 (s, 2H), 4.60−4.65 (m, 1H), 2.76 (d, <i>J</i> = 4.8 Hz, 3H), 2.72 (d, <i>J</i> = 5.1 Hz, 3H). </div><div class="NLM_p"><b>4-(3-Amino-4-hydroxyphenoxy)-pyridine-2-carboxylic Acid Methylamide (39j).</b> Starting from 4-(4-hydroxy-3-nitrophenoxy)-pyridine-2-carboxylic acid methylamide (185 mg, 0.69 mmol), 148 mg (89%) of the title compound was obtained as a white foam according to the method described for the synthesis of <b>39o</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.18 (s, 1H), 8.70−8.80 (m, 1H), 8.43 (d, <i>J</i> = 4.8 Hz, 1H), 7.30−7.35 (m, 1H), 7.06−7.20 (m, 1H), 6.67 (d, <i>J</i> = 8.4 Hz, 1H), 6.30−6.40 (m, 1H), 6.10−6.20 (m, 1H), 4.82 (s, 2H), 2.76 (d, <i>J</i> = 4.8 Hz, 3H). </div><div class="NLM_p"><b>4-(3-Amino-5-fluoro-4-hydroxyphenoxy)-pyridine-2-carboxylic Acid Methylamide (39k).</b> Starting from 4-(3-fluoro-4-hydroxy-5-nitrophenoxy)-pyridine-2-carboxylic acid methylamide (0.61 g, 1.98 mmol), 495 mg (90%) of the title compound was obtained according to the method described for the synthesis of <b>39o</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.07 (s, 1H), 8.70−8.80 (m, 1H), 8.46 (d, <i>J</i> = 5.2 Hz, 1H), 7.36 (d, <i>J</i> = 2.4 Hz, 1H), 7.09−7.11 (m, 1H), 6.25 (dd, <i>J</i> = 11.2, 2.8 Hz, 1H), 6.20−6.21 (m, 1H), 5.21 (s, 2H), 2.76 (d, <i>J</i> = 5.2 Hz, 3H). </div><div class="NLM_p"><b>2-Amino-4-(6,7-dimethoxyquinolin-4-yloxy)phenol (39l).</b> Starting from 4-(6,7-dimethoxyquinolin-4-yloxy)-2-nitrophenol (440 mg, 1.28 mmol), 220 mg (59%) of the title compound was obtained according to the method described for the synthesis of <b>39m</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.30 (bs, 1H), 8.42 (d, <i>J</i> = 5.2 Hz, 1H), 7.45 (s, 1H), 7.35 (s, 1H), 6.69 (d, <i>J</i> = 8.8 Hz, 1H), 6.40−6.45 (m, 2H), 6.24 (dd, <i>J</i> = 8.8, 3.3 Hz, 1H), 4.80 (bs, 2H), 3.90 (s, 3H). </div><div class="NLM_p"><b>2-Amino-4-(quinolin-4-yloxy)-phenol (39m).</b> To a cooled (0 °C) solution of 2-nitro-4-(quinolin-4-yloxy)-phenol (200 mg, 0.79 mmol) in THF (50 mL) and AcOH (0.88 mL), zinc dust (2.3 g, 35.2 mmol) was added. The mixture was stirred at rt for 1.5 h and filtered through a Celite pad. The solvent was evaporated, and the residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub>, washed with 1 M NaOH, dried, filtered, and concentrated in vacuo to give the title compound as a <a name="jm005001804365" id="jm005001804365"></a> brown solid (150 mg, 86%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.20 (s, 1H), 8.65 (d, <i>J</i> = 4.8 Hz, 1H), 8.30 (d, <i>J</i> = 9.5 Hz, 1H), 7.95 (d, <i>J</i> = 9.5 Hz, 1H), 7.70−7.80 (m, 1H), 7.55−7.60 (m, 1H), 6.70 (d, <i>J</i> = 9.5 Hz, 1H), 6.55 (d, <i>J</i> = 4.8 Hz, 1H), 6.40−6.45 (m, 1H), 6.20−6.30 (m, 1H), 4.80 (s, 2H). </div><div class="NLM_p"><b>4-(3-Amino-5-chloro-4-hydroxyphenoxy)-pyridine-2-carboxylic Acid Methylamide (39n).</b> Starting with 4-(3-chloro-4-hydroxy-5-nitrophenoxy)-pyridine-2-carboxylic acid methylamide (394 mg, approx 1.21 mmol), 66 mg (19%) of the title compound was obtained as a brown solid according to the method described for the synthesis of <b>46a</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.80−8.90 (bs, 1H), 8.70−8.80 (m, 1H), 8.47 (d, <i>J</i> = 5.3 Hz, 1H), 7.35 (d, <i>J</i> = 2.5 Hz, 1H), 7.10−7.12 (m, 2H), 6.39 (d, <i>J</i> = 2.9 Hz, 1H), 6.34 (d, <i>J</i> = 2.9 Hz, 1H), 5.20 (bs, 2H), 2.76 (d, <i>J</i> = 4.9 Hz, 3H). </div><div class="NLM_p"><b>2-Amino-4-(2-methylamino-pyrimidin-4-yloxy)-phenol (39o).</b> A flask was charged with 4−(2-methylamino-pyrimidin-4-yloxy)-2-nitro-phenol (0.16 g, 0.620 mmol), and the solid was dissolved in MeOH (7 mL) and EtOAc (15 mL). To the argon-degassed solution was added 10% by weight Pd/C (0.08 g). The reaction was stirred vigorously at rt under 1 atm H<sub>2</sub> gas for 18 h. The reaction was filtered through a Celite plug and concentrated in vacuo to yield the title compound (144 mg, 100%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.99 (s, 1H), 8.05 (s, 1H), 6.98 (s, 1H), 6.59 (d, <i>J</i> = 8.4 Hz, 1H), 6.31 (s, 1H), 6.10−6.15 (m, 1H), 5.73−6.00 (m, 1H), 4.69 (s, 2H), 2.69 (d, <i>J</i> = 4.0 Hz, 3H). </div><div class="NLM_p"><b>2-Amino-4-(6-methylamino-pyrimidin-4-yloxy)-phenol (39p).</b> Starting with 4−(6-methylamino-pyrimidin-4-yloxy)-2-nitro-phenol (0.15 g, 0.57 mmol), 133 mg (100%) of the title compound was obtained as a tan solid according to the method described for the synthesis of <b>39o</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.01 (s, 1H), 8.09 (s, 1H), 7.17 (q, <i>J</i> = 4.8 Hz, 1H), 6.60 (d, <i>J</i> = 8.4 Hz, 1H), 6.30 (d, <i>J</i> = 2.8 Hz, 1H), 6.10 (dd, <i>J</i> = 8.4, 2.8 Hz, 1H), 5.56 (s, 1H), 4.70 (s, 2H), 2.70 (s, 3H). </div><div class="NLM_p"><b>4-(1</b><b><i>H</i></b><b>-Indol-4-yloxy)-2-aminophenol (39q).</b> Starting with 4-(1<i>H</i>-indol-4-yloxy)phenol (0.80 g, 3.53 mmol), 400 mg (41%) of 4-(1<i>H</i>-indol-4-yloxy)-2-nitrophenol was obtained according to the method described for the synthesis of <b>59e</b>. This compound (400 mg, 1.46 mmol) was subjected to the conditions used in the preparation of <b>39o</b> to yield the title compound (400 mg, 113%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.60 (s, 1H), 9.08 (s, 1H), 8.00 (d, <i>J</i> = 5.6 Hz, 1H), 7.30−7.35 (m, 1H), 6.65 (d, <i>J</i> = 7.4 Hz, 1H), 6.40 (d, <i>J</i> = 1.8 Hz, 1H), 6.35 (d, <i>J</i> = 5.6 Hz, 1H), 6.20−6.25 (m, 2H), 4.80 (s, 2H). </div><div class="NLM_p"><b>4-(3-Amino-4-hydroxy-phenoxy)-pyridine-2-carboxylic Acid Amide (39r).</b> Starting with 4-(4-hydroxy-phenoxy)-pyridine-2-carboxylic acid amide (6.22 g, 27.0 mmol), 4-(4-hydroxy-3-nitro-phenoxy)-pyridine-2-carboxylic acid amide was obtained according to the method described for the synthesis of <b>59e</b>. A portion of this material (0.27 g, 0.98 mmol) was subjected to the conditions for the preparation of <b>39o</b> to yield the title compound (0.22 g, 90%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.18 (s, 1H), 8.43 (d, <i>J</i> = 5.6 Hz, 1H), 8.05−8.10 (m, 1H), 7.65−7.68 (m, 1H), 7.33 (d, <i>J</i> = 2.4 Hz, 1H), 7.08 (dd, <i>J</i> = 5.6, 2.8 Hz, 1H), 6.70 (d, <i>J</i> = 8.0 Hz, 1H), 6.34 (d, <i>J</i> = 2.4 Hz, 1H), 6.16 (dd, <i>J</i> = 8.4, 3.2 Hz, 1H), 4.82 (s, 2H). </div><div class="NLM_p"><b>2-Amino-4-(6,7-dimethoxyquinazolin-4-yloxy)-phenol (39s).</b> Starting with 4-(6,7-dimethoxyquinazolin-4-yloxy)-2-nitrophenol (0.48 g, 1.40 mmol), 0.22 g (51%) of the title compound was obtained according to the method described for the synthesis of <b>39o</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.05 (s, 1H), 8.50 (s, 1H), 7.45 (s, 1H), 7.30 (s, 1H), 6.65 (d, <i>J</i> = 9.0 Hz, 1H), 6.40 (d, <i>J</i> = 3.0, 1H), 6.20 (dd, <i>J</i> = 9.0, 3.0 Hz, 1H), 4.70 (bs, 2H), 3.95 (s, 3H), 3.90 (s, 3H). </div><div class="NLM_p"><b>1-(2-Chloro-5-isothiocyanato-benzyl)-4-methyl-piperazine (40a).</b> Starting from 1-(2-chloro-5-amino-benzyl)-4-methyl-piperazine (1.87 g, 7.79 mmol), 2.03 g (93%) of the title compound was obtained (as a mixture with imidazole; 3.71 g total) according to the method described for the synthesis of <b>40d</b>. The compound was used without further purification. <sup>1</sup>H NMR of the isothiocyanate (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.44−7.52 (m, 2H), 7.35 (dd, <i>J</i> = 8.4, 2.0 Hz, 1H), 3.51 (s, 2H), 2.32−2.46 (m, 8H), 2.17 (s, 3H). </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-2-((5-Isothiocyanato-2-(trifluoromethyl)phenoxy)methyl)-1-methylpyrrolidine (40b).</b> Starting from (<i>R</i>)-3-(1-methyl-pyrrolidin-2-ylmethoxy)-4-trifluoromethyl-phenylamine (225 mg, 0.82 mmol), 94 mg (36%) of the title compound was obtained as an off-white solid according to the method described for the synthesis of <b>40d</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.64 (d, <i>J</i> = 8.1 Hz, 1H), 7.38−7.41 (m, 1H), 7.08−7.12 (m, 1H), 4.08−4.14 (m, 1H), 3.93−4.00 (m, 1H), 2.91−2.98 (m, 1H), 2.52−2.60 (m, 1H), 2.34 (s, 3H), 2.12−2.26 (m, 1H), 1.88−2.00 (m, 1H), 1.50−1.75 (m, 3H). </div><div class="NLM_p"><b>1-Chloro-2-(2-chloro-ethoxy)-4-isothiocyanato-benzene (40c).</b> Starting from 4-chloro-3-(2-chloro-ethoxy)-phenylamine (2.54 mg, 11.5 mmol), 2.79 g (98%) of the title compound was obtained (as a 2:1 mixture with the bromide) as a beige solid according to the method described for the synthesis of <b>40d</b>. <sup>1</sup>H NMR of the major product (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.49 (d, <i>J</i> = 8.4 Hz, 1H), 7.34 (d, <i>J</i> = 2.4 Hz, 1H), 7.05 (dd, <i>J</i> = 8.4, 2.4 Hz, 1H), 4.36 (t, <i>J</i> = 5.2 Hz, 2H), 3.95 (t, <i>J</i> = 5.2 Hz, 1H). <sup>1</sup>H NMR of the minor product (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.49 (d, <i>J</i> = 8.4 Hz, 1H), 7.34 (d, <i>J</i> = 2.4 Hz, 1H), 7.05 (dd, <i>J</i> = 8.4, 2.4 Hz, 1H), 4.24 (t, <i>J</i> = 5.2 Hz, 2H), 3.81 (t, <i>J</i> = 5.2 Hz, 1H). </div><div class="NLM_p"><b>4-(2-Chloro-5-isothiocyanato-benzyl)-morpholine (40d).</b> To a 0 °C solution of 4-chloro-3-morpholin-4-ylmethyl-phenylamine (0.33 g, 1.46 mmol) in 10 mL of CH<sub>2</sub>Cl<sub>2</sub> was added 1,1‘-thiocarbonyldiimidazole (0.39 g, 2.18 mmol). The reaction was allowed to warm to rt and stirred for 1 h. The mixture was concentrated down to a small volume and purified by short column silica gel chromatography using EtOAc as the eluent to obtain the title compound (0.36 mg, 93%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.48−7.52 (m, 2H), 7.34−7.38 (m, 1H), 3.56−3.60 (m, 4H), 3.50−3.52 (s, 2H), 2.38−2.42 (m, 4H). </div><div class="NLM_p"><b>1-Chloro-4-isothiocyanato-2-(2-methoxyethoxy)benzene (40e).</b> Starting with 1-chloro-2-(2-methoxyethoxy)-4-nitrobenzene (1.30 g, 5.60 mmol), 4-chloro-3-(2-methoxyethoxy)phenylamine was obtained by the method described for the synthesis of <b>46a</b>. A portion of this material (0.20 g, 1.00 mmol) was converted to the title compound using the procedure described for the synthesis of <b>40d</b> (180 mg, 75%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.50 (d, <i>J</i> = 6.0 Hz, 1H), 7.35 (s, 1H), 7.00−7.05 (m, 2H), 4.20−4.25 (m, 2H), 3.65−3.75 (m, 2H), 3.30 (s, 3H). </div><div class="NLM_p"><b>5-Nitro-2-trifluoromethylanisole (41b).</b> To a cooled (−40 °C) solution of pyridine (140 mL), trifluoromethyl iodide (from a gas cylinder that had been kept in freezer overnight) was bubbled in over a 20 min period. To this solution was added 2-iodo-5-nitroanisole (29.76 g, 107 mmol) and copper powder (81.33 g, 128 mol), and the vessel sealed. The reaction was stirred vigorously for 22 h at 140 °C. The reaction was cooled to −50 °C, and the vessel was carefully opened and poured onto ice and Et<sub>2</sub>O and allowed to warm slowly to rt. The layers were separated, and the organic layer was washed with 1 N HCl (×3) and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The crude material was purified on a short silica gel column (4.5:1 hexanes/CH<sub>2</sub>Cl<sub>2</sub>) to provide the title compound as a yellow oil (10.72 g, 45%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.85−8.00 (m, 3H), 4.02 (s, 3H). </div><div class="NLM_p"><b>2-Methoxy-4-nitro-1-pentafluoroethylbenzene (41c).</b> To a cooled (0 °C) suspension of zinc powder (54.15 g, 828 mmol) in DMF (200 mL), pentafluoroethyl iodide (excess) was bubbled through while the mixture was gradually allowed to warm to rt. The reaction mixture was stirred at rt for 6 h, at which point the bubbling ceased. The solution was transferred to an addition funnel and added dropwise to a slurry of CuBr (66.57 g, 464 mmol) in DMF (200 mL) over 30 min, keeping the temperature below 30 °C. To this mixture, 2-nitro-5-iodoanisole (50.0 g, 179.2 mmol) was added and the reaction mixture was heated to 70 °C for 6 h, then allowed to cool to rt and stirred for 8 h. The reaction mixture was poured into a mixture of ice water (600 mL), 6 N HCl (500 mL), and ethyl acetate (300 mL). The layers were separated and the organic layer was washed with water then NaHCO<sub>3</sub> (satd) and brine. The solution was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by column chromatography (hexanes/ethyl acetate as the eluent) to give the title <a name="jm005001804366" id="jm005001804366"></a> compound as a yellow oil (41.0 g, 84%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.70−7.86 (m, 3H), 3.85 (s, 3H). </div><div class="NLM_p"><b>2-Chloro-5-nitrophenol (42a).</b> To a flask containing HOAc (78 mL) and 48% HBr (97 mL) was added 2-chloro-5-nitroanisole (9.7 g, 49.1 mmol). The mixture was heated for 18 h at 140 °C. The reaction mixture was allowed to cool to rt, diluted with ice water, and extracted with EtOAc once the ice had melted. The organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, concentrated, and dried under vacuum to yield the title compound as yellow-light brown solid (8.3 g, 98%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.32 (s, 1H), 7.74 (d, <i>J</i> = 1.6 Hz, 1H), 7.62−7.67 (m, 2H). </div><div class="NLM_p"><b>5-Nitro-2-trifluoromethylphenol (42b).</b> A round-bottom flask was charged with 5-nitro-2-trifluoromethylanisole (10.7 g, 48.5 mmol) and pyridine hydrochloride (44.9 g, 388 mmol) and heated at 210 °C for 2 h. The reaction mixture was allowed to cool to rt and dissolved into 6 N HCl and EtOAc. The layers were separated, and the organic layer was washed 4× with 2 N HCl and once with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The title compound was obtained as a dark red solid (8.98 g, 89%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.67 (s, 1H), 7.60−7.85 (m, 3H). </div><div class="NLM_p"><b>5-Nitro-2-pentafluoroethylphenol (42c).</b> A round-bottom flask was charged with 2-methoxy-4-nitro-1-pentafluoroethylbenzene (9.35 g) and pyridine hydrochloride and heated at 210 °C for 1 h. The mixture was allowed to cool to rt and dissolved in EtOAc and 2 N HCl (>500 mL). The organic layer was washed with 2 N HCl (2×) and concentrated in vacuo. The residue was dissolved in hexanes and Et<sub>2</sub>O and washed with 2 N HCl and then brine. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, concentrated in vacuo, and dried under high vacuum to provide 5-nitro-2-pentafluoromethylphenol as a dark brown oil (8.77 g, 99%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.50 (s, 1H), 7.60−7.70 (m, 3H). </div><div class="NLM_p"><b>1-Chloro-2-(2-chloro-ethoxy)-4-nitro-benzene (43a).</b> A flask was charged with 2-chloro-5-nitrophenol (4 g, 23 mmol), 1-bromo-2-chloroethane (9 mL, 115 mmol), K<sub>2</sub>CO<sub>3</sub> (8 g, 58 mmol), and DMF (50 mL) and heated at 80 °C for 18 h. The reaction mixture was allowed to cool to rt, diluted with water, and extracted several times with EtOAc. The combined organic layers were washed with 1 N NaOH and concentrated in vacuo to yield the title compound in a 2:1 ratio with the bromo adduct (3.9 g). <sup>1</sup>H NMR of the major product (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.92−7.94 (m, 1H), 7.84 (d, <i>J</i> = 3.0 Hz, 1H), 7.76 (s, 1H), 4.52 (t, <i>J</i> = 5.5 Hz, 2H), 4.00 (t, <i>J</i> = 5.5 Hz, 2H); <sup>1</sup>H NMR of the minor product (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.92−7.94 (m, 1H), 7.86 (d, <i>J</i> = 3 Hz, 1H), 7.72 (s, 1H), 4.58 (t, <i>J</i> = 5.5 Hz, 2H), 3.85 (t, <i>J</i> = 5.5 Hz, 2H). </div><div class="NLM_p"><b>4-(2-Chloro-5-nitro-phenoxymethyl)-piperidine-1-carboxylic Acid </b><b><i>tert</i></b><b>-Butyl Ester (43b).</b> To a cooled solution (−20 °C) of 2-chloro-5-nitro phenol (10 g, 63.497 mmol), <i>N-</i>boc-4-piperidine methanol (13.67 g, 63.49 mmol), and PPh<sub>3</sub> (16.63 g, 63.49 mmol) in THF (130 mL) was added a solution of DIAD (12.75 mL, 64.76 mmol) in THF (50 mL) dropwise over 1.5 h. The reaction mixture was allowed to warm to rt and stirred for 18 h. The mixture was concentrated in vacuo, and the residue was dissolved in Et<sub>2</sub>O and washed with water and then NaHCO<sub>3</sub> (satd). The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was treated with a mixture of hexanes and EtOAc (1:1), and the solid was filtered. The filtrate was evaporated and the residue was purified by silica gel column chromatography to yield the title compound as a yellow solid (5.59 g, 87%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.86 (d, <i>J</i> = 2.5 Hz, 1H), 7.80−7.83 (m, 1H), 7.73 (d, <i>J</i> = 7.8 Hz, 1H), 4.08 (d, <i>J</i> = 6.3 Hz, 2H), 3.90−4.00 (m, 2H), 2.60−2.80 (m, 2H), 1.90−2.05 (m, 1H), 1.70−1.80 (m, 2H), 1.37 (s, 9H), 1.10−1.25 (m, 2H). </div><div class="NLM_p"><b>1-Nitro-3-(2-dimethylamino-ethoxy)-4-trifluoromethylbenzene (43c).</b> A sealed tube was charged with 5-nitro-2-trifluoromethylphenol (3.48 g, 16.8 mmol), 2-(dimethylamino)ethylchloride hydrochloride (5.32 g, 37.0 mmol), K<sub>2</sub>CO<sub>3</sub> (9.76 g, 70.7 mmol), tetrabutylammonium iodide (0.5 g, 1.34 mmol), acetone (114 mL), and water (33 mL). The mixture was heated at 105 °C for 24 h, and then the temperature was raised and the mixture was heated at 120 °C for 24 h. The reaction mixture was cooled to rt and partially concentrated. The solution was diluted with brine and 6 N NaOH and extracted with EtOAc. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by silica gel column chromatography yielded the title compound as a light brown oil (1.26 g, 27%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.00 (s, 1H), 7.90−7.92 (m, 2H), 4.34 (t, <i>J</i> = 5.6 Hz, 2H), 2.69 (t, <i>J</i> = 5.6 Hz, 2H), 2.23 (s, 6H). </div><div class="NLM_p"><b>1-Chloro-2-(2-methoxyethoxy)-4-nitrobenzene (43d).</b> To a solution of 5-nitro-2-chlorophenol (1.00 g, 5.80 mmol) and 2-methyloxychloroethane (2.60 mL, 28.8 mmol) in DMF (20 mL) was added K<sub>2</sub>CO<sub>3</sub> (2.40 g, 17.4 mmol). The suspension was heated at 80 °C for 18 h. After cooling to rt, the mixture was filtered, the salts were washed with EtOAc, and the solvent was concentrated in vacuo. The residue was dissolved in EtOAc, washed with 1 N NaOH and water, dried over MgSO<sub>4</sub>, and concentrated in vacuo. The crude material was purified on silica gel using a hexanes/EtOAc gradient (100/0 to 50/50) to give the title compound (1.3 g, 96%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.95 (d, <i>J</i> = 2.6 Hz, 1H), 7.85 (dd, <i>J</i> = 9.1, 2.6 Hz, 1H), 7.75 (d, <i>J</i> = 9.1 Hz, 1H), 4.35−4.40 (m, 2H), 3.70−3.75 (m, 2H), 3.35 (s, 3H). </div><div class="NLM_p"><b>4-Chloro-3-(2-chloro-ethoxy)-phenylamine (44a).</b> To an argon-degassed solution of 1-chloro-2-(2-chloro-ethoxy)-4-nitro-benzene (2.9 g, <12.5 mmol due to contamination with the bromide) in EtOAc (50 mL) was added Pd/C (10% by wt, 1 g). The reaction was stirred under H<sub>2</sub> for 18 h, then filtered through Celite, and concentrated in vacuo to yield the title compound (as a mixture with the bromo adduct) (2.54 g, approx 92%). <sup>1</sup>H NMR of the major product (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.01 (d, <i>J</i> = 8.4 Hz, 1H), 6.35 (d, <i>J</i> = 2.8 Hz, 1H), 6.19 (dd, <i>J</i> = 8.4, 2.8 Hz, 1H), 5.70 (bs, 2H), 4.17 (t, <i>J</i> = 5.2 Hz, 2H), 3.91 (t, <i>J</i> = 5.2 Hz, 2H). <sup>1</sup>H NMR of the minor product (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.01 (d, <i>J</i> = 8.4 Hz, 1H), 6.35 (d, <i>J</i> = 2.8 Hz, 1H), 6.19 (dd, <i>J</i> = 8.4, 2.8 Hz, 1H), 5.70 (bs, 2H) 4.23 (t, <i>J</i> = 5.2 Hz, 2H), 3.77 (t, <i>J</i> = 5.2 Hz, 2H). </div><div class="NLM_p"><b>4-(5-Amino-2-chloro-phenoxymethyl)-piperidine-1-carboxylic Acid </b><b><i>tert</i></b><b>-Butyl Ester (44b).</b> Starting from 4-(2-chloro-5-nitro-phenoxymethyl)-piperidine-1-carboxylic acid <i>tert</i>-butyl ester (1.00 g, 2.69 mmol), 54 mg (6%) of the title compound was obtained according to the method described for the synthesis of <b>46a</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 6.93 (d, <i>J</i> = 8.7 Hz, 1H), 6.28 (d, <i>J</i> = 2.4 Hz, 1H), 6.10 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 3.95−4.00 (m, 2H), 5.20 (s, 2H), 3.75 (d, <i>J</i> = 6.3 Hz, 2H), 2.60−2.80 (m, 2H), 1.80−1.95 (m, 1H), 1.70−1.80 (m, 2H), 1.37 (s, 9H), 1.10−1.20 (m, 2H). </div><div class="NLM_p"><b>3-(2-Dimethylamino-ethoxy)-4-trifluoromethylaniline (44c).</b> A flask was charged with 1-nitro-3-(2-dimethylamino-ethoxy)-4-trifluoromethylbenzene (1.26 g, 4.51 mmol) and dissolved in MeOH (50 mL). To the nitrogen-degassed solution was added 10% Pd/C (0.10 g). The reaction was stirred vigorously at rt under 1 atm of H<sub>2</sub> gas for 18 h. The reaction was filtered through Celite and concentrated in vacuo to yield the title compound as a gray solid (1.03 g, 93%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.14 (d, <i>J</i> = 7.7 Hz, 1H), 6.27 (s, 1H), 6.13 (d, <i>J</i> = 7.7 Hz, 1H), 5.78 (s, 2H), 3.99 (t, <i>J</i> = 6.0 Hz, 2H), 2.60 (t, <i>J</i> = 6.0 Hz, 2H), 2.19 (s, 3H). </div><div class="NLM_p"><b>3-(2-Pyrrolin-1-yl-ethoxy)-5-trifluoromethyl-phenylamine (44d).</b> A flask charged with 1-methoxy-3-nitro-5-trifluoromethyl-benzene (10 g, 45.2 mmol) and pyridine·HCl (41.8 g) was heated at 210 °C open to the air. After 2.5 h, the reaction mixture was allowed to cool to rt and partitioned between 1 N HCl and EtOAc. The organic portion was washed with 1 N HCl and brine, dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to form 3-nitro-5-trifluoromethyl-phenol (42b) as an off-white solid. A portion of this material (2.00 g, 9.66 mmol) was combined with 1-(2-chloroethyl)pyrrolidine hydrochloride (3.40 g, 19.3 mmol), K<sub>2</sub>CO<sub>3</sub> (5.34 g, 38.64 mmol), and DMF (30 mL) and heated at 90 °C for 3 d. The reaction mixture was allowed to cool to rt, taken up in EtOAc, and washed with 2 N NaOH and brine. The organic layer was dried with MgSO<sub>4</sub>, filtered, and concentrated in vacuo. The aqueous layer was acidified, extracted with EtOAc, dried with MgSO<sub>4</sub>, filtered, concentrated in vacuo, and combined with the other portion. The crude 1-[2-(3-nitro-5-trifluoromethyl-phenoxy)ethyl]-pyrrolidine was reduced to the amine following the procedure outlined for <b>58e</b>. The title compound was obtained as a tan solid (560 mg, 21% over 2 steps). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 6.41 (s, 1H), 6.32 (s, 1H), 6.28 <a name="jm005001804367" id="jm005001804367"></a> (s, 1H), 5.55 (s, 2H), 3.98 (t, <i>J</i> = 5.5 Hz, 2H), 2.72 (t, <i>J</i> = 5.9 Hz, 2H), 2.50−2.55 (m, 4H), 1.60−1.68 (m, 4H). </div><div class="NLM_p"><b>1-(2-Chloro-5-nitro-benzyl)-4-methyl-piperazine (45a).</b> To a rt solution of 2-chloro-5-nitrobenzaldehyde (3.28 g, 17.7 mmol) and 1-methylpiperazine (1.77 g, 17.7 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (60 mL) was added NaBH(OAc)<sub>3</sub> (5.24 g, 24.7 mmol). The reaction mixture was stirred overnight at rt. The mixture was allowed to cool to rt, and 2 N NaOH (150 mL) was added and the mixture was stirred for 10 min. The reaction mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> and additional 2 N NaOH. The layers were separated, the CH<sub>2</sub>Cl<sub>2</sub> layer was washed with 2 N NaOH, and the aqueous layers were back-extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined CH<sub>2</sub>Cl<sub>2</sub> layers were extracted with 2 N HCl, which was then basified to pH > 12 by treatment with solid NaOH. This aqueous layer was extracted with EtOAc, and the EtOAc layers were combined, washed with a mix of brine and 2 N NaOH, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The title compound was isolated as an amber oil (4.24 g, 89%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.27 (d, <i>J</i> = 3.0 Hz, 1H), 8.11 (dd, <i>J</i> = 8.7, 3.3 Hz, 1H), 7.72 (d, <i>J</i> = 8.7 Hz, 1H), 3.62 (s, 2H), 2.42−2.50 (m, 4H), 2.30−2.40 (m, 4H), 2.16 (s, 3H). </div><div class="NLM_p"><b>4-(2-Chloro-5-nitro-benzyl)-morpholine (45b).</b> Starting from 2-chloro-5-nitrobenzaldehyde (6.14 g, 33.0 mmol), 5.96 g (70%) of the title compound was obtained as a yellow solid according to the method described for the synthesis of <b>45a</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.30 (d, <i>J</i> = 3.2 Hz, 1H), 8.12 (dd, <i>J</i> = 8.8, 3.2 Hz, 1H), 7.74 (d, <i>J</i> = 8.8 Hz, 1H), 3.64 (s, 2H), 3.57−3.60 (m, 4H), 2.43−2.46 (m, 4H). </div><div class="NLM_p"><b>1-(2-Chloro-5-amino-benzyl)-4-methyl-piperazine (46a).</b> To a solution of 1-(2-chloro-5-nitro-benzyl)-4-methyl-piperazine (1.04 g, 3.86 mmol) in EtOH (30 mL) was added SnCl<sub>2</sub> (2.2 g, 11.6 mmol), and the reaction mixture was heated at 70 °C for 4.5 h. An additional amount of SnCl<sub>2</sub> (0.7 g, 3.7 mmol) was added, and the reaction was heated at 80 °C for 1 h. The reaction was allowed to cool to rt and quenched with 1 N aqueous K<sub>2</sub>CO<sub>3</sub>. The white slurry was filtered through a Celite plug, the ethanol was evaporated, and the resulting aqueous suspension was diluted with EtOAc and 1 N NaOH. The layers were separated, and the organic layer was washed with a brine/1 N NaOH mixture. The aqueous layers were back-extracted with EtOAc. The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to yield the title compound as a light orange solid (793 mg, 86%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 6.97 (d, <i>J</i> = 8.4 Hz, 1H), 6.66 (s, 1H), 6.41 (d, <i>J</i> = 8.4 Hz, 1H), 5.18 (s, 2H), 3.32 (s, 2H), 2.28−2.42 (m, 8H), 2.13 (s, 3H). </div><div class="NLM_p"><b>4-Chloro-3-morpholin-4-ylmethyl-phenylamine (46b).</b> Starting from 4-(2-chloro-5-nitro-benzyl)-morpholine (5.96 g, 23.2 mmol), 2.60 mg (49%) of the title compound was obtained as a light orange solid according to the method described for the synthesis of <b>46a</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 6.98 (d, <i>J</i> = 8.4 Hz, 1H), 6.80 (d, <i>J</i> = 2.8 Hz, 1H), 6.42 (dd, <i>J</i> = 8.4, 2.8 Hz, 1H), 5.18 (s, 2H), 3.54−3.58 (m ,4H), 3.37 (s, 2H), 2.35−2.39 (m, 4H). </div><div class="NLM_p"><b>(</b><b><i>S</i></b><b>)-2-(2-Chloro-5-nitro-phenoxymethyl)-pyrrolidine-1-carboxylic Acid </b><b><i>tert</i></b><b>-Butyl Ester </b><b>(47a).</b> To a cooled solution (−15 °C) of 2-chloro-5-nitrophenol (5.06 g, 29.17 mmol), (<i>S</i>)-(−)-1-(<i>tert</i>-butoxycarbonyl)-2-pyrrolidinemethanol (5.87 g, 29.17 mmol), and triphenylphosphine (7.65 g, 29.17 mmol) in THF (50 mL) was added a solution of DIAD (6.02 g, 29.75 mmol) in THF dropwise over 75 min. Upon the complete addition, the reaction mixture was allowed to warm to rt and stirred for 18 h. The mixture was concentrated in vacuo, and the residue was treated with a mixture of Et<sub>2</sub>O and hexanes. The suspension was sonicated and the solid was filtered. The filtrate was concentrated in vacuo, and the resulting residue was purified by silica gel column chromatography using 7% EtOAc in hexanes to yield the title compound as a thick yellow oil (8.94 g, 97%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.91−7.96 (m, 1H), 7.80−7.86 (m, 1H), 7.72−7.76 (m, 1H), 4.16−4.30 (m, 2H), 4.02−4.10 (m, 1H), 3.24−3.30 (m, 2H), 1.90−2.10 (m, 3H), 1.74−1.84 (m, 1H), 1.36 (s, 9H). </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-2-(5-Nitro-2-trifluoromethyl-phenoxymethyl)-1-(</b><b><i>tert</i></b><b>-butoxycarbonyl)pyrrolidine (47b).</b> To a cooled solution (−20 °C) of 5-nitro-2-trifluoromethylphenol (5.50 g, 26.55 mmol), (<i>R</i>)-(+)-(<i>tert</i>-butoxy-carbonyl)-2-pyrrolidinemethanol (5.34 g, 26.55 mmol), and PPh<sub>3</sub> (6.96 g, 26.55 mmol) in THF (46 mL) was added a solution of DEAD (4.71 g, 27.08 mmol) in THF (23 mL) dropwise over 1.5 h. The reaction mixture was allowed to warm to rt and stirred for 18 h. The reaction was concentrated in vacuo and treated with a small mixture of hexanes and Et<sub>2</sub>O. After sonication, the solids were filtered off, and the filtrate was concentrated in vacuo. The crude mixture was dissolved in a small amount of EtOAc, then diluted with hexanes, and washed with 0.1 N HCl, 2 N NaOH, and brine. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was purified by silica gel column chromatography using 5% EtOAc in hexanes as the eluent to yield the title compound as a light yellow oil (6.36 g, 61%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.85−8.05 (m, 3H), 4.20−4.35 (m, 2H), 4.00−4.10 (m, 1H), 3.20−3.30 (m, 2H), 1.70−2.05 (m, 4H), 1.37 (s, 9H). </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-2-(5-Nitro-2-pentafluoroethyl-phenoxymethyl)-1-(</b><b><i>tert</i></b><b>-butoxycarbonyl)pyrrolidine (47c).</b> A flask was charged with 5-nitro-2-pentafluoroethyl-phenol (945.0 mg, 3.7 mmol), PPh<sub>3</sub> (965.0 mg, 3.7 mmol), <i>R-</i>(+)-(1-<i>tert</i>-butoxycarbonyl)-2-pyrrolidine-methanol (740 mg, 3.7 mmol), and THF (9 mL). The mixture was stirred to dissolve the solids and cooled to −20 °C. DIAD (738 μL, 3.8 mmol) in THF (4 mL) was added over 2 h, keeping the reaction temperature between −10 to −20 °C. The reaction was allowed to warm to rt and stirred for 19 h. The THF was concentrated in vacuo, and the crude mixture was dissolved in ethyl acetate, washed with water and brine, dried with MgSO<sub>4</sub>, filtered, and evaporated. The mixture was purified by column chromatography using EtOAc/hexanes as the eluent. The title compound was obtained as a viscous liquid (937 mg, 58%). <sup>1</sup>H NMR (rotamers) (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.00−8.05 (m, 1H), 7.80−7.95 (m, 2H), 4.20−4.30 (m, 2H), 4.00−4.10 (m, 1H), 3.20−3.20 (m, 2H), 1.70−2.00 (m, 4H), 1.36−1.38 (m, 9H). </div><div class="NLM_p"><b>(</b><b><i>S</i></b><b>)-2-(2-Chloro-5-nitro-phenoxymethyl)-pyrrolidine (48a).</b> (<i>S</i>)-2-(2-Chloro-5-nitro-phenoxymethyl)-pyrrolidine-1-carboxylic acid <i>tert</i>-butyl ester (6.94 g, 19.45 mmol) was stirred in CH<sub>2</sub>Cl<sub>2</sub> (30 mL) and TFA (20 mL) for 3 h. The reaction mixture was concentrated in vacuo, and the residue was dissolved in 0.1 N HCl. The solution was basified to pH > 12 with solid NaOH and extracted with EtOAc (×3). The organic layers were combined, washed with 1 N NaOH and then a mixture of brine and 1 N NaOH, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to dryness. The title compound was obtained as a yellow solid (4.82 g, 97%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.87−7.90 (m, 1H), 7.80−7.84 (m, 1H), 7.30 (d, <i>J</i> = 8.8 Hz, 1H), 4.05 (d, <i>J</i> = 6.0 Hz, 2H), 3.43−3.49 (m, 1H), 2.79−2.84 (m, 2H), 1.47−1.90 (m, 4H). </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-2-((5-Nitro-2-(trifluoromethyl)phenoxy)methyl)pyrrolidine (48b).</b> To a solution of (<i>R</i>)-<i>tert-</i>butyl 2-((5-nitro-2-(trifluoromethyl)phenoxy)methyl)pyrrolidine-1-carboxylate (6.36 g, 16.29 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL), TFA (20 mL) was added. After stirring for 1 h at rt, the mixture was concentrated in vacuo and treated with 6 N NaOH until pH 10. The mixture was taken up into ethyl acetate and washed with brine, and the organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated. The title compound was obtained as a dark yellow oil (4.16 g, 88%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.96 (s, 1H), 7.87−7.92 (m, 2H), 4.05−4.15 (m, 2H), 3.40−3.50 (m, 1H), 3.31 (bs, 1H), 2.47−2.50 (m, 2H), 1.80−1.89 (m, 1H), 1.58−1.77 (m, 2H), 1.46−1.56 (m, 1H). </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-2-(5-Nitro-2-pentafluoroethyl-phenoxymethyl)-pyrrolidine (48c).</b> To a solution of 2-(5-nitro-2-pentafluoroethyl-phenoxymethyl)-1-(<i>tert</i>-butoxycarbonyl)pyrrolidine (727 mg, 1.77 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (5 mL), TFA (2.5 mL) was added and stirred at rt for 1 h. The mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> (20 mL) and neutralized with satd NaHCO<sub>3</sub> and then 2 N NaOH. The mixture was transferred to a separatory funnel and the layers were separated. The aqueous layer was extracted with EtOAc and the combined organic layers were dried with MgSO<sub>4</sub>, filtered, and concentrated in vacuo to yield the title compound as a yellow solid (603 mg, 100%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.74 (bs, 1H), 7.97−8.04 (m, 1H), 7.89−7.94 (m, 1H), 4.45−4.50 (m, 1H), 4.35−4.40 <a name="jm005001804368" id="jm005001804368"></a> (m, 1H), 3.85−3.95 (m, 1H), 3.10−3.25 (m, 2H), 2.05−2.18 (m, 1H), 1.70−2.00 (m, 3H). </div><div class="NLM_p"><b>(</b><b><i>S</i></b><b>)-2-(2-Chloro-5-nitro-phenoxymethyl)-1-methylpyrrolidine (49a).</b> To a solution of (<i>S</i>)-2-(2-chloro-5-nitro-phenoxymethyl)-pyrrolidine (4.82 g, 18.77 mmol) in CH<sub>3</sub>CN (167 mL) was added 37% aqueous formaldehyde (7.58 mL) and NaCNBH<sub>3</sub> (1.887 g, 30.03 mmol) at rt. The mixture was stirred at rt for 1 h, with the reaction pH adjusted every 10 min to about 7 by adding small amounts of HOAc. The reaction mixture was concentrated in vacuo and dissolved in 2 N NaOH (aq) and Et<sub>2</sub>O. The layers were separated, and the organic layer was washed with 2 N NaOH, and extracted with 1 N HCl. The combined acidic aqueous layers were basified to pH > 12 with solid NaOH and extracted with EtOAc (×3). The EtOAc layers were combined and washed with 2 N NaOH and a mixture of brine and 2 N NaOH. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to yield the title compound (3.42 g, 67%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.89−7.91 (m, 1H), 7.80−7.84 (m, 1H), 7.71−7.74 (m, 1H), 4.12−4.14 (m, 2H), 2.93−2.98 (m, 1H), 2.60−2.70 (m, 1H), 2.40 (s, 3H), 2.18−2.40 (m, 1H), 1.90−2.0 (m, 1H), 1.60−1.76 (m, 3H). </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-1-Methyl-2-((5-nitro-2-(trifluoromethyl)phenoxy)methyl)pyrrolidine (49b).</b> To a solution of (<i>R</i>)-2-((5-nitro-2-(trifluoromethyl)phenoxy)methyl)pyrrolidine (4.16 g, 14.33 mmol) in CH<sub>3</sub>CN (128 mL), formaldehyde (5.8 mL, 37% aqueous) was added and the mixture was stirred. Sodium cyanoborohydride (1.44 g, 22.9 mmol) was added (exotherm observed), and the reaction was stirred at rt. The pH was monitored every 15 min and adjusted to ∼7 with AcOH. After 45 min, the mixture was concentrated in vacuo and the residue was dissolved in Et<sub>2</sub>O and washed with 6 N NaOH, 1 N NaOH, and 2 N HCl (3×). The acid washings were combined, adjusted to ∼pH 10 with solid Na<sub>2</sub>CO<sub>3</sub>, and extracted with EtOAc (×2). The EtOAc fractions were combined, dried with Na<sub>2</sub>SO<sub>4</sub>, and purified with flash chromatography (SiO<sub>2</sub>, 95:5:0.5 CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH) to afford the title compound (3.16 g, 73%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.80−8.00 (m, 3H), 4.00−4.15 (m, 1H), 4.20−4.30 (m, 1H), 2.90−3.00 (m, 1H), 2.60−2.70 (m, 1H), 2.37 (S, 3H), 2.10−2.20 (m, 1H), 1.80−2.00 (m, 1H), 1.50−1.75 (m, 3H). </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-1-Methyl-2-(5-nitro-2-pentafluoroethyl-phenoxymethyl)-pyrrolidine (49c).</b> To a solution of 2-(5-nitro-2-pentafluoroethyl-phenoxymethyl)-pyrrolidine (603.0 mg, 1.8 mmol) and formaldehyde (37% in water, 1 mL) in CH<sub>2</sub>Cl<sub>2</sub> (25 mL), NaBH(OAc)<sub>3</sub> (600 mg, 2.8 mmol) was added. The mixture was stirred at rt for 15 h. The reaction mixture was quenched with water, and the organic layer was washed with 2 N NaOH, dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated. The residue was purified by column chromatography to give the title compound as a yellow solid (455 mg, 73%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.00 (s, 1H), 7.90−7.94 (m, 1H), 7.84−7.85 (m, 1H), 4.24−4.30 (m, 1H), 3.98−4.04 (m, 1H), 2.90−2.98 (m ,1 H), 2.54−2.62 (m, 1H), 2.34 (s, 3H), 2.16−2.22 (m, 1H), 1.90−2.00 (m, 1H), 1.56−1.72 (m 3H). </div><div class="NLM_p"><b>(</b><b><i>S</i></b><b>)-4-Chloro-3-(1-methyl-pyrrolidin-2-ylmethoxy)-phenylamine (50a).</b> A flask charged with (<i>S</i>)-2-(2-chloro-5-nitro-phenoxymethyl)-pyrrolidine (3.42 g, 12.63 mmol), SnCl<sub>2</sub> (7.19 g, 37.9 mmol), and EtOH (45 mL) was heated at 75 °C for 11 h. The reaction mixture was allowed to cool to rt, treated with 15 mL 1 N K<sub>2</sub>CO<sub>3</sub>, and stirred 40 min. The suspension was filtered through Celite and the ethanol was evaporated. The remaining aqueous solution was diluted with 1 N NaOH and EtOAc. The layers were separated, and the organic layer was washed with 1 N NaOH and a mixture of brine and 1 N NaOH. The aqueous layers were extracted with EtOAc. The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to yield the title compound as a brown solid (2.77 g, 91%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 6.93−6.95 (m, 1H), 6.29−6.30 (m, 1H), 6.08−6.11 (m, 1H), 5.20 (s, 2H), 3.75−3.85 (m, 2H), 2.91−2.94 (m, 1H), 2.53−2.61 (m, 1H), 2.37 (s, 3H), 2.14−2.21 (m, 1H), 1.88−1.98 (m, 1H), 1.63−1.70 (m, 2H), 1.53−1.57 (m, 1H). </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-3-((1-Methylpyrrolidin-2-yl)methoxy)-4-(trifluoromethyl)benzenamine (50b).</b> To a degassed solution of (<i>R</i>)-1-methyl-2-((5-nitro-2-(trifluoromethyl)phenoxy)methyl)pyrrolidine (3.16 g, 10.89 mmol) in dioxane (80 mL) and methanol (80 mL), Pd/C (10 wt %, 650 mg) was added. The mixture was stirred under H<sub>2</sub> for several days until the starting material was consumed. The reaction mixture was filtered through Celite and concentrated in vacuo to yield the title compound as a light yellow solid (2.98 g, 100%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.13 (d, <i>J</i> = 8.4 Hz, 1H), 6.25−6.30 (m, 1H), 6.13 (dd, <i>J</i> = 8.4, 1.6 Hz, 1H), 5.75 (bs, 2H), 3.88−3.94 (m, 1H), 3.70−3.88 (m, 1H), 2.90−2.97 (m, 1H), 2.50−2.58 (m, 1H), 2.33 (s, 3H), 2.13−2.22 (m, 1H), 1.88−1.98 (m, 1H), 1.62−1.72 (m, 2H), 1.50−1.58 (m, 1H). </div><div class="NLM_p"><b>(</b><b><i>R</i></b><b>)-1-Methyl-2-(5-amino-2-pentafluoroethyl-phenoxymethyl)-pyrrolidine (50c).</b> Starting from (<i>R</i>)-1-methyl-2-(5-nitro-2-pentafluoroethyl-phenoxymethyl)-pyrrolidine (455 mg, 1.28 mmol), 313 mg (75%) of the title compound was obtained according to the method described for the synthesis of <b>58e</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.06 (d, <i>J</i> = 8.5 Hz, 1H), 6.28 (d, <i>J</i> = 1.5 Hz, 1H), 6.19 (dd, <i>J</i> = 8.5, 1.8 Hz, 1H), 5.79 (s, 2H), 3.90−3.95 (m, 1H), 3.60−3.70 (m, 1H), 2.90−2.95 (m, 1H), 2.32 (s, 3H), 2.15−2.20 (m, 1H), 1.90−2.00 (M, 1H), 1.60−1.70 (m, 2H), 1.50−1.60 (m, 1H). </div><div class="NLM_p"><b>4-(3,4-Dinitrophenoxy)pyridine-2-carboxylic Acid Methylamide (52a).</b> A 50 mL flask was charged with 3,4-dinitrophenol (12.3 g, 66.8 mmol) and 4-chloro-pyridine-2-carboxylic acid methylamide<sup><a onclick="showRef(event, 'jm070034ib00020'); return false;" href="javascript:void(0);" class="ref jm070034ib00020">20</a></sup> (<b>53</b>; 7.79 g, 45.7 mmol) and fitted with a running water condenser. The mixture was heated at 150 °C for 1 h and at 170 °C for 16 h. The flask was allowed to cool to rt, and the crude mixture was dissolved in CH<sub>2</sub>Cl<sub>2</sub> and 2 N NaOH (aq). The layers were separated, and the organic layer was washed with a mix of brine and 2 N NaOH. The aqueous layers were back-extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The crude residue was purified by silica gel column chromatography using a hexanes to hexanes/EtOAc gradient to yield the title compound (93.5 mg, 15%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.80−8.88 (m, 1H), 8.63 (d, <i>J</i> = 5.7 Hz, 1H), 8.34 (d, <i>J</i> = 9.0 Hz, 1H), 8.12 (d, <i>J</i> = 2.4 Hz, 1H), 7.70 (dd, <i>J</i> = 9.0, 2.4 Hz, 1H), 7.66 (d, <i>J</i> = 2.4 Hz, 1H), 7.40−7.43 (m, 1H), 2.81 (d, <i>J</i> = 4.5 Hz, 3H). </div><div class="NLM_p"><b>4-(3,4-Dinitrophenoxy)-6,7-dimethoxyquinoline (52b).</b> A flask was charged with 6,7-dimethoxy-4-chloroquinoline (0.35 g, 1.6 mmol) and 3,4-dinitrophenol (0.85 g, 4.6 mmol) and heated at 150 °C for 4 h. The reaction mixture was allowed to cool at rt suspended in methanol. The suspension was stirred with methanol for 3 h at which point the precipitate was filtered and washed with fresh methanol to afford the title compound (256 mg, 46%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.93 (d, <i>J</i> = 6.3 Hz, 1H), 8.65 (d, <i>J</i> = 8.4 Hz, 1H), 8.40 (d, <i>J</i> = 2.1 Hz, 1H), 7.98 (dd, <i>J</i> = 8.4 Hz, 2.1 Hz, 1H), 7.73 (s, 1H), 7.67 (s, 1H), 7.34 (d, <i>J</i> = 6.3 Hz, 1H), 4.03 (s, 3H), 3.95 (s, 3H). </div><div class="NLM_p"><b>4-(3,4-Dinitro-phenoxy)-quinoline (52c).</b> A flask charged with 4-chloroquinoline (4.3 g, 26.3 mmol) and 3,4-dinitrophenol (4.5 g, 24.4 mmol) was heated (neat) at 150 °C for 30 min. The mixture was allowed to cool to rt, and the residue was dissolved in CH<sub>2</sub>Cl<sub>2</sub>, washed with 2 M NaOH, dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The residue was dissolved in EtOAc and filtered through a pad of silica gel, and the solvent was concentrated in vacuo to give the title compound as a brown solid (2.6 g, 33%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.86 (d, <i>J</i> = 5.6 Hz, 1H), 8.33 (d, <i>J</i> = 8.4 Hz, 1H), 8.18−8.21 (m, 1H), 8.15 (d, <i>J</i> = 8.4 Hz, 1H), 8.10 (d, <i>J</i> = 8.4 Hz, 1H), 7.83−7.88 (m, 1H), 7.64−7.73 (m, 2H), 7.20 (d, <i>J</i> = 5.6 Hz, 1H). </div><div class="NLM_p"><b>4-(3,4-Dinitro-phenoxy)-7,7a-dihydro-4a</b><b><i>H</i></b><b>-pyrrolo[2,3-</b><b><i>d</i></b><b>]pyrimidine (52d).</b> A flask was charged with 4-chloro-7,7a-dihydro-4a<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (1.66 g, 10.8 mmol), 3,4-dinitrophenol (2.4 g, 13 mmol), and a TFA/TEA mixture (1.1 mL), and the reaction mixture was heated at 150 °C for 2 h. The mixture was allowed to cool to rt and a green solid formed. This material was purified on silica gel using a hexane/EtOAc gradient (100/0 to 50/50) to give the title compound (460 mg, 14%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.36−8.38 (m, 2H), 8.34 (s, 1H), 8.30 (d, <i>J</i> = 2.9 Hz, 1H), 7.90 (dd, <i>J</i> = 8.7, 2.9 Hz, 1H), 7.56−7.89 (m, 1H), 6.73−6.76 (m, 1H). </div><div class="NLM_p"><a name="jm005001804369" id="jm005001804369"></a><b>4-(3,4-Dinitro-phenoxy)-1</b><b><i>H</i></b><b>-pyrrolo[2,3-</b><b><i>b</i></b><b>]pyridine (52e).</b> To cooled solution of POCl<sub>3</sub> (50 mL) was added 1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine 7-oxide<sup><a onclick="showRef(event, 'jm070034ib00021'); return false;" href="javascript:void(0);" class="ref jm070034ib00021">21</a></sup> (6.60 g, 55.0 mmol) in portions. Upon complete addition, the mixture was heated to reflux for 5 h and allowed to cool to rt. The POCl<sub>3</sub> was evaporated under high vacuum with gentle heating (40−50 °C) to give a black residue. The residue was diluted with water (50 mL), and the pH was adjusted to 8−9 with Na<sub>2</sub>CO<sub>3</sub> (first with solid, and then a saturated aqueous solution). The resulting precipitate was collected by filtration, washed with cold H<sub>2</sub>O, and dried in a vacuum oven (50 °C) to give 4-chloro-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine as a tan powder (7.7 g, regioisomeric mixture). A portion of this mixture (0.85 g, 5.50 mmol) was combined with 3,4-dinitrophenol (1.23 g, 6.7 mmol), and the mixture was heated at 150 °C for 8 h. The reaction mixture was allowed to cool to rt, and the resulting solid was dissolved in 12 N NaOH and CH<sub>2</sub>Cl<sub>2</sub>. The aqueous layer was extracted several times with CH<sub>2</sub>Cl<sub>2</sub>. The insoluble material was solubilized in acetone, and the acetone solution was diluted with CH<sub>2</sub>Cl<sub>2</sub> and washed with water. The combined CH<sub>2</sub>Cl<sub>2</sub> layers were dried and concentrated in vacuo. The crude material was purified on silica gel using a CH<sub>2</sub>Cl<sub>2</sub>/EtOH gradient (100/0 to 90/10) to yield the title compound (350 mg, 21%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 12.00 (bs, 1H), 8.23−8.29 (m, 2H), 7.99 (d, <i>J</i> = 2.9 Hz, 1H), 7.46−7.49 (m, 2H), 6.89 (d, <i>J</i> = 5.5 Hz, 1H), 6.25−6.35 (m, 1H). </div><div class="NLM_p"><b>(3,4-Dinitro-phenoxy)-pyridine (52f).</b> A flask charged with 4-chloropyridine (2.45 g, 21.5 mmol) and 3,4-dinitrophenol (4.56 g, 247 mmol) was fitted with a condenser and heated (open to the air) at 145 °C. After 45 min, 4 N HCl/dioxane (2.1 mL) was added, and the mixture was heated for an additional 25 min and allowed to cool to rt. The material was dissolved in a mixture of EtOAc and 0.5 N HCl/water, and the aqueous layer was basified with 6 N NaOH. The organic layer was washed with brine, dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to afford the title compound as a beige solid (1.36 g, 21%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.58−8.62 (m, 2H), 8.32 (d, <i>J</i> = 8.8 Hz, 1H), 8.07 (d, <i>J</i> = 2.4 Hz, 1H), 7.63 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 7.22−7.26 (m, 2H). </div><div class="NLM_p"><b>4-(3,4-Dinitro-phenoxy)-2-methylsulfanyl-pyrimidine (52g).</b> A flask charged with 3,4-dinitrophenol (6.10 g, 38.0 mmol) and 2-thiomethyl-4-chloro-1,2-pyrimidine (7.02 g, 38.0 mmol) was heated at 150 °C for 2 h. The mixture was allowed to cool to rt, and the resulting solid was finely ground and washed several times with methyl-<i>t</i>-butylether. The solid was suspended in 2 N NaOH, recovered by filtration, washed with water and dried under vacuum over P<sub>2</sub>O<sub>5</sub> to give the title compound (11.26 g, 95%). <sup>1</sup>H NMR (400 MHz, DMSO-d<sub>6</sub>) δ 8.60 (d, <i>J</i> = 5.2 Hz, 1H), 8.37 (d, <i>J</i> = 9.0 Hz, 1H), 8.34 (d, <i>J</i> = 2.6 Hz, 1H), 7.88 (dd, <i>J</i> = 9.0, 2.6 Hz, 1H), 7.02 (d, <i>J</i> = 5.2 Hz, 1H), 2.35 (s, 3H). </div><div class="NLM_p"><b>4-(3,4-Dinitro-phenoxy)-2-methylsulfonyl-pyrimidine (52h).</b> To a cooled solution (0 °C) of 4-(3,4-dinitro-phenoxy)-2-methylsulfanyl-pyrimidine (0.50 g, 1.60 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (100 mL) was added <i>m</i>-CPBA (0.70 g, 4.00 mmol). The solution was allowed to warm to rt and stirred for 16 h. The reaction mixture was washed with satd NaHCO<sub>3</sub>, dried over MgSO<sub>4</sub>, filtered, and concentrated in vacuo to afford the title compound (0.43 g, 78%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.03 (d, <i>J</i> = 5.8 Hz, 1H), 8.40−8.42 (m, 2H), 7.98 (dd, <i>J</i> = 9.2, 2.5 Hz, 1H), 7.65 (d, <i>J</i> = 5.8 Hz, 1H), 3.30 (s, 3H). </div><div class="NLM_p"><b>4-(4-Amino-3-nitro-phenoxy)-pyridine-2-carboxylic Acid Methylamide (54).</b> A solution of 4-amino-3-nitrophenol (97.6 g, 633 mmol) in DMSO (39 g) was treated with KO<i>t</i>-Bu (71.0 g, 633 mmol), and the mixture was stirred at rt for 2 h. The contents of the flask were treated with 4-chloro-<i>N</i>-methyl-2-pyridine-2-carboxylic acid methylamide (90 g, 527.5 mmol) and K<sub>2</sub>CO<sub>3</sub> (38.6 g, 460 mmol) and heated at 110 °C for 16 h. To the stirred mixture, water (200 mL) was added slowly. The precipitate was filtered, washed with water (400 mL), and dried in a vacuum oven overnight to give the title compound as a purple solid (190 g, 93%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.80−8.82 (m, 1H), 8.49 (d, <i>J</i> = 5.7 Hz, 1H), 7.90 (s, 1H), 7.78 (s, 2H), 7.35−7.40 (m, 2H), 7.13−7.16 (m, 2H), 2.80 (s, 3H). </div><div class="NLM_p"><b>4-(4-Methylamino-3-nitrophenoxy)-pyridine-2-carboxylic Acid Methylamide (55).</b> To a cooled (0 °C) flask containing CH<sub>2</sub>Cl<sub>2</sub> (18 mL) and 4-(4-amino-3-nitro-phenoxy)-pyridine-2-carboxylic acid methylamide (1.0 g, 3.5 mmol), trifluoroacetic anhydride (0.93 mL, 6.59 mmol) was added dropwise over 15 min and the mixture was stirred for 45 min. To this cooled solution, tetrabutylammonium chloride (0.48 g, 1.73 mmol), dimethyl sulfate (0.66 mL, 6.94 mmol), and 50% NaOH/water (by wt, 14 mL) were added. The mixture was allowed to warm to rt and stirred 16 h. The mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub>, washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The title compound was obtained as an orange solid after crystallization from 3:1 EtOH/water (0.87 g, 83% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.90−8.95 (m, 1H), 8.65 (d, <i>J</i> = 5.7 Hz, 1H), 8.35−8.45 (m, 1H), 8.04 (d, <i>J</i> = 2.8 Hz, 1H), 7.67 (dd, <i>J</i> = 9.4, 2.7 Hz, 1H), 7.54 (d, <i>J</i> = 2.6 Hz, 1H), 7.27−7.35 (m, 2H), 3.14 (s, 3H), 2.92 (s, 3H). </div><div class="NLM_p"><b>4-Benzyloxy-3-chlorophenol (56c).</b><sup><a onclick="showRef(event, 'jm070034ib00022'); return false;" href="javascript:void(0);" class="ref jm070034ib00022">22</a></sup> To a solution of 4-benzyloxy-3-chlorobenzaldehyde (4 g, 16.2 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (65 mL), <i>m</i>-CPBA (3.63 g, 77% max, 21.05 mmol) was added, and the reaction mixture was stirred at rt for 5 days. The mixture was washed with a Na<sub>2</sub>S<sub>2</sub>O<sub>3</sub> solution and then NaHCO<sub>3</sub> (satd) and concentrated in vacuo. The residue was suspended in MeOH (150 mL), NaOMe (0.5 M in MeOH, 60 mL) was added, and the mixture was stirred for 1 h. The mixture was concentrated, and the residue was dissolved in water and extracted with a mixture of Et<sub>2</sub>O/EtOAc. The aqueous layer was acidified and extracted with EtOAc. The combined organic portions were dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated. The mixture was purified by column chromatography using CH<sub>2</sub>Cl<sub>2</sub> as the eluent to yield the title compound as an off-white solid (3.32 g, 87%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.37 (s, 1H), 7.27−7.44 (m, 5H), 7.02 (d, <i>J</i> = 8.8 Hz, 1H), 6.81 (d, <i>J</i> = 2.9 Hz, 1H), 6.65 (dd, <i>J</i> = 8.8, 2.9 Hz, 1H). </div><div class="NLM_p"><b>4-(4-Benzyloxy-phenoxy)-pyridine-2-carboxylic Acid Methylamide (57a).</b> To a stirred slurry of NaH (2.24 g of 60% oil dispersion, 55.9 mmol) in DMF (40 mL) was added 4-benzyloxyphenol (11.2 g, 55.9 mmol). The mixture was stirred at rt for 10 min, followed by addition of 4-chloro-pyridine-2-carboxylic acid methylamide (3.18 g, 18.6 mmol). The reaction mixture was stirred at rt for 5 min, then heated to 75 °C for 2 h, and finally at 85 °C for 6 h. The reaction was allowed to cool to rt, quenched with saturated aqueous NaHCO<sub>3</sub>, then diluted with Et<sub>2</sub>O and 6 N NaOH. The layers were separated, and the organic layer was washed with 6 N NaOH and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to yield the title compound as a light salmon-colored solid (6.45 g, 103%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.66−8.69 (m, 1H), 8.47 (d, <i>J</i> = 5.6 Hz, 1H), 7.40−7.47 (m, 2H), 7.29−7.40 (m, 4H), 7.09−7.17 (m, 5H), 5.12 (s, 2H), 2.76 (d, <i>J</i> = 4.8 Hz, 3H). </div><div class="NLM_p"><b>4-(4-(Benzyloxy)phenoxy)quinoline (57b).</b> Starting from 4-chloroquinoline (3.0 g, 18.4 mmol), 3.8 g (63%) of the title compound was obtained as a tan solid according to the method described for the synthesis of <b>57a</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.64 (d, <i>J</i> = 5.7 Hz, 1H), 8.27−8.32 (m, 1H), 7.95 (d, <i>J</i> = 9.5 Hz, 1H), 7.76−7.82 (m, 1H), 7.58−7.65 (m, 1H), 7.42−7.48 (m, 2H), 7.36−7.42 (m, 2H), 7.30−7.35 (m, 1H), 7.20−7.26 (m, 2H), 7.10−7.16 (m, 2H), 6.50 (d, <i>J</i> = 5.7 Hz, 1H, 5.12 (s, 2H). </div><div class="NLM_p"><b>4-(4-(Benzyloxy)-3-chlorophenoxy)quinoline (57c).</b> Starting with 4-chloroquinoline (725 mg, 5.0 mmol) and 4-benzyloxy-3-chlorophenol (3 g, 12.78 mmol), 1.37 g (76%) of the title compound was obtained as a pink solid according to the method described for the synthesis of <b>57a</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.67 (d, <i>J</i> = 5.7 Hz, 1H), 8.28 (d, <i>J</i> = 8.4 Hz, 1H), 8.01 (d, <i>J</i> = 8.4 Hz, 1H), 7.79−7.82 (m, 1H), 7.61−7.64 (m, 1H), 7.46−7.54 (m, 3H), 7.30−7.42 (m, 4H), 7.24−7.30 (m, 1H), 6.58 (d, <i>J</i> = 5.1 Hz, 1H), 5.23 (s, 2H). </div><div class="NLM_p"><b>4-(4-(Benzyloxy)-3-chlorophenoxy)-pyridine-2-carboxylic Acid Methylamide (57d).</b> Starting with 4-chloro-pyridine-2-carboxylic acid methylamide (367 mg, 2.15 mmol), 609 mg (87%) of the title compound was obtained as a brown solid according to the method described for the synthesis of <b>57a</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.75−8.85 (m, 1H), 8.48−8.50 (m, 1H), 7.46−7.50 (m, 3H), <a name="jm005001804370" id="jm005001804370"></a> 7.38−7.44 (m, 2H), 7.32−7.37 (m, 3H), 7.51−7.55 (m, 1H), 7.19−7.30 (m, 1H), 5.23 (s, 2H), 2.77 (d, <i>J</i> = 4.8 Hz, 3H). </div><div class="NLM_p"><b>[4-(4-Benzyloxy-phenoxy)-pyrimidin-2-yl]-methyl-amine (57e).</b> To a stirred rt slurry of NaH (0.5 g of 60% oil dispersion, 12.6 mmol) in DMF (15 mL) was added 4-benzyloxyphenol (2.40 g, 12.0 mmol). The mixture was stirred for 10 min before 2,4-dichloropyrimidine (1.79 g, 12.0 mmol) was added. A mild exotherm occurred. The reaction mixture was stirred for 2 h, quenched with saturated aqueous NaHCO<sub>3</sub>, and diluted with EtOAc and the layers were separated. The organic layer was washed with 2 N NaOH and brine, then dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to yield crude 4-(4-benzyloxy-phenoxy)-2-chloro-pyrimidine (4.0 g contaminated with minor 4-Cl impurity). A portion of this material (2.03 g, approx 6.49 mmol) was dissolved in 10 mL of DMSO in a sealed tube at 0 °C, and 2 N methylamine (in THF) was added (4.9 mL, 9.7 mmol) and the tube was sealed. The mixture was allowed to warm to rt, stirred for 2 h, and then heated to 70 °C for 2 h. The reaction mixture was allowed to cool to rt and concentrated in vacuo. The crude solution was diluted with Et<sub>2</sub>O, and washed with 1 N NaOH, water, and then brine. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The crude material was purified by silica gel column chromatography using a hexanes/EtOAc gradient to yield the title compound as a white solid (1.67 g, 84%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.10 (bs, 1H), 7.30−7.50 (m, 5H), 7.00−7.10 (m, 5H), 5.90−6.10 (m ,1H), 5.08 (s, 2H), 2.60−2.70 (bs, 3H). </div><div class="NLM_p"><b>6-(4-(Benzyloxy)phenoxy)-</b><b><i>N</i></b><b>-methylpyrimidin-4-amine (57f).</b> Starting with 4,6-dichloropyrimidine (4.10 g, 27.6 mmol), 2.89 g (34%) of the title compound was obtained according to the method described for the synthesis of <b>57a</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.08 (bs, 1H), 7.22−7.48 (m, 6H), 7.00−7.08 (m, 4H), 5.68 (s, 1H), 5.08 (s, 2H), 2.73 (s, 3H). </div><div class="NLM_p"><b>4-(4-Benzyloxy-phenoxy)-pyridine-2-carboxylic Acid Amide (57g).</b> Starting with 4-chloro-pyridine-2-carboxylic acid amide<sup><a onclick="showRef(event, 'jm070034ib00023'); return false;" href="javascript:void(0);" class="ref jm070034ib00023">23</a></sup> (4.27 g, 27.26 mmol), 8.90 g (102%) of the title compound was obtained according to the method described for the synthesis of <b>57a</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.48 (d, <i>J</i> = 5.6 Hz, 1H), 8.09−8.12 (m, 1H), 7.68−7.70 (m, 1H), 7.44−7.48 (m, 2H), 7.38−7.42 (m, 2H), 7.30−7.36 (m, 2H), 7.10−7.18 (m, 5H), 5.15 (s, 2H). </div><div class="NLM_p"><b>4-(4-Benzyloxyphenoxy)-6,7-dimethoxyquinazoline (57h).</b> Starting with 4-chloro-6,7-dimethoxyquinazoline (2.30 g, 11.1 mmol), 2.0 g (46%) of the title compound was obtained according to the method described for the synthesis of <b>57a</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.50 (s, 1H), 7.52 (s, 1H), 7.40−7.50 (m, 2H), 7.30−7.40 (m, 3H), 7.20 (d, <i>J</i> = 8.7 Hz, 2H), 7.06 (d, <i>J</i> = 9.0 Hz, 2H), 5.13 (s, 2H), 3.96 (s, 3H), 3.95 (s, 3H). </div><div class="NLM_p"><b>4-(4-Hydroxyphenoxy)-pyridine-2-carboxylic Acid Methylamide (58a).</b> Starting from 4-(4-benzyloxy-phenoxy)-pyridine-2-carboxylic acid methylamide (0.44 g, 1.32 mmol), 282 mg (88%) of the title compound was obtained as a pink oil according to the method described for the synthesis of <b>58e</b>. <sup>1</sup>H NMR (400 MHz, DMSO-d<sub>6</sub>) δ 9.59 (s, 1H), 8.70−8.80 (m, 1H), 8.45 (d, <i>J</i> = 5.6 Hz, 1H), 7.31 (d, <i>J</i> = 2.0 Hz, 1H), 7.06−7.08 (m, 1H), 6.98−7.02 (m, 2H), 6.82−6.86 (m, 2H), 2.76 (d, <i>J</i> = 4.8 Hz, 3H). </div><div class="NLM_p"><b>4-(Quinolin-4-yloxy)phenol (58b).</b> Starting from 4-(4-(benzyloxy)phenoxy)quinoline (3.8 g, 11.6 mmol), 800 mg (30%) of the title compound was obtained according to the method described for the synthesis of <b>58e</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.60 (s, 1H), 8.65 (d, <i>J</i> = 5.8 Hz, 1H), 8.30 (d, <i>J</i> = 5.8 Hz, 1H), 8.00 (d, <i>J</i> = 8.7 Hz, 1H), 7.70−7.80 (m, 1H), 7.55−7.65 (m, 1H), 7.10 (d, <i>J</i> = 8.7 Hz, 2H), 6.85 (d, <i>J</i> = 8.7 Hz, 2H), 6.50 (d, <i>J</i> = 3.8 Hz, 1H). </div><div class="NLM_p"><b>2-Chloro-4-(quinolin-4-yloxy)phenol (58c).</b> A solution of 4-(4-(benzyloxy)-3-chlorophenoxy)quinoline (1.37 g, 3.79 mmol) in TFA (10 mL) was refluxed for 20 h, and the mixture was allowed to cool to rt and concentrated in vacuo. The residue was diluted with water and basified with NH<sub>4</sub>OH (concd) and a solid precipitated. The solid was collected and washed with water and Et<sub>2</sub>O, yielding the title compound (983 mg, 95%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.37 (s, 1H), 8.66 (d, <i>J</i> = 4.8 Hz, 1H), 8.28 (d, <i>J</i> = 7.3 Hz, 1H), 8.00 (d, <i>J</i> = 8.3 Hz, 1H), 7.75−7.85 (m, 1H), 7.60−7.70 (m, 1H), 7.35−7.40 (m ,1H), 7.00−7.15 (m, 2H), 6.57 (d, <i>J</i> = 5.4 Hz, 1H). </div><div class="NLM_p"><b>4-(3-Chloro-4-hydroxyphenoxy)-pyridine-2-carboxylic Acid Methylamide (58d).</b> Starting with 4-(4-(benzyloxy)-3-chlorophenoxy)-pyridine-2-carboxylic acid methylamide (0.60 g, 1.65 mmol), 578 mg (crude, mixed with salts) of the title compound was obtained as a tan solid according to the method described for the synthesis of <b>58c</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.39 (s, 1H), 8.70−8.85 (m, 1H), 8.47 (d, <i>J</i> = 5.4 Hz, 1H), 7.30−7.40 (m, 1H), 7.00−7.15 (m, 4H), 2.76 (d, <i>J</i> = 4.9 Hz, 3H). </div><div class="NLM_p"><b>4-(2-Methylamino-pyrimidin-4-yloxy)-phenol (58e).</b> A flask was charged with [4-(4-benzyloxy-phenoxy)-pyrimidin-2-yl]-methyl-amine (0.75 g, 2.44 mmol) and the solid was dissolved in MeOH (5 mL) and EtOAc (10 mL). To the argon-degassed solution was added 10% by weight Pd/C (0.15 g). The reaction mixture was stirred vigorously at rt under 1 atm H<sub>2</sub> gas for 4 days, filtered through Celite, and concentrated in vacuo to yield the title compound (517 mg, 98%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.39 (s, 1H), 8.08 (s, 1H), 6.90−7.05 (m, 3H), 6.75 (d, <i>J</i> = 8.8 Hz, 2H), 5.80−6.00 (m, 1H), 2.66 (s, 3H). </div><div class="NLM_p"><b>4-(6-Methylamino-pyrimidin-4-yloxy)-phenol (58f).</b> Starting with 6-(4-(benzyloxy)phenoxy)-<i>N</i>-methylpyrimidin-4-amine (1.29 g, 4.20 mmol), 833 mg (97%) of the title compound was obtained as an off-white solid according to the method described for the synthesis of <b>58e</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.39 (s, 1H), 8.08 (bs, 1H), 7.15−7.25 (m, 1H), 6.88−6.92 (m, 2H), 6.73−6.80 (m, 2H), 5.61 (s, 1H), 2.72 (s, 3H). </div><div class="NLM_p"><b>4-(4-Hydroxy-phenoxy)-pyridine-2-carboxylic Acid Amide (58g).</b> Starting with 4-(4-benzyloxy-phenoxy)-pyridine-2-carboxylic acid amide (8.90 g, 27.78 mmol), 6.22 g (97%) of the title compound was obtained according to the method described for the synthesis of <b>58e</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.61 (bs, 1H), 8.46 (d, <i>J</i> = 5.6 Hz, 1H), 8.08−8.12 (m, 1H), 7.65−7.70 (m, 1H), 7.31 (d, <i>J</i> = 2.4 Hz, 1H), 7.09 (dd, <i>J</i> = 5.6, 2.4 Hz, 1H), 6.98−7.05 (m, 2H), 6.80−6.90 (m, 2H). </div><div class="NLM_p"><b>4-(1</b><b><i>H</i></b><b>-Indol-4-yloxy)phenol (58i).</b> A mixture of 4-chloro-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (3.10 g, 20.0 mmol), 4-benzyloxyphenol (8.10 g, 40.0 mmol) and Et<sub>3</sub>N/TFA 1:1 mixture (3.0 mL) was heated at 150 °C for 96 h. The crude material was directly purified on silica gel without workup using a hexanes/EtOAc gradient (100/0 to 0/100) to afford 4-(4-benzyloxy-phenoxy)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine (1.20 g) as a 2:1 mixture with the phenol starting material. This material was subjected to the conditions for the synthesis of <b>58e</b> at a pressure of 60 psi to afford the title compound (0.80 g, 93%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.90 (s, 1H), 9.55 (s, 1H), 8.10 (d, <i>J</i> = 6.6 Hz, 1H), 7.35−7.40 (m, 1H), 7.05 (d, <i>J</i> = 8.3 Hz, 2H), 6.85 (d, <i>J</i> = 8.3 Hz, 2H), 6.40 (d, <i>J</i> = 6.6 Hz, 1H), 6.25−6.30 (m, 1H). </div><div class="NLM_p"><b>4-(4-Hydroxy-3-nitrophenoxy)-pyridine-2-carboxylic Acid Methylamide (59a).</b> Starting from 4-(4-hydroxyphenoxy)-pyridine-2-carboxylic acid methylamide(0.28 g, 1.15 mmol), 187 mg (56%) of the title compound was obtained as a yellow foam according to the method described for the synthesis of <b>59e</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.19 (s, 1H), 8.70−8.80 (m, 1H), 8.50 (d, <i>J</i> = 5.6 Hz, 1H), 7.80 (d, <i>J</i> = 2.8 Hz, 1H), 7.44−7.47 (m, 1H), 7.38 (d, <i>J</i> = 2.4 Hz, 1H), 7.22 (d, <i>J</i> = 9.2 Hz, 1H), 7.14−7.16 (m, 1H), 2.77 (d, <i>J</i> = 4.8 Hz, 3H). </div><div class="NLM_p"><b>2-Nitro-4-(quinolin-4-yloxy)phenol (59b).</b> Starting from 4-(quinolin-4-yloxy)phenol (800 mg, 3.79 mmol), 760 mg (76%) of the title compound was obtained as an orange solid according to the method described for the synthesis of <b>59e</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.68 (d, <i>J</i> = 7.3 Hz, 1H), 8.25−8.30 (m, 1H), 8.02 (d, <i>J</i> = 9.7 Hz, 1H), 7.88 (d, <i>J</i> = 4.8 Hz, 1H), 7.75−7.85 (m, 1H), 7.60−7.70 (m, 1H), 7.55 (d, <i>J</i> = 4.8 Hz, 1H), 7.50 (d, <i>J</i> = 4.8 Hz, 1H), 7.25 (d, <i>J</i> = 12.1 Hz, 1H), 6.65 (d, <i>J</i> = 5.8 Hz, 1H). </div><div class="NLM_p"><b>4-(3-Chloro-4-hydroxy-5-nitrophenoxy)-pyridine-2-carboxylic Acid Methylamide (59d).</b> Starting with 4-(3-chloro-4-hydroxyphenoxy)-pyridine-2-carboxylic acid methylamide (578 mg, appx 1.83 mmol), 394 mg (crude, with salts) of the title compound was obtained as an orange solid according to the method described for <a name="jm005001804371" id="jm005001804371"></a> the synthesis of <b>59e</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.76 (s, 1H), 8.40−8.50 (m, 1H), 7.38−7.45 (m, 2H), 7.00−7.25 (m, 3H), 2.75−2.80 (m, 3H). </div><div class="NLM_p"><b>4</b><b>−</b><b>(2-Methylamino-pyrimidin-4-yloxy)-2-nitro-phenol (59e).</b> A flask was charged with 4-(2-methylamino-pyrimidin-4-yloxy)-phenol (0.20 g, 0.92 mmol) was the solid dissolved in AcOH (5 mL). To this solution was added fuming HNO<sub>3</sub> (64 mg, 0.92 mmol; diluted with water (∼12 μL) dropwise over 1 min. The reaction mixture was stirred at rt for 18 h, after which it was poured slowly to 40 mL saturated aqueous NaHCO<sub>3</sub> and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was washed with NaHCO<sub>3</sub> (satd) and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. The crude residue was purified by silica gel column chromatography using hexanes/EtOAc gradient to yield the title compound (163 mg, 68%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.98 (s, 1H), 8.15 (s, 1H), 7.70−7.80 (m, 1H), 7.35−7.45 (m, 1H), 7.14 (d, <i>J</i> = 9.2 Hz, 1H), 6.95−7.05 (m, 1H), 6.10−6.20 (m, 1H), 2.48 (s, 3H). </div><div class="NLM_p"><b>4-(6-Methylamino-pyrimidin-4-yloxy)-2-nitro-phenol (59f).</b> Starting with 4-(6-methylamino-pyrimidin-4-yloxy)-phenol (0.88 g, 4.06 mmol), 740 mg (69%) of the title compound was obtained as a light yellow solid according to the method described for the synthesis of <b>59e</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.96 (s, 1H), 8.09 (bs, 1H), 7.65 (d, <i>J</i> = 2.8 Hz, 1H), 7.33−7.36 (m, 2H), 7.13 (d, <i>J</i> = 8.4 Hz, 1H), 5.82 (s, 1H), 2.76 (s, 3H). </div><div class="NLM_p"><b>4-(6,7-Dimethoxyquinazolin-4-yloxy)-2-nitrophenol (59h).</b> Starting with 4-(4-benzyloxy-phenoxy)-6,7-dimethoxyquinazoline (2.0 g, 5.15 mmol), 0.76 g (2.36 mmol, 46%) of 4-(6,7-dimethoxyquinazolin-4-yloxy)-phenol was obtained according to the method described for the synthesis of <b>58e</b> (using a mixture of DMF and methanol as the solvent). This compound was converted to 4-(6,7-dimethoxyquinazolin-4-yloxy)-2-nitrophenol using the conditions described for <b>59e</b> to obtain the title compound as a yellow solid (0.48 g, 59%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.05 (bs, 1H), 8.60 (s, 1H), 7.85−7.90 (m, 1H), 7.50−7.60 (m, 2H), 7.35−7.40 (m, 1H), 7.15−7.25 (m, 1H), 3.95−4.00 (m, 6H). </div><div class="NLM_p"><b>4-(3-Fluoro-4-hydroxy-5-nitrophenoxy)-pyridine-2-carboxylic Acid Methylamide (59j).</b> To a stirred rt slurry of NaH (0.10 g of 60% oil dispersion, 4.51 mmol) in DMF (8 mL) was added 4-(benzyloxy)-3-fluorophenol (0.98 g, 4.50 mmol). The mixture was stirred at rt for 10 min before adding 4-chloro-pyridine-2-carboxylic acid methylamide (0.77 g, 4.50 mmol). The reaction mixture was stirred at rt for 10 min and then heated at 85 °C for 16 h. The reaction was allowed to cool to rt, quenched with saturated aqueous NaHCO<sub>3</sub>, and then diluted with Et<sub>2</sub>O and 6 N NaOH. The layers were separated, and the organic layer was washed with 6 N NaOH and then brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to yield 4-(4-(benzyloxy)-3-fluorophenoxy)-pyridine-2-carboxylic acid methylamide as a 1:1 mixture with 4-chloro-pyridine-2-carboxylic acid methylamide (1.24 g). This crude material was dissolved in ethanol (20 mL). To the argon-degassed solution was added Pd/C (10% by wt, 0.40 g), and the reaction was stirred vigorously at rt under 1 atm H<sub>2</sub> gas for 4 days. The mixture was filtered through Celite and concentrated in vacuo to yield 4-(3-fluoro-4-hydroxyphenoxy)-pyridine-2-carboxylic acid methylamide (655 mg) as a 1:1 mixture with pyridine-2-carboxylic acid methylamide (996 mg total). The title compound was further obtained as a thick oil (611 mg, 80%) according to the method described for the synthesis of <b>59e</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.37 (s, 1H), 8.70−8.80 (m, 1H), 8.51 (d, <i>J</i> = 5.7 Hz, 1H), 7.55−7.65 (m, 2H), 7.43 (d, <i>J</i> = 2.4 Hz, 1H), 7.17−7.20 (m, 1H), 2.78 (d, <i>J</i> = 5.1 Hz, 3H). </div><div class="NLM_p"><b>4-(6,7-Dimethoxyquinolin-4-yloxy)-2-nitrophenol (59k).</b> Starting from 4-chloro-6,7-dimethoxyquinoline<sup><a onclick="showRef(event, 'jm070034ib00024'); return false;" href="javascript:void(0);" class="ref jm070034ib00024">24</a></sup> (3 g, 13.4 mmol), 6.43 g of 4-(4-(benzyloxy)phenoxy)-6,7-dimethoxyquinoline (contaminated with the phenol) was obtained according to the method described for the synthesis of <b>57a</b>. The mixture was treated with Pd/C according to the procedure described in <b>39o</b> to give 4-(6,7-dimethoxyquinolin-4-yloxy)phenol. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.60(s, 1H), 8.42 (d, <i>J</i> = 5.6 Hz, 1H), 7.50 (s, 1H), 7.35 (s, 1H), 7.05 (d, <i>J</i> = 7.5 Hz, 1H), 6.85 (d, <i>J</i> = 7.5 Hz, 1H), 6.35 (d, <i>J</i> = 5.6 Hz, 1H), 3.95 (s, 6H). A portion of 4-(6,7-dimethoxyquinolin-4-yloxy)phenol (200 mg, 0.67 mmol) was converted to 4-(6,7-dimethoxyquinolin-4-yloxy)-2-nitrophenol (160 mg, 69%) using the method described in <b>59e</b>. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.40 (bs, 1H), 8.85 (d, <i>J</i> = 8.0 Hz, 1H), 8.02 (d, <i>J</i> = 3.3 Hz, 1H), 7.70 (s, 1H), 7.52 (dd, <i>J</i> = 8.0, 3.3 Hz, 1H), 7.50 (s, 1H), 7.30 (d, <i>J</i> = 10.0 Hz, 1H), 7.00 (d, <i>J</i> = 8.0 Hz, 1H), 4.04 (s, 3H), 4.01 (s, 3H). </div><div class="NLM_p"><b>Bioligical Assays.</b><b>KDR Enzyme Assay:</b> In a 96-well plate, 5 nM of either the phosphorylated or unphosphorylated form of the KDR kinase domain was incubated with a 10-point titration of compound ranging from 3 μM to 0.15 nM and 1 μM gastrin substrate, sequence {N} EEEEA YGWLD F {C}, in 20 mM Tris-HCl pH 7.5, 10 mM MgCl<sub>2</sub>, 100 mM NaCl, 1.5 mM EGTA, 1 mM DTT, 0.2 mM sodium orthovanadate, and 20 μg/mL BSA for 30 min at 25 °C. ATP was added at a final concentration of 11.8 μM and incubated for 60 min at room temperature. From this reaction mix, 5 μL was transferred to a black 96-well plate containing 80 μL of 2.75 μg/mL SA-APC (Prozyme, Inc., catalog #PJ25S) and 0.1125 nM Eu-labeled antiphosphotyrosine pT66 antibody (Perkin-Elmer) in 50 mM Tris-HCl pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% Tween-20, and incubated for 30 min at 25 °C. The plate was read on a RubyStar and data was fitted using the Levenburg−Marquardt algorithm into a four-parameter logistic equation. </div><div class="NLM_p"><b>Inhibition of LCK Kinase Domain</b>. In a 96-well black polypropylene costar plate, 1 μM biotinylated gastrin substrate (sequence {N} EEEEA<i>Y</i>GWLDF {C}) and 0.5 μM ATP (at <i>K</i><sub>m</sub>) were added to a 10-point, 5-fold titration of compound ranging from 25 μM to 12.8 pM. The reaction was initiated by adding 50 pM of the GST-tagged form of the LCK kinase domain in 50 mM HEPES pH 7.5, 20 mM MgCl<sub>2</sub>, 5 mM MgCl<sub>2</sub>, 50 mM NaCl, 1 mM DTT, and 0.05% BSA. The reaction was incubated for 90 min at rt. The reaction was quenched by the addition of 160 μL of detection mix consisting of 50 mM TRIS pH 7.5, 100 mM NaCl, 0.05% BSA, 0.1% Tween-20, 3 mM EDTA, 40 μg/mL SA-APC (Perkin-Elmer), 25 nM Eu-labeled anti-phosphotyrosine pT66 antibody (Perkin-Elmer), and incubated at room temperature for 30 min. The plate was read on a BMG RubyStar. All enzymes were run at the apparent <i>K</i><sub>m</sub> of ATP, and peptide substrates were dependent upon enzymes:  gastrin (LCK, cMet, Src, EGFR, Zap-70, IGF); biotinyl-GGMEDIYFEFMGGKKK (Tie-2, cFMS, cKit); and biotinyl-KEAPEDLYKDFLTL (FGFR). </div><div class="NLM_p"><b>Inhibition of p38</b>α<b>, p38</b>β<b>, JNK1, JNK2, JNK3.</b> In a 96-well black polypropylene costar plate, 100 nM biotinyl-ATF2, and 50 μM ATP(p38α, p38β) or 2 μM ATP(JNK1, JNK2, JNK3) were added to a 10-point, 3-fold titration of compound. Adding 1 nM p38α, 5 nM p38β, 0.5 nM JNK1, 1 nM JNK2, or 1.5 nM JNK3 in 50 mM Tris HCl, pH 7.5, 5 mM MgCl<sub>2</sub>, 0.5 mM DTT, 0.1 mM Na<sub>3</sub>VO<sub>4</sub>, and 0.1 mg/mL BSA initiated the reaction. The 30 μL of reaction volume was incubated for 60 min at rt. The reaction was quenched by the addition of 30 μL of detection mix consisting of 50 mM Hepes, pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% Tween-20, 10 mM EDTA, 4nM streptavidin allophycocyanin (Prozyme), and 0.1 nM Eu-labeled antiphosphothreonine proline antibody (Perkin-Elmer). </div><div class="NLM_p"><b>Inhibition of CDK1, CDK2, and p25CDK5.</b> In a 96-well black polypropylene costar plate, 0.5 μM biotinylated histone H1 and 25 μM ATP (<<i>K</i><sub>m</sub>) were added to a 10-point, 3-fold titration of compound. Adding 5 nM CDK1, 1 nM cyclin E<sub>2</sub>-CDK2, or 0.2 nM of p25CDK5 in 50 mM Tris HCl, pH 7.5, 5 mM MgCl<sub>2</sub>, 5 mM DTT, 5 mM β-glycerolphosphate, and 0.2 mg/mL BSA initiated the reaction. The 30 μL of reaction volume was incubated for 60 min at rt. The reaction was quenched by the addition of 30 μL of detection mix consisting of 100 mM Hepes, pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% Tween-20, 10 mM EDTA, 1nM streptavidin allophycocyanin (Prozyme), and 0.05 nM Eu-labeled antiphosphothreonine proline antibody (Perkin-Elmer) and incubated at rt for 60 min. The plate was read on a Discovery Plate Reader (Perkin-Elmer). </div><div class="NLM_p"><b>Inhibition of GSK3</b>β<b>.</b> In a 96-well polypropylene costar plate, 0.5 μM biotinylated phosphorylated CREB-T peptide (KKRREILTRRP[pS]YR) and 25 μM ATP (<<i>K</i><sub>m</sub>) were added to a 10-point, <a name="jm005001804372" id="jm005001804372"></a> 3-fold titration of compound. Adding 0.2 nM of GSK3β in 50 mM Tris HCl, pH 7.5, 5 mM MgCl<sub>2</sub>, 5 mM DTT, 10 mM β-glycerolphosphate, and 0.2 mg/mL BSA initiated the reaction. The 50 μL of reaction volume was incubated for 60 min at rt. The reaction was quenched by a 30-fold dilution into detection mix consisting of 100 mM Tris HCl, pH 7.5, 100 mM NaCl, 0.1% BSA, 0.05% Tween-20, 10 mM EDTA, 1 nM ruthenylated antirabbit antibody (BioVeris), 1 nM antiphosphothreonine antibody (Cell Signaling Technology), and 7.5 μg streptavidin paramagnetic beads (Dynal) and incubated with agitation at rt for 60 min. The plate was read on a M-Series M8 Analyzer (BioVeris). The proportion of substrate phosphorylated in the kinase reactions in the presence of compound compared with that phosphorylated in the presence of DMSO vehicle alone (HI control) was calculated using the formula:  % control (POC) = (cmpd − average LO)/(average HI − average LO) × 100. Data (consisting of POC and inhibitor concentration in μM) was fitted to a four-parameter equation (<i>y</i> = <i>A</i> + ((<i>B</i> − <i>A</i>)/(1 + ((<i>x</i>/<i>C</i>)<sup>∧</sup><i>D</i>))), where <i>A</i> is the minimum <i>y</i> (POC) value, <i>B</i> is the maximum <i>y</i> (POC), <i>C</i> is the <i>x</i> (cmpd concentration) at the point of inflection, and <i>D</i> is the slope factor) using a Levenburg−Marquardt nonlinear regression algorithm. The inhibition constant (<i>K</i><sub>i</sub>) of the inhibitor was estimated from the IC<sub>50</sub> (cmpd concentration at the point of inflection; <i>C</i>) using the Cheng−Prussof equation:  <i>K</i><sub>i</sub> = IC<sub>50</sub> /(1 + <i>S</i>/<i>K</i><sub>m</sub>), where <i>S</i> is the ATP substrate concentration and <i>K</i><sub>m</sub> is the Michaelis constant for ATP as determined experimentally. </div><div class="NLM_p"><b>HUVEC Proliferation Assay.</b> HUVEC proliferation assays were performed as previously described.<sup>10e</sup> Briefly HUVECs were cultured in endothelial growth medium-2 (Cambrex). One day before the assay was run, HUVEC were seeded into flat-bottom, 96-well plates (BD Falcon) at 3000 cells per well in DMEM medium with 10% qualified fetal bovine serum (FBS) and 1× penicillin, streptomycin, and <span class="smallcaps smallerCapital">l</span>-glutamine (1× PSG). After culture for 22 h, media was removed and HUVEC were preincubated for 2 h with serial dilutions of small molecule diluted 1:400 in DMEM with 10% FBS plus 1× PSG. HUVEC were then challenged with 50 ng/mL VEGF or 20 ng/mL bFGF and incubated for 72 h at 37 °C, 5% CO<sub>2</sub>. Cells were washed 2× with DPBS, and plates were frozen at −70 °C for 24 h. Plates were thawed, incubated with CyQuant dye (Molecular Probes), and read on a Victor 1420 Workstation (Perkin-Elmer Corporation). IC<sub>50</sub> data was calculated using the Levenburg−Marquardt algorithm into a 4-parameter logistic equation (ID Business Solutions, Ltd.) and expressed in μM. </div><div class="NLM_p"><b>Pharmacokinetic Studies</b>. Male Sprague−Dawley rats were dosed via femoral vein (intravenous, DMSO solution, dose 1 mg/kg) or via oral gavage (suspensions in Ora-Plus, pH adjusted to a range of 2.0−2.2 using methanesulfonic acid, dose 10 mg/kg). Concentrations of all formulations were selected as to allow for dose volumes in accordance with the highest scientific, humane, and ethical principals as defined by IACUC (Institutional Animal Care and Use Committees).<sup><a onclick="showRef(event, 'jm070034ib00025'); return false;" href="javascript:void(0);" class="ref jm070034ib00025">25</a></sup> Serial blood samples were collected from jugular vein into heparized tubes over a 12−24 h period. Plasma was separated by centrifugation, and the sample was prepared for analysis by protein precipitation with acetonitrile. Quantitation of the test compounds was accomplished by reversed liquid chromatography with mass spectral detection in multiple reaction monitoring mode, with an appropriate internal standard. Pharmacokinetic parameters such as clearance, volume of distribution, and terminal half-life were calculated by a noncompartmental method. </div><div class="NLM_p"><b>Vascular Permeability Assay.</b> Vascular permeability was induced using a modified Miles assay.<sup>18</sup> HEK 293 cells overexpressing murine VEGF were used to induce vascular permeability in nude mice. Briefly, 2 × 10<sup>5</sup> VEGF-expressing or vector control HEK 293 cells were mixed with Matrigel and injected subcutaneously on the ventral surface of nude mice. Approximately 22 h later, a single oral dose of compound or vehicle was administered. After 6 h, the mice received an intravenous injection of 0.1 mL 1% Evan's blue dye for 10 min prior to sacrifice. A 1 cm<sup>2</sup> piece of skin overlying the cells was harvested and placed in formamide at 60 °C overnight. The extracted Evan's blue dye was measured using a spectrophotometer at OD<sub>630</sub>. Relative Evan's blue units refer to the % Evan's blue, as determined by the standard curve, multiplied by 10<sup>4</sup>. Data represent mean ± standard error; <i>n</i> = 5. Statistical analysis was performed by one-way ANOVA with Bonferroni−Dunn post hoc test. <i>p</i> < 0.0009 was considered significant. </div><div class="NLM_p last"><b>Rat Corneal Angiogenesis Model.</b> Corneal angiogenesis was evaluated in female CD rats as described.<sup><a onclick="showRef(event, 'jm070034ib00026'); return false;" href="javascript:void(0);" class="ref jm070034ib00026">26</a></sup> Briefly, rats weighing approximately 250 grams were randomized into one of six treatment groups. Angiogenesis was induced by surgically implanting a VEGF (or BSA control)-soaked nylon disk into the corneal stroma (<i>n</i> = 8/group). Rats were treated with 1, 3, 10, or 30 mg/kg orally once a day with compound or vehicle. Treatment began on the day of surgery and was continued for 7 days. Two vascular endpoints were evaluated:  the number of blood vessels at the midpoint between the limbal vessels and the disk and the mean blood vessel area. After 7 days, the implanted corneas were photographed at 25× using a Nikon SV-3 Ophthalmic Slit Lamp (Nikon Ophthalmic) equipped with a Nikon D-1 digital camera back. A reference stage micrometer was photographed for calibration. The images were transferred to a desktop PC, reformatted for image analysis, and transferred to a Metamorph IA system for computerized analysis. Numerical data were generated from the digital images using the Metamorph image analysis system (Universal Imaging). Three endpoints were analyzed on each corneal image:  (1) disk placement distance from the limbus, (2) number of vessels intersecting a perpendicular line at the midpoint of the disk placement distance, and (3) blood vessel area, as determined by RGB thresholding and automated pixel counting. Image analysis was performed in a blinded fashion. Values represent the group mean ± standard error. Statistical analysis was performed using one-way ANOVA followed by Fisher's protected least significant difference post hoc test. </div></div><div class="NLM_back"><div class="article_supporting-info" id=""><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm070034i/suppl_file/jm070034isi20070110_023532.pdf">jm070034isi20070110_023532.pdf (79.16 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm070034i" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76305" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76305" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><ul></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michele H. Potashman</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Oncology Research, Pharmaceutics, and Pharmacokinetic Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James Bready</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Oncology Research, Pharmaceutics, and Pharmacokinetic Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angela Coxon</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Oncology Research, Pharmaceutics, and Pharmacokinetic Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas M. DeMelfi,</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Oncology Research, Pharmaceutics, and Pharmacokinetic Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lucian DiPietro</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Oncology Research, Pharmaceutics, and Pharmacokinetic Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicholas Doerr</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Oncology Research, Pharmaceutics, and Pharmacokinetic Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Elbaum</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Oncology Research, Pharmaceutics, and Pharmacokinetic Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Juan Estrada</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Oncology Research, Pharmaceutics, and Pharmacokinetic Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Gallant</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Oncology Research, Pharmaceutics, and Pharmacokinetic Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julie Germain</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Oncology Research, Pharmaceutics, and Pharmacokinetic Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yan Gu</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Oncology Research, Pharmaceutics, and Pharmacokinetic Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean-Christophe Harmange</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Oncology Research, Pharmaceutics, and Pharmacokinetic Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen A. Kaufman</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Oncology Research, Pharmaceutics, and Pharmacokinetic Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rick Kendall</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Oncology Research, Pharmaceutics, and Pharmacokinetic Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph L. Kim</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Oncology Research, Pharmaceutics, and Pharmacokinetic Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gondi N. Kumar</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Oncology Research, Pharmaceutics, and Pharmacokinetic Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexander M. Long</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Oncology Research, Pharmaceutics, and Pharmacokinetic Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Seshadri Neervannan</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Oncology Research, Pharmaceutics, and Pharmacokinetic Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vinod F. Patel</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Oncology Research, Pharmaceutics, and Pharmacokinetic Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anthony Polverino</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Oncology Research, Pharmaceutics, and Pharmacokinetic Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Rose</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Oncology Research, Pharmaceutics, and Pharmacokinetic Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simon van der Plas</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Oncology Research, Pharmaceutics, and Pharmacokinetic Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Douglas Whittington</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Oncology Research, Pharmaceutics, and Pharmacokinetic Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roger Zanon</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Oncology Research, Pharmaceutics, and Pharmacokinetic Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Huilin Zhao</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry, Amgen Inc., One Kendall Square, Building 1000, Cambridge, Massachusetts 02139, and Oncology Research, Pharmaceutics, and Pharmacokinetic Drug Metabolism, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799 </span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i44">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77686" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77686" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank our colleagues Pamela Sproul, Elizabeth Tominey, Michael Shiue in PKDM; Paul Schnier for obtaining high-resolution MS analysis; Karen L. Rex for assistance with the VP assay; Julie Calahan, Gabrielle Palluconi, Anu Gore, Dennis Lei, and Mark Cappucci from Pharmaceutics; and Erin DiMauro, Matt Martin, and Mark Duggan for helpful discussions regarding this manuscript. </p></div><div class="NLM_fn" id="jm070034in00001"><p class="first last">Abbreviations:  VEGF, vascular endothelial growth factor; KDR, kinase insert domain receptor; HUVEC, human umbilical vein endothelial cells.</p></div><div class="refs-header-label"></div><p class="references-count">
            This article references 26 other publications.
        </p><ol id="references" class="useLabel"><li id="jm070034ib00001"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm070034ib00001'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="jm070034ib00001_1"><span><span class="NLM_string-ref">Ferrara, N. Role of Vascular Endothelial Growth Factor in Physiologic and Pathologic Angiogenesis:  Therapeutic Implications. <i>  Semin. Oncol.</i><b>2002</b>, <i>29</i> (6 Suppl. 16), 10−14.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29+%286+Suppl.+16&publication_year=2002&pages=14&author=N+Ferrara&title=Role+of+Vascular+Endothelial+Growth+Factor+in+Physiologic+and+Pathologic+Angiogenesis%3A%E2%80%89+Therapeutic+Implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00001_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN%26atitle%3DRole%2520of%2520Vascular%2520Endothelial%2520Growth%2520Factor%2520in%2520Physiologic%2520and%2520Pathologic%2520Angiogenesis%253A%25E2%2580%2589%2520Therapeutic%2520Implications%26jtitle%3DSemin.%2520Oncol.%26date%3D2002%26volume%3D29%2520%25286%2520Suppl.%252016%26spage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm070034ib00002"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm070034ib00002'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="jm070034ib00002_1"><span><span class="NLM_string-ref">Walsh, D. A. Angiogenesis and Arthritis. <i>  Rheumatology</i><b>1999</b>, <i>38</i>, 103−112.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=112&author=D.+A+Walsh&title=Angiogenesis+and+Arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00002_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DD.%2BA%26atitle%3DAngiogenesis%2520and%2520Arthritis%26jtitle%3DRheumatology%26date%3D1999%26volume%3D38%26spage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm070034ib00003"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm070034ib00003'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="jm070034ib00003_1"><span><span class="NLM_string-ref">Ferrara, N.; Alitalo, K. Clinical Applications of Angiogenic Growth Factors and their Inhibitors. <i>  Nat. Med.</i><b>1999</b>, <i>5</i>, 1359−1364.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1999&pages=1364&author=N.+Ferrara&author=K+Alitalo&title=Clinical+Applications+of+Angiogenic+Growth+Factors+and+their+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00003_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26atitle%3DClinical%2520Applications%2520of%2520Angiogenic%2520Growth%2520Factors%2520and%2520their%2520Inhibitors%26jtitle%3DNat.%2520Med.%26date%3D1999%26volume%3D5%26spage%3D1364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm070034ib00004"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm070034ib00004'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="jm070034ib00004_1"><span><span class="NLM_string-ref">Folkman, J. Role of Angiogenesis in Tumor Growth and Metastasis. <i>  Semin. Oncol</i>. <b>2002</b>, <i>29</i> (6 Suppl. 16), 15−18.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29+%286+Suppl.+16&publication_year=2002&pages=18&author=J+Folkman&title=Role+of+Angiogenesis+in+Tumor+Growth+and+Metastasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00004_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ%26atitle%3DRole%2520of%2520Angiogenesis%2520in%2520Tumor%2520Growth%2520and%2520Metastasis%26jtitle%3DSemin.%2520Oncol.%26date%3D2002%26volume%3D29%2520%25286%2520Suppl.%252016%26spage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm070034ib00005"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm070034ib00005'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="jm070034ib00005_1"><span><span class="NLM_string-ref">Ferrara, N. Role of Vascular Endothelial Growth Factor in the Regulation of Angiogenesis. <i>  Kidney Int.</i><b>1999</b>, <i>56</i>, 794−814.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1999&pages=814&author=N+Ferrara&title=Role+of+Vascular+Endothelial+Growth+Factor+in+the+Regulation+of+Angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00005_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN%26atitle%3DRole%2520of%2520Vascular%2520Endothelial%2520Growth%2520Factor%2520in%2520the%2520Regulation%2520of%2520Angiogenesis%26jtitle%3DKidney%2520Int.%26date%3D1999%26volume%3D56%26spage%3D814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm070034ib00006"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm070034ib00006'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="jm070034ib00006_1"><span><span class="NLM_string-ref">Gasparini, G.; Longo, R.; Toi, M.; Ferrara, N. Angiogenic Inhibitors:  A New Therapeutic Strategy in Oncology. <i>  Nat. Clin. Prac. Oncol.</i><b>2005</b>, <i>2</i>, 562−577.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Gasparini%2C+G.%3B+Longo%2C+R.%3B+Toi%2C+M.%3B+Ferrara%2C+N.+Angiogenic+Inhibitors%3A%E2%80%89+A+New+Therapeutic+Strategy+in+Oncology.+Nat.+Clin.+Prac.+Oncol.+2005%2C+2%2C+562%E2%88%92577.+Gasparini%2C+G.%3B+Longo%2C+R.%3B+Toi%2C+M.%3B+Ferrara%2C+N.+Angiogenic+Inhibitors%3A%E2%80%89+A+New+Therapeutic+Strategy+in+Oncology.+Nat.+Clin.+Prac.+Oncol.2005%2C+2%2C+562%E2%88%92577."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00006_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGasparini%26aufirst%3DG.%26jtitle%3DNat.%2520Clin.%2520Prac.%2520Oncol.%26date%3D2005%26volume%3D2%26spage%3D577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm070034ib00007"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm070034ib00007'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="jm070034ib00007_1"><span><span class="NLM_string-ref">Ferrara, N.; Hillan, K. J.; Gerber, H. P.; Novotny, W. Discovery and Development of Bevacizumab, an anti-VEGF Antibody for Treating Cancer. <i>  Nat. Rev. Drug Discovery</i><b>2004</b>, <i>3</i>, 391−400.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=400&author=N.+Ferrara&author=K.+J.+Hillan&author=H.+P.+Gerber&author=W+Novotny&title=Discovery+and+Development+of+Bevacizumab%2C+an+anti-VEGF+Antibody+for+Treating+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00007_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26atitle%3DDiscovery%2520and%2520Development%2520of%2520Bevacizumab%252C%2520an%2520anti-VEGF%2520Antibody%2520for%2520Treating%2520Cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm070034ib00008"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm070034ib00008'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="jm070034ib00008_1"><span><span class="NLM_string-ref">Sakamoto, K. M. SU-11248 SUGEN. <i>  Curr. Opin. Invest. Drugs</i><b>2004</b>, <i>5</i>, 1329−1339.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Sakamoto%2C+K.+M.+SU-11248+SUGEN.+Curr.+Opin.+Invest.+Drugs+2004%2C+5%2C+1329%E2%88%921339.+Sakamoto%2C+K.+M.+SU-11248+SUGEN.+Curr.+Opin.+Invest.+Drugs2004%2C+5%2C+1329%E2%88%921339."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00008_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSakamoto%26aufirst%3DK.%2BM.%26aulast%3D%26aulast%3D%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2004%26volume%3D5%26spage%3D1339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm070034ib00009"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm070034ib00009'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="jm070034ib00009_1"><span><span class="NLM_string-ref">Ahman, T.; Eisen, T. Kinase Inhibition with BAY 43−9006 in Renal Cell Carcinoma. <i>  Clin. Cancer Res.</i><b>2004</b>, <i>10</i> (Suppl.), 6388s−6392s.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10+%28Suppl.&publication_year=2004&pages=6392s&author=T.+Ahman&author=T+Eisen&title=Kinase+Inhibition+with+BAY+43%E2%88%929006+in+Renal+Cell+Carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00009_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhman%26aufirst%3DT.%26atitle%3DKinase%2520Inhibition%2520with%2520BAY%252043%25E2%2588%25929006%2520in%2520Renal%2520Cell%2520Carcinoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%2520%2528Suppl%26spage%3D6392s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm070034ib00010"><div class="reference"><div class="NLM_citation" id="jm070034ib00010_1"><span><span class="NLM_string-ref">(a) PTK-787:  Thomas, A. L.; Morgan, B.; Dreves, J.; Unger, C.; Wiedenmann, B.; Vanhoefer, U.; Laurent, D.; Dugan, M; Steward, W. P. Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors:  PTK787/ZK 222584. <i>  Semin. Oncol</i>. <b>2003</b>, <i>30</i> (Suppl 6), 32−38.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30+%28Suppl+6&publication_year=2003&pages=38&author=A.+L.+Thomas&author=B.+Morgan&author=J.+Dreves&author=C.+Unger&author=B.+Wiedenmann&author=U.+Vanhoefer&author=D.+Laurent&author=+Dugan&title=Vascular+Endothelial+Growth+Factor+Receptor+Tyrosine+Kinase+Inhibitors%3A%E2%80%89+PTK787%2FZK+222584"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00010_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DA.%2BL.%26atitle%3DVascular%2520Endothelial%2520Growth%2520Factor%2520Receptor%2520Tyrosine%2520Kinase%2520Inhibitors%253A%25E2%2580%2589%2520PTK787%252FZK%2520222584%26jtitle%3DSemin.%2520Oncol.%26date%3D2003%26volume%3D30%2520%2528Suppl%25206%26spage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm070034ib00010_2"><span><span class="NLM_string-ref">(b) ZD-6474:  Ryan, A. J.; Wedge, S. R. ZD6474-A Novel Inhibitor of VEGFR and EGFR Tyrosine Kinase Activity. <i>  Br. J. Cancer</i><b>2005</b>, <i>92</i> (Suppl 1), S6−S13.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%28b%29+ZD-6474%3A%E2%80%89+Ryan%2C+A.+J.%3B+Wedge%2C+S.+R.+ZD6474-A+Novel+Inhibitor+of+VEGFR+and+EGFR+Tyrosine+Kinase+Activity.+Br.+J.+Cancer+2005%2C+92+%28Suppl+1%29%2C+S6%E2%88%92S13.+%28b%29+ZD-6474%3A%E2%80%89+Ryan%2C+A.+J.%3B+Wedge%2C+S.+R.+ZD6474-A+Novel+Inhibitor+of+VEGFR+and+EGFR+Tyrosine+Kinase+Activity.+Br.+J.+Cancer2005%2C+92+%28Suppl+1%29%2C+S6%E2%88%92S13."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00010_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRyan%26aufirst%3DA.%2BJ.%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2005%26volume%3D92%2520%2528Suppl%25201%26spage%3DS13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm070034ib00010_3"><span><span class="NLM_string-ref">(c) CEP-7055:  Ruggeri, B.;  4373  Singh, J.; Gingrich, D.; Angeles, T.; Albom, M.; Chang, H.; Robinson, C.; Hunter, K.; Dobrzanski, P.; Jones-Bolin, S.; Aimone, L.; Klein-Szanto, A.; Herbet, J.-M.; Bono, F.; Scheffer, P.; Casellas, P.; Bourie, B.; Pili, R.; Isaacs, J.; Ator, M.; Hudkins, R.; Vaught, J.; Mallamo, J.; Dionne, C. CEP-7055:  A Novel, Orally Active Pan Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases with Potent Antiangiogenic Activity and Antitumor Efficacy in Preclinical Models. <i>  Cancer Res.</i><b>2003</b>, <i>63</i>, 5978−5991.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%28c%29+CEP-7055%3A%E2%80%89+Ruggeri%2C+B.%3B+4373+Singh%2C+J.%3B+Gingrich%2C+D.%3B+Angeles%2C+T.%3B+Albom%2C+M.%3B+Chang%2C+H.%3B+Robinson%2C+C.%3B+Hunter%2C+K.%3B+Dobrzanski%2C+P.%3B+Jones-Bolin%2C+S.%3B+Aimone%2C+L.%3B+Klein-Szanto%2C+A.%3B+Herbet%2C+J.-M.%3B+Bono%2C+F.%3B+Scheffer%2C+P.%3B+Casellas%2C+P.%3B+Bourie%2C+B.%3B+Pili%2C+R.%3B+Isaacs%2C+J.%3B+Ator%2C+M.%3B+Hudkins%2C+R.%3B+Vaught%2C+J.%3B+Mallamo%2C+J.%3B+Dionne%2C+C.+CEP-7055%3A%E2%80%89+A+Novel%2C+Orally+Active+Pan+Inhibitor+of+Vascular+Endothelial+Growth+Factor+Receptor+Tyrosine+Kinases+with+Potent+Antiangiogenic+Activity+and+Antitumor+Efficacy+in+Preclinical+Models.+Cancer+Res.+2003%2C+63%2C+5978%E2%88%925991.+%28c%29+CEP-7055%3A%E2%80%89+Ruggeri%2C+B.%3B+4373+Singh%2C+J.%3B+Gingrich%2C+D.%3B+Angeles%2C+T.%3B+Albom%2C+M.%3B+Chang%2C+H.%3B+Robinson%2C+C.%3B+Hunter%2C+K.%3B+Dobrzanski%2C+P.%3B+Jones-Bolin%2C+S.%3B+Aimone%2C+L.%3B+Klein-Szanto%2C+A.%3B+Herbet%2C+J.-M.%3B+Bono%2C+F.%3B+Scheffer%2C+P.%3B+Casellas%2C+P.%3B+Bourie%2C+B.%3B+Pili%2C+R.%3B+Isaacs%2C+J.%3B+Ator%2C+M.%3B+Hudkins%2C+R.%3B+Vaught%2C+J.%3B+Mallamo%2C+J.%3B+Dionne%2C+C.+CEP-7055%3A%E2%80%89+A+Novel%2C+Orally+Active+Pan+Inhibitor+of+Vascular+Endothelial+Growth+Factor+Receptor+Tyrosine+Kinases+with+Potent+Antiangiogenic+Activity+and+Antitumor+Efficacy+in+Preclinical+Models.+Cancer+Res.2003%2C+63%2C+5978%E2%88%925991."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00010_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRuggeri%26aufirst%3DB.%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D5991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm070034ib00010_4"><span><span class="NLM_string-ref">(d) CP-547632:  Beebe, J. S.; Jani, J. P.; Knauth, E.; Goodwin, P.; Higdon, C.; Rossi, A. M.; Emerson, E.; Finkelstein, M.; Floyd, E.; Harriman, S.; Atherton, J.; Hillerman, S.; Soderstrom, C.; Kou, K.; Gant, T.; Noe, M. C.; Foster, B.; Rastinejad, F.; Marx, M. A.; Schaeffer, T.; Whalen, P. M.; Roberts, W. G. Pharmacological Characterization of CP-547,632, a novel Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor for Cancer Therapy. <i>  Cancer Res.</i><b>2003</b>, <i>63</i>, 7301−7309.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=7309&author=J.+S.+Beebe&author=J.+P.+Jani&author=E.+Knauth&author=P.+Goodwin&author=C.+Higdon&author=A.+M.+Rossi&author=E.+Emerson&author=M.+Finkelstein&author=E.+Floyd&author=S.+Harriman&author=J.+Atherton&author=S.+Hillerman&author=C.+Soderstrom&author=K.+Kou&author=T.+Gant&author=M.+C.+Noe&author=B.+Foster&author=F.+Rastinejad&author=M.+A.+Marx&author=T.+Schaeffer&author=P.+M.+Whalen&author=W.+G+Roberts&title=Pharmacological+Characterization+of+CP-547%2C632%2C+a+novel+Vascular+Endothelial+Growth+Factor+Receptor-2+Tyrosine+Kinase+Inhibitor+for+Cancer+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00010_4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeebe%26aufirst%3DJ.%2BS.%26atitle%3DPharmacological%2520Characterization%2520of%2520CP-547%252C632%252C%2520a%2520novel%2520Vascular%2520Endothelial%2520Growth%2520Factor%2520Receptor-2%2520Tyrosine%2520Kinase%2520Inhibitor%2520for%2520Cancer%2520Therapy%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D7309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="jm070034ib00010_5"><span><span class="NLM_string-ref">(e) Motesanib:  Polverino, A.; Coxon, A.; Starnes, C.; Diaz, Z.; DeMelfi, T.; Wang, L.; Bready, J.; Estrada, J.; Cattley, R.; Kaufman, S.; Chen, D.; Gan, Y.; Kumar, G.; Meyer, J.; Neervannan, S.; Alva, G.; Talvenheimo, J.; Montestruque, S.; Tasker, A.; Patel, V.; Radinsky, R.; Kendall, R. AMG 706, an Oral, Multikinase Inhibitor that Selectively Targets Vascular Endothelial Growth Factor, Platelet-Derived Growth Factor and Kit Receptors, Potently Inhibits Angiogenesis and Induces Regression in Tumor Xenografts. <i>  Cancer Res.</i><b>2006</b>, <i>66</i>, 8715−8721.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%28e%29+Motesanib%3A%E2%80%89+Polverino%2C+A.%3B+Coxon%2C+A.%3B+Starnes%2C+C.%3B+Diaz%2C+Z.%3B+DeMelfi%2C+T.%3B+Wang%2C+L.%3B+Bready%2C+J.%3B+Estrada%2C+J.%3B+Cattley%2C+R.%3B+Kaufman%2C+S.%3B+Chen%2C+D.%3B+Gan%2C+Y.%3B+Kumar%2C+G.%3B+Meyer%2C+J.%3B+Neervannan%2C+S.%3B+Alva%2C+G.%3B+Talvenheimo%2C+J.%3B+Montestruque%2C+S.%3B+Tasker%2C+A.%3B+Patel%2C+V.%3B+Radinsky%2C+R.%3B+Kendall%2C+R.+AMG+706%2C+an+Oral%2C+Multikinase+Inhibitor+that+Selectively+Targets+Vascular+Endothelial+Growth+Factor%2C+Platelet-Derived+Growth+Factor+and+Kit+Receptors%2C+Potently+Inhibits+Angiogenesis+and+Induces+Regression+in+Tumor+Xenografts.+Cancer+Res.+2006%2C+66%2C+8715%E2%88%928721.+%28e%29+Motesanib%3A%E2%80%89+Polverino%2C+A.%3B+Coxon%2C+A.%3B+Starnes%2C+C.%3B+Diaz%2C+Z.%3B+DeMelfi%2C+T.%3B+Wang%2C+L.%3B+Bready%2C+J.%3B+Estrada%2C+J.%3B+Cattley%2C+R.%3B+Kaufman%2C+S.%3B+Chen%2C+D.%3B+Gan%2C+Y.%3B+Kumar%2C+G.%3B+Meyer%2C+J.%3B+Neervannan%2C+S.%3B+Alva%2C+G.%3B+Talvenheimo%2C+J.%3B+Montestruque%2C+S.%3B+Tasker%2C+A.%3B+Patel%2C+V.%3B+Radinsky%2C+R.%3B+Kendall%2C+R.+AMG+706%2C+an+Oral%2C+Multikinase+Inhibitor+that+Selectively+Targets+Vascular+Endothelial+Growth+Factor%2C+Platelet-Derived+Growth+Factor+and+Kit+Receptors%2C+Potently+Inhibits+Angiogenesis+and+Induces+Regression+in+Tumor+Xenografts.+Cancer+Res.2006%2C+66%2C+8715%E2%88%928721."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00010_5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMotesanib%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D8721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm070034ib00011"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm070034ib00011'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="jm070034ib00011_1"><span><span class="NLM_string-ref">Compound <b>2</b> was subsequently disclosed as a KDR inhibitor with a reported IC<sub>50</sub> of 90 nM. Wilhelm, S. M.; Carter, C.; Tang, L.; Wilkie, D.; McNabola, A.; Rong, H.; Chen, C.; Zhang, X.; Vincent, P.; McHugh, M.; Cao, Y.; Shujath, J.; Gawlak, S.; Eveleigh, D.; Rowley, B.; Liu, L.; Adnane, L.; Lynch, M.; Auclair, D.; Taylor, I.; Gedrich, R.; Voznesensky, A.; Riedl, B.; Post, L. E.; Bollag, G.; Trail, P. BAY 43−9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis. <i>  Cancer Res.</i><b>2004</b>, <i>64</i>, 7099−7109.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+Compound&author=S.+M.+Wilhelm&author=C.+Carter&author=L.+Tang&author=D.+Wilkie&author=A.+McNabola&author=H.+Rong&author=C.+Chen&author=X.+Zhang&author=P.+Vincent&author=M.+McHugh&author=Y.+Cao&author=J.+Shujath&author=S.+Gawlak&author=D.+Eveleigh&author=B.+Rowley&author=L.+Liu&author=L.+Adnane&author=M.+Lynch&author=D.+Auclair&author=I.+Taylor&author=R.+Gedrich&author=A.+Voznesensky&author=B.+Riedl&author=L.+E.+Post&author=G.+Bollag&author=P.+Trail&title=BAY+43%E2%88%929006+Exhibits+Broad+Spectrum+Oral+Antitumor+Activity+and+Targets+the+RAF%2FMEK%2FERK+Pathway+and+Receptor+Tyrosine+Kinases+Involved+in+Tumor+Progression+and+Angiogenesis.+Cancer+Res"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00011_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCompound%26aufirst%3DM.%26btitle%3DBAY%252043%25E2%2588%25929006%2520Exhibits%2520Broad%2520Spectrum%2520Oral%2520Antitumor%2520Activity%2520and%2520Targets%2520the%2520RAF%252FMEK%252FERK%2520Pathway%2520and%2520Receptor%2520Tyrosine%2520Kinases%2520Involved%2520in%2520Tumor%2520Progression%2520and%2520Angiogenesis.%2520Cancer%2520Res%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm070034ib00012"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm070034ib00012'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="jm070034ib00012_1"><span><span class="NLM_string-ref">Patel, V. The Discovery and Properties of AMG 706:  A Multikinase Angiogenesis Inhibitor in Clinical Trials. Presented at ACS ProSpectives, Cambridge, MA, May 2006.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&conference=ACS+ProSpectives&author=V.+Patel&title=The+Discovery+and+Properties+of+AMG+706%3A%E2%80%89+A+Multikinase+Angiogenesis+Inhibitor+in+Clinical+Trials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00012_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dproceeding%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DV.%26atitle%3DThe%2520Discovery%2520and%2520Properties%2520of%2520AMG%2520706%253A%25E2%2580%2589%2520A%2520Multikinase%2520Angiogenesis%2520Inhibitor%2520in%2520Clinical%2520Trials%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm070034ib00013"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm070034ib00013'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="jm070034ib00013_1"><span><span class="NLM_string-ref">Schindler, T.; Bornmann, W.; Pellicena, P.; Miller, W. T.; Clarkson, B.; Kuriyan, J. Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase. <i>  Science</i><b>2000</b>, <i>289</i>, 1938−1942. Other receptor tyrosine kinases have been shown to adopt this conformation also. (a) Mol, C. D.; Dougan, D. R.; Schneider, T. R.; Skene, R. J.; Kraus, M. L.; Scheibe, D. N.; Snell, G. P.; Zou, H.; Sang, B.−C.; Wilson, K. P. Structural Basis for the Autoinhibition and STI-571 Inhibition of c-Kit Tyrosine Kinase. <i>J. Biol. </i><i>Chem.</i><b>2004</b>, <i>279</i>, 31655−31663. (b) Pargellis, C.; Tong, L.; Churchill, L.; Cirillo, P. F.; Gilmore, T.; Graham, A. G.; Grob, P. M.; Hickey, E. R.; Moss, N.; Pav, S.; Regan, J. Inhibition of p38 MAP Kinase by Utilizing a Novel Allosteric Binding Site. <i>Nat. Struct. Biol.</i><b>2002</b>, <i>9</i>, 268−272. (c) Liu, Y.; Gray, N. S. Rational Design of Inhibitors that Bind to Inactive Conformations. <i>Nat. Chem. Biol.</i><b>2006</b>, <i>2</i>, 358−364.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2000&pages=1942&author=T.+Schindler&author=W.+Bornmann&author=P.+Pellicena&author=W.+T.+Miller&author=B.+Clarkson&author=J+Kuriyan&title=Structural+Mechanism+for+STI-571+Inhibition+of+Abelson+Tyrosine+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00013_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchindler%26aufirst%3DT.%26atitle%3DStructural%2520Mechanism%2520for%2520STI-571%2520Inhibition%2520of%2520Abelson%2520Tyrosine%2520Kinase%26jtitle%3DScience%26date%3D2000%26volume%3D289%26spage%3D1942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm070034ib00014"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm070034ib00014'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="jm070034ib00014_1"><span><span class="NLM_string-ref">Veber, D. F.; Johnson, S. R.; Cheng, H.-Y.; Smith, B. R.; Ward, K. W.; Kopple, K. D. Molecular Properties that Influence the Oral Bioavailability of Drug Candidates. <i>  J. Med. Chem</i>. <b>2002</b>, <i>45</i>, 2615−2623.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2623&author=D.+F.+Veber&author=S.+R.+Johnson&author=H.-Y.+Cheng&author=B.+R.+Smith&author=K.+W.+Ward&author=K.+D+Kopple&title=Molecular+Properties+that+Influence+the+Oral+Bioavailability+of+Drug+Candidates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00014_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVeber%26aufirst%3DD.%2BF.%26atitle%3DMolecular%2520Properties%2520that%2520Influence%2520the%2520Oral%2520Bioavailability%2520of%2520Drug%2520Candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm070034ib00015"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm070034ib00015'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="jm070034ib00015_1"><span><span class="NLM_string-ref">Compound <b>3</b> was claimed as a raf inhibitor in the following Chiron patent application:  Substituted Benzoxazoles and Use Thereof as Raf Kinase Inhibitors. WO2003082272, 2003.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=082272&publication_year=2003&pages=2003&author=+Compound&title=3+was+claimed+as+a+raf+inhibitor+in+the+following+Chiron+patent+application%3A%E2%80%89+Substituted+Benzoxazoles+and+Use+Thereof+as+Raf+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00015_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCompound%26atitle%3D3%2520was%2520claimed%2520as%2520a%2520raf%2520inhibitor%2520in%2520the%2520following%2520Chiron%2520patent%2520application%253A%25E2%2580%2589%2520Substituted%2520Benzoxazoles%2520and%2520Use%2520Thereof%2520as%2520Raf%2520Kinase%2520Inhibitors%26jtitle%3DWO%26date%3D2003%26volume%3D082272%26spage%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm070034ib00016"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm070034ib00016'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="jm070034ib00016_1"><span><span class="NLM_string-ref">For most of the substrates, the reactions were carried out neat. However, in the preparation of compound <b>52d</b> (containing the pyrrolopyrimidine moiety), use of triethylamine and trifluroacetic acid (1:1 mixture) as the solvent was required. Even under these conditions, the product was isolated in a poor 14% yield.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+For+most+of+the+substrates%2C+the+reactions+were+carried+out+neat.+However%2C+in+the+preparation+of+compound+52d+%28containing+the+pyrrolopyrimidine+moiety%29%2C+use+of+triethylamine+and+trifluroacetic+acid+%281%3A1+mixture%29+as+the+solvent+was+required.+Even+under+these+conditions%2C+the+product+was+isolated+in+a+poor+14%25+yield.+For+most+of+the+substrates%2C+the+reactions+were+carried+out+neat.+However%2C+in+the+preparation+of+compound+52d+%28containing+the+pyrrolopyrimidine+moiety%29%2C+use+of+triethylamine+and+trifluroacetic+acid+%281%3A1+mixture%29+as+the+solvent+was+required.+Even+under+these+conditions%2C+the+product+was+isolated+in+a+poor+14%25+yield."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00016_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm070034ib00017"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm070034ib00017'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="jm070034ib00017_1"><span><span class="NLM_string-ref">The following reference provides support for CH−O hydrogen-bonds in protein−ligand interactions:  Pierce, A. C.; Sandrettio, K. L.; Bemis, G. W. Kinase Inhibitors and the Case for CH−O Hydrogen Bonds in Protein−Ligand Binding. <i>  Proteins:  Struct., Funct., Genet</i>. <b>2002</b>, <i>49</i>, 567−576.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=+The&author=K.+L.+Sandrettio&author=G.+W.+Bemis&title=Funct.%2C+Genet."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00017_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DThe%26atitle%3DKinase%2520Inhibitors%2520and%2520the%2520Case%2520for%2520CH%25E2%2588%2592O%2520Hydrogen%2520Bonds%2520in%2520Protein%25E2%2588%2592Ligand%2520Binding.%2520Proteins%253A%25E2%2580%2589%2520Struct%26btitle%3DFunct.%252C%2520Genet.%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm070034ib00018"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm070034ib00018'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="jm070034ib00018_1"><span><span class="NLM_string-ref">Miles, A. A.; Miles, E. M. Vascular Reactions to Histamine, Histamine-Liberator and Leucotaxin in the Skin of Guinea Pigs. <i>  J. Physiol</i>. <b>1952</b>, <i>118</i>, 228−257.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1952&pages=257&author=A.+A.+Miles&author=E.+M+Miles&title=Vascular+Reactions+to+Histamine%2C+Histamine-Liberator+and+Leucotaxin+in+the+Skin+of+Guinea+Pigs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00018_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiles%26aufirst%3DA.%2BA.%26atitle%3DVascular%2520Reactions%2520to%2520Histamine%252C%2520Histamine-Liberator%2520and%2520Leucotaxin%2520in%2520the%2520Skin%2520of%2520Guinea%2520Pigs%26jtitle%3DJ.%2520Physiol.%26date%3D1952%26volume%3D118%26spage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm070034ib00019"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm070034ib00019'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="jm070034ib00019_1"><span><span class="NLM_string-ref">Comparison of the rat corneal models of motesanib vs compound <b>22</b>, motesanib had an ED<sub>50</sub> of 4.9 mg/kg (AUC = 13.40 μM·h; ref 10e), whereas <b>22</b> displayed an ED<sub>50</sub> of 16.3 mg/kg (AUC = 17.03 μM·h).</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Comparison+of+the+rat+corneal+models+of+motesanib+vs+compound+22%2C+motesanib+had+an+ED50+of+4.9+mg%2Fkg+%28AUC+%3D+13.40+%CE%BCM%C2%B7h%3B+ref+10e%29%2C+whereas+22+displayed+an+ED50+of+16.3+mg%2Fkg+%28AUC+%3D+17.03+%CE%BCM%C2%B7h%29.+Comparison+of+the+rat+corneal+models+of+motesanib+vs+compound+22%2C+motesanib+had+an+ED50+of+4.9+mg%2Fkg+%28AUC+%3D+13.40+%CE%BCM%C2%B7h%3B+ref+10e%29%2C+whereas+22+displayed+an+ED50+of+16.3+mg%2Fkg+%28AUC+%3D+17.03+%CE%BCM%C2%B7h%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00019_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DComparison%26btitle%3Dmotesanib%2520had%2520an%2520ED50%2520of%25204.9%2520mg%252Fkg%2520%2528AUC%2520%253D%252013.40%2520%25CE%25BCM%25C2%25B7h%26pub%3D%2528AUC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm070034ib00020"><div class="reference"><div class="NLM_citation" id="jm070034ib00020_1"><span><span class="NLM_string-ref">Bankston, D.; Dumas, J.; Natero, R.; Riedl, B.; Monahan, M.-K.; Sibley, R. A Scaleable Synthesis of BAY 43−9006:  A Potent Raf Kinase Inhibitor for the Treatment of Cancer. <i>  Org. Proc. Res. Dev.</i><b>2002</b>, <i>6</i>, 777−781.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2002&pages=781&author=D.+Bankston&author=J.+Dumas&author=R.+Natero&author=B.+Riedl&author=M.-K.+Monahan&author=R+Sibley&title=A+Scaleable+Synthesis+of+BAY+43%E2%88%929006%3A%E2%80%89+A+Potent+Raf+Kinase+Inhibitor+for+the+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00020_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBankston%26aufirst%3DD.%26atitle%3DA%2520Scaleable%2520Synthesis%2520of%2520BAY%252043%25E2%2588%25929006%253A%25E2%2580%2589%2520A%2520Potent%2520Raf%2520Kinase%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Cancer%26jtitle%3DOrg.%2520Proc.%2520Res.%2520Dev.%26date%3D2002%26volume%3D6%26spage%3D781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm070034ib00021"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm070034ib00021'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="jm070034ib00021_1"><span><span class="NLM_string-ref">Schneller, S. W.; Luo, J.-K. Synthesis of 4-Amino-1<i>H</i>-Pyrrolo[2,3-<i>b</i>]pyridine (1,7-Dideazaadenine) and 1<i>H</i>-Pyrrolo[2,3-<i>b</i>]pyridine-4-ol (1,7-Dideazahypoxanthine). <i>  J. Org. Chem</i>. <b>1980</b>, <i>45</i>, 4045−4048.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1980&pages=4048&author=S.+W.+Schneller&author=J.-K+Luo&title=Synthesis+of+4-Amino-1H-Pyrrolo%5B2%2C3-b%5Dpyridine+%281%2C7-Dideazaadenine%29+and+1H-Pyrrolo%5B2%2C3-b%5Dpyridine-4-ol+%281%2C7-Dideazahypoxanthine%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00021_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchneller%26aufirst%3DS.%2BW.%26atitle%3DSynthesis%2520of%25204-Amino-1H-Pyrrolo%255B2%252C3-b%255Dpyridine%2520%25281%252C7-Dideazaadenine%2529%2520and%25201H-Pyrrolo%255B2%252C3-b%255Dpyridine-4-ol%2520%25281%252C7-Dideazahypoxanthine%2529%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1980%26volume%3D45%26spage%3D4048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm070034ib00022"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm070034ib00022'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="jm070034ib00022_1"><span><span class="NLM_string-ref">Machin, P. J.; Hurst, D. N.; Bradshaw, R. M.; Blaber, L. C.; Burden, D. T.; Fryer, A. D.; Melarange, R. A.; Shivdasani, C. β<sub>1</sub>-Selective Adrenoceptor Antagonists. 2. 4-Ether-Linked Phenoxypropanolamines. <i>  J. </i><i>Med. Chem.</i><b>1983</b>, <i>26</i>, 1570−1576.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Machin%2C+P.+J.%3B+Hurst%2C+D.+N.%3B+Bradshaw%2C+R.+M.%3B+Blaber%2C+L.+C.%3B+Burden%2C+D.+T.%3B+Fryer%2C+A.+D.%3B+Melarange%2C+R.+A.%3B+Shivdasani%2C+C.+%CE%B21-Selective+Adrenoceptor+Antagonists.+2.+4-Ether-Linked+Phenoxypropanolamines.+J.+Med.+Chem.+1983%2C+26%2C+1570%E2%88%921576.+Machin%2C+P.+J.%3B+Hurst%2C+D.+N.%3B+Bradshaw%2C+R.+M.%3B+Blaber%2C+L.+C.%3B+Burden%2C+D.+T.%3B+Fryer%2C+A.+D.%3B+Melarange%2C+R.+A.%3B+Shivdasani%2C+C.+%CE%B21-Selective+Adrenoceptor+Antagonists.+2.+4-Ether-Linked+Phenoxypropanolamines.+J.+Med.+Chem.1983%2C+26%2C+1570%E2%88%921576."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00022_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMachin%26aufirst%3DP.%2BJ.%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1983%26volume%3D26%26spage%3D1576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm070034ib00023"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm070034ib00023'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="jm070034ib00023_1"><span><span class="NLM_string-ref">Meigh, J.-P.; Alvarez, M.; Joule, J. A. Cyclic Ureas as <i>ortho</i>-Directing Substituents. <i>  J. Chem. Soc., Perkin Trans. 1</i><b>2001</b>, 2012−2021.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2001&pages=2021&author=J.-P.+Meigh&author=M.+Alvarez&author=J.+A+Joule&title=Cyclic+Ureas+as+ortho-Directing+Substituents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00023_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeigh%26aufirst%3DJ.-P.%26atitle%3DCyclic%2520Ureas%2520as%2520ortho-Directing%2520Substituents%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D2001%26volume%3D2012%26spage%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm070034ib00024"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm070034ib00024'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="jm070034ib00024_1"><span><span class="NLM_string-ref">Kubo, K.; Ohyama, S.-i.; Shimizu, T.; Takami, A.; Murooka, H.; Nishitoba, T.; Kato, S.; Yagi, M.; Kobayashi, T.; Iinuma, N.; Isoe, T.; Nakamura, K.; Iijima, H.; Osawa, T.; Izawa, T. Synthesis and Structure−Activity Relationship for New Series of 4-Phenoxyquinoline Derivatives as Specific Inhibitors of Platelet-Derived Growth Factor Tyrosine Kinase. <i>  Bioorg. Med. Chem.</i><b>2003</b>, <i>11</i>, 5117−5133.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=5133&author=K.+Kubo&author=S.+Ohyama&author=T.+Shimizu&author=A.+Takami&author=H.+Murooka&author=T.+Nishitoba&author=S.+Kato&author=M.+Yagi&author=T.+Kobayashi&author=N.+Iinuma&author=T.+Isoe&author=K.+Nakamura&author=H.+Iijima&author=T.+Osawa&author=T+Izawa&title=Synthesis+and+Structure%E2%88%92Activity+Relationship+for+New+Series+of+4-Phenoxyquinoline+Derivatives+as+Specific+Inhibitors+of+Platelet-Derived+Growth+Factor+Tyrosine+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00024_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKubo%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520Structure%25E2%2588%2592Activity%2520Relationship%2520for%2520New%2520Series%2520of%25204-Phenoxyquinoline%2520Derivatives%2520as%2520Specific%2520Inhibitors%2520of%2520Platelet-Derived%2520Growth%2520Factor%2520Tyrosine%2520Kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D5133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm070034ib00025"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm070034ib00025'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="jm070034ib00025_1"><span><span class="NLM_string-ref">Diehl, K.-H.; Hull, R.; Morton D.; Pfister, R.; Rabemampianina, Y.; Smith, D.; Vidal, J. M.; van de Vorstenbosch, C. A Good Practice to Guide the Administration of Substances and Removal of Blood, Including Routes and Volumes. <i>  J. Appl. Toxicol.</i><b>2001</b>, <i>21</i>, 15−23.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=23&author=K.-H.+Diehl&author=R.+Hull&author=D.+Morton&author=R.+Pfister&author=Y.+Rabemampianina&author=D.+Smith&author=J.+M.+Vidal&author=C+van+de+Vorstenbosch&title=A+Good+Practice+to+Guide+the+Administration+of+Substances+and+Removal+of+Blood%2C+Including+Routes+and+Volumes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00025_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDiehl%26aufirst%3DK.-H.%26atitle%3DA%2520Good%2520Practice%2520to%2520Guide%2520the%2520Administration%2520of%2520Substances%2520and%2520Removal%2520of%2520Blood%252C%2520Including%2520Routes%2520and%2520Volumes%26jtitle%3DJ.%2520Appl.%2520Toxicol.%26date%3D2001%26volume%3D21%26spage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="jm070034ib00026"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'jm070034ib00026'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="jm070034ib00026_1"><span><span class="NLM_string-ref">Coxon, A.; Bolon, B.; Estrada, J.; Kaufman, S.; Scully, S.; Rattan, A.; Duryea, D.; Hu, Y.-L.; Rex, K.; Pacheco, E.; Van, G.; Zack, D.; Feige, U. Inhibition of Interleukin-1 but Not Tumor Necrosis Factor Suppresses Neovascularization in Rat Models of Corneal Angiogenesis and Adjuvant Arthritis. <i>  Arthritis Rheum.</i><b>2002</b>, <i>46</i>, 2604−2612.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2002&pages=2612&author=A.+Coxon&author=B.+Bolon&author=J.+Estrada&author=S.+Kaufman&author=S.+Scully&author=A.+Rattan&author=D.+Duryea&author=Y.-L.+Hu&author=K.+Rex&author=E.+Pacheco&author=G.+Van&author=D.+Zack&author=U+Feige&title=Inhibition+of+Interleukin-1+but+Not+Tumor+Necrosis+Factor+Suppresses+Neovascularization+in+Rat+Models+of+Corneal+Angiogenesis+and+Adjuvant+Arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00026_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCoxon%26aufirst%3DA.%26atitle%3DInhibition%2520of%2520Interleukin-1%2520but%2520Not%2520Tumor%2520Necrosis%2520Factor%2520Suppresses%2520Neovascularization%2520in%2520Rat%2520Models%2520of%2520Corneal%2520Angiogenesis%2520and%2520Adjuvant%2520Arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D2002%26volume%3D46%26spage%3D2612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'jm070034ib00001':['jm070034ib00001_1'],'jm070034ib00002':['jm070034ib00002_1'],'jm070034ib00003':['jm070034ib00003_1'],'jm070034ib00004':['jm070034ib00004_1'],'jm070034ib00005':['jm070034ib00005_1'],'jm070034ib00006':['jm070034ib00006_1'],'jm070034ib00007':['jm070034ib00007_1'],'jm070034ib00008':['jm070034ib00008_1'],'jm070034ib00009':['jm070034ib00009_1'],'jm070034ib00010':['jm070034ib00010_1','jm070034ib00010_2','jm070034ib00010_3','jm070034ib00010_4','jm070034ib00010_5'],'jm070034ib00011':['jm070034ib00011_1'],'jm070034ib00012':['jm070034ib00012_1'],'jm070034ib00013':['jm070034ib00013_1'],'jm070034ib00014':['jm070034ib00014_1'],'jm070034ib00015':['jm070034ib00015_1'],'jm070034ib00016':['jm070034ib00016_1'],'jm070034ib00017':['jm070034ib00017_1'],'jm070034ib00018':['jm070034ib00018_1'],'jm070034ib00019':['jm070034ib00019_1'],'jm070034ib00020':['jm070034ib00020_1'],'jm070034ib00021':['jm070034ib00021_1'],'jm070034ib00022':['jm070034ib00022_1'],'jm070034ib00023':['jm070034ib00023_1'],'jm070034ib00024':['jm070034ib00024_1'],'jm070034ib00025':['jm070034ib00025_1'],'jm070034ib00026':['jm070034ib00026_1']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 110 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ramachandra Reddy Putta, Simin Chun, Seung Hyun Choi, Seok Beom Lee, Dong-Chan Oh, <span class="NLM_string-name hlFld-ContribAuthor">Suckchang Hong</span>. </span><span class="cited-content_cbyCitation_article-title">Iron(0)-Catalyzed Transfer Hydrogenative Condensation of Nitroarenes with Alcohols: A Straightforward Approach to Benzoxazoles, Benzothiazoles, and Benzimidazoles. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (23)
                                     , 15396-15405. <a href="https://doi.org/10.1021/acs.joc.0c02191" title="DOI URL">https://doi.org/10.1021/acs.joc.0c02191</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c02191&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c02191%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DIron%2525280%252529-Catalyzed%252BTransfer%252BHydrogenative%252BCondensation%252Bof%252BNitroarenes%252Bwith%252BAlcohols%25253A%252BA%252BStraightforward%252BApproach%252Bto%252BBenzoxazoles%25252C%252BBenzothiazoles%25252C%252Band%252BBenzimidazoles%26aulast%3DPutta%26aufirst%3DRamachandra%2BReddy%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D10092020%26date%3D02112020%26volume%3D85%26issue%3D23%26spage%3D15396%26epage%3D15405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Veronika Šlachtová, Jan Chasák, <span class="NLM_string-name hlFld-ContribAuthor">Lucie Brulíková</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Various 2-Aminobenzoxazoles: The Study of Cyclization and Smiles Rearrangement. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2019,</strong> <em>4 </em>
                                    (21)
                                     , 19314-19323. <a href="https://doi.org/10.1021/acsomega.9b02702" title="DOI URL">https://doi.org/10.1021/acsomega.9b02702</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.9b02702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.9b02702%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DSynthesis%252Bof%252BVarious%252B2-Aminobenzoxazoles%25253A%252BThe%252BStudy%252Bof%252BCyclization%252Band%252BSmiles%252BRearrangement%26aulast%3D%25C5%25A0lachtov%25C3%25A1%26aufirst%3DVeronika%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D21082019%26date%3D18102019%26date%3D05112019%26volume%3D4%26issue%3D21%26spage%3D19314%26epage%3D19323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Giampiero Colombano, John J. Caldwell, Thomas P. Matthews, Chitra Bhatia, Amar Joshi, Tatiana McHardy, Ngai Yi Mok, Yvette Newbatt, Lisa Pickard, Jade Strover, Somaieh Hedayat, Michael I. Walton, Stephanie M. Myers, Alan M. Jones, Harry Saville, Craig McAndrew, Rosemary Burke, Suzanne A. Eccles, Faith E. Davies, Richard Bayliss, <span class="NLM_string-name hlFld-ContribAuthor">Ian Collins</span>. </span><span class="cited-content_cbyCitation_article-title">Binding to an Unusual Inactive Kinase Conformation by Highly Selective Inhibitors of Inositol-Requiring Enzyme 1α Kinase-Endoribonuclease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (5)
                                     , 2447-2465. <a href="https://doi.org/10.1021/acs.jmedchem.8b01721" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01721</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01721%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBinding%252Bto%252Ban%252BUnusual%252BInactive%252BKinase%252BConformation%252Bby%252BHighly%252BSelective%252BInhibitors%252Bof%252BInositol-Requiring%252BEnzyme%252B1%2525CE%2525B1%252BKinase-Endoribonuclease%26aulast%3DColombano%26aufirst%3DGiampiero%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D04112018%26date%3D05032019%26date%3D19022019%26volume%3D62%26issue%3D5%26spage%3D2447%26epage%3D2465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Pamela A. Haile, Linda N. Casillas, Michael J. Bury, John F. Mehlmann, Robert Singhaus, Jr., Adam K. Charnley, Terry V. Hughes, Michael P. DeMartino, Gren Z. Wang, Joseph J. Romano, Xiaoyang Dong, Nikolay V. Plotnikov, Ami S. Lakdawala, Maire A. Convery, Bartholomew J. Votta, David B. Lipshutz, Biva M. Desai, Barbara Swift, Carol A. Capriotti, Scott B. Berger, Mukesh K. Mahajan, Michael A. Reilly, Elizabeth J. Rivera, Helen H. Sun, Rakesh Nagilla, Carol LePage, Michael T. Ouellette, Rachel D. Totoritis, Brian T. Donovan, Barry S. Brown, Khuram W. Chaudhary, Peter J. Gough, John Bertin, <span class="NLM_string-name hlFld-ContribAuthor">Robert W. Marquis</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Quinoline-Based RIP2 Kinase Inhibitors with an Improved Therapeutic Index to the hERG Ion Channel. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>9 </em>
                                    (10)
                                     , 1039-1044. <a href="https://doi.org/10.1021/acsmedchemlett.8b00344" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.8b00344</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.8b00344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.8b00344%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DIdentification%252Bof%252BQuinoline-Based%252BRIP2%252BKinase%252BInhibitors%252Bwith%252Ban%252BImproved%252BTherapeutic%252BIndex%252Bto%252Bthe%252BhERG%252BIon%252BChannel%26aulast%3DHaile%26aufirst%3DPamela%2BA.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D27072018%26date%3D11092018%26date%3D26092018%26volume%3D9%26issue%3D10%26spage%3D1039%26epage%3D1044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian G.  Lawhorn</span>, <span class="hlFld-ContribAuthor ">Joanne  Philp</span>, <span class="hlFld-ContribAuthor ">Alan P.  Graves</span>, <span class="hlFld-ContribAuthor ">Dennis A.  Holt</span>, <span class="hlFld-ContribAuthor ">Gregory J.  Gatto, Jr.</span>, and <span class="hlFld-ContribAuthor ">Lara S.  Kallander</span>  . </span><span class="cited-content_cbyCitation_article-title">Substituent Effects on Drug–Receptor H-bond Interactions: Correlations Useful for the Design of Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (23)
                                     , 10629-10641. <a href="https://doi.org/10.1021/acs.jmedchem.6b01342" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01342</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01342%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSubstituent%252BEffects%252Bon%252BDrug%2525E2%252580%252593Receptor%252BH-bond%252BInteractions%25253A%252BCorrelations%252BUseful%252Bfor%252Bthe%252BDesign%252Bof%252BKinase%252BInhibitors%26aulast%3DLawhorn%26aufirst%3DBrian%2BG.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D09092016%26date%3D22112016%26date%3D08122016%26volume%3D59%26issue%3D23%26spage%3D10629%26epage%3D10641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pamela A.  Haile</span>, <span class="hlFld-ContribAuthor ">Bartholomew J.  Votta</span>, <span class="hlFld-ContribAuthor ">Robert W.  Marquis</span>, <span class="hlFld-ContribAuthor ">Michael J.  Bury</span>, <span class="hlFld-ContribAuthor ">John F.  Mehlmann</span>, <span class="hlFld-ContribAuthor ">Robert  Singhaus, Jr.</span>, <span class="hlFld-ContribAuthor ">Adam K.  Charnley</span>, <span class="hlFld-ContribAuthor ">Ami S.  Lakdawala</span>, <span class="hlFld-ContribAuthor ">Máire A.  Convery</span>, <span class="hlFld-ContribAuthor ">David B.  Lipshutz</span>, <span class="hlFld-ContribAuthor ">Biva M.  Desai</span>, <span class="hlFld-ContribAuthor ">Barbara  Swift</span>, <span class="hlFld-ContribAuthor ">Carol A.  Capriotti</span>, <span class="hlFld-ContribAuthor ">Scott B.  Berger</span>, <span class="hlFld-ContribAuthor ">Mukesh K.  Mahajan</span>, <span class="hlFld-ContribAuthor ">Michael A.  Reilly</span>, <span class="hlFld-ContribAuthor ">Elizabeth J.  Rivera</span>, <span class="hlFld-ContribAuthor ">Helen H.  Sun</span>, <span class="hlFld-ContribAuthor ">Rakesh  Nagilla</span>, <span class="hlFld-ContribAuthor ">Allison M.  Beal</span>, <span class="hlFld-ContribAuthor ">Joshua N.  Finger</span>, <span class="hlFld-ContribAuthor ">Michael N.  Cook</span>, <span class="hlFld-ContribAuthor ">Bryan W.  King</span>, <span class="hlFld-ContribAuthor ">Michael T.  Ouellette</span>, <span class="hlFld-ContribAuthor ">Rachel D.  Totoritis</span>, <span class="hlFld-ContribAuthor ">Maria  Pierdomenico</span>, <span class="hlFld-ContribAuthor ">Anna  Negroni</span>, <span class="hlFld-ContribAuthor ">Laura  Stronati</span>, <span class="hlFld-ContribAuthor ">Salvatore  Cucchiara</span>, <span class="hlFld-ContribAuthor ">Bartłomiej  Ziółkowski</span>, <span class="hlFld-ContribAuthor ">Anna  Vossenkämper</span>, <span class="hlFld-ContribAuthor ">Thomas T.  MacDonald</span>, <span class="hlFld-ContribAuthor ">Peter J.  Gough</span>, <span class="hlFld-ContribAuthor ">John  Bertin</span>, and <span class="hlFld-ContribAuthor ">Linda N.  Casillas</span>  . </span><span class="cited-content_cbyCitation_article-title">The Identification and Pharmacological Characterization of 6-(tert-Butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a Highly Potent and Selective Inhibitor of RIP2 Kinase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (10)
                                     , 4867-4880. <a href="https://doi.org/10.1021/acs.jmedchem.6b00211" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00211</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00211%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BIdentification%252Band%252BPharmacological%252BCharacterization%252Bof%252B6-%252528tert-Butylsulfonyl%252529-N-%2525285-fluoro-1H-indazol-3-yl%252529quinolin-4-amine%252B%252528GSK583%252529%25252C%252Ba%252BHighly%252BPotent%252Band%252BSelective%252BInhibitor%252Bof%252BRIP2%252BKinase%26aulast%3DHaile%26aufirst%3DPamela%2BA.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D09022016%26date%3D04052016%26date%3D26052016%26date%3D25042016%26volume%3D59%26issue%3D10%26spage%3D4867%26epage%3D4880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher W.  Murray</span>, <span class="hlFld-ContribAuthor ">Valerio  Berdini</span>, <span class="hlFld-ContribAuthor ">Ildiko M.  Buck</span>, <span class="hlFld-ContribAuthor ">Maria E.  Carr</span>, <span class="hlFld-ContribAuthor ">Anne  Cleasby</span>, <span class="hlFld-ContribAuthor ">Joseph E.  Coyle</span>, <span class="hlFld-ContribAuthor ">Jayne E.  Curry</span>, <span class="hlFld-ContribAuthor ">James E. H.  Day</span>, <span class="hlFld-ContribAuthor ">Phillip J.  Day</span>, <span class="hlFld-ContribAuthor ">Keisha  Hearn</span>, <span class="hlFld-ContribAuthor ">Aman  Iqbal</span>, <span class="hlFld-ContribAuthor ">Lydia Y. W.  Lee</span>, <span class="hlFld-ContribAuthor ">Vanessa  Martins</span>, <span class="hlFld-ContribAuthor ">Paul N.  Mortenson</span>, <span class="hlFld-ContribAuthor ">Joanne M.  Munck</span>, <span class="hlFld-ContribAuthor ">Lee W.  Page</span>, <span class="hlFld-ContribAuthor ">Sahil  Patel</span>, <span class="hlFld-ContribAuthor ">Susan  Roomans</span>, <span class="hlFld-ContribAuthor ">Kirsten  Smith</span>, <span class="hlFld-ContribAuthor ">Emiliano  Tamanini</span>, and <span class="hlFld-ContribAuthor ">Gordon  Saxty</span>  . </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Discovery of Potent and Selective DDR1/2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>6 </em>
                                    (7)
                                     , 798-803. <a href="https://doi.org/10.1021/acsmedchemlett.5b00143" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.5b00143</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.5b00143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.5b00143%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DFragment-Based%252BDiscovery%252Bof%252BPotent%252Band%252BSelective%252BDDR1%25252F2%252BInhibitors%26aulast%3DMurray%26aufirst%3DChristopher%2BW.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D07042015%26date%3D04062015%26date%3D08062015%26date%3D09072015%26date%3D04062015%26volume%3D6%26issue%3D7%26spage%3D798%26epage%3D803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oscar  Méndez-Lucio</span>, <span class="hlFld-ContribAuthor ">Albert J.  Kooistra</span>, <span class="hlFld-ContribAuthor ">Chris de  Graaf</span>, <span class="hlFld-ContribAuthor ">Andreas  Bender</span>, and <span class="hlFld-ContribAuthor ">José L.  Medina-Franco</span>  . </span><span class="cited-content_cbyCitation_article-title">Analyzing Multitarget Activity Landscapes Using Protein–Ligand Interaction Fingerprints: Interaction Cliffs. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2015,</strong> <em>55 </em>
                                    (2)
                                     , 251-262. <a href="https://doi.org/10.1021/ci500721x" title="DOI URL">https://doi.org/10.1021/ci500721x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci500721x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci500721x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DAnalyzing%252BMultitarget%252BActivity%252BLandscapes%252BUsing%252BProtein%2525E2%252580%252593Ligand%252BInteraction%252BFingerprints%25253A%252BInteraction%252BCliffs%26aulast%3DM%25C3%25A9ndez-Lucio%26aufirst%3DOscar%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D04122014%26date%3D06022015%26date%3D23022015%26date%3D23012015%26volume%3D55%26issue%3D2%26spage%3D251%26epage%3D262" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valentine G.  Nenajdenko</span>, <span class="hlFld-ContribAuthor ">Vasiliy M.  Muzalevskiy</span>, and <span class="hlFld-ContribAuthor ">Aleksey V.  Shastin</span>  . </span><span class="cited-content_cbyCitation_article-title">Polyfluorinated Ethanes as Versatile Fluorinated C2-Building Blocks for Organic Synthesis. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2015,</strong> <em>115 </em>
                                    (2)
                                     , 973-1050. <a href="https://doi.org/10.1021/cr500465n" title="DOI URL">https://doi.org/10.1021/cr500465n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr500465n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr500465n%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DPolyfluorinated%252BEthanes%252Bas%252BVersatile%252BFluorinated%252BC2-Building%252BBlocks%252Bfor%252BOrganic%252BSynthesis%26aulast%3DNenajdenko%26aufirst%3DValentine%2BG.%26date%3D2015%26date%3D2015%26date%3D2013%26date%3D15102013%26date%3D16012015%26date%3D28012015%26volume%3D115%26issue%3D2%26spage%3D973%26epage%3D1050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew A.  Larsen</span> and <span class="hlFld-ContribAuthor ">John F.  Hartwig</span>  . </span><span class="cited-content_cbyCitation_article-title">Iridium-Catalyzed C–H Borylation of Heteroarenes: Scope, Regioselectivity, Application to Late-Stage Functionalization, and Mechanism. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2014,</strong> <em>136 </em>
                                    (11)
                                     , 4287-4299. <a href="https://doi.org/10.1021/ja412563e" title="DOI URL">https://doi.org/10.1021/ja412563e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja412563e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja412563e%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DIridium-Catalyzed%252BC%2525E2%252580%252593H%252BBorylation%252Bof%252BHeteroarenes%25253A%252BScope%25252C%252BRegioselectivity%25252C%252BApplication%252Bto%252BLate-Stage%252BFunctionalization%25252C%252Band%252BMechanism%26aulast%3DLarsen%26aufirst%3DMatthew%2BA.%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D15122013%26date%3D06032014%26date%3D19032014%26date%3D07022014%26volume%3D136%26issue%3D11%26spage%3D4287%26epage%3D4299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bifu  Liu</span>, <span class="hlFld-ContribAuthor ">Meizhou  Yin</span>, <span class="hlFld-ContribAuthor ">Hanling  Gao</span>, <span class="hlFld-ContribAuthor ">Wanqing  Wu</span>, and <span class="hlFld-ContribAuthor ">Huanfeng  Jiang</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2-Aminobenzoxazoles and 3-Aminobenzoxazines via Palladium-Catalyzed Aerobic Oxidation of o-Aminophenols with Isocyanides. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2013,</strong> <em>78 </em>
                                    (7)
                                     , 3009-3020. <a href="https://doi.org/10.1021/jo400002f" title="DOI URL">https://doi.org/10.1021/jo400002f</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo400002f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo400002f%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252B2-Aminobenzoxazoles%252Band%252B3-Aminobenzoxazines%252Bvia%252BPalladium-Catalyzed%252BAerobic%252BOxidation%252Bof%252Bo-Aminophenols%252Bwith%252BIsocyanides%26aulast%3DLiu%26aufirst%3DBifu%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D01012013%26date%3D15032013%26date%3D05042013%26date%3D11032013%26volume%3D78%26issue%3D7%26spage%3D3009%26epage%3D3020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Olesya A.  Tomashenko</span> and <span class="hlFld-ContribAuthor ">Vladimir V.  Grushin</span>  . </span><span class="cited-content_cbyCitation_article-title">Aromatic Trifluoromethylation with Metal Complexes. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2011,</strong> <em>111 </em>
                                    (8)
                                     , 4475-4521. <a href="https://doi.org/10.1021/cr1004293" title="DOI URL">https://doi.org/10.1021/cr1004293</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr1004293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr1004293%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DAromatic%252BTrifluoromethylation%252Bwith%252BMetal%252BComplexes%26aulast%3DTomashenko%26aufirst%3DOlesya%2BA.%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D15122010%26date%3D01042011%26date%3D10082011%26volume%3D111%26issue%3D8%26spage%3D4475%26epage%3D4521" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jesús M.  Planesas</span>, <span class="hlFld-ContribAuthor ">Rosa M.  Claramunt</span>, <span class="hlFld-ContribAuthor ">Jordi  Teixidó</span>, <span class="hlFld-ContribAuthor ">José I.  Borrell</span>, and <span class="hlFld-ContribAuthor ">Violeta I.  Pérez-Nueno</span>  . </span><span class="cited-content_cbyCitation_article-title">Improving VEGFR-2 Docking-Based Screening by Pharmacophore Postfiltering and Similarity Search Postprocessing. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2011,</strong> <em>51 </em>
                                    (4)
                                     , 777-787. <a href="https://doi.org/10.1021/ci1002763" title="DOI URL">https://doi.org/10.1021/ci1002763</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci1002763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci1002763%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DImproving%252BVEGFR-2%252BDocking-Based%252BScreening%252Bby%252BPharmacophore%252BPostfiltering%252Band%252BSimilarity%252BSearch%252BPostprocessing%26aulast%3DPlanesas%26aufirst%3DJes%25C3%25BAs%2BM.%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D17072010%26date%3D18032011%26date%3D25042011%26volume%3D51%26issue%3D4%26spage%3D777%26epage%3D787" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Prasenjit  Saha</span>, <span class="hlFld-ContribAuthor ">Tamminana  Ramana</span>, <span class="hlFld-ContribAuthor ">Nibadita  Purkait</span>, <span class="hlFld-ContribAuthor ">Md Ashif  Ali</span>, <span class="hlFld-ContribAuthor ">Rajesh  Paul</span> and <span class="hlFld-ContribAuthor ">Tharmalingam  Punniyamurthy</span>. </span><span class="cited-content_cbyCitation_article-title">Ligand-Free Copper-Catalyzed Synthesis of Substituted Benzimidazoles, 2-Aminobenzimidazoles, 2-Aminobenzothiazoles, and Benzoxazoles. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2009,</strong> <em>74 </em>
                                    (22)
                                     , 8719-8725. <a href="https://doi.org/10.1021/jo901813g" title="DOI URL">https://doi.org/10.1021/jo901813g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo901813g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo901813g%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DLigand-Free%252BCopper-Catalyzed%252BSynthesis%252Bof%252BSubstituted%252BBenzimidazoles%25252C%252B2-Aminobenzimidazoles%25252C%252B2-Aminobenzothiazoles%25252C%252Band%252BBenzoxazoles%26aulast%3DSaha%26aufirst%3DPrasenjit%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D25082009%26date%3D20102009%26date%3D20112009%26volume%3D74%26issue%3D22%26spage%3D8719%26epage%3D8725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ki Duk  Park</span>, <span class="hlFld-ContribAuthor ">Pierre  Morieux</span>, <span class="hlFld-ContribAuthor ">Christophe  Salomé</span>, <span class="hlFld-ContribAuthor ">Steven W.  Cotten</span>, <span class="hlFld-ContribAuthor ">Onrapak  Reamtong</span>, <span class="hlFld-ContribAuthor ">Claire  Eyers</span>, <span class="hlFld-ContribAuthor ">Simon J.  Gaskell</span>, <span class="hlFld-ContribAuthor ">James P.  Stables</span>, <span class="hlFld-ContribAuthor ">Rihe  Liu</span> and <span class="hlFld-ContribAuthor ">Harold  Kohn</span>  . </span><span class="cited-content_cbyCitation_article-title">Lacosamide Isothiocyanate-Based Agents: Novel Agents To Target and Identify Lacosamide Receptors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2009,</strong> <em>52 </em>
                                    (21)
                                     , 6897-6911. <a href="https://doi.org/10.1021/jm9012054" title="DOI URL">https://doi.org/10.1021/jm9012054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm9012054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm9012054%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLacosamide%252BIsothiocyanate-Based%252BAgents%25253A%252BNovel%252BAgents%252BTo%252BTarget%252Band%252BIdentify%252BLacosamide%252BReceptors%26aulast%3DPark%26aufirst%3DKi%2BDuk%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D12082009%26date%3D01102009%26date%3D12112009%26volume%3D52%26issue%3D21%26spage%3D6897%26epage%3D6911" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frederick A.  Luzzio</span> and <span class="hlFld-ContribAuthor ">Juan  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetically Useful Brønsted Acid-Promoted Arylbenzyl Ether → o-Benzylphenol Rearrangements. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2009,</strong> <em>74 </em>
                                    (15)
                                     , 5629-5632. <a href="https://doi.org/10.1021/jo9007833" title="DOI URL">https://doi.org/10.1021/jo9007833</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo9007833&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo9007833%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthetically%252BUseful%252BBr%2525C3%2525B8nsted%252BAcid-Promoted%252BArylbenzyl%252BEther%252B%2525E2%252586%252592%252Bo-Benzylphenol%252BRearrangements%26aulast%3DLuzzio%26aufirst%3DFrederick%2BA.%26date%3D2009%26date%3D2009%26date%3D2009%26date%3D15042009%26date%3D11062009%26date%3D07082009%26volume%3D74%26issue%3D15%26spage%3D5629%26epage%3D5632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carmen  Gil</span> and <span class="hlFld-ContribAuthor ">Stefan  Bräse</span>. </span><span class="cited-content_cbyCitation_article-title">Solid-Phase Synthesis of Biologically Active Benzoannelated Nitrogen Heterocycles: An Update. </span><span class="cited-content_cbyCitation_journal-name">Journal of Combinatorial Chemistry</span><span> <strong>2009,</strong> <em>11 </em>
                                    (2)
                                     , 175-197. <a href="https://doi.org/10.1021/cc800102t" title="DOI URL">https://doi.org/10.1021/cc800102t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cc800102t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcc800102t%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Combinatorial%2520Chemistry%26atitle%3DSolid-Phase%252BSynthesis%252Bof%252BBiologically%252BActive%252BBenzoannelated%252BNitrogen%252BHeterocycles%25253A%252BAn%252BUpdate%26aulast%3DGil%26aufirst%3DCarmen%26date%3D2009%26date%3D2008%26date%3D2008%26date%3D09%252003%25202009%26date%3D14%252011%25202008%26date%3D20%252006%25202008%26volume%3D11%26issue%3D2%26spage%3D175%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Julien  Bonnamour</span> and <span class="hlFld-ContribAuthor ">Carsten  Bolm</span>. </span><span class="cited-content_cbyCitation_article-title">Iron-Catalyzed Intramolecular O-Arylation: Synthesis of 2-Aryl Benzoxazoles. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2008,</strong> <em>10 </em>
                                    (13)
                                     , 2665-2667. <a href="https://doi.org/10.1021/ol800744y" title="DOI URL">https://doi.org/10.1021/ol800744y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol800744y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol800744y%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DIron-Catalyzed%252BIntramolecular%252BO-Arylation%25253A%252BSynthesis%252Bof%252B2-Aryl%252BBenzoxazoles%26aulast%3DBonnamour%26aufirst%3DJulien%26date%3D2008%26date%3D2008%26date%3D2008%26date%3D03%252007%25202008%26date%3D29%252005%25202008%26date%3D02%252004%25202008%26volume%3D10%26issue%3D13%26spage%3D2665%26epage%3D2667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Angela  Salcedo</span>, <span class="hlFld-ContribAuthor ">Luc  Neuville</span> and <span class="hlFld-ContribAuthor ">Jieping  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Palladium-Catalyzed Intramolecular C-Arylation of Benzylic Carbon: Synthesis of 3-Benzoxazolylisoindolinones by a Sequence of Ugi-4CR/Postfunctionalization. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2008,</strong> <em>73 </em>
                                    (9)
                                     , 3600-3603. <a href="https://doi.org/10.1021/jo800266y" title="DOI URL">https://doi.org/10.1021/jo800266y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo800266y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo800266y%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPalladium-Catalyzed%252BIntramolecular%252BC-Arylation%252Bof%252BBenzylic%252BCarbon%25253A%252BSynthesis%252Bof%252B3-Benzoxazolylisoindolinones%252Bby%252Ba%252BSequence%252Bof%252BUgi-4CR%25252FPostfunctionalization%26aulast%3DSalcedo%26aufirst%3DAngela%26date%3D2008%26date%3D2008%26date%3D2008%26date%3D02%252005%25202008%26date%3D02%252004%25202008%26date%3D1%252002%25202008%26volume%3D73%26issue%3D9%26spage%3D3600%26epage%3D3603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jean-Christophe  Harmange</span>, <span class="hlFld-ContribAuthor ">Matthew M.  Weiss</span>, <span class="hlFld-ContribAuthor ">Julie  Germain</span>, <span class="hlFld-ContribAuthor ">Anthony J.  Polverino</span>, <span class="hlFld-ContribAuthor ">George  Borg</span>, <span class="hlFld-ContribAuthor ">James  Bready</span>, <span class="hlFld-ContribAuthor ">Danlin  Chen</span>, <span class="hlFld-ContribAuthor ">Deborah  Choquette</span>, <span class="hlFld-ContribAuthor ">Angela  Coxon</span>, <span class="hlFld-ContribAuthor ">Tom  DeMelfi</span>, <span class="hlFld-ContribAuthor ">Lucian  DiPietro</span>, <span class="hlFld-ContribAuthor ">Nicholas  Doerr</span>, <span class="hlFld-ContribAuthor ">Juan  Estrada</span>, <span class="hlFld-ContribAuthor ">Julie  Flynn</span>, <span class="hlFld-ContribAuthor ">Russell F.  Graceffa</span>, <span class="hlFld-ContribAuthor ">Shawn P.  Harriman</span>, <span class="hlFld-ContribAuthor ">Stephen  Kaufman</span>, <span class="hlFld-ContribAuthor ">Daniel S.  La</span>, <span class="hlFld-ContribAuthor ">Alexander  Long</span>, <span class="hlFld-ContribAuthor ">Matthew W.  Martin</span>, <span class="hlFld-ContribAuthor ">Sesha  Neervannan</span>, <span class="hlFld-ContribAuthor ">Vinod F.  Patel</span>, <span class="hlFld-ContribAuthor ">Michele  Potashman</span>, <span class="hlFld-ContribAuthor ">Kelly  Regal</span>, <span class="hlFld-ContribAuthor ">Phillip M.  Roveto</span>, <span class="hlFld-ContribAuthor ">Michael L.  Schrag</span>, <span class="hlFld-ContribAuthor ">Charlie  Starnes</span>, <span class="hlFld-ContribAuthor ">Andrew  Tasker</span>, <span class="hlFld-ContribAuthor ">Yohannes  Teffera</span>, <span class="hlFld-ContribAuthor ">Ling  Wang</span>, <span class="hlFld-ContribAuthor ">Ryan D.  White</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span> and <span class="hlFld-ContribAuthor ">Roger  Zanon</span>. </span><span class="cited-content_cbyCitation_article-title">Naphthamides as Novel and Potent Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors: Design, Synthesis, and Evaluation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2008,</strong> <em>51 </em>
                                    (6)
                                     , 1649-1667. <a href="https://doi.org/10.1021/jm701097z" title="DOI URL">https://doi.org/10.1021/jm701097z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm701097z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm701097z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNaphthamides%252Bas%252BNovel%252Band%252BPotent%252BVascular%252BEndothelial%252BGrowth%252BFactor%252BReceptor%252BTyrosine%252BKinase%252BInhibitors%25253A%252BDesign%25252C%252BSynthesis%25252C%252Band%252BEvaluation%26aulast%3DHarmange%26aufirst%3DJean-Christophe%26date%3D2008%26date%3D2008%26date%3D2007%26date%3D27%252003%25202008%26date%3D07%252003%25202008%26date%3D04%252009%25202007%26volume%3D51%26issue%3D6%26spage%3D1649%26epage%3D1667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yasemin  Budama-Kilinc</span>, <span class="hlFld-ContribAuthor ">Serda  Kecel-Gunduz</span>, <span class="hlFld-ContribAuthor ">Rabia  Cakir-Koc</span>, <span class="hlFld-ContribAuthor ">Bahar  Aslan</span>, <span class="hlFld-ContribAuthor ">Bilge  Bicak</span>, <span class="hlFld-ContribAuthor ">Yagmur  Kokcu</span>, <span class="hlFld-ContribAuthor ">Aysen E.  Ozel</span>, <span class="hlFld-ContribAuthor ">Sevim  Akyuz</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Characterization and Drug Delivery System of Natural Growth-Modulating Peptide Against Glioblastoma Cancer. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Peptide Research and Therapeutics</span><span> <strong>2021,</strong> <em>27 </em>
                                    (3)
                                     , 2015-2028. <a href="https://doi.org/10.1007/s10989-021-10229-5" title="DOI URL">https://doi.org/10.1007/s10989-021-10229-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10989-021-10229-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10989-021-10229-5%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Peptide%2520Research%2520and%2520Therapeutics%26atitle%3DStructural%252BCharacterization%252Band%252BDrug%252BDelivery%252BSystem%252Bof%252BNatural%252BGrowth-Modulating%252BPeptide%252BAgainst%252BGlioblastoma%252BCancer%26aulast%3DBudama-Kilinc%26aufirst%3DYasemin%26date%3D2021%26date%3D2021%26volume%3D27%26issue%3D3%26spage%3D2015%26epage%3D2028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lakshmi  Kondraganti</span>, <span class="hlFld-ContribAuthor ">Ramana  Tamminana</span>, <span class="hlFld-ContribAuthor ">Srinivasa Rao  Nathani</span>, <span class="hlFld-ContribAuthor ">Manabolu Surendra  Babu</span>, <span class="hlFld-ContribAuthor ">Dittakavi  Ramachandran</span>. </span><span class="cited-content_cbyCitation_article-title">Cobalt-catalyzed domino
              C-N
              cross-coupling reaction between phenyl(2-halo)isothiourea and aryl halide. </span><span class="cited-content_cbyCitation_journal-name">Phosphorus, Sulfur, and Silicon and the Related Elements</span><span> <strong>2021,</strong> <em>196 </em>
                                    (6)
                                     , 559-568. <a href="https://doi.org/10.1080/10426507.2021.1871731" title="DOI URL">https://doi.org/10.1080/10426507.2021.1871731</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10426507.2021.1871731&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10426507.2021.1871731%26sid%3Dliteratum%253Aachs%26jtitle%3DPhosphorus%252C%2520Sulfur%252C%2520and%2520Silicon%2520and%2520the%2520Related%2520Elements%26atitle%3DCobalt-catalyzed%252Bdomino%252BC-N%252Bcross-coupling%252Breaction%252Bbetween%252Bphenyl%2525282-halo%252529isothiourea%252Band%252Baryl%252Bhalide%26aulast%3DKondraganti%26aufirst%3DLakshmi%26date%3D2021%26date%3D2021%26volume%3D196%26issue%3D6%26spage%3D559%26epage%3D568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nana  Meng</span>, <span class="hlFld-ContribAuthor ">Shuyan  Zhou</span>, <span class="hlFld-ContribAuthor ">Min  Hu</span>, <span class="hlFld-ContribAuthor ">Youzhi  Xu</span>, <span class="hlFld-ContribAuthor ">Yong  Xia</span>, <span class="hlFld-ContribAuthor ">Xiuxiu  Zeng</span>, <span class="hlFld-ContribAuthor ">Luoting  Yu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Novel 4-(4-Formamidophenylamino)-N-methylpicolinamide Derivatives as Potential Antitumor Agents. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (4)
                                     , 1150. <a href="https://doi.org/10.3390/molecules26041150" title="DOI URL">https://doi.org/10.3390/molecules26041150</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26041150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26041150%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252B4-%2525284-Formamidophenylamino%252529-N-methylpicolinamide%252BDerivatives%252Bas%252BPotential%252BAntitumor%252BAgents%26aulast%3DMeng%26aufirst%3DNana%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D4%26spage%3D1150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana L.R.  Silva</span>, <span class="hlFld-ContribAuthor ">Maria D.M.C.  Ribeiro da Silva</span>. </span><span class="cited-content_cbyCitation_article-title">Effects of the functional groups amino and nitro on the reactivity of benzoxazoles and comparison with homologous benzothiazoles. </span><span class="cited-content_cbyCitation_journal-name">Journal of Physical Organic Chemistry</span><span> <strong>2021,</strong> <em>34 </em>
                                    (1)
                                     <a href="https://doi.org/10.1002/poc.4118" title="DOI URL">https://doi.org/10.1002/poc.4118</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/poc.4118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fpoc.4118%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Physical%2520Organic%2520Chemistry%26atitle%3DEffects%252Bof%252Bthe%252Bfunctional%252Bgroups%252Bamino%252Band%252Bnitro%252Bon%252Bthe%252Breactivity%252Bof%252Bbenzoxazoles%252Band%252Bcomparison%252Bwith%252Bhomologous%252Bbenzothiazoles%26aulast%3DSilva%26aufirst%3DAna%2BL.R.%26date%3D2021%26date%3D2020%26volume%3D34%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie-Yu  Yue</span>, <span class="hlFld-ContribAuthor ">Ling  Wang</span>, <span class="hlFld-ContribAuthor ">Li  Zhang</span>, <span class="hlFld-ContribAuthor ">Yu  Ma</span>, <span class="hlFld-ContribAuthor ">Peng  Yang</span>, <span class="hlFld-ContribAuthor ">Bo  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Phenanthroline-functionalized porous aromatic framework: An efficient heterogeneous catalyst for the tandem reaction of 2-iodoanilines and isothiocyanates in water. </span><span class="cited-content_cbyCitation_journal-name">Microporous and Mesoporous Materials</span><span> <strong>2020,</strong> <em>305 </em>, 110313. <a href="https://doi.org/10.1016/j.micromeso.2020.110313" title="DOI URL">https://doi.org/10.1016/j.micromeso.2020.110313</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.micromeso.2020.110313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.micromeso.2020.110313%26sid%3Dliteratum%253Aachs%26jtitle%3DMicroporous%2520and%2520Mesoporous%2520Materials%26atitle%3DPhenanthroline-functionalized%252Bporous%252Baromatic%252Bframework%25253A%252BAn%252Befficient%252Bheterogeneous%252Bcatalyst%252Bfor%252Bthe%252Btandem%252Breaction%252Bof%252B2-iodoanilines%252Band%252Bisothiocyanates%252Bin%252Bwater%26aulast%3DYue%26aufirst%3DJie-Yu%26date%3D2020%26volume%3D305%26spage%3D110313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mickaël  Henrion</span>, <span class="hlFld-ContribAuthor ">Simon  Smolders</span>, <span class="hlFld-ContribAuthor ">Dirk E.  De Vos</span>. </span><span class="cited-content_cbyCitation_article-title">Cu
              II
              /H-USY as a regenerable bifunctional catalyst for the additive-free C–H amination of azoles. </span><span class="cited-content_cbyCitation_journal-name">Catalysis Science & Technology</span><span> <strong>2020,</strong> <em>10 </em>
                                    (4)
                                     , 940-943. <a href="https://doi.org/10.1039/C9CY02153A" title="DOI URL">https://doi.org/10.1039/C9CY02153A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9CY02153A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9CY02153A%26sid%3Dliteratum%253Aachs%26jtitle%3DCatalysis%2520Science%2520%2526%2520Technology%26atitle%3DCu%252BII%252B%25252FH-USY%252Bas%252Ba%252Bregenerable%252Bbifunctional%252Bcatalyst%252Bfor%252Bthe%252Badditive-free%252BC%2525E2%252580%252593H%252Bamination%252Bof%252Bazoles%26aulast%3DHenrion%26aufirst%3DMicka%25C3%25ABl%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D4%26spage%3D940%26epage%3D943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.N.Murthy  Boddapati</span>, <span class="hlFld-ContribAuthor ">Jagan Mohana Rao  Saketi</span>, <span class="hlFld-ContribAuthor ">Baby Ramana  Mutchu</span>, <span class="hlFld-ContribAuthor ">Hari Babu  Bollikolla</span>, <span class="hlFld-ContribAuthor ">Syed Farooq  Adil</span>, <span class="hlFld-ContribAuthor ">Mujeeb  Khan</span>. </span><span class="cited-content_cbyCitation_article-title">Copper promoted desulfurization and C-N cross coupling reactions: Simple approach to the synthesis of substituted 2-aminobenzoxazoles and 2,5-disubstituted tetrazole amines. </span><span class="cited-content_cbyCitation_journal-name">Arabian Journal of Chemistry</span><span> <strong>2020,</strong> <em>13 </em>
                                    (2)
                                     , 4477-4494. <a href="https://doi.org/10.1016/j.arabjc.2019.09.001" title="DOI URL">https://doi.org/10.1016/j.arabjc.2019.09.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.arabjc.2019.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.arabjc.2019.09.001%26sid%3Dliteratum%253Aachs%26jtitle%3DArabian%2520Journal%2520of%2520Chemistry%26atitle%3DCopper%252Bpromoted%252Bdesulfurization%252Band%252BC-N%252Bcross%252Bcoupling%252Breactions%25253A%252BSimple%252Bapproach%252Bto%252Bthe%252Bsynthesis%252Bof%252Bsubstituted%252B2-aminobenzoxazoles%252Band%252B2%25252C5-disubstituted%252Btetrazole%252Bamines%26aulast%3DBoddapati%26aufirst%3DS.N.Murthy%26date%3D2020%26volume%3D13%26issue%3D2%26spage%3D4477%26epage%3D4494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sulaksha  Desai</span>, <span class="hlFld-ContribAuthor ">Vidya  Desai</span>, <span class="hlFld-ContribAuthor ">Sunil  Shingade</span>. </span><span class="cited-content_cbyCitation_article-title">In-vitro Anti-cancer assay and apoptotic cell pathway of newly synthesized benzoxazole-N-heterocyclic hybrids as potent tyrosine kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>94 </em>, 103382. <a href="https://doi.org/10.1016/j.bioorg.2019.103382" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103382</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103382%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DIn-vitro%252BAnti-cancer%252Bassay%252Band%252Bapoptotic%252Bcell%252Bpathway%252Bof%252Bnewly%252Bsynthesized%252Bbenzoxazole-N-heterocyclic%252Bhybrids%252Bas%252Bpotent%252Btyrosine%252Bkinase%252Binhibitors%26aulast%3DDesai%26aufirst%3DSulaksha%26date%3D2020%26volume%3D94%26spage%3D103382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdel‐Ghany A.  El‐Helby</span>, <span class="hlFld-ContribAuthor ">Helmy  Sakr</span>, <span class="hlFld-ContribAuthor ">Ibrahim H.  Eissa</span>, <span class="hlFld-ContribAuthor ">Ahmed A.  Al‐Karmalawy</span>, <span class="hlFld-ContribAuthor ">Khaled  El‐Adl</span>. </span><span class="cited-content_cbyCitation_article-title">Benzoxazole/benzothiazole‐derived VEGFR‐2 inhibitors: Design, synthesis, molecular docking, and anticancer evaluations. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2019,</strong> <em>352 </em>
                                    (12)
                                     , 1900178. <a href="https://doi.org/10.1002/ardp.201900178" title="DOI URL">https://doi.org/10.1002/ardp.201900178</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201900178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201900178%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DBenzoxazole%25252Fbenzothiazole%2525E2%252580%252590derived%252BVEGFR%2525E2%252580%2525902%252Binhibitors%25253A%252BDesign%25252C%252Bsynthesis%25252C%252Bmolecular%252Bdocking%25252C%252Band%252Banticancer%252Bevaluations%26aulast%3DEl%25E2%2580%2590Helby%26aufirst%3DAbdel%25E2%2580%2590Ghany%2BA.%26date%3D2019%26date%3D2019%26volume%3D352%26issue%3D12%26spage%3D1900178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ling-Li  Zheng</span>, <span class="hlFld-ContribAuthor ">Bo  Yin</span>, <span class="hlFld-ContribAuthor ">Xing-Chuan  Tian</span>, <span class="hlFld-ContribAuthor ">Ming-Yong  Yuan</span>, <span class="hlFld-ContribAuthor ">Xiao-Huan  Li</span>, <span class="hlFld-ContribAuthor ">Feng  Gao</span>. </span><span class="cited-content_cbyCitation_article-title">Pd/Cu bimetallic co-catalyzed direct 2-arylation of benzoxazole with aryl chloride. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2019,</strong> <em>60 </em>
                                    (51)
                                     , 151316. <a href="https://doi.org/10.1016/j.tetlet.2019.151316" title="DOI URL">https://doi.org/10.1016/j.tetlet.2019.151316</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2019.151316&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2019.151316%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DPd%25252FCu%252Bbimetallic%252Bco-catalyzed%252Bdirect%252B2-arylation%252Bof%252Bbenzoxazole%252Bwith%252Baryl%252Bchloride%26aulast%3DZheng%26aufirst%3DLing-Li%26date%3D2019%26volume%3D60%26issue%3D51%26spage%3D151316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abdel‐Ghany A.  El‐Helby</span>, <span class="hlFld-ContribAuthor ">Helmy  Sakr</span>, <span class="hlFld-ContribAuthor ">Ibrahim H.  Eissa</span>, <span class="hlFld-ContribAuthor ">Hamada  Abulkhair</span>, <span class="hlFld-ContribAuthor ">Ahmed A.  Al‐Karmalawy</span>, <span class="hlFld-ContribAuthor ">Khaled  El‐Adl</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, molecular docking, and anticancer activity of benzoxazole derivatives as VEGFR‐2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2019,</strong> <em>352 </em>
                                    (10)
                                     , 1900113. <a href="https://doi.org/10.1002/ardp.201900113" title="DOI URL">https://doi.org/10.1002/ardp.201900113</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201900113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201900113%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bmolecular%252Bdocking%25252C%252Band%252Banticancer%252Bactivity%252Bof%252Bbenzoxazole%252Bderivatives%252Bas%252BVEGFR%2525E2%252580%2525902%252Binhibitors%26aulast%3DEl%25E2%2580%2590Helby%26aufirst%3DAbdel%25E2%2580%2590Ghany%2BA.%26date%3D2019%26date%3D2019%26volume%3D352%26issue%3D10%26spage%3D1900113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Siddharth J.  Modi</span>, <span class="hlFld-ContribAuthor ">Vithal M.  Kulkarni</span>. </span><span class="cited-content_cbyCitation_article-title">Vascular Endothelial Growth Factor Receptor (VEGFR-2)/KDR Inhibitors: Medicinal Chemistry Perspective. </span><span class="cited-content_cbyCitation_journal-name">Medicine in Drug Discovery</span><span> <strong>2019,</strong> <em>2 </em>, 100009. <a href="https://doi.org/10.1016/j.medidd.2019.100009" title="DOI URL">https://doi.org/10.1016/j.medidd.2019.100009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.medidd.2019.100009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.medidd.2019.100009%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicine%2520in%2520Drug%2520Discovery%26atitle%3DVascular%252BEndothelial%252BGrowth%252BFactor%252BReceptor%252B%252528VEGFR-2%252529%25252FKDR%252BInhibitors%25253A%252BMedicinal%252BChemistry%252BPerspective%26aulast%3DModi%26aufirst%3DSiddharth%2BJ.%26date%3D2019%26volume%3D2%26spage%3D100009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Balakrishna  Moku</span>, <span class="hlFld-ContribAuthor ">Lekkala  Ravindar</span>, <span class="hlFld-ContribAuthor ">K.P.  Rakesh</span>, <span class="hlFld-ContribAuthor ">Hua-Li  Qin</span>. </span><span class="cited-content_cbyCitation_article-title">The significance of N-methylpicolinamides in the development of anticancer therapeutics: Synthesis and structure-activity relationship (SAR) studies. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>86 </em>, 513-537. <a href="https://doi.org/10.1016/j.bioorg.2019.02.030" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.02.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.02.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.02.030%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DThe%252Bsignificance%252Bof%252BN-methylpicolinamides%252Bin%252Bthe%252Bdevelopment%252Bof%252Banticancer%252Btherapeutics%25253A%252BSynthesis%252Band%252Bstructure-activity%252Brelationship%252B%252528SAR%252529%252Bstudies%26aulast%3DMoku%26aufirst%3DBalakrishna%26date%3D2019%26volume%3D86%26spage%3D513%26epage%3D537" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Srinivasa rao  Pinapati</span>, <span class="hlFld-ContribAuthor ">Usha rani  Mandapati</span>, <span class="hlFld-ContribAuthor ">Ramana  Tamminana</span>, <span class="hlFld-ContribAuthor ">Ramesh raju  Rudraraju</span>. </span><span class="cited-content_cbyCitation_article-title">A Novel Route to Substituted 2-(
              N
              -Arylamino)benzothiazoles via Iron-Promoted
              C-S
              Bond Formation. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2019,</strong> <em>4 </em>
                                    (1)
                                     , 254-258. <a href="https://doi.org/10.1002/slct.201803441" title="DOI URL">https://doi.org/10.1002/slct.201803441</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201803441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201803441%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DA%252BNovel%252BRoute%252Bto%252BSubstituted%252B2-%252528%252BN%252B-Arylamino%252529benzothiazoles%252Bvia%252BIron-Promoted%252BC-S%252BBond%252BFormation%26aulast%3DPinapati%26aufirst%3DSrinivasa%2Brao%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D1%26spage%3D254%26epage%3D258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shailima  Rampogu</span>, <span class="hlFld-ContribAuthor ">Ayoung  Baek</span>, <span class="hlFld-ContribAuthor ">Amir  Zeb</span>, <span class="hlFld-ContribAuthor ">Keun Woo  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Exploration for novel inhibitors showing back-to-front approach against VEGFR-2 kinase domain (4AG8) employing molecular docking mechanism and molecular dynamics simulations. </span><span class="cited-content_cbyCitation_journal-name">BMC Cancer</span><span> <strong>2018,</strong> <em>18 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12885-018-4050-1" title="DOI URL">https://doi.org/10.1186/s12885-018-4050-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12885-018-4050-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12885-018-4050-1%26sid%3Dliteratum%253Aachs%26jtitle%3DBMC%2520Cancer%26atitle%3DExploration%252Bfor%252Bnovel%252Binhibitors%252Bshowing%252Bback-to-front%252Bapproach%252Bagainst%252BVEGFR-2%252Bkinase%252Bdomain%252B%2525284AG8%252529%252Bemploying%252Bmolecular%252Bdocking%252Bmechanism%252Band%252Bmolecular%252Bdynamics%252Bsimulations%26aulast%3DRampogu%26aufirst%3DShailima%26date%3D2018%26date%3D2018%26volume%3D18%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S. N. Murthy  Boddapati</span>, <span class="hlFld-ContribAuthor ">Chandra Mohan  Kurmarayuni</span>, <span class="hlFld-ContribAuthor ">Baby Ramana  Mutchu</span>, <span class="hlFld-ContribAuthor ">Ramana  Tamminana</span>, <span class="hlFld-ContribAuthor ">Hari Babu  Bollikolla</span>. </span><span class="cited-content_cbyCitation_article-title">Copper-catalyzed synthesis of 2-aminophenyl benzothiazoles: a novel approach. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2018,</strong> <em>16 </em>
                                    (37)
                                     , 8267-8272. <a href="https://doi.org/10.1039/C8OB02018C" title="DOI URL">https://doi.org/10.1039/C8OB02018C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C8OB02018C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC8OB02018C%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DCopper-catalyzed%252Bsynthesis%252Bof%252B2-aminophenyl%252Bbenzothiazoles%25253A%252Ba%252Bnovel%252Bapproach%26aulast%3DBoddapati%26aufirst%3DS.%2BN.%2BMurthy%26date%3D2018%26date%3D2018%26volume%3D16%26issue%3D37%26spage%3D8267%26epage%3D8272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.  Sivakumar</span>, <span class="hlFld-ContribAuthor ">K.  Saravanan</span>, <span class="hlFld-ContribAuthor ">K.  Rajavelu</span>, <span class="hlFld-ContribAuthor ">P.  Rajakumar</span>, <span class="hlFld-ContribAuthor ">S.  Aravindhan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, crystal structure and Hirshfeld surface analysis of a benzoxazole derivative [2-[2-(4-Methylphenyl)ethenyl]-1,3-benzoxazole]. </span><span class="cited-content_cbyCitation_journal-name">Chemical Data Collections</span><span> <strong>2018,</strong> <em>15-16 </em>, 161-169. <a href="https://doi.org/10.1016/j.cdc.2018.05.006" title="DOI URL">https://doi.org/10.1016/j.cdc.2018.05.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cdc.2018.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cdc.2018.05.006%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Data%2520Collections%26atitle%3DSynthesis%25252C%252Bcrystal%252Bstructure%252Band%252BHirshfeld%252Bsurface%252Banalysis%252Bof%252Ba%252Bbenzoxazole%252Bderivative%252B%25255B2-%25255B2-%2525284-Methylphenyl%252529ethenyl%25255D-1%25252C3-benzoxazole%25255D%26aulast%3DSivakumar%26aufirst%3DM.%26date%3D2018%26volume%3D15-16%26spage%3D161%26epage%3D169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wuji  Sun</span>, <span class="hlFld-ContribAuthor ">Shengquan  Hu</span>, <span class="hlFld-ContribAuthor ">Shubiao  Fang</span>, <span class="hlFld-ContribAuthor ">Hong  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of pyrimidine-based derivatives as VEGFR-2 tyrosine kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2018,</strong> <em>78 </em>, 393-405. <a href="https://doi.org/10.1016/j.bioorg.2018.04.005" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.04.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.04.005%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bpyrimidine-based%252Bderivatives%252Bas%252BVEGFR-2%252Btyrosine%252Bkinase%252Binhibitors%26aulast%3DSun%26aufirst%3DWuji%26date%3D2018%26volume%3D78%26spage%3D393%26epage%3D405" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuanyuan  Wang</span>, <span class="hlFld-ContribAuthor ">Shanhe  Wan</span>, <span class="hlFld-ContribAuthor ">Zhonghuang  Li</span>, <span class="hlFld-ContribAuthor ">Yu  Fu</span>, <span class="hlFld-ContribAuthor ">Guangfa  Wang</span>, <span class="hlFld-ContribAuthor ">Jiajie  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaoyun  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, biological evaluation and molecular modeling of novel 1H-pyrazolo[3,4-d]pyrimidine derivatives as BRAFV600E and VEGFR-2 dual inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>155 </em>, 210-228. <a href="https://doi.org/10.1016/j.ejmech.2018.05.054" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.05.054</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.05.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.05.054%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bbiological%252Bevaluation%252Band%252Bmolecular%252Bmodeling%252Bof%252Bnovel%252B1H-pyrazolo%25255B3%25252C4-d%25255Dpyrimidine%252Bderivatives%252Bas%252BBRAFV600E%252Band%252BVEGFR-2%252Bdual%252Binhibitors%26aulast%3DWang%26aufirst%3DYuanyuan%26date%3D2018%26volume%3D155%26spage%3D210%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaofeng  Sun</span>, <span class="hlFld-ContribAuthor ">Zuopeng  He</span>, <span class="hlFld-ContribAuthor ">Mindong  Huang</span>, <span class="hlFld-ContribAuthor ">Ningning  Wang</span>, <span class="hlFld-ContribAuthor ">Zongzhong  He</span>, <span class="hlFld-ContribAuthor ">Xiangkai  Kong</span>, <span class="hlFld-ContribAuthor ">Jianwen  Yao</span>. </span><span class="cited-content_cbyCitation_article-title">Design and discovery of thioether and nicotinamide containing sorafenib analogues as multikinase inhibitors targeting B-Raf, B-RafV600E and VEGFR-2. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (9)
                                     , 2381-2391. <a href="https://doi.org/10.1016/j.bmc.2018.03.039" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.03.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.03.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.03.039%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bdiscovery%252Bof%252Bthioether%252Band%252Bnicotinamide%252Bcontaining%252Bsorafenib%252Banalogues%252Bas%252Bmultikinase%252Binhibitors%252Btargeting%252BB-Raf%25252C%252BB-RafV600E%252Band%252BVEGFR-2%26aulast%3DSun%26aufirst%3DShaofeng%26date%3D2018%26volume%3D26%26issue%3D9%26spage%3D2381%26epage%3D2391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heba A.  Ibrahim</span>, <span class="hlFld-ContribAuthor ">Fadi M.  Awadallah</span>, <span class="hlFld-ContribAuthor ">Hanan M.  Refaat</span>, <span class="hlFld-ContribAuthor ">Kamilia M.  Amin</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular docking simulation, synthesis and 3D pharmacophore studies of novel 2-substituted-5-nitro-benzimidazole derivatives as anticancer agents targeting VEGFR-2 and c-Met. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2018,</strong> <em>77 </em>, 457-470. <a href="https://doi.org/10.1016/j.bioorg.2018.01.014" title="DOI URL">https://doi.org/10.1016/j.bioorg.2018.01.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2018.01.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2018.01.014%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DMolecular%252Bdocking%252Bsimulation%25252C%252Bsynthesis%252Band%252B3D%252Bpharmacophore%252Bstudies%252Bof%252Bnovel%252B2-substituted-5-nitro-benzimidazole%252Bderivatives%252Bas%252Banticancer%252Bagents%252Btargeting%252BVEGFR-2%252Band%252Bc-Met%26aulast%3DIbrahim%26aufirst%3DHeba%2BA.%26date%3D2018%26volume%3D77%26spage%3D457%26epage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heba A  Ibrahim</span>, <span class="hlFld-ContribAuthor ">Fadi M  Awadallah</span>, <span class="hlFld-ContribAuthor ">Hanan M  Refaat</span>, <span class="hlFld-ContribAuthor ">Kamilia M  Amin</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and molecular modeling study for some new 2-substituted benzimidazoles as dual inhibitors for VEGFR-2 and c-Met. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2018,</strong> <em>10 </em>
                                    (5)
                                     , 493-509. <a href="https://doi.org/10.4155/fmc-2017-0174" title="DOI URL">https://doi.org/10.4155/fmc-2017-0174</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0174%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bmolecular%252Bmodeling%252Bstudy%252Bfor%252Bsome%252Bnew%252B2-substituted%252Bbenzimidazoles%252Bas%252Bdual%252Binhibitors%252Bfor%252BVEGFR-2%252Band%252Bc-Met%26aulast%3DIbrahim%26aufirst%3DHeba%2BA%26date%3D2018%26volume%3D10%26issue%3D5%26spage%3D493%26epage%3D509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">De  Kang</span>, <span class="hlFld-ContribAuthor ">Xiaocong  Pang</span>, <span class="hlFld-ContribAuthor ">Wenwen  Lian</span>, <span class="hlFld-ContribAuthor ">Lvjie  Xu</span>, <span class="hlFld-ContribAuthor ">Jinhua  Wang</span>, <span class="hlFld-ContribAuthor ">Hao  Jia</span>, <span class="hlFld-ContribAuthor ">Baoyue  Zhang</span>, <span class="hlFld-ContribAuthor ">Ai-Lin  Liu</span>, <span class="hlFld-ContribAuthor ">Guan-Hua  Du</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of VEGFR2 inhibitors by integrating naïve Bayesian classification, molecular docking and drug screening approaches. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2018,</strong> <em>8 </em>
                                    (10)
                                     , 5286-5297. <a href="https://doi.org/10.1039/C7RA12259D" title="DOI URL">https://doi.org/10.1039/C7RA12259D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7RA12259D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7RA12259D%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DDiscovery%252Bof%252BVEGFR2%252Binhibitors%252Bby%252Bintegrating%252Bna%2525C3%2525AFve%252BBayesian%252Bclassification%25252C%252Bmolecular%252Bdocking%252Band%252Bdrug%252Bscreening%252Bapproaches%26aulast%3DKang%26aufirst%3DDe%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D10%26spage%3D5286%26epage%3D5297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min  Liu</span>, <span class="hlFld-ContribAuthor ">Meng-Tian  Zeng</span>, <span class="hlFld-ContribAuthor ">Wan  Xu</span>, <span class="hlFld-ContribAuthor ">Li  Wu</span>, <span class="hlFld-ContribAuthor ">Zhi-Bing  Dong</span>. </span><span class="cited-content_cbyCitation_article-title">Selective synthesis of 2-aminobenzoxazoles and 2-mercaptobenzoxazoles by using o-aminophenols as starting material. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2017,</strong> <em>58 </em>
                                    (46)
                                     , 4352-4356. <a href="https://doi.org/10.1016/j.tetlet.2017.09.092" title="DOI URL">https://doi.org/10.1016/j.tetlet.2017.09.092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2017.09.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2017.09.092%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DSelective%252Bsynthesis%252Bof%252B2-aminobenzoxazoles%252Band%252B2-mercaptobenzoxazoles%252Bby%252Busing%252Bo-aminophenols%252Bas%252Bstarting%252Bmaterial%26aulast%3DLiu%26aufirst%3DMin%26date%3D2017%26volume%3D58%26issue%3D46%26spage%3D4352%26epage%3D4356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Niranjan  Panda</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of 2-Aryl Benzoxazoles from Aldoximes. </span><span class="cited-content_cbyCitation_journal-name">MOJ Bioorganic & Organic Chemistry</span><span> <strong>2017,</strong> <em>1 </em>
                                    (5)
                                     <a href="https://doi.org/10.15406/mojboc.2017.01.00032" title="DOI URL">https://doi.org/10.15406/mojboc.2017.01.00032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.15406/mojboc.2017.01.00032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.15406%2Fmojboc.2017.01.00032%26sid%3Dliteratum%253Aachs%26jtitle%3DMOJ%2520Bioorganic%2520%2526%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252B2-Aryl%252BBenzoxazoles%252Bfrom%252BAldoximes%26aulast%3DPanda%26aufirst%3DNiranjan%26date%3D2017%26date%3D2017%26volume%3D1%26issue%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shinu  Chacko</span>, <span class="hlFld-ContribAuthor ">Subir  Samanta</span>. </span><span class="cited-content_cbyCitation_article-title">A novel approach towards design, synthesis and evaluation of some Schiff base analogues of 2-aminopyridine and 2-aminobezothiazole against hepatocellular carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2017,</strong> <em>89 </em>, 162-176. <a href="https://doi.org/10.1016/j.biopha.2017.01.108" title="DOI URL">https://doi.org/10.1016/j.biopha.2017.01.108</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2017.01.108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2017.01.108%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DA%252Bnovel%252Bapproach%252Btowards%252Bdesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bsome%252BSchiff%252Bbase%252Banalogues%252Bof%252B2-aminopyridine%252Band%252B2-aminobezothiazole%252Bagainst%252Bhepatocellular%252Bcarcinoma%26aulast%3DChacko%26aufirst%3DShinu%26date%3D2017%26volume%3D89%26spage%3D162%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guang-cheng  Wang</span>, <span class="hlFld-ContribAuthor ">Jing  Wang</span>, <span class="hlFld-ContribAuthor ">Lu-yao  Li</span>, <span class="hlFld-ContribAuthor ">Shan  Chen</span>, <span class="hlFld-ContribAuthor ">Ya-ping  Peng</span>, <span class="hlFld-ContribAuthor ">Zhen-zhen  Xie</span>, <span class="hlFld-ContribAuthor ">Ming  Chen</span>, <span class="hlFld-ContribAuthor ">Bing  Deng</span>, <span class="hlFld-ContribAuthor ">Wen-biao  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of N-Aryl-2-aminobenzoxazoles from Substituted Benzoxazole-2-thiol and 2-Chloro-N-arylacetamides in KOH-DMF System. </span><span class="cited-content_cbyCitation_journal-name">HETEROCYCLES</span><span> <strong>2017,</strong> <em>94 </em>
                                    (7)
                                     , 1257. <a href="https://doi.org/10.3987/COM-17-13712" title="DOI URL">https://doi.org/10.3987/COM-17-13712</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3987/COM-17-13712&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3987%2FCOM-17-13712%26sid%3Dliteratum%253Aachs%26jtitle%3DHETEROCYCLES%26atitle%3DSynthesis%252Bof%252BN-Aryl-2-aminobenzoxazoles%252Bfrom%252BSubstituted%252BBenzoxazole-2-thiol%252Band%252B2-Chloro-N-arylacetamides%252Bin%252BKOH-DMF%252BSystem%26aulast%3DWang%26aufirst%3DGuang-cheng%26date%3D2017%26volume%3D94%26issue%3D7%26spage%3D1257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Padmavathy Nandha  Premnath</span>, <span class="hlFld-ContribAuthor ">Sandra N.  Craig</span>, <span class="hlFld-ContribAuthor ">Shu  Liu</span>, <span class="hlFld-ContribAuthor ">Campbell  McInnes</span>. </span><span class="cited-content_cbyCitation_article-title">Benzamide capped peptidomimetics as non-ATP competitive inhibitors of CDK2 using the REPLACE strategy. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (15)
                                     , 3754-3760. <a href="https://doi.org/10.1016/j.bmcl.2016.05.067" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.05.067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.05.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.05.067%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DBenzamide%252Bcapped%252Bpeptidomimetics%252Bas%252Bnon-ATP%252Bcompetitive%252Binhibitors%252Bof%252BCDK2%252Busing%252Bthe%252BREPLACE%252Bstrategy%26aulast%3DPremnath%26aufirst%3DPadmavathy%2BNandha%26date%3D2016%26volume%3D26%26issue%3D15%26spage%3D3754%26epage%3D3760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashraf Kareem  El-Damasy</span>, <span class="hlFld-ContribAuthor ">Ju-Hyeon  Lee</span>, <span class="hlFld-ContribAuthor ">Seon Hee  Seo</span>, <span class="hlFld-ContribAuthor ">Nam-Chul  Cho</span>, <span class="hlFld-ContribAuthor ">Ae Nim  Pae</span>, <span class="hlFld-ContribAuthor ">Gyochang  Keum</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of new potent anticancer benzothiazole amides and ureas featuring pyridylamide moiety and possessing dual B-RafV600E and C-Raf kinase inhibitory activities. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>115 </em>, 201-216. <a href="https://doi.org/10.1016/j.ejmech.2016.02.039" title="DOI URL">https://doi.org/10.1016/j.ejmech.2016.02.039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2016.02.039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2016.02.039%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bnew%252Bpotent%252Banticancer%252Bbenzothiazole%252Bamides%252Band%252Bureas%252Bfeaturing%252Bpyridylamide%252Bmoiety%252Band%252Bpossessing%252Bdual%252BB-RafV600E%252Band%252BC-Raf%252Bkinase%252Binhibitory%252Bactivities%26aulast%3DEl-Damasy%26aufirst%3DAshraf%2BKareem%26date%3D2016%26volume%3D115%26spage%3D201%26epage%3D216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingya  Zhang</span>, <span class="hlFld-ContribAuthor ">Linna  Zhang</span>, <span class="hlFld-ContribAuthor ">Yuanyou  Wang</span>, <span class="hlFld-ContribAuthor ">Guisen  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Development of anti-angiogenic tyrosine kinases inhibitors: molecular structures and binding modes. </span><span class="cited-content_cbyCitation_journal-name">Cancer Chemotherapy and Pharmacology</span><span> <strong>2016,</strong> <em>77 </em>
                                    (5)
                                     , 905-926. <a href="https://doi.org/10.1007/s00280-016-2961-6" title="DOI URL">https://doi.org/10.1007/s00280-016-2961-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00280-016-2961-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00280-016-2961-6%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Chemotherapy%2520and%2520Pharmacology%26atitle%3DDevelopment%252Bof%252Banti-angiogenic%252Btyrosine%252Bkinases%252Binhibitors%25253A%252Bmolecular%252Bstructures%252Band%252Bbinding%252Bmodes%26aulast%3DZhang%26aufirst%3DJingya%26date%3D2016%26date%3D2016%26volume%3D77%26issue%3D5%26spage%3D905%26epage%3D926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Leilei  Shi</span>, <span class="hlFld-ContribAuthor ">Jianfeng  Zhou</span>, <span class="hlFld-ContribAuthor ">Jifeng  Wu</span>, <span class="hlFld-ContribAuthor ">Junya  Cao</span>, <span class="hlFld-ContribAuthor ">Yuemao  Shen</span>, <span class="hlFld-ContribAuthor ">Hua  Zhou</span>, <span class="hlFld-ContribAuthor ">Xun  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Quinoxalinone (Part II). Discovery of (Z)-3-(2-(pyridin-4-yl)vinyl)quinoxalinone derivates as potent VEGFR-2 kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (8)
                                     , 1840-1852. <a href="https://doi.org/10.1016/j.bmc.2016.03.008" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.03.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.03.008%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DQuinoxalinone%252B%252528Part%252BII%252529.%252BDiscovery%252Bof%252B%252528Z%252529-3-%2525282-%252528pyridin-4-yl%252529vinyl%252529quinoxalinone%252Bderivates%252Bas%252Bpotent%252BVEGFR-2%252Bkinase%252Binhibitors%26aulast%3DShi%26aufirst%3DLeilei%26date%3D2016%26volume%3D24%26issue%3D8%26spage%3D1840%26epage%3D1852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hai-Qi  Zhang</span>, <span class="hlFld-ContribAuthor ">Fei-Hu  Gong</span>, <span class="hlFld-ContribAuthor ">Chuan-Gui  Li</span>, <span class="hlFld-ContribAuthor ">Chi  Zhang</span>, <span class="hlFld-ContribAuthor ">Yan-Jie  Wang</span>, <span class="hlFld-ContribAuthor ">Yun-Gen  Xu</span>, <span class="hlFld-ContribAuthor ">Li-Ping  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Design and discovery of 4-anilinoquinazoline-acylamino derivatives as EGFR and VEGFR-2 dual TK inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>109 </em>, 371-379. <a href="https://doi.org/10.1016/j.ejmech.2015.12.032" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.12.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.12.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.12.032%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bdiscovery%252Bof%252B4-anilinoquinazoline-acylamino%252Bderivatives%252Bas%252BEGFR%252Band%252BVEGFR-2%252Bdual%252BTK%252Binhibitors%26aulast%3DZhang%26aufirst%3DHai-Qi%26date%3D2016%26volume%3D109%26spage%3D371%26epage%3D379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fan-Wei  Peng</span>, <span class="hlFld-ContribAuthor ">Ji  Xuan</span>, <span class="hlFld-ContribAuthor ">Ting-Ting  Wu</span>, <span class="hlFld-ContribAuthor ">Jia-Yu  Xue</span>, <span class="hlFld-ContribAuthor ">Zi-Wei  Ren</span>, <span class="hlFld-ContribAuthor ">Da-Ke  Liu</span>, <span class="hlFld-ContribAuthor ">Xiu-Qi  Wang</span>, <span class="hlFld-ContribAuthor ">Xin-Hang  Chen</span>, <span class="hlFld-ContribAuthor ">Jia-Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Yun-Gen  Xu</span>, <span class="hlFld-ContribAuthor ">Lei  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of N-phenylquinazolin-4-amine hybrids as dual inhibitors of VEGFR-2 and HDAC. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>109 </em>, 1-12. <a href="https://doi.org/10.1016/j.ejmech.2015.12.033" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.12.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.12.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.12.033%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252BN-phenylquinazolin-4-amine%252Bhybrids%252Bas%252Bdual%252Binhibitors%252Bof%252BVEGFR-2%252Band%252BHDAC%26aulast%3DPeng%26aufirst%3DFan-Wei%26date%3D2016%26volume%3D109%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lin  Li</span>, <span class="hlFld-ContribAuthor ">Cun-Long  Zhang</span>, <span class="hlFld-ContribAuthor ">Hong-Rui  Song</span>, <span class="hlFld-ContribAuthor ">Chun-Yan  Tan</span>, <span class="hlFld-ContribAuthor ">Huai-Wei  Ding</span>, <span class="hlFld-ContribAuthor ">Yu-Yang  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel dual inhibitors of VEGFR and PI3K kinases containing 2-ureidothiazole scaffold. </span><span class="cited-content_cbyCitation_journal-name">Chinese Chemical Letters</span><span> <strong>2016,</strong> <em>27 </em>
                                    (1)
                                     , 1-6. <a href="https://doi.org/10.1016/j.cclet.2015.09.008" title="DOI URL">https://doi.org/10.1016/j.cclet.2015.09.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cclet.2015.09.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cclet.2015.09.008%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Chemical%2520Letters%26atitle%3DDiscovery%252Bof%252Bnovel%252Bdual%252Binhibitors%252Bof%252BVEGFR%252Band%252BPI3K%252Bkinases%252Bcontaining%252B2-ureidothiazole%252Bscaffold%26aulast%3DLi%26aufirst%3DLin%26date%3D2016%26volume%3D27%26issue%3D1%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sarbjit  Singh</span>, <span class="hlFld-ContribAuthor ">Gajulapati  Veeraswamy</span>, <span class="hlFld-ContribAuthor ">Deepak  Bhattarai</span>, <span class="hlFld-ContribAuthor ">Ja-Il  Goo</span>, <span class="hlFld-ContribAuthor ">Kyeong  Lee</span>, <span class="hlFld-ContribAuthor ">Yongseok  Choi</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in the Development of Pharmacologically Active Compounds that Contain a Benzoxazole Scaffold. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>4 </em>
                                    (12)
                                     , 1338-1361. <a href="https://doi.org/10.1002/ajoc.201500235" title="DOI URL">https://doi.org/10.1002/ajoc.201500235</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.201500235&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.201500235%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRecent%252BAdvances%252Bin%252Bthe%252BDevelopment%252Bof%252BPharmacologically%252BActive%252BCompounds%252Bthat%252BContain%252Ba%252BBenzoxazole%252BScaffold%26aulast%3DSingh%26aufirst%3DSarbjit%26date%3D2015%26date%3D2015%26volume%3D4%26issue%3D12%26spage%3D1338%26epage%3D1361" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fan-Wei  Peng</span>, <span class="hlFld-ContribAuthor ">Ting-Ting  Wu</span>, <span class="hlFld-ContribAuthor ">Zi-Wei  Ren</span>, <span class="hlFld-ContribAuthor ">Jia-Yu  Xue</span>, <span class="hlFld-ContribAuthor ">Lei  Shi</span>. </span><span class="cited-content_cbyCitation_article-title">Hybrids from 4-anilinoquinazoline and hydroxamic acid as dual inhibitors of vascular endothelial growth factor receptor-2 and histone deacetylase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (22)
                                     , 5137-5141. <a href="https://doi.org/10.1016/j.bmcl.2015.10.006" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.10.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.10.006%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DHybrids%252Bfrom%252B4-anilinoquinazoline%252Band%252Bhydroxamic%252Bacid%252Bas%252Bdual%252Binhibitors%252Bof%252Bvascular%252Bendothelial%252Bgrowth%252Bfactor%252Breceptor-2%252Band%252Bhistone%252Bdeacetylase%26aulast%3DPeng%26aufirst%3DFan-Wei%26date%3D2015%26volume%3D25%26issue%3D22%26spage%3D5137%26epage%3D5141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashraf Kareem  El-Damasy</span>, <span class="hlFld-ContribAuthor ">Seon Hee  Seo</span>, <span class="hlFld-ContribAuthor ">Nam-Chul  Cho</span>, <span class="hlFld-ContribAuthor ">Soon Bang  Kang</span>, <span class="hlFld-ContribAuthor ">Ae Nim  Pae</span>, <span class="hlFld-ContribAuthor ">Key-Sun  Kim</span>, <span class="hlFld-ContribAuthor ">Gyochang  Keum</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, in-vitro antiproliferative activity and kinase profile of new picolinamide based 2-amido and ureido quinoline derivatives. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>101 </em>, 754-768. <a href="https://doi.org/10.1016/j.ejmech.2015.07.025" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.07.025</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.07.025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.07.025%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Bin-vitro%252Bantiproliferative%252Bactivity%252Band%252Bkinase%252Bprofile%252Bof%252Bnew%252Bpicolinamide%252Bbased%252B2-amido%252Band%252Bureido%252Bquinoline%252Bderivatives%26aulast%3DEl-Damasy%26aufirst%3DAshraf%2BKareem%26date%3D2015%26volume%3D101%26spage%3D754%26epage%3D768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">R.N.  Gacche</span>, <span class="hlFld-ContribAuthor ">R.J.  Meshram</span>, <span class="hlFld-ContribAuthor ">H.D.  Shegokar</span>, <span class="hlFld-ContribAuthor ">D.S.  Gond</span>, <span class="hlFld-ContribAuthor ">S.S.  Kamble</span>, <span class="hlFld-ContribAuthor ">V.N.  Dhabadge</span>, <span class="hlFld-ContribAuthor ">B.G.  Utage</span>, <span class="hlFld-ContribAuthor ">K.K.  Patil</span>, <span class="hlFld-ContribAuthor ">R.A.  More</span>. </span><span class="cited-content_cbyCitation_article-title">Flavonoids as a scaffold for development of novel anti-angiogenic agents: An experimental and computational enquiry. </span><span class="cited-content_cbyCitation_journal-name">Archives of Biochemistry and Biophysics</span><span> <strong>2015,</strong> <em>577-578 </em>, 35-48. <a href="https://doi.org/10.1016/j.abb.2015.04.009" title="DOI URL">https://doi.org/10.1016/j.abb.2015.04.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.abb.2015.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.abb.2015.04.009%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Biochemistry%2520and%2520Biophysics%26atitle%3DFlavonoids%252Bas%252Ba%252Bscaffold%252Bfor%252Bdevelopment%252Bof%252Bnovel%252Banti-angiogenic%252Bagents%25253A%252BAn%252Bexperimental%252Band%252Bcomputational%252Benquiry%26aulast%3DGacche%26aufirst%3DR.N.%26date%3D2015%26volume%3D577-578%26spage%3D35%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elia  Rancan</span>, <span class="hlFld-ContribAuthor ">Fabio  Aricò</span>, <span class="hlFld-ContribAuthor ">Giuseppe  Quartarone</span>, <span class="hlFld-ContribAuthor ">Lucio  Ronchin</span>, <span class="hlFld-ContribAuthor ">Andrea  Vavasori</span>. </span><span class="cited-content_cbyCitation_article-title">Acid Catalyzed Direct-Amidation–Dehydrocyclization of 2-Hydroxy-acetophenones to Benzoxazoles by a One-Pot Sustainable Synthesis. </span><span class="cited-content_cbyCitation_journal-name">Catalysis Letters</span><span> <strong>2015,</strong> <em>145 </em>
                                    (3)
                                     , 939-946. <a href="https://doi.org/10.1007/s10562-014-1466-3" title="DOI URL">https://doi.org/10.1007/s10562-014-1466-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10562-014-1466-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10562-014-1466-3%26sid%3Dliteratum%253Aachs%26jtitle%3DCatalysis%2520Letters%26atitle%3DAcid%252BCatalyzed%252BDirect-Amidation%2525E2%252580%252593Dehydrocyclization%252Bof%252B2-Hydroxy-acetophenones%252Bto%252BBenzoxazoles%252Bby%252Ba%252BOne-Pot%252BSustainable%252BSynthesis%26aulast%3DRancan%26aufirst%3DElia%26date%3D2015%26date%3D2015%26volume%3D145%26issue%3D3%26spage%3D939%26epage%3D946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">NARESH KUMAR  KATARI</span>, <span class="hlFld-ContribAuthor ">M  VENKATANARAYANA</span>, <span class="hlFld-ContribAuthor ">KUMMARI  SRINIVAS</span>. </span><span class="cited-content_cbyCitation_article-title">Dithiocarbamate promoted practical synthesis of N-Aryl-2-aminobenzazoles: Synthesis of novel Aurora-A kinase inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Sciences</span><span> <strong>2015,</strong> <em>127 </em>
                                    (3)
                                     , 447-453. <a href="https://doi.org/10.1007/s12039-015-0803-4" title="DOI URL">https://doi.org/10.1007/s12039-015-0803-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12039-015-0803-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12039-015-0803-4%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Sciences%26atitle%3DDithiocarbamate%252Bpromoted%252Bpractical%252Bsynthesis%252Bof%252BN-Aryl-2-aminobenzazoles%25253A%252BSynthesis%252Bof%252Bnovel%252BAurora-A%252Bkinase%252Binhibitor%26aulast%3DKATARI%26aufirst%3DNARESH%2BKUMAR%26date%3D2015%26date%3D2015%26volume%3D127%26issue%3D3%26spage%3D447%26epage%3D453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaolong  Jiang</span>, <span class="hlFld-ContribAuthor ">Hongyan  Liu</span>, <span class="hlFld-ContribAuthor ">Zilan  Song</span>, <span class="hlFld-ContribAuthor ">Xia  Peng</span>, <span class="hlFld-ContribAuthor ">Yinchun  Ji</span>, <span class="hlFld-ContribAuthor ">Qizheng  Yao</span>, <span class="hlFld-ContribAuthor ">Meiyu  Geng</span>, <span class="hlFld-ContribAuthor ">Jing  Ai</span>, <span class="hlFld-ContribAuthor ">Ao  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and SAR study of c-Met kinase inhibitors bearing an 3-amino-benzo[d]isoxazole or 3-aminoindazole scaffold. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (3)
                                     , 564-578. <a href="https://doi.org/10.1016/j.bmc.2014.12.002" title="DOI URL">https://doi.org/10.1016/j.bmc.2014.12.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2014.12.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2014.12.002%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BSAR%252Bstudy%252Bof%252Bc-Met%252Bkinase%252Binhibitors%252Bbearing%252Ban%252B3-amino-benzo%25255Bd%25255Disoxazole%252Bor%252B3-aminoindazole%252Bscaffold%26aulast%3DJiang%26aufirst%3DXiaolong%26date%3D2015%26volume%3D23%26issue%3D3%26spage%3D564%26epage%3D578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Jiao</span>, <span class="hlFld-ContribAuthor ">Bo-Tao  Xin</span>, <span class="hlFld-ContribAuthor ">Yanmin  Zhang</span>, <span class="hlFld-ContribAuthor ">Jianbing  Wu</span>, <span class="hlFld-ContribAuthor ">Xiaolin  Lu</span>, <span class="hlFld-ContribAuthor ">Ying  Zheng</span>, <span class="hlFld-ContribAuthor ">Weifang  Tang</span>, <span class="hlFld-ContribAuthor ">Xiang  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of novel 2-(1H-imidazol-2-yl) pyridine Sorafenib derivatives as potential BRAF inhibitors and anti-tumor agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>90 </em>, 170-183. <a href="https://doi.org/10.1016/j.ejmech.2014.11.008" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.11.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.11.008%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bnovel%252B2-%2525281H-imidazol-2-yl%252529%252Bpyridine%252BSorafenib%252Bderivatives%252Bas%252Bpotential%252BBRAF%252Binhibitors%252Band%252Banti-tumor%252Bagents%26aulast%3DJiao%26aufirst%3DYu%26date%3D2015%26volume%3D90%26spage%3D170%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Shi</span>, <span class="hlFld-ContribAuthor ">Ting-Ting  Wu</span>, <span class="hlFld-ContribAuthor ">Zhi  Wang</span>, <span class="hlFld-ContribAuthor ">Jia-Yu  Xue</span>, <span class="hlFld-ContribAuthor ">Yun-Gen  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of quinazolin-4-amines bearing benzimidazole fragments as dual inhibitors of c-Met and VEGFR-2. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (17)
                                     , 4735-4744. <a href="https://doi.org/10.1016/j.bmc.2014.07.008" title="DOI URL">https://doi.org/10.1016/j.bmc.2014.07.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2014.07.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2014.07.008%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bquinazolin-4-amines%252Bbearing%252Bbenzimidazole%252Bfragments%252Bas%252Bdual%252Binhibitors%252Bof%252Bc-Met%252Band%252BVEGFR-2%26aulast%3DShi%26aufirst%3DLei%26date%3D2014%26volume%3D22%26issue%3D17%26spage%3D4735%26epage%3D4744" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elodie  Martinand-Lurin</span>, <span class="hlFld-ContribAuthor ">Laurent  El Kaïm</span>, <span class="hlFld-ContribAuthor ">Laurence  Grimaud</span>. </span><span class="cited-content_cbyCitation_article-title">Benzoxazinone synthesis via Passerini–Smiles couplings. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2014,</strong> <em>55 </em>
                                    (37)
                                     , 5144-5146. <a href="https://doi.org/10.1016/j.tetlet.2014.07.088" title="DOI URL">https://doi.org/10.1016/j.tetlet.2014.07.088</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2014.07.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2014.07.088%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DBenzoxazinone%252Bsynthesis%252Bvia%252BPasserini%2525E2%252580%252593Smiles%252Bcouplings%26aulast%3DMartinand-Lurin%26aufirst%3DElodie%26date%3D2014%26volume%3D55%26issue%3D37%26spage%3D5144%26epage%3D5146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Prinka  Singla</span>, <span class="hlFld-ContribAuthor ">Vijay  Luxami</span>, <span class="hlFld-ContribAuthor ">Kamaldeep  Paul</span>. </span><span class="cited-content_cbyCitation_article-title">Benzimidazole-biologically attractive scaffold for protein kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2014,</strong> <em>4 </em>
                                    (24)
                                     , 12422. <a href="https://doi.org/10.1039/c3ra46304d" title="DOI URL">https://doi.org/10.1039/c3ra46304d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3ra46304d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3ra46304d%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DBenzimidazole-biologically%252Battractive%252Bscaffold%252Bfor%252Bprotein%252Bkinase%252Binhibitors%26aulast%3DSingla%26aufirst%3DPrinka%26date%3D2014%26volume%3D4%26issue%3D24%26spage%3D12422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hua  Wang</span>, <span class="hlFld-ContribAuthor ">Hua  Yang</span>, <span class="hlFld-ContribAuthor ">Yiping  Li</span>, <span class="hlFld-ContribAuthor ">Xin-Hua  Duan</span>. </span><span class="cited-content_cbyCitation_article-title">Oxone-mediated oxidative carbon-heteroatom bond cleavage: synthesis of benzoxazinones from benzoxazoles with α-oxocarboxylic acids. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2014,</strong> <em>4 </em>
                                    (17)
                                     , 8720. <a href="https://doi.org/10.1039/c3ra47660j" title="DOI URL">https://doi.org/10.1039/c3ra47660j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3ra47660j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3ra47660j%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DOxone-mediated%252Boxidative%252Bcarbon-heteroatom%252Bbond%252Bcleavage%25253A%252Bsynthesis%252Bof%252Bbenzoxazinones%252Bfrom%252Bbenzoxazoles%252Bwith%252B%2525CE%2525B1-oxocarboxylic%252Bacids%26aulast%3DWang%26aufirst%3DHua%26date%3D2014%26volume%3D4%26issue%3D17%26spage%3D8720" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingze  Qin</span>, <span class="hlFld-ContribAuthor ">Weike  Liao</span>, <span class="hlFld-ContribAuthor ">Chen  Xu</span>, <span class="hlFld-ContribAuthor ">Baolin  Fu</span>, <span class="hlFld-ContribAuthor ">Jianguo  Ren</span>, <span class="hlFld-ContribAuthor ">Yucheng  Gu</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Novel 4-(2-Fluorophenoxy)-2-(1
              H
              -tetrazol-1-yl)pyridines Bearing Semicarbazone Moieties as Potent Antitumor Agents. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2013,</strong> <em>346 </em>
                                    (11)
                                     , 840-850. <a href="https://doi.org/10.1002/ardp.201300188" title="DOI URL">https://doi.org/10.1002/ardp.201300188</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201300188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201300188%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252B4-%2525282-Fluorophenoxy%252529-2-%2525281%252BH%252B-tetrazol-1-yl%252529pyridines%252BBearing%252BSemicarbazone%252BMoieties%252Bas%252BPotent%252BAntitumor%252BAgents%26aulast%3DQin%26aufirst%3DMingze%26date%3D2013%26date%3D2013%26volume%3D346%26issue%3D11%26spage%3D840%26epage%3D850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Can  Luo</span>, <span class="hlFld-ContribAuthor ">Ke  Tang</span>, <span class="hlFld-ContribAuthor ">Yan  Li</span>, <span class="hlFld-ContribAuthor ">DaLi  Yin</span>, <span class="hlFld-ContribAuthor ">XiaoGuang  Chen</span>, <span class="hlFld-ContribAuthor ">HaiHong  Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and in vitro antitumor evaluation of novel diaryl urea derivatives bearing sulfonamide moiety. </span><span class="cited-content_cbyCitation_journal-name">Science China Chemistry</span><span> <strong>2013,</strong> <em>56 </em>
                                    (11)
                                     , 1564-1572. <a href="https://doi.org/10.1007/s11426-013-4903-z" title="DOI URL">https://doi.org/10.1007/s11426-013-4903-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11426-013-4903-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11426-013-4903-z%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520China%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bin%252Bvitro%252Bantitumor%252Bevaluation%252Bof%252Bnovel%252Bdiaryl%252Burea%252Bderivatives%252Bbearing%252Bsulfonamide%252Bmoiety%26aulast%3DLuo%26aufirst%3DCan%26date%3D2013%26date%3D2013%26volume%3D56%26issue%3D11%26spage%3D1564%26epage%3D1572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianwen  Yao</span>, <span class="hlFld-ContribAuthor ">Jing  Chen</span>, <span class="hlFld-ContribAuthor ">Zuopeng  He</span>, <span class="hlFld-ContribAuthor ">Wei  Sun</span>, <span class="hlFld-ContribAuthor ">Hao  Fang</span>, <span class="hlFld-ContribAuthor ">Wenfang  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Thiourea and thioether derivatives of sorafenib: synthesis, crystal structure, and antiproliferative activity. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2013,</strong> <em>22 </em>
                                    (8)
                                     , 3959-3968. <a href="https://doi.org/10.1007/s00044-012-0400-8" title="DOI URL">https://doi.org/10.1007/s00044-012-0400-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-012-0400-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-012-0400-8%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DThiourea%252Band%252Bthioether%252Bderivatives%252Bof%252Bsorafenib%25253A%252Bsynthesis%25252C%252Bcrystal%252Bstructure%25252C%252Band%252Bantiproliferative%252Bactivity%26aulast%3DYao%26aufirst%3DJianwen%26date%3D2013%26date%3D2012%26volume%3D22%26issue%3D8%26spage%3D3959%26epage%3D3968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claudio  Dalvit</span>, <span class="hlFld-ContribAuthor ">Soo Young  Ko</span>, <span class="hlFld-ContribAuthor ">Anna  Vulpetti</span>. </span><span class="cited-content_cbyCitation_article-title">Application of the rule of shielding in the design of novel fluorinated structural motifs and peptidomimetics. </span><span class="cited-content_cbyCitation_journal-name">Journal of Fluorine Chemistry</span><span> <strong>2013,</strong> <em>152 </em>, 129-135. <a href="https://doi.org/10.1016/j.jfluchem.2013.01.017" title="DOI URL">https://doi.org/10.1016/j.jfluchem.2013.01.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jfluchem.2013.01.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jfluchem.2013.01.017%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Fluorine%2520Chemistry%26atitle%3DApplication%252Bof%252Bthe%252Brule%252Bof%252Bshielding%252Bin%252Bthe%252Bdesign%252Bof%252Bnovel%252Bfluorinated%252Bstructural%252Bmotifs%252Band%252Bpeptidomimetics%26aulast%3DDalvit%26aufirst%3DClaudio%26date%3D2013%26volume%3D152%26spage%3D129%26epage%3D135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jagannath  Jadhav</span>, <span class="hlFld-ContribAuthor ">Vipul  Gaikwad</span>, <span class="hlFld-ContribAuthor ">Rajanikant  Kurane</span>, <span class="hlFld-ContribAuthor ">Rajashri  Salunkhe</span>, <span class="hlFld-ContribAuthor ">Gajanan  Rashinkar</span>. </span><span class="cited-content_cbyCitation_article-title">Intramolecular O-arylation route to 2-substituted benzoxazoles mediated by ferrocene tethered polymer supported ionic liquid phase catalyst. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2013,</strong> <em>69 </em>
                                    (14)
                                     , 2920-2926. <a href="https://doi.org/10.1016/j.tet.2013.02.028" title="DOI URL">https://doi.org/10.1016/j.tet.2013.02.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2013.02.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2013.02.028%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DIntramolecular%252BO-arylation%252Broute%252Bto%252B2-substituted%252Bbenzoxazoles%252Bmediated%252Bby%252Bferrocene%252Btethered%252Bpolymer%252Bsupported%252Bionic%252Bliquid%252Bphase%252Bcatalyst%26aulast%3DJadhav%26aufirst%3DJagannath%26date%3D2013%26volume%3D69%26issue%3D14%26spage%3D2920%26epage%3D2926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Zhai</span>, <span class="hlFld-ContribAuthor ">Ying  He</span>, <span class="hlFld-ContribAuthor ">Zhen  Yang</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Syntheses and antiproliferative activities of novel diarylthiosemicarbazide derivatives. </span><span class="cited-content_cbyCitation_journal-name">Chemical Research in Chinese Universities</span><span> <strong>2013,</strong> <em>29 </em>
                                    (1)
                                     , 62-66. <a href="https://doi.org/10.1007/s40242-013-2136-5" title="DOI URL">https://doi.org/10.1007/s40242-013-2136-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s40242-013-2136-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs40242-013-2136-5%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Research%2520in%2520Chinese%2520Universities%26atitle%3DSyntheses%252Band%252Bantiproliferative%252Bactivities%252Bof%252Bnovel%252Bdiarylthiosemicarbazide%252Bderivatives%26aulast%3DZhai%26aufirst%3DXin%26date%3D2013%26date%3D2013%26volume%3D29%26issue%3D1%26spage%3D62%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Naoki  Miyamoto</span>, <span class="hlFld-ContribAuthor ">Yuya  Oguro</span>, <span class="hlFld-ContribAuthor ">Terufumi  Takagi</span>, <span class="hlFld-ContribAuthor ">Hidehisa  Iwata</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Miki</span>, <span class="hlFld-ContribAuthor ">Akira  Hori</span>, <span class="hlFld-ContribAuthor ">Shinichi  Imamura</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and evaluation of imidazo[1,2-b]pyridazine derivatives having a benzamide unit as novel VEGFR2 kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2012,</strong> <em>20 </em>
                                    (24)
                                     , 7051-7058. <a href="https://doi.org/10.1016/j.bmc.2012.10.004" title="DOI URL">https://doi.org/10.1016/j.bmc.2012.10.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2012.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2012.10.004%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bevaluation%252Bof%252Bimidazo%25255B1%25252C2-b%25255Dpyridazine%252Bderivatives%252Bhaving%252Ba%252Bbenzamide%252Bunit%252Bas%252Bnovel%252BVEGFR2%252Bkinase%252Binhibitors%26aulast%3DMiyamoto%26aufirst%3DNaoki%26date%3D2012%26volume%3D20%26issue%3D24%26spage%3D7051%26epage%3D7058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Xuejian  Wang</span>, <span class="hlFld-ContribAuthor ">Jinhong  Feng</span>, <span class="hlFld-ContribAuthor ">Yuping  Jia</span>, <span class="hlFld-ContribAuthor ">Fuming  Xu</span>, <span class="hlFld-ContribAuthor ">Wenfang  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Vascular Endothelial Growth Factor Receptor 2 Inhibitors: A Virtual Screening Approach. </span><span class="cited-content_cbyCitation_journal-name">Chemical Biology & Drug Design</span><span> <strong>2012,</strong> <em>80 </em>
                                    (6)
                                     , 893-901. <a href="https://doi.org/10.1111/cbdd.12036" title="DOI URL">https://doi.org/10.1111/cbdd.12036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cbdd.12036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcbdd.12036%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Biology%2520%2526%2520Drug%2520Design%26atitle%3DDiscovery%252Bof%252BNovel%252BVascular%252BEndothelial%252BGrowth%252BFactor%252BReceptor%252B2%252BInhibitors%25253A%252BA%252BVirtual%252BScreening%252BApproach%26aulast%3DZhang%26aufirst%3DLei%26date%3D2012%26date%3D2012%26volume%3D80%26issue%3D6%26spage%3D893%26epage%3D901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Cornelis  Matijssen</span>, <span class="hlFld-ContribAuthor ">M. Cris  Silva-Santisteban</span>, <span class="hlFld-ContribAuthor ">Isaac M.  Westwood</span>, <span class="hlFld-ContribAuthor ">Samerene  Siddique</span>, <span class="hlFld-ContribAuthor ">Vanessa  Choi</span>, <span class="hlFld-ContribAuthor ">Peter  Sheldrake</span>, <span class="hlFld-ContribAuthor ">Rob L.M.  van Montfort</span>, <span class="hlFld-ContribAuthor ">Julian  Blagg</span>. </span><span class="cited-content_cbyCitation_article-title">Benzimidazole inhibitors of the protein kinase CHK2: Clarification of the binding mode by flexible side chain docking and protein–ligand crystallography. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2012,</strong> <em>20 </em>
                                    (22)
                                     , 6630-6639. <a href="https://doi.org/10.1016/j.bmc.2012.09.024" title="DOI URL">https://doi.org/10.1016/j.bmc.2012.09.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2012.09.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2012.09.024%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DBenzimidazole%252Binhibitors%252Bof%252Bthe%252Bprotein%252Bkinase%252BCHK2%25253A%252BClarification%252Bof%252Bthe%252Bbinding%252Bmode%252Bby%252Bflexible%252Bside%252Bchain%252Bdocking%252Band%252Bprotein%2525E2%252580%252593ligand%252Bcrystallography%26aulast%3DMatijssen%26aufirst%3DCornelis%26date%3D2012%26volume%3D20%26issue%3D22%26spage%3D6630%26epage%3D6639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianwen  Yao</span>, <span class="hlFld-ContribAuthor ">Zuopeng  He</span>, <span class="hlFld-ContribAuthor ">Jing  Chen</span>, <span class="hlFld-ContribAuthor ">Wei  Sun</span>, <span class="hlFld-ContribAuthor ">Hao  Fang</span>, <span class="hlFld-ContribAuthor ">Wenfang  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological activities of sorafenib derivatives as antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (21)
                                     , 6549-6553. <a href="https://doi.org/10.1016/j.bmcl.2012.09.031" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.09.031</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.09.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.09.031%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bactivities%252Bof%252Bsorafenib%252Bderivatives%252Bas%252Bantitumor%252Bagents%26aulast%3DYao%26aufirst%3DJianwen%26date%3D2012%26volume%3D22%26issue%3D21%26spage%3D6549%26epage%3D6553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianwen  Yao</span>, <span class="hlFld-ContribAuthor ">Zuopeng  He</span>, <span class="hlFld-ContribAuthor ">Jing  Chen</span>, <span class="hlFld-ContribAuthor ">Daquan  Chen</span>, <span class="hlFld-ContribAuthor ">Wei  Sun</span>, <span class="hlFld-ContribAuthor ">Wenfang  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Antiproliferative Activities of Diaryl Thiourea Derivatives as Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name">Chinese Journal of Chemistry</span><span> <strong>2012,</strong> <em>30 </em>
                                    (10)
                                     , 2423-2430. <a href="https://doi.org/10.1002/cjoc.201200708" title="DOI URL">https://doi.org/10.1002/cjoc.201200708</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cjoc.201200708&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcjoc.201200708%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Journal%2520of%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BAntiproliferative%252BActivities%252Bof%252BDiaryl%252BThiourea%252BDerivatives%252Bas%252BAnticancer%252BAgents%26aulast%3DYao%26aufirst%3DJianwen%26date%3D2012%26date%3D2012%26volume%3D30%26issue%3D10%26spage%3D2423%26epage%3D2430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Linda F.  Epstein</span>, <span class="hlFld-ContribAuthor ">Hao  Chen</span>, <span class="hlFld-ContribAuthor ">Renee  Emkey</span>, <span class="hlFld-ContribAuthor ">Douglas A.  Whittington</span>. </span><span class="cited-content_cbyCitation_article-title">The R1275Q Neuroblastoma Mutant and Certain ATP-competitive Inhibitors Stabilize Alternative Activation Loop Conformations of Anaplastic Lymphoma Kinase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2012,</strong> <em>287 </em>
                                    (44)
                                     , 37447-37457. <a href="https://doi.org/10.1074/jbc.M112.391425" title="DOI URL">https://doi.org/10.1074/jbc.M112.391425</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.M112.391425&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.M112.391425%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DThe%252BR1275Q%252BNeuroblastoma%252BMutant%252Band%252BCertain%252BATP-competitive%252BInhibitors%252BStabilize%252BAlternative%252BActivation%252BLoop%252BConformations%252Bof%252BAnaplastic%252BLymphoma%252BKinase%26aulast%3DEpstein%26aufirst%3DLinda%2BF.%26date%3D2012%26volume%3D287%26issue%3D44%26spage%3D37447%26epage%3D37457" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Zhang</span>, <span class="hlFld-ContribAuthor ">Wenlu  Liu</span>, <span class="hlFld-ContribAuthor ">Xizhen  Jiang</span>, <span class="hlFld-ContribAuthor ">Faqin  Jiang</span>, <span class="hlFld-ContribAuthor ">Lei  Fu</span>. </span><span class="cited-content_cbyCitation_article-title">One-Pot Synthesis of Hydroxybenzo[d]-oxazole-2-aliphatic Acid Derivatives by Meerwein's Reagent. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2012,</strong> <em>42 </em>
                                    (18)
                                     , 2772-2779. <a href="https://doi.org/10.1080/00397911.2011.567435" title="DOI URL">https://doi.org/10.1080/00397911.2011.567435</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2011.567435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2011.567435%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DOne-Pot%252BSynthesis%252Bof%252BHydroxybenzo%25255Bd%25255D-oxazole-2-aliphatic%252BAcid%252BDerivatives%252Bby%252BMeerwein%252527s%252BReagent%26aulast%3DZhang%26aufirst%3DWei%26date%3D2012%26date%3D2012%26volume%3D42%26issue%3D18%26spage%3D2772%26epage%3D2779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lingyi  Huang</span>, <span class="hlFld-ContribAuthor ">Zhengui  Huang</span>, <span class="hlFld-ContribAuthor ">Zhiqiang  Bai</span>, <span class="hlFld-ContribAuthor ">Rui  Xie</span>, <span class="hlFld-ContribAuthor ">Liping  Sun</span>, <span class="hlFld-ContribAuthor ">Kejiang  Lin</span>. </span><span class="cited-content_cbyCitation_article-title">Development and strategies of VEGFR-2/KDR inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2012,</strong> <em>4 </em>
                                    (14)
                                     , 1839-1852. <a href="https://doi.org/10.4155/fmc.12.121" title="DOI URL">https://doi.org/10.4155/fmc.12.121</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.12.121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.12.121%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Band%252Bstrategies%252Bof%252BVEGFR-2%25252FKDR%252Binhibitors%26aulast%3DHuang%26aufirst%3DLingyi%26date%3D2012%26volume%3D4%26issue%3D14%26spage%3D1839%26epage%3D1852" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lingzhou  Zhao</span>, <span class="hlFld-ContribAuthor ">Yongjuan  Liu</span>, <span class="hlFld-ContribAuthor ">Shiyuan  Hu</span>, <span class="hlFld-ContribAuthor ">Huabei  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">3D-QSAR study of Chk1 kinase inhibitors based on docking. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Modeling</span><span> <strong>2012,</strong> <em>18 </em>
                                    (8)
                                     , 3669-3694. <a href="https://doi.org/10.1007/s00894-012-1363-x" title="DOI URL">https://doi.org/10.1007/s00894-012-1363-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00894-012-1363-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00894-012-1363-x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Modeling%26atitle%3D3D-QSAR%252Bstudy%252Bof%252BChk1%252Bkinase%252Binhibitors%252Bbased%252Bon%252Bdocking%26aulast%3DZhao%26aufirst%3DLingzhou%26date%3D2012%26date%3D2012%26volume%3D18%26issue%3D8%26spage%3D3669%26epage%3D3694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna Maria  Almerico</span>, <span class="hlFld-ContribAuthor ">Marco  Tutone</span>, <span class="hlFld-ContribAuthor ">Antonino  Lauria</span>. </span><span class="cited-content_cbyCitation_article-title">Receptor-guided 3D-QSAR approach for the discovery of c-kit tyrosine kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Modeling</span><span> <strong>2012,</strong> <em>18 </em>
                                    (7)
                                     , 2885-2895. <a href="https://doi.org/10.1007/s00894-011-1304-0" title="DOI URL">https://doi.org/10.1007/s00894-011-1304-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00894-011-1304-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00894-011-1304-0%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Modeling%26atitle%3DReceptor-guided%252B3D-QSAR%252Bapproach%252Bfor%252Bthe%252Bdiscovery%252Bof%252Bc-kit%252Btyrosine%252Bkinase%252Binhibitors%26aulast%3DAlmerico%26aufirst%3DAnna%2BMaria%26date%3D2012%26date%3D2011%26volume%3D18%26issue%3D7%26spage%3D2885%26epage%3D2895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter M.  Murphy</span>, <span class="hlFld-ContribAuthor ">Christopher S.  Baldwin</span>, <span class="hlFld-ContribAuthor ">Robert C.  Buck</span>. </span><span class="cited-content_cbyCitation_article-title">Syntheses utilizing n-perfluoroalkyl iodides [RFI, CnF2n+1-I] 2000–2010. </span><span class="cited-content_cbyCitation_journal-name">Journal of Fluorine Chemistry</span><span> <strong>2012,</strong> <em>138 </em>, 3-23. <a href="https://doi.org/10.1016/j.jfluchem.2012.03.011" title="DOI URL">https://doi.org/10.1016/j.jfluchem.2012.03.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jfluchem.2012.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jfluchem.2012.03.011%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Fluorine%2520Chemistry%26atitle%3DSyntheses%252Butilizing%252Bn-perfluoroalkyl%252Biodides%252B%25255BRFI%25252C%252BCnF2n%25252B1-I%25255D%252B2000%2525E2%252580%2525932010%26aulast%3DMurphy%26aufirst%3DPeter%2BM.%26date%3D2012%26volume%3D138%26spage%3D3%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Zhai</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Dong  Chen</span>, <span class="hlFld-ContribAuthor ">Ruiwei  Lai</span>, <span class="hlFld-ContribAuthor ">Jun  Liu</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of 2-Iminothiazolidin-4-one Moiety-Containing Compounds as Potent Antiproliferative Agents. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2012,</strong> <em>345 </em>
                                    (5)
                                     , 360-367. <a href="https://doi.org/10.1002/ardp.201100064" title="DOI URL">https://doi.org/10.1002/ardp.201100064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201100064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201100064%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252B2-Iminothiazolidin-4-one%252BMoiety-Containing%252BCompounds%252Bas%252BPotent%252BAntiproliferative%252BAgents%26aulast%3DZhai%26aufirst%3DXin%26date%3D2012%26date%3D2012%26volume%3D345%26issue%3D5%26spage%3D360%26epage%3D367" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C  PRAVEEN</span>, <span class="hlFld-ContribAuthor ">A  NANDAKUMAR</span>, <span class="hlFld-ContribAuthor ">P  DHEENKUMAR</span>, <span class="hlFld-ContribAuthor ">D  MURALIDHARAN</span>, <span class="hlFld-ContribAuthor ">P T  PERUMAL</span>. </span><span class="cited-content_cbyCitation_article-title">Microwave-assisted one-pot synthesis of benzothiazole and benzoxazole libraries as analgesic agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Sciences</span><span> <strong>2012,</strong> <em>124 </em>
                                    (3)
                                     , 609-624. <a href="https://doi.org/10.1007/s12039-012-0251-3" title="DOI URL">https://doi.org/10.1007/s12039-012-0251-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12039-012-0251-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12039-012-0251-3%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Sciences%26atitle%3DMicrowave-assisted%252Bone-pot%252Bsynthesis%252Bof%252Bbenzothiazole%252Band%252Bbenzoxazole%252Blibraries%252Bas%252Banalgesic%252Bagents%26aulast%3DPRAVEEN%26aufirst%3DC%26date%3D2012%26date%3D2012%26volume%3D124%26issue%3D3%26spage%3D609%26epage%3D624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianwen  Yao</span>, <span class="hlFld-ContribAuthor ">Jing  Chen</span>, <span class="hlFld-ContribAuthor ">Zuopeng  He</span>, <span class="hlFld-ContribAuthor ">Wei  Sun</span>, <span class="hlFld-ContribAuthor ">Wenfang  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological activities of thiourea containing sorafenib analogs as antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2012,</strong> <em>20 </em>
                                    (9)
                                     , 2923-2929. <a href="https://doi.org/10.1016/j.bmc.2012.03.018" title="DOI URL">https://doi.org/10.1016/j.bmc.2012.03.018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2012.03.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2012.03.018%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bactivities%252Bof%252Bthiourea%252Bcontaining%252Bsorafenib%252Banalogs%252Bas%252Bantitumor%252Bagents%26aulast%3DYao%26aufirst%3DJianwen%26date%3D2012%26volume%3D20%26issue%3D9%26spage%3D2923%26epage%3D2929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K.C.  Majumdar</span>, <span class="hlFld-ContribAuthor ">Sintu  Ganai</span>, <span class="hlFld-ContribAuthor ">Raj Kumar  Nandi</span>, <span class="hlFld-ContribAuthor ">Krishanu  Ray</span>. </span><span class="cited-content_cbyCitation_article-title">Catalyst-free synthesis of coumarin-, quinolone- and pyridine-annulated oxazole derivatives. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2012,</strong> <em>53 </em>
                                    (13)
                                     , 1553-1557. <a href="https://doi.org/10.1016/j.tetlet.2012.01.015" title="DOI URL">https://doi.org/10.1016/j.tetlet.2012.01.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2012.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2012.01.015%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DCatalyst-free%252Bsynthesis%252Bof%252Bcoumarin-%25252C%252Bquinolone-%252Band%252Bpyridine-annulated%252Boxazole%252Bderivatives%26aulast%3DMajumdar%26aufirst%3DK.C.%26date%3D2012%26volume%3D53%26issue%3D13%26spage%3D1553%26epage%3D1557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rocco  Caliandro</span>, <span class="hlFld-ContribAuthor ">Domenica  Dibenedetto</span>, <span class="hlFld-ContribAuthor ">Giovanni Luca  Cascarano</span>, <span class="hlFld-ContribAuthor ">Annamaria  Mazzone</span>, <span class="hlFld-ContribAuthor ">Giovanni  Nico</span>. </span><span class="cited-content_cbyCitation_article-title">Automatic α-helix identification in Patterson maps. </span><span class="cited-content_cbyCitation_journal-name">Acta Crystallographica Section D Biological Crystallography</span><span> <strong>2012,</strong> <em>68 </em>
                                    (1)
                                     , 1-12. <a href="https://doi.org/10.1107/S0907444911046282" title="DOI URL">https://doi.org/10.1107/S0907444911046282</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1107/S0907444911046282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1107%2FS0907444911046282%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Crystallographica%2520Section%2520D%2520Biological%2520Crystallography%26atitle%3DAutomatic%252B%2525CE%2525B1-helix%252Bidentification%252Bin%252BPatterson%252Bmaps%26aulast%3DCaliandro%26aufirst%3DRocco%26date%3D2012%26date%3D2011%26volume%3D68%26issue%3D1%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhao-Kui  Wan</span>, <span class="hlFld-ContribAuthor ">Erena Farah  Ousman</span>, <span class="hlFld-ContribAuthor ">Nikolaos  Papaioannou</span>, <span class="hlFld-ContribAuthor ">Eddine  Saiah</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphonium-mediated cyclization of N-(2-aminophenyl)thioureas: efficient synthesis of 2-aminobenzimidazoles. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2011,</strong> <em>52 </em>
                                    (32)
                                     , 4149-4152. <a href="https://doi.org/10.1016/j.tetlet.2011.05.146" title="DOI URL">https://doi.org/10.1016/j.tetlet.2011.05.146</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2011.05.146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2011.05.146%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DPhosphonium-mediated%252Bcyclization%252Bof%252BN-%2525282-aminophenyl%252529thioureas%25253A%252Befficient%252Bsynthesis%252Bof%252B2-aminobenzimidazoles%26aulast%3DWan%26aufirst%3DZhao-Kui%26date%3D2011%26volume%3D52%26issue%3D32%26spage%3D4149%26epage%3D4152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Xin  Zhai</span>, <span class="hlFld-ContribAuthor ">Zheng  Zhong</span>, <span class="hlFld-ContribAuthor ">Guangyue  Li</span>, <span class="hlFld-ContribAuthor ">Yongxiao  Pu</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Evaluation of Novel Rhodanine-containing Sorafenib Analogs as Potential Antitumor Agents. </span><span class="cited-content_cbyCitation_journal-name">Archiv der Pharmazie</span><span> <strong>2011,</strong> <em>344 </em>
                                    (6)
                                     , 349-357. <a href="https://doi.org/10.1002/ardp.201000326" title="DOI URL">https://doi.org/10.1002/ardp.201000326</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ardp.201000326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fardp.201000326%26sid%3Dliteratum%253Aachs%26jtitle%3DArchiv%2520der%2520Pharmazie%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BEvaluation%252Bof%252BNovel%252BRhodanine-containing%252BSorafenib%252BAnalogs%252Bas%252BPotential%252BAntitumor%252BAgents%26aulast%3DLi%26aufirst%3DWei%26date%3D2011%26date%3D2011%26volume%3D344%26issue%3D6%26spage%3D349%26epage%3D357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel  Mucs</span>, <span class="hlFld-ContribAuthor ">Richard A.  Bryce</span>, <span class="hlFld-ContribAuthor ">Pascal  Bonnet</span>. </span><span class="cited-content_cbyCitation_article-title">Application of shape-based and pharmacophore-based in silico screens for identification of Type II protein kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2011,</strong> <em>25 </em>
                                    (6)
                                     , 569-581. <a href="https://doi.org/10.1007/s10822-011-9442-0" title="DOI URL">https://doi.org/10.1007/s10822-011-9442-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-011-9442-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-011-9442-0%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DApplication%252Bof%252Bshape-based%252Band%252Bpharmacophore-based%252Bin%252Bsilico%252Bscreens%252Bfor%252Bidentification%252Bof%252BType%252BII%252Bprotein%252Bkinase%252Binhibitors%26aulast%3DMucs%26aufirst%3DDaniel%26date%3D2011%26date%3D2011%26volume%3D25%26issue%3D6%26spage%3D569%26epage%3D581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Savithri  Ramurthy</span>, <span class="hlFld-ContribAuthor ">Mina  Aikawa</span>, <span class="hlFld-ContribAuthor ">Payman  Amiri</span>, <span class="hlFld-ContribAuthor ">Abran  Costales</span>, <span class="hlFld-ContribAuthor ">Ahmad  Hashash</span>, <span class="hlFld-ContribAuthor ">Johanna M.  Jansen</span>, <span class="hlFld-ContribAuthor ">Song  Lin</span>, <span class="hlFld-ContribAuthor ">Sylvia  Ma</span>, <span class="hlFld-ContribAuthor ">Paul A.  Renhowe</span>, <span class="hlFld-ContribAuthor ">Cynthia M.  Shafer</span>, <span class="hlFld-ContribAuthor ">Sharadha  Subramanian</span>, <span class="hlFld-ContribAuthor ">Leonard  Sung</span>, <span class="hlFld-ContribAuthor ">Joelle  Verhagen</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of 5,6-fused heterocyclic amides as Raf kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (11)
                                     , 3286-3289. <a href="https://doi.org/10.1016/j.bmcl.2011.04.023" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.04.023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.04.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.04.023%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252B5%25252C6-fused%252Bheterocyclic%252Bamides%252Bas%252BRaf%252Bkinase%252Binhibitors%26aulast%3DRamurthy%26aufirst%3DSavithri%26date%3D2011%26volume%3D21%26issue%3D11%26spage%3D3286%26epage%3D3289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giovanni  Marzaro</span>, <span class="hlFld-ContribAuthor ">Adriana  Chilin</span>, <span class="hlFld-ContribAuthor ">Adriano  Guiotto</span>, <span class="hlFld-ContribAuthor ">Eugenio  Uriarte</span>, <span class="hlFld-ContribAuthor ">Paola  Brun</span>, <span class="hlFld-ContribAuthor ">Ignazio  Castagliuolo</span>, <span class="hlFld-ContribAuthor ">Francesca  Tonus</span>, <span class="hlFld-ContribAuthor ">Humberto  González-Díaz</span>. </span><span class="cited-content_cbyCitation_article-title">Using the TOPS-MODE approach to fit multi-target QSAR models for tyrosine kinases inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>46 </em>
                                    (6)
                                     , 2185-2192. <a href="https://doi.org/10.1016/j.ejmech.2011.02.072" title="DOI URL">https://doi.org/10.1016/j.ejmech.2011.02.072</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2011.02.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2011.02.072%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DUsing%252Bthe%252BTOPS-MODE%252Bapproach%252Bto%252Bfit%252Bmulti-target%252BQSAR%252Bmodels%252Bfor%252Btyrosine%252Bkinases%252Binhibitors%26aulast%3DMarzaro%26aufirst%3DGiovanni%26date%3D2011%26volume%3D46%26issue%3D6%26spage%3D2185%26epage%3D2192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Xin  Zhai</span>, <span class="hlFld-ContribAuthor ">Lu  Ding</span>, <span class="hlFld-ContribAuthor ">Limin  Sun</span>, <span class="hlFld-ContribAuthor ">Xiaomei  Chen</span>, <span class="hlFld-ContribAuthor ">Ping  Gong</span>, <span class="hlFld-ContribAuthor ">Tiemin  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Cytotoxic Evaluation of Novel N-Methyl-4-phenoxypicolinamide Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2011,</strong> <em>16 </em>
                                    (6)
                                     , 5130-5141. <a href="https://doi.org/10.3390/molecules16065130" title="DOI URL">https://doi.org/10.3390/molecules16065130</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules16065130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules16065130%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthesis%252Band%252BCytotoxic%252BEvaluation%252Bof%252BNovel%252BN-Methyl-4-phenoxypicolinamide%252BDerivatives%26aulast%3DLi%26aufirst%3DWei%26date%3D2011%26date%3D2011%26volume%3D16%26issue%3D6%26spage%3D5130%26epage%3D5141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander C.  Backes</span>, <span class="hlFld-ContribAuthor ">Gerhard  Müller</span>, <span class="hlFld-ContribAuthor ">Peter C.  Sennhenn</span>. </span><span class="cited-content_cbyCitation_article-title">Design Principles of Deep Pocket-Targeting Protein Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,, 145-193. <a href="https://doi.org/10.1002/9783527633470.ch6" title="DOI URL">https://doi.org/10.1002/9783527633470.ch6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527633470.ch6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527633470.ch6%26sid%3Dliteratum%253Aachs%26atitle%3DDesign%252BPrinciples%252Bof%252BDeep%252BPocket-Targeting%252BProtein%252BKinase%252BInhibitors%26aulast%3DBackes%26aufirst%3DAlexander%2BC.%26date%3D2011%26date%3D2011%26spage%3D145%26epage%3D193%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DProtein%252BKinases%252Bas%252BDrug%252BTargets%26aulast%3DKlebl%26aufirst%3DBert%26date%3D2011%26volume%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shahnaz  Rostamizadeh</span>, <span class="hlFld-ContribAuthor ">Reza  Aryan</span>, <span class="hlFld-ContribAuthor ">Hamid Reza  Ghaieni</span>. </span><span class="cited-content_cbyCitation_article-title">Aqueous 1 M Glucose Solution as a Novel and Fully Green Reaction Medium and Catalyst for the Oxidant-Free Synthesis of 2-Arylbenzimidazoles. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2011,</strong> <em>41 </em>
                                    (12)
                                     , 1794-1804. <a href="https://doi.org/10.1080/00397911.2010.492460" title="DOI URL">https://doi.org/10.1080/00397911.2010.492460</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2010.492460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2010.492460%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DAqueous%252B1%2525C2%2525A0M%252BGlucose%252BSolution%252Bas%252Ba%252BNovel%252Band%252BFully%252BGreen%252BReaction%252BMedium%252Band%252BCatalyst%252Bfor%252Bthe%252BOxidant-Free%252BSynthesis%252Bof%252B2-Arylbenzimidazoles%26aulast%3DRostamizadeh%26aufirst%3DShahnaz%26date%3D2011%26volume%3D41%26issue%3D12%26spage%3D1794%26epage%3D1804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinsong  Peng</span>, <span class="hlFld-ContribAuthor ">Cuijuan  Zong</span>, <span class="hlFld-ContribAuthor ">Min  Ye</span>, <span class="hlFld-ContribAuthor ">Tonghui  Chen</span>, <span class="hlFld-ContribAuthor ">Dewei  Gao</span>, <span class="hlFld-ContribAuthor ">Yufeng  Wang</span>, <span class="hlFld-ContribAuthor ">Chunxia  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Direct transition-metal-free intramolecular C–O bond formation: synthesis of benzoxazole derivatives. </span><span class="cited-content_cbyCitation_journal-name">Org. Biomol. Chem.</span><span> <strong>2011,</strong> <em>9 </em>
                                    (4)
                                     , 1225-1230. <a href="https://doi.org/10.1039/C0OB00454E" title="DOI URL">https://doi.org/10.1039/C0OB00454E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C0OB00454E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC0OB00454E%26sid%3Dliteratum%253Aachs%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26atitle%3DDirect%252Btransition-metal-free%252Bintramolecular%252BC%2525E2%252580%252593O%252Bbond%252Bformation%25253A%252Bsynthesis%252Bof%252Bbenzoxazole%252Bderivatives%26aulast%3DPeng%26aufirst%3DJinsong%26date%3D2011%26date%3D2011%26volume%3D9%26issue%3D4%26spage%3D1225%26epage%3D1230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roderick C.  Jones</span>, <span class="hlFld-ContribAuthor ">Maja W.  Chojnacka</span>, <span class="hlFld-ContribAuthor ">J. Wilson  Quail</span>, <span class="hlFld-ContribAuthor ">Michael G.  Gardiner</span>, <span class="hlFld-ContribAuthor ">Andreas  Decken</span>, <span class="hlFld-ContribAuthor ">Brian F.  Yates</span>, <span class="hlFld-ContribAuthor ">Robert A.  Gossage</span>. </span><span class="cited-content_cbyCitation_article-title">Oxazoles revisited: On the nature of binding of benzoxazole and 2-methylbenzoxazole with the zinc and palladium halides. </span><span class="cited-content_cbyCitation_journal-name">Dalton Transactions</span><span> <strong>2011,</strong> <em>40 </em>
                                    (7)
                                     , 1594. <a href="https://doi.org/10.1039/c0dt01266a" title="DOI URL">https://doi.org/10.1039/c0dt01266a</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c0dt01266a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc0dt01266a%26sid%3Dliteratum%253Aachs%26jtitle%3DDalton%2520Transactions%26atitle%3DOxazoles%252Brevisited%25253A%252BOn%252Bthe%252Bnature%252Bof%252Bbinding%252Bof%252Bbenzoxazole%252Band%252B2-methylbenzoxazole%252Bwith%252Bthe%252Bzinc%252Band%252Bpalladium%252Bhalides%26aulast%3DJones%26aufirst%3DRoderick%2BC.%26date%3D2011%26volume%3D40%26issue%3D7%26spage%3D1594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huahui  Zeng</span>, <span class="hlFld-ContribAuthor ">Huabei  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Combined 3D-QSAR modeling and molecular docking study on 1,4-dihydroindeno[1,2-c]pyrazoles as VEGFR-2 kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2010,</strong> <em>29 </em>
                                    (1)
                                     , 54-71. <a href="https://doi.org/10.1016/j.jmgm.2010.04.004" title="DOI URL">https://doi.org/10.1016/j.jmgm.2010.04.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2010.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2010.04.004%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DCombined%252B3D-QSAR%252Bmodeling%252Band%252Bmolecular%252Bdocking%252Bstudy%252Bon%252B1%25252C4-dihydroindeno%25255B1%25252C2-c%25255Dpyrazoles%252Bas%252BVEGFR-2%252Bkinase%252Binhibitors%26aulast%3DZeng%26aufirst%3DHuahui%26date%3D2010%26volume%3D29%26issue%3D1%26spage%3D54%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min  Sun</span>, <span class="hlFld-ContribAuthor ">Xiaoqing  Wu</span>, <span class="hlFld-ContribAuthor ">Junqing  Chen</span>, <span class="hlFld-ContribAuthor ">Jin  Cai</span>, <span class="hlFld-ContribAuthor ">Meng  Cao</span>, <span class="hlFld-ContribAuthor ">Min  Ji</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and in vitro antitumor evaluation of novel diaryl ureas derivatives. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2010,</strong> <em>45 </em>
                                    (6)
                                     , 2299-2306. <a href="https://doi.org/10.1016/j.ejmech.2010.02.005" title="DOI URL">https://doi.org/10.1016/j.ejmech.2010.02.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2010.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2010.02.005%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bin%252Bvitro%252Bantitumor%252Bevaluation%252Bof%252Bnovel%252Bdiaryl%252Bureas%252Bderivatives%26aulast%3DSun%26aufirst%3DMin%26date%3D2010%26volume%3D45%26issue%3D6%26spage%3D2299%26epage%3D2306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm070034i&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm070034i%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2007.50.issue-18%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;citedByCount=110&amp;pagesCount=2&amp;pageNumber=-1" title="Load all citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load all citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034in00001.gif" alt="" id="_i2" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034in00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070034i&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm070034if00001" data-index="1" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034if00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034if00001.jpeg" id="rightTab-_i5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 1 KDR inhibitors under clinical investigation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034if00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070034i&amp;id=jm070034if00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm070034if00002" data-index="2" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034if00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034if00002.jpeg" id="rightTab-_i7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 2 Model of urea <b>2</b> (yellow) overlaid with cocrystal structure of nicotinamide <b>1</b> (green) and KDR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034if00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070034i&amp;id=jm070034if00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm070034if00003" data-index="3" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034if00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034if00003.jpeg" id="rightTab-_i9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 3 Lead compound <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034if00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070034i&amp;id=jm070034if00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm070034ih00001" data-index="4" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034ih00001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034ih00001.jpeg" id="rightTab-_i12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 1.  General Synthesis of 2-Aminobenzimidazoles and 2-Aminobenzoxazoles <b>3</b>−<b>38</b><i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) EDC, CH<sub>3</sub>CN.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034ih00001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070034i&amp;id=jm070034ih00001"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm070034ih00002" data-index="5" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034ih00002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034ih00002.jpeg" id="rightTab-_i13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 2.  Preparation of Substituted Anilines<i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) pyridine·HCl, 210 °C; (b) HOAc, HBr, 140−180 °C; (c) R-Cl, K<sub>2</sub>CO<sub>3</sub>, Bu<sub>4</sub>N<sup>+</sup>I<sup>-</sup>, acetone; (d) R-Cl, K<sub>2</sub>CO<sub>3</sub>, DMF; (e) triphenylphosphine, DIAD, R-OH, THF; (f) Pd/C, H<sub>2</sub>, ethyl acetate or MeOH; (g) SnCl<sub>2</sub>, EtOH; (h) amine, NaBH(OAc)<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034ih00002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070034i&amp;id=jm070034ih00002"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm070034ih00003" data-index="6" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034ih00003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034ih00003.jpeg" id="rightTab-_i14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 3.  Preparation of <i>N</i>-Methylpyrrolidine-Substituted Anilines<i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) (<i>S</i> or <i>R</i>)-(−)-1-(<i>tert</i>-butoxycarbonyl)-2-pyrrolidinemethanol, triphenylphosphine, DIAD, THF; (b) TFA, CH<sub>2</sub>Cl<sub>2</sub>; (c) NaBH<sub>3</sub>CN, CH<sub>2</sub>O, CH<sub>3</sub>CN; (d) Pd/C, H<sub>2</sub>, MeOH and dioxane/ethyl acetate or SnCl<sub>2</sub>, EtOH. </p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034ih00003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070034i&amp;id=jm070034ih00003"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm070034ih00004" data-index="7" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034ih00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034ih00004.jpeg" id="rightTab-_i16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 4.  Synthesis of Thioisocyanates<i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents:  (a) 1,1’-thiocarbonyldiimidazole, CH<sub>3</sub>CN.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034ih00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070034i&amp;id=jm070034ih00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm070034ih00005" data-index="8" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034ih00005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034ih00005.jpeg" id="rightTab-_i18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 5.  Preparation of Phenylene Diamines<i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) neat, 145−170 °C; (b) NEt<sub>3</sub>/TFA; (c) HCl, 145−150 °C; (d) Pd/C, H<sub>2</sub>, MeOH and/or ethyl acetate; (e) Zn, AcOH, THF.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034ih00005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070034i&amp;id=jm070034ih00005"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm070034ih00006" data-index="9" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034ih00006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034ih00006.jpeg" id="rightTab-_i20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 6.  Synthesis of Intermediate <b>39i</b><i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) KO<i>t</i>-Bu, K<sub>2</sub>CO<sub>3</sub>, DMSO, rt−110 °C; (b) (i) TFAA, (ii) TBACl, Me<sub>2</sub>SO<sub>4</sub>, (iii) NaOH, H<sub>2</sub>O; (c) Pd/C, H<sub>2</sub>, MeOH/ethyl acetate.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034ih00006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070034i&amp;id=jm070034ih00006"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm070034ih00007" data-index="10" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034ih00007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034ih00007.jpeg" id="rightTab-_i21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first"> Scheme 7.  Preparation of Aminophenols<i><sup>a</sup></i><sup></sup></p><p class="last"><p class="last"><i><sup>a</sup></i><sup></sup> Reagents and conditions:  (a) NaH, DMF, rt−85 °C; (b) NEt<sub>3</sub>/TFA, 150 °C; (c) Pd/C, H<sub>2</sub>, MeOH, ethyl acetate; (d) TFA, heat; (e) HNO<sub>3</sub>, AcOH; (f) Fe, HCl, EtOH; (g) Zn, AcOH, THF; (h) SnCl<sub>2</sub>, EtOH.</p></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034ih00007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070034i&amp;id=jm070034ih00007"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm070034if00004" data-index="11" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034if00004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034if00004.jpeg" id="rightTab-_i23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 4 Crystal structure of <b>3</b> bound to KDR. Asp 1046, Phe 1047, and Gly 1048 (not shown for clarity) constitute the residues of the “DFG” motif. Potential hydrogen-bond interactions are indicated by dotted lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034if00004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070034i&amp;id=jm070034if00004"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm070034if00005" data-index="12" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034if00005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034if00005.jpeg" id="rightTab-_i34" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 5 Surface diagram of compound <b>3</b> bound to KDR. The 7-position is indicated by the arrow.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034if00005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070034i&amp;id=jm070034if00005"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm070034if00006" data-index="13" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034if00006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034if00006.jpeg" id="rightTab-_i37" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 6 Effect of <b>22</b> on VEGF-induced vascular permeability in mice. (◆) Indicates drug concentration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034if00006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070034i&amp;id=jm070034if00006"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm070034if00007" data-index="14" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034if00007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034if00007.jpeg" id="rightTab-_i39" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 7 Inhibition of VEGF-induced angiogenesis in rats by <b>22</b>. (◆) Indicates drug concentration.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034if00007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070034i&amp;id=jm070034if00007"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="jm070034if00008" data-index="15" class="article__inlineFigure"><h2 class="fig-label"></h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/medium/jm070034if00008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034if00008.jpeg" id="rightTab-_i41" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last"> Figure 8 Crystal structure of <b>22</b> bound to KDR. </p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2007/jmcmar.2007.50.issue-18/jm070034i/production/images/large/jm070034if00008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm070034i&amp;id=jm070034if00008"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"></div><p class="rightTab-references-count">
            This article references 26 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-jm070034ib00001"><div class="reference"><strong class="refLabel"><a href="#jm070034ib00001" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-jm070034ib00001_1"><span><span class="NLM_string-ref">Ferrara, N. Role of Vascular Endothelial Growth Factor in Physiologic and Pathologic Angiogenesis:  Therapeutic Implications. <i>  Semin. Oncol.</i><b>2002</b>, <i>29</i> (6 Suppl. 16), 10−14.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29+%286+Suppl.+16&publication_year=2002&pages=14&author=N+Ferrara&title=Role+of+Vascular+Endothelial+Growth+Factor+in+Physiologic+and+Pathologic+Angiogenesis%3A%E2%80%89+Therapeutic+Implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00001_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN%26atitle%3DRole%2520of%2520Vascular%2520Endothelial%2520Growth%2520Factor%2520in%2520Physiologic%2520and%2520Pathologic%2520Angiogenesis%253A%25E2%2580%2589%2520Therapeutic%2520Implications%26jtitle%3DSemin.%2520Oncol.%26date%3D2002%26volume%3D29%2520%25286%2520Suppl.%252016%26spage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm070034ib00002"><div class="reference"><strong class="refLabel"><a href="#jm070034ib00002" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-jm070034ib00002_1"><span><span class="NLM_string-ref">Walsh, D. A. Angiogenesis and Arthritis. <i>  Rheumatology</i><b>1999</b>, <i>38</i>, 103−112.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=112&author=D.+A+Walsh&title=Angiogenesis+and+Arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00002_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalsh%26aufirst%3DD.%2BA%26atitle%3DAngiogenesis%2520and%2520Arthritis%26jtitle%3DRheumatology%26date%3D1999%26volume%3D38%26spage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm070034ib00003"><div class="reference"><strong class="refLabel"><a href="#jm070034ib00003" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-jm070034ib00003_1"><span><span class="NLM_string-ref">Ferrara, N.; Alitalo, K. Clinical Applications of Angiogenic Growth Factors and their Inhibitors. <i>  Nat. Med.</i><b>1999</b>, <i>5</i>, 1359−1364.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1999&pages=1364&author=N.+Ferrara&author=K+Alitalo&title=Clinical+Applications+of+Angiogenic+Growth+Factors+and+their+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00003_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26atitle%3DClinical%2520Applications%2520of%2520Angiogenic%2520Growth%2520Factors%2520and%2520their%2520Inhibitors%26jtitle%3DNat.%2520Med.%26date%3D1999%26volume%3D5%26spage%3D1364" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm070034ib00004"><div class="reference"><strong class="refLabel"><a href="#jm070034ib00004" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-jm070034ib00004_1"><span><span class="NLM_string-ref">Folkman, J. Role of Angiogenesis in Tumor Growth and Metastasis. <i>  Semin. Oncol</i>. <b>2002</b>, <i>29</i> (6 Suppl. 16), 15−18.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29+%286+Suppl.+16&publication_year=2002&pages=18&author=J+Folkman&title=Role+of+Angiogenesis+in+Tumor+Growth+and+Metastasis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00004_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFolkman%26aufirst%3DJ%26atitle%3DRole%2520of%2520Angiogenesis%2520in%2520Tumor%2520Growth%2520and%2520Metastasis%26jtitle%3DSemin.%2520Oncol.%26date%3D2002%26volume%3D29%2520%25286%2520Suppl.%252016%26spage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm070034ib00005"><div class="reference"><strong class="refLabel"><a href="#jm070034ib00005" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-jm070034ib00005_1"><span><span class="NLM_string-ref">Ferrara, N. Role of Vascular Endothelial Growth Factor in the Regulation of Angiogenesis. <i>  Kidney Int.</i><b>1999</b>, <i>56</i>, 794−814.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=1999&pages=814&author=N+Ferrara&title=Role+of+Vascular+Endothelial+Growth+Factor+in+the+Regulation+of+Angiogenesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00005_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN%26atitle%3DRole%2520of%2520Vascular%2520Endothelial%2520Growth%2520Factor%2520in%2520the%2520Regulation%2520of%2520Angiogenesis%26jtitle%3DKidney%2520Int.%26date%3D1999%26volume%3D56%26spage%3D814" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm070034ib00006"><div class="reference"><strong class="refLabel"><a href="#jm070034ib00006" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-jm070034ib00006_1"><span><span class="NLM_string-ref">Gasparini, G.; Longo, R.; Toi, M.; Ferrara, N. Angiogenic Inhibitors:  A New Therapeutic Strategy in Oncology. <i>  Nat. Clin. Prac. Oncol.</i><b>2005</b>, <i>2</i>, 562−577.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Gasparini%2C+G.%3B+Longo%2C+R.%3B+Toi%2C+M.%3B+Ferrara%2C+N.+Angiogenic+Inhibitors%3A%E2%80%89+A+New+Therapeutic+Strategy+in+Oncology.+Nat.+Clin.+Prac.+Oncol.+2005%2C+2%2C+562%E2%88%92577.+Gasparini%2C+G.%3B+Longo%2C+R.%3B+Toi%2C+M.%3B+Ferrara%2C+N.+Angiogenic+Inhibitors%3A%E2%80%89+A+New+Therapeutic+Strategy+in+Oncology.+Nat.+Clin.+Prac.+Oncol.2005%2C+2%2C+562%E2%88%92577."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00006_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGasparini%26aufirst%3DG.%26jtitle%3DNat.%2520Clin.%2520Prac.%2520Oncol.%26date%3D2005%26volume%3D2%26spage%3D577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm070034ib00007"><div class="reference"><strong class="refLabel"><a href="#jm070034ib00007" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-jm070034ib00007_1"><span><span class="NLM_string-ref">Ferrara, N.; Hillan, K. J.; Gerber, H. P.; Novotny, W. Discovery and Development of Bevacizumab, an anti-VEGF Antibody for Treating Cancer. <i>  Nat. Rev. Drug Discovery</i><b>2004</b>, <i>3</i>, 391−400.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=400&author=N.+Ferrara&author=K.+J.+Hillan&author=H.+P.+Gerber&author=W+Novotny&title=Discovery+and+Development+of+Bevacizumab%2C+an+anti-VEGF+Antibody+for+Treating+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00007_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerrara%26aufirst%3DN.%26atitle%3DDiscovery%2520and%2520Development%2520of%2520Bevacizumab%252C%2520an%2520anti-VEGF%2520Antibody%2520for%2520Treating%2520Cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm070034ib00008"><div class="reference"><strong class="refLabel"><a href="#jm070034ib00008" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-jm070034ib00008_1"><span><span class="NLM_string-ref">Sakamoto, K. M. SU-11248 SUGEN. <i>  Curr. Opin. Invest. Drugs</i><b>2004</b>, <i>5</i>, 1329−1339.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Sakamoto%2C+K.+M.+SU-11248+SUGEN.+Curr.+Opin.+Invest.+Drugs+2004%2C+5%2C+1329%E2%88%921339.+Sakamoto%2C+K.+M.+SU-11248+SUGEN.+Curr.+Opin.+Invest.+Drugs2004%2C+5%2C+1329%E2%88%921339."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00008_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSakamoto%26aufirst%3DK.%2BM.%26aulast%3D%26aulast%3D%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2004%26volume%3D5%26spage%3D1339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm070034ib00009"><div class="reference"><strong class="refLabel"><a href="#jm070034ib00009" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-jm070034ib00009_1"><span><span class="NLM_string-ref">Ahman, T.; Eisen, T. Kinase Inhibition with BAY 43−9006 in Renal Cell Carcinoma. <i>  Clin. Cancer Res.</i><b>2004</b>, <i>10</i> (Suppl.), 6388s−6392s.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10+%28Suppl.&publication_year=2004&pages=6392s&author=T.+Ahman&author=T+Eisen&title=Kinase+Inhibition+with+BAY+43%E2%88%929006+in+Renal+Cell+Carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00009_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAhman%26aufirst%3DT.%26atitle%3DKinase%2520Inhibition%2520with%2520BAY%252043%25E2%2588%25929006%2520in%2520Renal%2520Cell%2520Carcinoma%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%2520%2528Suppl%26spage%3D6392s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm070034ib00010"><div class="reference"><div class="NLM_citation" id="rightTab-jm070034ib00010_1"><span><span class="NLM_string-ref">(a) PTK-787:  Thomas, A. L.; Morgan, B.; Dreves, J.; Unger, C.; Wiedenmann, B.; Vanhoefer, U.; Laurent, D.; Dugan, M; Steward, W. P. Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitors:  PTK787/ZK 222584. <i>  Semin. Oncol</i>. <b>2003</b>, <i>30</i> (Suppl 6), 32−38.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30+%28Suppl+6&publication_year=2003&pages=38&author=A.+L.+Thomas&author=B.+Morgan&author=J.+Dreves&author=C.+Unger&author=B.+Wiedenmann&author=U.+Vanhoefer&author=D.+Laurent&author=+Dugan&title=Vascular+Endothelial+Growth+Factor+Receptor+Tyrosine+Kinase+Inhibitors%3A%E2%80%89+PTK787%2FZK+222584"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00010_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DA.%2BL.%26atitle%3DVascular%2520Endothelial%2520Growth%2520Factor%2520Receptor%2520Tyrosine%2520Kinase%2520Inhibitors%253A%25E2%2580%2589%2520PTK787%252FZK%2520222584%26jtitle%3DSemin.%2520Oncol.%26date%3D2003%26volume%3D30%2520%2528Suppl%25206%26spage%3D38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm070034ib00010_2"><span><span class="NLM_string-ref">(b) ZD-6474:  Ryan, A. J.; Wedge, S. R. ZD6474-A Novel Inhibitor of VEGFR and EGFR Tyrosine Kinase Activity. <i>  Br. J. Cancer</i><b>2005</b>, <i>92</i> (Suppl 1), S6−S13.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%28b%29+ZD-6474%3A%E2%80%89+Ryan%2C+A.+J.%3B+Wedge%2C+S.+R.+ZD6474-A+Novel+Inhibitor+of+VEGFR+and+EGFR+Tyrosine+Kinase+Activity.+Br.+J.+Cancer+2005%2C+92+%28Suppl+1%29%2C+S6%E2%88%92S13.+%28b%29+ZD-6474%3A%E2%80%89+Ryan%2C+A.+J.%3B+Wedge%2C+S.+R.+ZD6474-A+Novel+Inhibitor+of+VEGFR+and+EGFR+Tyrosine+Kinase+Activity.+Br.+J.+Cancer2005%2C+92+%28Suppl+1%29%2C+S6%E2%88%92S13."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00010_2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRyan%26aufirst%3DA.%2BJ.%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2005%26volume%3D92%2520%2528Suppl%25201%26spage%3DS13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm070034ib00010_3"><span><span class="NLM_string-ref">(c) CEP-7055:  Ruggeri, B.;  4373  Singh, J.; Gingrich, D.; Angeles, T.; Albom, M.; Chang, H.; Robinson, C.; Hunter, K.; Dobrzanski, P.; Jones-Bolin, S.; Aimone, L.; Klein-Szanto, A.; Herbet, J.-M.; Bono, F.; Scheffer, P.; Casellas, P.; Bourie, B.; Pili, R.; Isaacs, J.; Ator, M.; Hudkins, R.; Vaught, J.; Mallamo, J.; Dionne, C. CEP-7055:  A Novel, Orally Active Pan Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases with Potent Antiangiogenic Activity and Antitumor Efficacy in Preclinical Models. <i>  Cancer Res.</i><b>2003</b>, <i>63</i>, 5978−5991.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%28c%29+CEP-7055%3A%E2%80%89+Ruggeri%2C+B.%3B+4373+Singh%2C+J.%3B+Gingrich%2C+D.%3B+Angeles%2C+T.%3B+Albom%2C+M.%3B+Chang%2C+H.%3B+Robinson%2C+C.%3B+Hunter%2C+K.%3B+Dobrzanski%2C+P.%3B+Jones-Bolin%2C+S.%3B+Aimone%2C+L.%3B+Klein-Szanto%2C+A.%3B+Herbet%2C+J.-M.%3B+Bono%2C+F.%3B+Scheffer%2C+P.%3B+Casellas%2C+P.%3B+Bourie%2C+B.%3B+Pili%2C+R.%3B+Isaacs%2C+J.%3B+Ator%2C+M.%3B+Hudkins%2C+R.%3B+Vaught%2C+J.%3B+Mallamo%2C+J.%3B+Dionne%2C+C.+CEP-7055%3A%E2%80%89+A+Novel%2C+Orally+Active+Pan+Inhibitor+of+Vascular+Endothelial+Growth+Factor+Receptor+Tyrosine+Kinases+with+Potent+Antiangiogenic+Activity+and+Antitumor+Efficacy+in+Preclinical+Models.+Cancer+Res.+2003%2C+63%2C+5978%E2%88%925991.+%28c%29+CEP-7055%3A%E2%80%89+Ruggeri%2C+B.%3B+4373+Singh%2C+J.%3B+Gingrich%2C+D.%3B+Angeles%2C+T.%3B+Albom%2C+M.%3B+Chang%2C+H.%3B+Robinson%2C+C.%3B+Hunter%2C+K.%3B+Dobrzanski%2C+P.%3B+Jones-Bolin%2C+S.%3B+Aimone%2C+L.%3B+Klein-Szanto%2C+A.%3B+Herbet%2C+J.-M.%3B+Bono%2C+F.%3B+Scheffer%2C+P.%3B+Casellas%2C+P.%3B+Bourie%2C+B.%3B+Pili%2C+R.%3B+Isaacs%2C+J.%3B+Ator%2C+M.%3B+Hudkins%2C+R.%3B+Vaught%2C+J.%3B+Mallamo%2C+J.%3B+Dionne%2C+C.+CEP-7055%3A%E2%80%89+A+Novel%2C+Orally+Active+Pan+Inhibitor+of+Vascular+Endothelial+Growth+Factor+Receptor+Tyrosine+Kinases+with+Potent+Antiangiogenic+Activity+and+Antitumor+Efficacy+in+Preclinical+Models.+Cancer+Res.2003%2C+63%2C+5978%E2%88%925991."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00010_3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRuggeri%26aufirst%3DB.%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D5991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm070034ib00010_4"><span><span class="NLM_string-ref">(d) CP-547632:  Beebe, J. S.; Jani, J. P.; Knauth, E.; Goodwin, P.; Higdon, C.; Rossi, A. M.; Emerson, E.; Finkelstein, M.; Floyd, E.; Harriman, S.; Atherton, J.; Hillerman, S.; Soderstrom, C.; Kou, K.; Gant, T.; Noe, M. C.; Foster, B.; Rastinejad, F.; Marx, M. A.; Schaeffer, T.; Whalen, P. M.; Roberts, W. G. Pharmacological Characterization of CP-547,632, a novel Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor for Cancer Therapy. <i>  Cancer Res.</i><b>2003</b>, <i>63</i>, 7301−7309.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=7309&author=J.+S.+Beebe&author=J.+P.+Jani&author=E.+Knauth&author=P.+Goodwin&author=C.+Higdon&author=A.+M.+Rossi&author=E.+Emerson&author=M.+Finkelstein&author=E.+Floyd&author=S.+Harriman&author=J.+Atherton&author=S.+Hillerman&author=C.+Soderstrom&author=K.+Kou&author=T.+Gant&author=M.+C.+Noe&author=B.+Foster&author=F.+Rastinejad&author=M.+A.+Marx&author=T.+Schaeffer&author=P.+M.+Whalen&author=W.+G+Roberts&title=Pharmacological+Characterization+of+CP-547%2C632%2C+a+novel+Vascular+Endothelial+Growth+Factor+Receptor-2+Tyrosine+Kinase+Inhibitor+for+Cancer+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00010_4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeebe%26aufirst%3DJ.%2BS.%26atitle%3DPharmacological%2520Characterization%2520of%2520CP-547%252C632%252C%2520a%2520novel%2520Vascular%2520Endothelial%2520Growth%2520Factor%2520Receptor-2%2520Tyrosine%2520Kinase%2520Inhibitor%2520for%2520Cancer%2520Therapy%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D7309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-jm070034ib00010_5"><span><span class="NLM_string-ref">(e) Motesanib:  Polverino, A.; Coxon, A.; Starnes, C.; Diaz, Z.; DeMelfi, T.; Wang, L.; Bready, J.; Estrada, J.; Cattley, R.; Kaufman, S.; Chen, D.; Gan, Y.; Kumar, G.; Meyer, J.; Neervannan, S.; Alva, G.; Talvenheimo, J.; Montestruque, S.; Tasker, A.; Patel, V.; Radinsky, R.; Kendall, R. AMG 706, an Oral, Multikinase Inhibitor that Selectively Targets Vascular Endothelial Growth Factor, Platelet-Derived Growth Factor and Kit Receptors, Potently Inhibits Angiogenesis and Induces Regression in Tumor Xenografts. <i>  Cancer Res.</i><b>2006</b>, <i>66</i>, 8715−8721.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=%28e%29+Motesanib%3A%E2%80%89+Polverino%2C+A.%3B+Coxon%2C+A.%3B+Starnes%2C+C.%3B+Diaz%2C+Z.%3B+DeMelfi%2C+T.%3B+Wang%2C+L.%3B+Bready%2C+J.%3B+Estrada%2C+J.%3B+Cattley%2C+R.%3B+Kaufman%2C+S.%3B+Chen%2C+D.%3B+Gan%2C+Y.%3B+Kumar%2C+G.%3B+Meyer%2C+J.%3B+Neervannan%2C+S.%3B+Alva%2C+G.%3B+Talvenheimo%2C+J.%3B+Montestruque%2C+S.%3B+Tasker%2C+A.%3B+Patel%2C+V.%3B+Radinsky%2C+R.%3B+Kendall%2C+R.+AMG+706%2C+an+Oral%2C+Multikinase+Inhibitor+that+Selectively+Targets+Vascular+Endothelial+Growth+Factor%2C+Platelet-Derived+Growth+Factor+and+Kit+Receptors%2C+Potently+Inhibits+Angiogenesis+and+Induces+Regression+in+Tumor+Xenografts.+Cancer+Res.+2006%2C+66%2C+8715%E2%88%928721.+%28e%29+Motesanib%3A%E2%80%89+Polverino%2C+A.%3B+Coxon%2C+A.%3B+Starnes%2C+C.%3B+Diaz%2C+Z.%3B+DeMelfi%2C+T.%3B+Wang%2C+L.%3B+Bready%2C+J.%3B+Estrada%2C+J.%3B+Cattley%2C+R.%3B+Kaufman%2C+S.%3B+Chen%2C+D.%3B+Gan%2C+Y.%3B+Kumar%2C+G.%3B+Meyer%2C+J.%3B+Neervannan%2C+S.%3B+Alva%2C+G.%3B+Talvenheimo%2C+J.%3B+Montestruque%2C+S.%3B+Tasker%2C+A.%3B+Patel%2C+V.%3B+Radinsky%2C+R.%3B+Kendall%2C+R.+AMG+706%2C+an+Oral%2C+Multikinase+Inhibitor+that+Selectively+Targets+Vascular+Endothelial+Growth+Factor%2C+Platelet-Derived+Growth+Factor+and+Kit+Receptors%2C+Potently+Inhibits+Angiogenesis+and+Induces+Regression+in+Tumor+Xenografts.+Cancer+Res.2006%2C+66%2C+8715%E2%88%928721."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00010_5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMotesanib%26jtitle%3DCancer%2520Res.%26date%3D2006%26volume%3D66%26spage%3D8721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm070034ib00011"><div class="reference"><strong class="refLabel"><a href="#jm070034ib00011" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-jm070034ib00011_1"><span><span class="NLM_string-ref">Compound <b>2</b> was subsequently disclosed as a KDR inhibitor with a reported IC<sub>50</sub> of 90 nM. Wilhelm, S. M.; Carter, C.; Tang, L.; Wilkie, D.; McNabola, A.; Rong, H.; Chen, C.; Zhang, X.; Vincent, P.; McHugh, M.; Cao, Y.; Shujath, J.; Gawlak, S.; Eveleigh, D.; Rowley, B.; Liu, L.; Adnane, L.; Lynch, M.; Auclair, D.; Taylor, I.; Gedrich, R.; Voznesensky, A.; Riedl, B.; Post, L. E.; Bollag, G.; Trail, P. BAY 43−9006 Exhibits Broad Spectrum Oral Antitumor Activity and Targets the RAF/MEK/ERK Pathway and Receptor Tyrosine Kinases Involved in Tumor Progression and Angiogenesis. <i>  Cancer Res.</i><b>2004</b>, <i>64</i>, 7099−7109.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+Compound&author=S.+M.+Wilhelm&author=C.+Carter&author=L.+Tang&author=D.+Wilkie&author=A.+McNabola&author=H.+Rong&author=C.+Chen&author=X.+Zhang&author=P.+Vincent&author=M.+McHugh&author=Y.+Cao&author=J.+Shujath&author=S.+Gawlak&author=D.+Eveleigh&author=B.+Rowley&author=L.+Liu&author=L.+Adnane&author=M.+Lynch&author=D.+Auclair&author=I.+Taylor&author=R.+Gedrich&author=A.+Voznesensky&author=B.+Riedl&author=L.+E.+Post&author=G.+Bollag&author=P.+Trail&title=BAY+43%E2%88%929006+Exhibits+Broad+Spectrum+Oral+Antitumor+Activity+and+Targets+the+RAF%2FMEK%2FERK+Pathway+and+Receptor+Tyrosine+Kinases+Involved+in+Tumor+Progression+and+Angiogenesis.+Cancer+Res"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00011_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DCompound%26aufirst%3DM.%26btitle%3DBAY%252043%25E2%2588%25929006%2520Exhibits%2520Broad%2520Spectrum%2520Oral%2520Antitumor%2520Activity%2520and%2520Targets%2520the%2520RAF%252FMEK%252FERK%2520Pathway%2520and%2520Receptor%2520Tyrosine%2520Kinases%2520Involved%2520in%2520Tumor%2520Progression%2520and%2520Angiogenesis.%2520Cancer%2520Res%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm070034ib00012"><div class="reference"><strong class="refLabel"><a href="#jm070034ib00012" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-jm070034ib00012_1"><span><span class="NLM_string-ref">Patel, V. The Discovery and Properties of AMG 706:  A Multikinase Angiogenesis Inhibitor in Clinical Trials. Presented at ACS ProSpectives, Cambridge, MA, May 2006.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&conference=ACS+ProSpectives&author=V.+Patel&title=The+Discovery+and+Properties+of+AMG+706%3A%E2%80%89+A+Multikinase+Angiogenesis+Inhibitor+in+Clinical+Trials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00012_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dproceeding%26sid%3Dliteratum%253Aachs%26aulast%3DPatel%26aufirst%3DV.%26atitle%3DThe%2520Discovery%2520and%2520Properties%2520of%2520AMG%2520706%253A%25E2%2580%2589%2520A%2520Multikinase%2520Angiogenesis%2520Inhibitor%2520in%2520Clinical%2520Trials%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm070034ib00013"><div class="reference"><strong class="refLabel"><a href="#jm070034ib00013" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-jm070034ib00013_1"><span><span class="NLM_string-ref">Schindler, T.; Bornmann, W.; Pellicena, P.; Miller, W. T.; Clarkson, B.; Kuriyan, J. Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase. <i>  Science</i><b>2000</b>, <i>289</i>, 1938−1942. Other receptor tyrosine kinases have been shown to adopt this conformation also. (a) Mol, C. D.; Dougan, D. R.; Schneider, T. R.; Skene, R. J.; Kraus, M. L.; Scheibe, D. N.; Snell, G. P.; Zou, H.; Sang, B.−C.; Wilson, K. P. Structural Basis for the Autoinhibition and STI-571 Inhibition of c-Kit Tyrosine Kinase. <i>J. Biol. </i><i>Chem.</i><b>2004</b>, <i>279</i>, 31655−31663. (b) Pargellis, C.; Tong, L.; Churchill, L.; Cirillo, P. F.; Gilmore, T.; Graham, A. G.; Grob, P. M.; Hickey, E. R.; Moss, N.; Pav, S.; Regan, J. Inhibition of p38 MAP Kinase by Utilizing a Novel Allosteric Binding Site. <i>Nat. Struct. Biol.</i><b>2002</b>, <i>9</i>, 268−272. (c) Liu, Y.; Gray, N. S. Rational Design of Inhibitors that Bind to Inactive Conformations. <i>Nat. Chem. Biol.</i><b>2006</b>, <i>2</i>, 358−364.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2000&pages=1942&author=T.+Schindler&author=W.+Bornmann&author=P.+Pellicena&author=W.+T.+Miller&author=B.+Clarkson&author=J+Kuriyan&title=Structural+Mechanism+for+STI-571+Inhibition+of+Abelson+Tyrosine+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00013_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchindler%26aufirst%3DT.%26atitle%3DStructural%2520Mechanism%2520for%2520STI-571%2520Inhibition%2520of%2520Abelson%2520Tyrosine%2520Kinase%26jtitle%3DScience%26date%3D2000%26volume%3D289%26spage%3D1942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm070034ib00014"><div class="reference"><strong class="refLabel"><a href="#jm070034ib00014" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-jm070034ib00014_1"><span><span class="NLM_string-ref">Veber, D. F.; Johnson, S. R.; Cheng, H.-Y.; Smith, B. R.; Ward, K. W.; Kopple, K. D. Molecular Properties that Influence the Oral Bioavailability of Drug Candidates. <i>  J. Med. Chem</i>. <b>2002</b>, <i>45</i>, 2615−2623.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=2623&author=D.+F.+Veber&author=S.+R.+Johnson&author=H.-Y.+Cheng&author=B.+R.+Smith&author=K.+W.+Ward&author=K.+D+Kopple&title=Molecular+Properties+that+Influence+the+Oral+Bioavailability+of+Drug+Candidates"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00014_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVeber%26aufirst%3DD.%2BF.%26atitle%3DMolecular%2520Properties%2520that%2520Influence%2520the%2520Oral%2520Bioavailability%2520of%2520Drug%2520Candidates%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm070034ib00015"><div class="reference"><strong class="refLabel"><a href="#jm070034ib00015" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-jm070034ib00015_1"><span><span class="NLM_string-ref">Compound <b>3</b> was claimed as a raf inhibitor in the following Chiron patent application:  Substituted Benzoxazoles and Use Thereof as Raf Kinase Inhibitors. WO2003082272, 2003.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=082272&publication_year=2003&pages=2003&author=+Compound&title=3+was+claimed+as+a+raf+inhibitor+in+the+following+Chiron+patent+application%3A%E2%80%89+Substituted+Benzoxazoles+and+Use+Thereof+as+Raf+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00015_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCompound%26atitle%3D3%2520was%2520claimed%2520as%2520a%2520raf%2520inhibitor%2520in%2520the%2520following%2520Chiron%2520patent%2520application%253A%25E2%2580%2589%2520Substituted%2520Benzoxazoles%2520and%2520Use%2520Thereof%2520as%2520Raf%2520Kinase%2520Inhibitors%26jtitle%3DWO%26date%3D2003%26volume%3D082272%26spage%3D2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm070034ib00016"><div class="reference"><strong class="refLabel"><a href="#jm070034ib00016" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-jm070034ib00016_1"><span><span class="NLM_string-ref">For most of the substrates, the reactions were carried out neat. However, in the preparation of compound <b>52d</b> (containing the pyrrolopyrimidine moiety), use of triethylamine and trifluroacetic acid (1:1 mixture) as the solvent was required. Even under these conditions, the product was isolated in a poor 14% yield.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+For+most+of+the+substrates%2C+the+reactions+were+carried+out+neat.+However%2C+in+the+preparation+of+compound+52d+%28containing+the+pyrrolopyrimidine+moiety%29%2C+use+of+triethylamine+and+trifluroacetic+acid+%281%3A1+mixture%29+as+the+solvent+was+required.+Even+under+these+conditions%2C+the+product+was+isolated+in+a+poor+14%25+yield.+For+most+of+the+substrates%2C+the+reactions+were+carried+out+neat.+However%2C+in+the+preparation+of+compound+52d+%28containing+the+pyrrolopyrimidine+moiety%29%2C+use+of+triethylamine+and+trifluroacetic+acid+%281%3A1+mixture%29+as+the+solvent+was+required.+Even+under+these+conditions%2C+the+product+was+isolated+in+a+poor+14%25+yield."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00016_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dfootnote%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm070034ib00017"><div class="reference"><strong class="refLabel"><a href="#jm070034ib00017" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-jm070034ib00017_1"><span><span class="NLM_string-ref">The following reference provides support for CH−O hydrogen-bonds in protein−ligand interactions:  Pierce, A. C.; Sandrettio, K. L.; Bemis, G. W. Kinase Inhibitors and the Case for CH−O Hydrogen Bonds in Protein−Ligand Binding. <i>  Proteins:  Struct., Funct., Genet</i>. <b>2002</b>, <i>49</i>, 567−576.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=+The&author=K.+L.+Sandrettio&author=G.+W.+Bemis&title=Funct.%2C+Genet."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00017_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DThe%26atitle%3DKinase%2520Inhibitors%2520and%2520the%2520Case%2520for%2520CH%25E2%2588%2592O%2520Hydrogen%2520Bonds%2520in%2520Protein%25E2%2588%2592Ligand%2520Binding.%2520Proteins%253A%25E2%2580%2589%2520Struct%26btitle%3DFunct.%252C%2520Genet.%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm070034ib00018"><div class="reference"><strong class="refLabel"><a href="#jm070034ib00018" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-jm070034ib00018_1"><span><span class="NLM_string-ref">Miles, A. A.; Miles, E. M. Vascular Reactions to Histamine, Histamine-Liberator and Leucotaxin in the Skin of Guinea Pigs. <i>  J. Physiol</i>. <b>1952</b>, <i>118</i>, 228−257.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1952&pages=257&author=A.+A.+Miles&author=E.+M+Miles&title=Vascular+Reactions+to+Histamine%2C+Histamine-Liberator+and+Leucotaxin+in+the+Skin+of+Guinea+Pigs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00018_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiles%26aufirst%3DA.%2BA.%26atitle%3DVascular%2520Reactions%2520to%2520Histamine%252C%2520Histamine-Liberator%2520and%2520Leucotaxin%2520in%2520the%2520Skin%2520of%2520Guinea%2520Pigs%26jtitle%3DJ.%2520Physiol.%26date%3D1952%26volume%3D118%26spage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm070034ib00019"><div class="reference"><strong class="refLabel"><a href="#jm070034ib00019" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-jm070034ib00019_1"><span><span class="NLM_string-ref">Comparison of the rat corneal models of motesanib vs compound <b>22</b>, motesanib had an ED<sub>50</sub> of 4.9 mg/kg (AUC = 13.40 μM·h; ref 10e), whereas <b>22</b> displayed an ED<sub>50</sub> of 16.3 mg/kg (AUC = 17.03 μM·h).</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Comparison+of+the+rat+corneal+models+of+motesanib+vs+compound+22%2C+motesanib+had+an+ED50+of+4.9+mg%2Fkg+%28AUC+%3D+13.40+%CE%BCM%C2%B7h%3B+ref+10e%29%2C+whereas+22+displayed+an+ED50+of+16.3+mg%2Fkg+%28AUC+%3D+17.03+%CE%BCM%C2%B7h%29.+Comparison+of+the+rat+corneal+models+of+motesanib+vs+compound+22%2C+motesanib+had+an+ED50+of+4.9+mg%2Fkg+%28AUC+%3D+13.40+%CE%BCM%C2%B7h%3B+ref+10e%29%2C+whereas+22+displayed+an+ED50+of+16.3+mg%2Fkg+%28AUC+%3D+17.03+%CE%BCM%C2%B7h%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00019_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DComparison%26btitle%3Dmotesanib%2520had%2520an%2520ED50%2520of%25204.9%2520mg%252Fkg%2520%2528AUC%2520%253D%252013.40%2520%25CE%25BCM%25C2%25B7h%26pub%3D%2528AUC" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm070034ib00020"><div class="reference"><div class="NLM_citation" id="rightTab-jm070034ib00020_1"><span><span class="NLM_string-ref">Bankston, D.; Dumas, J.; Natero, R.; Riedl, B.; Monahan, M.-K.; Sibley, R. A Scaleable Synthesis of BAY 43−9006:  A Potent Raf Kinase Inhibitor for the Treatment of Cancer. <i>  Org. Proc. Res. Dev.</i><b>2002</b>, <i>6</i>, 777−781.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2002&pages=781&author=D.+Bankston&author=J.+Dumas&author=R.+Natero&author=B.+Riedl&author=M.-K.+Monahan&author=R+Sibley&title=A+Scaleable+Synthesis+of+BAY+43%E2%88%929006%3A%E2%80%89+A+Potent+Raf+Kinase+Inhibitor+for+the+Treatment+of+Cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00020_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBankston%26aufirst%3DD.%26atitle%3DA%2520Scaleable%2520Synthesis%2520of%2520BAY%252043%25E2%2588%25929006%253A%25E2%2580%2589%2520A%2520Potent%2520Raf%2520Kinase%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Cancer%26jtitle%3DOrg.%2520Proc.%2520Res.%2520Dev.%26date%3D2002%26volume%3D6%26spage%3D781" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm070034ib00021"><div class="reference"><strong class="refLabel"><a href="#jm070034ib00021" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-jm070034ib00021_1"><span><span class="NLM_string-ref">Schneller, S. W.; Luo, J.-K. Synthesis of 4-Amino-1<i>H</i>-Pyrrolo[2,3-<i>b</i>]pyridine (1,7-Dideazaadenine) and 1<i>H</i>-Pyrrolo[2,3-<i>b</i>]pyridine-4-ol (1,7-Dideazahypoxanthine). <i>  J. Org. Chem</i>. <b>1980</b>, <i>45</i>, 4045−4048.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1980&pages=4048&author=S.+W.+Schneller&author=J.-K+Luo&title=Synthesis+of+4-Amino-1H-Pyrrolo%5B2%2C3-b%5Dpyridine+%281%2C7-Dideazaadenine%29+and+1H-Pyrrolo%5B2%2C3-b%5Dpyridine-4-ol+%281%2C7-Dideazahypoxanthine%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00021_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchneller%26aufirst%3DS.%2BW.%26atitle%3DSynthesis%2520of%25204-Amino-1H-Pyrrolo%255B2%252C3-b%255Dpyridine%2520%25281%252C7-Dideazaadenine%2529%2520and%25201H-Pyrrolo%255B2%252C3-b%255Dpyridine-4-ol%2520%25281%252C7-Dideazahypoxanthine%2529%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1980%26volume%3D45%26spage%3D4048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm070034ib00022"><div class="reference"><strong class="refLabel"><a href="#jm070034ib00022" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-jm070034ib00022_1"><span><span class="NLM_string-ref">Machin, P. J.; Hurst, D. N.; Bradshaw, R. M.; Blaber, L. C.; Burden, D. T.; Fryer, A. D.; Melarange, R. A.; Shivdasani, C. β<sub>1</sub>-Selective Adrenoceptor Antagonists. 2. 4-Ether-Linked Phenoxypropanolamines. <i>  J. </i><i>Med. Chem.</i><b>1983</b>, <i>26</i>, 1570−1576.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Machin%2C+P.+J.%3B+Hurst%2C+D.+N.%3B+Bradshaw%2C+R.+M.%3B+Blaber%2C+L.+C.%3B+Burden%2C+D.+T.%3B+Fryer%2C+A.+D.%3B+Melarange%2C+R.+A.%3B+Shivdasani%2C+C.+%CE%B21-Selective+Adrenoceptor+Antagonists.+2.+4-Ether-Linked+Phenoxypropanolamines.+J.+Med.+Chem.+1983%2C+26%2C+1570%E2%88%921576.+Machin%2C+P.+J.%3B+Hurst%2C+D.+N.%3B+Bradshaw%2C+R.+M.%3B+Blaber%2C+L.+C.%3B+Burden%2C+D.+T.%3B+Fryer%2C+A.+D.%3B+Melarange%2C+R.+A.%3B+Shivdasani%2C+C.+%CE%B21-Selective+Adrenoceptor+Antagonists.+2.+4-Ether-Linked+Phenoxypropanolamines.+J.+Med.+Chem.1983%2C+26%2C+1570%E2%88%921576."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00022_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMachin%26aufirst%3DP.%2BJ.%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1983%26volume%3D26%26spage%3D1576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm070034ib00023"><div class="reference"><strong class="refLabel"><a href="#jm070034ib00023" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-jm070034ib00023_1"><span><span class="NLM_string-ref">Meigh, J.-P.; Alvarez, M.; Joule, J. A. Cyclic Ureas as <i>ortho</i>-Directing Substituents. <i>  J. Chem. Soc., Perkin Trans. 1</i><b>2001</b>, 2012−2021.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2001&pages=2021&author=J.-P.+Meigh&author=M.+Alvarez&author=J.+A+Joule&title=Cyclic+Ureas+as+ortho-Directing+Substituents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00023_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeigh%26aufirst%3DJ.-P.%26atitle%3DCyclic%2520Ureas%2520as%2520ortho-Directing%2520Substituents%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D2001%26volume%3D2012%26spage%3D2021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm070034ib00024"><div class="reference"><strong class="refLabel"><a href="#jm070034ib00024" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-jm070034ib00024_1"><span><span class="NLM_string-ref">Kubo, K.; Ohyama, S.-i.; Shimizu, T.; Takami, A.; Murooka, H.; Nishitoba, T.; Kato, S.; Yagi, M.; Kobayashi, T.; Iinuma, N.; Isoe, T.; Nakamura, K.; Iijima, H.; Osawa, T.; Izawa, T. Synthesis and Structure−Activity Relationship for New Series of 4-Phenoxyquinoline Derivatives as Specific Inhibitors of Platelet-Derived Growth Factor Tyrosine Kinase. <i>  Bioorg. Med. Chem.</i><b>2003</b>, <i>11</i>, 5117−5133.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=5133&author=K.+Kubo&author=S.+Ohyama&author=T.+Shimizu&author=A.+Takami&author=H.+Murooka&author=T.+Nishitoba&author=S.+Kato&author=M.+Yagi&author=T.+Kobayashi&author=N.+Iinuma&author=T.+Isoe&author=K.+Nakamura&author=H.+Iijima&author=T.+Osawa&author=T+Izawa&title=Synthesis+and+Structure%E2%88%92Activity+Relationship+for+New+Series+of+4-Phenoxyquinoline+Derivatives+as+Specific+Inhibitors+of+Platelet-Derived+Growth+Factor+Tyrosine+Kinase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00024_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKubo%26aufirst%3DK.%26atitle%3DSynthesis%2520and%2520Structure%25E2%2588%2592Activity%2520Relationship%2520for%2520New%2520Series%2520of%25204-Phenoxyquinoline%2520Derivatives%2520as%2520Specific%2520Inhibitors%2520of%2520Platelet-Derived%2520Growth%2520Factor%2520Tyrosine%2520Kinase%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D5133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm070034ib00025"><div class="reference"><strong class="refLabel"><a href="#jm070034ib00025" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-jm070034ib00025_1"><span><span class="NLM_string-ref">Diehl, K.-H.; Hull, R.; Morton D.; Pfister, R.; Rabemampianina, Y.; Smith, D.; Vidal, J. M.; van de Vorstenbosch, C. A Good Practice to Guide the Administration of Substances and Removal of Blood, Including Routes and Volumes. <i>  J. Appl. Toxicol.</i><b>2001</b>, <i>21</i>, 15−23.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=23&author=K.-H.+Diehl&author=R.+Hull&author=D.+Morton&author=R.+Pfister&author=Y.+Rabemampianina&author=D.+Smith&author=J.+M.+Vidal&author=C+van+de+Vorstenbosch&title=A+Good+Practice+to+Guide+the+Administration+of+Substances+and+Removal+of+Blood%2C+Including+Routes+and+Volumes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00025_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDiehl%26aufirst%3DK.-H.%26atitle%3DA%2520Good%2520Practice%2520to%2520Guide%2520the%2520Administration%2520of%2520Substances%2520and%2520Removal%2520of%2520Blood%252C%2520Including%2520Routes%2520and%2520Volumes%26jtitle%3DJ.%2520Appl.%2520Toxicol.%26date%3D2001%26volume%3D21%26spage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-jm070034ib00026"><div class="reference"><strong class="refLabel"><a href="#jm070034ib00026" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-jm070034ib00026_1"><span><span class="NLM_string-ref">Coxon, A.; Bolon, B.; Estrada, J.; Kaufman, S.; Scully, S.; Rattan, A.; Duryea, D.; Hu, Y.-L.; Rex, K.; Pacheco, E.; Van, G.; Zack, D.; Feige, U. Inhibition of Interleukin-1 but Not Tumor Necrosis Factor Suppresses Neovascularization in Rat Models of Corneal Angiogenesis and Adjuvant Arthritis. <i>  Arthritis Rheum.</i><b>2002</b>, <i>46</i>, 2604−2612.</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2002&pages=2612&author=A.+Coxon&author=B.+Bolon&author=J.+Estrada&author=S.+Kaufman&author=S.+Scully&author=A.+Rattan&author=D.+Duryea&author=Y.-L.+Hu&author=K.+Rex&author=E.+Pacheco&author=G.+Van&author=D.+Zack&author=U+Feige&title=Inhibition+of+Interleukin-1+but+Not+Tumor+Necrosis+Factor+Suppresses+Neovascularization+in+Rat+Models+of+Corneal+Angiogenesis+and+Adjuvant+Arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=jm070034ib00026_1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCoxon%26aufirst%3DA.%26atitle%3DInhibition%2520of%2520Interleukin-1%2520but%2520Not%2520Tumor%2520Necrosis%2520Factor%2520Suppresses%2520Neovascularization%2520in%2520Rat%2520Models%2520of%2520Corneal%2520Angiogenesis%2520and%2520Adjuvant%2520Arthritis%26jtitle%3DArthritis%2520Rheum.%26date%3D2002%26volume%3D46%26spage%3D2612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="NLM_notes" id="rightTab-"><div id="" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45"><a href="/doi/suppl/10.1021%2Fjm070034i">Supporting Information Available</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48415" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48415" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Elemental analysis and X-ray crystallographic data. This material is available free of charge via the Internet at <a class="ext-link" href="http://pubs.acs.org" target="_blank">http://pubs.acs.org</a>. </div></div></div><div class="article_supporting-info" id=""><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm070034i/suppl_file/jm070034isi20070110_023532.pdf">jm070034isi20070110_023532.pdf (79.16 kb)</a></li></ul></div></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm070034i&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm070034i%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2007.50.issue-18%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm070034i" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                673KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67993602f84dd1bf","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
